Query psy1666
Match_columns 981
No_of_seqs 464 out of 2892
Neff 8.2
Searched_HMMs 46136
Date Fri Aug 16 18:44:59 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy1666.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/1666hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG1056|consensus 100.0 9.1E-93 2E-97 831.1 29.1 494 41-568 167-827 (878)
2 KOG1056|consensus 100.0 1.4E-73 2.9E-78 669.6 27.4 402 524-981 280-684 (878)
3 cd06375 PBP1_mGluR_groupII Lig 100.0 3.1E-43 6.8E-48 412.3 23.2 282 49-342 152-454 (458)
4 cd06365 PBP1_Pheromone_recepto 100.0 8.9E-43 1.9E-47 410.0 26.4 291 49-348 150-463 (469)
5 cd06364 PBP1_CaSR Ligand-bindi 100.0 9.1E-41 2E-45 395.6 23.9 292 49-348 165-504 (510)
6 cd06374 PBP1_mGluR_groupI Liga 100.0 2.9E-39 6.3E-44 381.5 23.4 294 49-349 164-471 (472)
7 cd06376 PBP1_mGluR_groupIII Li 100.0 7.8E-39 1.7E-43 377.2 23.9 293 49-348 150-457 (463)
8 cd06362 PBP1_mGluR Ligand bind 100.0 3.5E-35 7.5E-40 345.9 24.3 284 49-342 150-446 (452)
9 cd06365 PBP1_Pheromone_recepto 100.0 1.7E-29 3.7E-34 297.4 19.6 199 525-777 259-469 (469)
10 cd06361 PBP1_GPC6A_like Ligand 100.0 4.8E-29 1E-33 287.7 21.9 230 49-343 150-394 (403)
11 cd06364 PBP1_CaSR Ligand-bindi 100.0 6.1E-29 1.3E-33 294.8 18.3 203 524-777 271-510 (510)
12 cd06375 PBP1_mGluR_groupII Lig 100.0 9.8E-29 2.1E-33 289.9 17.2 182 529-765 265-454 (458)
13 KOG1055|consensus 100.0 2E-29 4.4E-34 287.3 9.1 427 39-528 152-730 (865)
14 cd06376 PBP1_mGluR_groupIII Li 99.9 3.3E-27 7.1E-32 278.5 18.8 197 529-777 266-463 (463)
15 PF00003 7tm_3: 7 transmembran 99.9 2.3E-28 5E-33 262.6 7.2 175 350-528 61-237 (238)
16 cd06374 PBP1_mGluR_groupI Liga 99.9 1.8E-25 3.8E-30 264.3 17.2 196 525-772 274-471 (472)
17 cd06362 PBP1_mGluR Ligand bind 99.9 3.9E-22 8.5E-27 235.0 18.2 182 529-765 265-446 (452)
18 cd06379 PBP1_iGluR_NMDA_NR1 N- 99.9 6.4E-21 1.4E-25 219.3 16.6 216 49-348 132-369 (377)
19 cd06367 PBP1_iGluR_NMDA N-term 99.8 1.3E-19 2.9E-24 207.3 16.7 216 49-342 114-351 (362)
20 cd06363 PBP1_Taste_receptor Li 99.8 4.9E-18 1.1E-22 197.5 23.0 233 50-348 155-403 (410)
21 cd06390 PBP1_iGluR_AMPA_GluR1 99.8 1.3E-18 2.9E-23 197.8 17.0 240 49-342 98-359 (364)
22 cd06378 PBP1_iGluR_NMDA_NR2 N- 99.8 5E-18 1.1E-22 192.8 16.3 224 49-348 113-356 (362)
23 cd06391 PBP1_iGluR_delta_2 N-t 99.7 1.5E-16 3.3E-21 183.0 17.2 251 56-342 123-394 (400)
24 PF07562 NCD3G: Nine Cysteines 99.7 2.5E-18 5.5E-23 137.1 1.1 53 785-837 1-54 (54)
25 PF01094 ANF_receptor: Recepto 99.7 1E-16 2.2E-21 181.9 12.0 266 8-325 62-348 (348)
26 cd06372 PBP1_GC_G_like Ligand- 99.7 5E-16 1.1E-20 179.7 16.4 237 50-342 116-385 (391)
27 cd06370 PBP1_Speract_GC_like L 99.6 5.7E-15 1.2E-19 171.5 14.4 233 50-326 115-383 (404)
28 cd06387 PBP1_iGluR_AMPA_GluR3 99.6 2.5E-14 5.5E-19 162.6 18.4 232 58-342 111-367 (372)
29 PF00003 7tm_3: 7 transmembran 99.6 4.2E-16 9.1E-21 167.5 3.7 113 868-980 1-123 (238)
30 cd06386 PBP1_NPR_C_like Ligand 99.5 5E-14 1.1E-18 162.5 14.9 235 50-341 116-377 (387)
31 cd06361 PBP1_GPC6A_like Ligand 99.5 6.6E-14 1.4E-18 161.9 13.4 83 675-765 311-393 (403)
32 KOG1055|consensus 99.5 3.6E-15 7.8E-20 171.6 2.1 240 674-980 343-602 (865)
33 cd06392 PBP1_iGluR_delta_1 N-t 99.5 2.3E-13 4.9E-18 155.5 16.4 246 57-342 124-394 (400)
34 cd06385 PBP1_NPR_A Ligand-bind 99.5 2.8E-13 6E-18 157.6 14.8 237 50-342 122-390 (405)
35 cd06352 PBP1_NPR_GC_like Ligan 99.4 9E-13 2E-17 152.4 15.6 217 72-342 152-381 (389)
36 cd06380 PBP1_iGluR_AMPA N-term 99.4 4.7E-12 1E-16 146.1 19.4 221 74-342 141-377 (382)
37 cd06373 PBP1_NPR_like Ligand b 99.4 1E-12 2.3E-17 152.3 13.6 239 49-342 120-388 (396)
38 cd06389 PBP1_iGluR_AMPA_GluR2 99.4 6.4E-12 1.4E-16 143.9 19.0 236 59-343 106-365 (370)
39 cd06384 PBP1_NPR_B Ligand-bind 99.4 9.1E-12 2E-16 144.5 16.5 237 50-342 122-391 (399)
40 cd06393 PBP1_iGluR_Kainate_Glu 99.4 9.2E-12 2E-16 143.7 16.4 241 51-342 119-377 (384)
41 cd06350 PBP1_GPCR_family_C_lik 99.4 6.2E-12 1.3E-16 143.0 14.5 185 50-342 139-339 (348)
42 cd06388 PBP1_iGluR_AMPA_GluR4 99.3 2.2E-11 4.8E-16 139.3 18.7 229 59-342 112-365 (371)
43 cd06371 PBP1_sensory_GC_DEF_li 99.3 1.7E-10 3.8E-15 132.9 18.9 210 60-325 121-359 (382)
44 cd06383 PBP1_iGluR_AMPA_Like N 99.2 1.2E-11 2.7E-16 141.1 9.2 222 49-325 111-359 (368)
45 cd06379 PBP1_iGluR_NMDA_NR1 N- 99.2 6.4E-11 1.4E-15 136.4 9.9 99 674-778 274-376 (377)
46 cd06377 PBP1_iGluR_NMDA_NR3 N- 99.1 4.5E-10 9.7E-15 126.6 14.7 223 49-347 129-376 (382)
47 cd06381 PBP1_iGluR_delta_like 99.1 5.9E-10 1.3E-14 127.1 13.8 159 117-342 197-358 (363)
48 KOG4440|consensus 99.0 4.6E-10 9.9E-15 125.4 9.5 149 116-341 221-375 (993)
49 cd06367 PBP1_iGluR_NMDA N-term 99.0 9.5E-10 2.1E-14 126.0 9.5 98 674-778 259-362 (362)
50 cd06366 PBP1_GABAb_receptor Li 98.9 4E-09 8.6E-14 120.2 11.6 207 51-342 115-342 (350)
51 cd06363 PBP1_Taste_receptor Li 98.9 8.8E-09 1.9E-13 120.0 12.3 99 674-778 310-410 (410)
52 cd06342 PBP1_ABC_LIVBP_like Ty 98.7 3.1E-08 6.8E-13 111.8 10.6 183 72-324 149-334 (334)
53 cd06369 PBP1_GC_C_enterotoxin_ 98.7 4.8E-07 1E-11 99.9 16.4 168 106-342 197-364 (380)
54 cd06382 PBP1_iGluR_Kainate N-t 98.6 1.5E-07 3.2E-12 106.3 9.9 201 50-342 108-322 (327)
55 cd06394 PBP1_iGluR_Kainate_KA1 98.6 6E-08 1.3E-12 109.0 5.4 137 49-192 112-259 (333)
56 cd06372 PBP1_GC_G_like Ligand- 98.4 8.9E-07 1.9E-11 102.5 8.7 81 673-765 302-385 (391)
57 cd06338 PBP1_ABC_ligand_bindin 98.3 2.3E-06 4.9E-11 97.2 11.2 184 72-324 155-345 (345)
58 cd06390 PBP1_iGluR_AMPA_GluR1 98.3 1.3E-06 2.9E-11 99.7 9.0 86 674-765 266-359 (364)
59 cd06378 PBP1_iGluR_NMDA_NR2 N- 98.3 2.7E-06 5.8E-11 97.1 9.5 95 675-778 261-361 (362)
60 KOG1053|consensus 98.2 2E-05 4.4E-10 92.6 14.2 220 51-348 153-393 (1258)
61 cd06392 PBP1_iGluR_delta_1 N-t 98.2 3.5E-06 7.6E-11 96.8 8.2 90 674-765 298-394 (400)
62 cd06368 PBP1_iGluR_non_NMDA_li 98.2 5.4E-06 1.2E-10 93.3 9.1 74 74-154 142-216 (324)
63 PF01094 ANF_receptor: Recepto 98.1 3E-06 6.6E-11 95.9 6.9 73 672-748 274-348 (348)
64 cd06346 PBP1_ABC_ligand_bindin 98.1 7.1E-06 1.5E-10 91.9 9.7 111 72-191 151-261 (312)
65 cd06348 PBP1_ABC_ligand_bindin 98.1 4.4E-05 9.4E-10 86.8 15.8 185 72-316 151-337 (344)
66 cd06345 PBP1_ABC_ligand_bindin 98.1 1.5E-05 3.3E-10 90.6 11.5 178 72-318 158-339 (344)
67 cd06391 PBP1_iGluR_delta_2 N-t 98.1 6.6E-06 1.4E-10 95.2 8.7 91 674-765 298-394 (400)
68 cd06377 PBP1_iGluR_NMDA_NR3 N- 98.1 1E-05 2.2E-10 91.6 9.3 97 673-770 269-376 (382)
69 cd06370 PBP1_Speract_GC_like L 98.0 7.7E-06 1.7E-10 95.2 6.6 67 674-750 318-384 (404)
70 cd06387 PBP1_iGluR_AMPA_GluR3 98.0 1.5E-05 3.2E-10 91.2 8.5 86 673-765 273-367 (372)
71 PRK15404 leucine ABC transport 97.9 0.00032 7E-09 80.5 18.6 185 72-326 175-361 (369)
72 KOG1054|consensus 97.9 0.00042 9E-09 78.6 18.1 231 60-342 140-394 (897)
73 cd06385 PBP1_NPR_A Ligand-bind 97.9 2.8E-05 6.2E-10 90.5 9.1 91 674-777 312-405 (405)
74 cd06389 PBP1_iGluR_AMPA_GluR2 97.9 2.5E-05 5.5E-10 89.6 8.5 86 673-765 270-364 (370)
75 KOG4440|consensus 97.8 2.1E-05 4.5E-10 89.0 5.6 103 674-781 285-392 (993)
76 cd06380 PBP1_iGluR_AMPA N-term 97.8 6.6E-05 1.4E-09 86.7 8.9 86 674-765 278-377 (382)
77 cd06388 PBP1_iGluR_AMPA_GluR4 97.8 6.1E-05 1.3E-09 86.4 8.5 86 673-765 271-365 (371)
78 cd06373 PBP1_NPR_like Ligand b 97.7 5.6E-05 1.2E-09 87.7 8.0 79 674-765 310-388 (396)
79 cd06351 PBP1_iGluR_N_LIVBP_lik 97.7 8.2E-05 1.8E-09 83.5 8.5 137 49-193 110-260 (328)
80 cd06386 PBP1_NPR_C_like Ligand 97.7 0.00015 3.3E-09 83.9 9.7 79 674-765 300-378 (387)
81 cd06340 PBP1_ABC_ligand_bindin 97.6 0.00018 3.8E-09 82.0 10.0 177 72-316 158-340 (347)
82 cd06347 PBP1_ABC_ligand_bindin 97.6 0.00052 1.1E-08 77.4 13.4 176 74-319 152-330 (334)
83 cd06360 PBP1_alkylbenzenes_lik 97.6 0.0014 3E-08 74.0 16.7 180 72-317 148-329 (336)
84 cd06269 PBP1_glutamate_recepto 97.4 0.00028 6.2E-09 77.5 7.6 105 49-159 118-235 (298)
85 cd06336 PBP1_ABC_ligand_bindin 97.3 0.0012 2.6E-08 75.2 10.7 70 72-147 152-222 (347)
86 cd06352 PBP1_NPR_GC_like Ligan 97.3 0.00055 1.2E-08 79.2 8.0 79 673-765 303-381 (389)
87 cd06384 PBP1_NPR_B Ligand-bind 97.2 0.00093 2E-08 77.6 9.4 79 674-765 313-391 (399)
88 cd06369 PBP1_GC_C_enterotoxin_ 97.2 0.0011 2.4E-08 73.8 8.9 78 673-765 287-364 (380)
89 cd06393 PBP1_iGluR_Kainate_Glu 97.2 0.00084 1.8E-08 77.6 8.0 82 673-765 290-377 (384)
90 cd06343 PBP1_ABC_ligand_bindin 97.2 0.03 6.4E-07 64.0 20.7 189 72-325 158-358 (362)
91 cd06355 PBP1_FmdD_like Peripla 97.1 0.026 5.7E-07 64.2 18.7 187 72-325 147-337 (348)
92 cd06332 PBP1_aromatic_compound 97.0 0.016 3.6E-07 65.1 16.6 155 106-321 174-330 (333)
93 cd06331 PBP1_AmiC_like Type I 97.0 0.022 4.8E-07 64.3 17.4 179 72-316 146-326 (333)
94 cd06344 PBP1_ABC_ligand_bindin 97.0 0.0031 6.6E-08 71.3 10.2 175 72-316 149-325 (332)
95 cd06357 PBP1_AmiC Periplasmic 96.9 0.067 1.5E-06 61.2 20.1 180 72-315 146-327 (360)
96 cd06327 PBP1_SBP_like_1 Peripl 96.8 0.022 4.8E-07 64.3 15.2 176 72-315 149-327 (334)
97 cd06359 PBP1_Nba_like Type I p 96.8 0.035 7.6E-07 62.7 16.5 157 106-323 174-332 (333)
98 cd06349 PBP1_ABC_ligand_bindin 96.8 0.044 9.6E-07 62.0 17.2 184 72-325 149-336 (340)
99 cd06358 PBP1_NHase Type I peri 96.6 0.062 1.3E-06 60.7 16.7 177 72-315 146-325 (333)
100 cd06381 PBP1_iGluR_delta_like 96.6 0.007 1.5E-07 69.3 8.9 62 673-765 296-358 (363)
101 PF13458 Peripla_BP_6: Peripla 96.4 0.049 1.1E-06 61.5 14.6 212 41-325 121-339 (343)
102 TIGR03407 urea_ABC_UrtA urea A 96.3 0.21 4.5E-06 57.1 19.1 187 72-325 148-338 (359)
103 cd06330 PBP1_Arsenic_SBP_like 96.2 0.086 1.9E-06 59.7 15.1 178 72-312 152-333 (346)
104 COG0683 LivK ABC-type branched 96.2 0.29 6.3E-06 56.2 19.5 190 72-328 162-356 (366)
105 cd06371 PBP1_sensory_GC_DEF_li 96.0 0.015 3.2E-07 67.2 7.9 63 675-749 298-360 (382)
106 cd06329 PBP1_SBP_like_3 Peripl 96.0 0.17 3.6E-06 57.4 16.5 170 72-311 157-330 (342)
107 TIGR03669 urea_ABC_arch urea A 95.8 0.34 7.3E-06 55.8 17.4 187 72-325 147-337 (374)
108 cd06383 PBP1_iGluR_AMPA_Like N 95.5 0.011 2.4E-07 67.7 3.9 75 673-749 276-360 (368)
109 PF07699 GCC2_GCC3: GCC2 and G 95.3 0.01 2.3E-07 46.2 1.8 28 810-837 10-37 (48)
110 KOG1054|consensus 94.9 0.099 2.2E-06 60.0 8.9 86 674-765 301-394 (897)
111 PTZ00382 Variant-specific surf 94.3 0.042 9.2E-07 49.6 3.4 86 787-880 4-91 (96)
112 cd06339 PBP1_YraM_LppC_lipopro 94.2 1.1 2.5E-05 50.5 15.8 84 72-160 138-243 (336)
113 cd06337 PBP1_ABC_ligand_bindin 93.7 0.76 1.6E-05 52.4 13.3 62 80-147 170-231 (357)
114 PHA02637 TNF-alpha-receptor-li 93.6 0.053 1.2E-06 50.5 2.8 46 787-832 41-87 (127)
115 cd06328 PBP1_SBP_like_2 Peripl 93.3 1.6 3.6E-05 49.1 15.1 68 72-145 150-218 (333)
116 cd06356 PBP1_Amide_Urea_BP_lik 93.2 1.7 3.8E-05 48.9 15.1 90 42-144 120-212 (334)
117 cd04509 PBP1_ABC_transporter_G 93.0 0.8 1.7E-05 49.8 11.7 108 72-186 150-257 (299)
118 cd06342 PBP1_ABC_LIVBP_like Ty 92.5 0.2 4.3E-06 56.3 6.0 58 674-747 276-334 (334)
119 cd06335 PBP1_ABC_ligand_bindin 91.8 3.8 8.3E-05 46.4 15.5 69 72-146 152-220 (347)
120 PF13433 Peripla_BP_5: Peripla 91.7 1 2.2E-05 50.7 10.3 174 72-311 148-323 (363)
121 cd06326 PBP1_STKc_like Type I 91.5 6.4 0.00014 44.1 16.9 70 72-147 150-219 (336)
122 cd06350 PBP1_GPCR_family_C_lik 90.7 0.73 1.6E-05 52.1 8.2 71 5-87 172-242 (348)
123 cd06334 PBP1_ABC_ligand_bindin 89.7 4.7 0.0001 45.9 13.7 110 72-190 154-265 (351)
124 KOG1052|consensus 89.1 6.9 0.00015 48.7 15.7 173 117-342 11-190 (656)
125 cd06341 PBP1_ABC_ligand_bindin 89.0 12 0.00027 41.9 16.5 174 72-310 147-324 (341)
126 cd00185 TNFR Tumor necrosis fa 85.9 0.59 1.3E-05 42.6 2.6 44 788-831 12-56 (98)
127 KOG0196|consensus 84.9 0.62 1.3E-05 56.2 2.8 41 791-836 277-317 (996)
128 KOG4418|consensus 84.6 0.045 9.8E-07 60.0 -6.1 171 350-534 16-197 (438)
129 PF07699 GCC2_GCC3: GCC2 and G 80.7 1 2.2E-05 35.0 1.7 32 791-826 12-43 (48)
130 cd06338 PBP1_ABC_ligand_bindin 78.7 2.9 6.3E-05 47.2 5.4 57 675-747 289-345 (345)
131 cd06345 PBP1_ABC_ligand_bindin 77.2 3.1 6.7E-05 47.0 5.0 51 675-741 289-339 (344)
132 PHA02637 TNF-alpha-receptor-li 77.1 2.9 6.3E-05 39.3 3.7 48 784-837 23-74 (127)
133 KOG1053|consensus 77.0 6.5 0.00014 48.1 7.5 97 674-778 297-398 (1258)
134 PRK15404 leucine ABC transport 77.0 4.6 9.9E-05 46.4 6.3 59 675-749 302-361 (369)
135 COG5472 Predicted small integr 76.1 4.1 8.8E-05 38.0 4.3 40 448-487 77-118 (164)
136 PF07354 Sp38: Zona-pellucida- 75.4 1.4 3E-05 46.7 1.3 44 791-835 220-263 (271)
137 PF12191 stn_TNFRSF12A: Tumour 75.4 2.2 4.7E-05 39.8 2.4 38 790-834 33-70 (129)
138 cd06268 PBP1_ABC_transporter_L 75.1 21 0.00045 38.5 10.8 99 72-179 149-247 (298)
139 cd06269 PBP1_glutamate_recepto 73.2 12 0.00025 40.6 8.1 69 5-87 152-220 (298)
140 cd00185 TNFR Tumor necrosis fa 71.2 4.4 9.4E-05 36.9 3.4 49 793-846 1-55 (98)
141 cd06366 PBP1_GABAb_receptor Li 68.7 15 0.00033 41.4 8.0 72 5-88 147-218 (350)
142 KOG0196|consensus 68.0 3.5 7.5E-05 50.2 2.5 56 784-846 256-312 (996)
143 PTZ00087 thrombosponding-relat 63.6 14 0.0003 39.0 5.5 34 767-803 223-258 (340)
144 cd00064 FU Furin-like repeats. 62.4 5.6 0.00012 30.9 2.0 32 810-844 16-48 (49)
145 cd06346 PBP1_ABC_ligand_bindin 60.3 33 0.00071 38.1 8.5 69 5-87 149-217 (312)
146 cd06368 PBP1_iGluR_non_NMDA_li 57.5 29 0.00064 38.5 7.6 68 5-87 138-205 (324)
147 cd06347 PBP1_ABC_ligand_bindin 57.0 37 0.00081 37.7 8.4 69 5-87 148-216 (334)
148 cd06343 PBP1_ABC_ligand_bindin 55.7 41 0.00088 38.1 8.5 69 5-87 156-224 (362)
149 cd06335 PBP1_ABC_ligand_bindin 52.9 50 0.0011 37.3 8.5 69 5-87 150-218 (347)
150 cd06332 PBP1_aromatic_compound 51.9 28 0.00061 38.7 6.3 54 675-742 275-328 (333)
151 cd06336 PBP1_ABC_ligand_bindin 50.8 43 0.00094 37.8 7.6 69 5-87 150-219 (347)
152 cd06349 PBP1_ABC_ligand_bindin 50.0 56 0.0012 36.6 8.3 69 5-87 147-215 (340)
153 cd06382 PBP1_iGluR_Kainate N-t 49.9 13 0.00028 41.5 3.1 36 724-765 286-322 (327)
154 cd06359 PBP1_Nba_like Type I p 49.0 32 0.0007 38.5 6.2 58 674-745 274-331 (333)
155 PTZ00359 hypothetical protein; 48.5 59 0.0013 36.9 7.6 97 846-943 17-123 (443)
156 cd06348 PBP1_ABC_ligand_bindin 48.5 59 0.0013 36.5 8.2 69 5-87 149-217 (344)
157 cd06340 PBP1_ABC_ligand_bindin 42.1 77 0.0017 35.7 7.9 69 5-87 156-224 (347)
158 cd04509 PBP1_ABC_transporter_G 37.8 1.1E+02 0.0024 32.8 8.1 69 5-87 148-216 (299)
159 cd01391 Periplasmic_Binding_Pr 37.5 1.4E+02 0.0031 30.9 8.7 81 73-158 140-221 (269)
160 cd06333 PBP1_ABC-type_HAAT_lik 37.1 3.3E+02 0.0071 29.8 11.8 78 72-157 147-224 (312)
161 cd06360 PBP1_alkylbenzenes_lik 37.1 1.1E+02 0.0024 33.9 8.1 69 5-87 146-214 (336)
162 KOG4418|consensus 36.5 14 0.0003 41.3 0.6 40 917-956 5-44 (438)
163 PF00020 TNFR_c6: TNFR/NGFR cy 35.7 17 0.00036 26.8 0.7 27 793-820 1-27 (39)
164 cd06327 PBP1_SBP_like_1 Peripl 33.9 99 0.0021 34.5 7.0 69 5-87 147-215 (334)
165 KOG1052|consensus 33.5 1.3E+02 0.0029 37.3 8.7 85 674-765 102-190 (656)
166 PF14946 DUF4501: Domain of un 33.3 1.5E+02 0.0033 29.2 6.8 10 793-802 28-37 (180)
167 cd06329 PBP1_SBP_like_3 Peripl 33.0 1.2E+02 0.0026 34.0 7.6 70 5-87 155-226 (342)
168 KOG4611|consensus 32.1 28 0.00062 38.0 2.0 49 783-834 25-74 (747)
169 cd06334 PBP1_ABC_ligand_bindin 31.6 1.3E+02 0.0028 34.1 7.5 69 5-87 152-220 (351)
170 KOG4611|consensus 31.2 22 0.00048 38.8 1.0 48 791-840 53-112 (747)
171 cd06394 PBP1_iGluR_Kainate_KA1 30.9 52 0.0011 37.2 4.0 36 724-765 291-327 (333)
172 COG0683 LivK ABC-type branched 30.9 1.6E+02 0.0034 33.6 8.1 62 674-750 292-355 (366)
173 cd06328 PBP1_SBP_like_2 Peripl 30.6 1.4E+02 0.003 33.5 7.4 43 5-52 148-190 (333)
174 PF05915 DUF872: Eukaryotic pr 29.7 1.2E+02 0.0026 28.5 5.5 40 839-884 28-67 (115)
175 cd06331 PBP1_AmiC_like Type I 28.0 2E+02 0.0043 32.1 8.2 69 5-87 144-212 (333)
176 PF03302 VSP: Giardia variant- 27.6 57 0.0012 37.8 3.6 87 788-882 302-394 (397)
177 PF05462 Dicty_CAR: Slime mold 26.5 1.4E+02 0.0031 33.1 6.4 67 861-932 15-84 (303)
178 PF09463 Opy2: Opy2 protein; 26.3 38 0.00082 24.5 1.2 23 810-833 10-32 (35)
179 PF05571 DUF766: Protein of un 25.9 92 0.002 34.0 4.5 22 810-833 22-43 (296)
180 cd06330 PBP1_Arsenic_SBP_like 24.7 1.6E+02 0.0034 33.0 6.6 71 5-87 150-220 (346)
181 PF07645 EGF_CA: Calcium-bindi 24.6 27 0.00059 26.1 0.2 24 820-844 19-42 (42)
182 PF13433 Peripla_BP_5: Peripla 24.5 1.6E+02 0.0034 33.6 6.2 66 674-770 279-345 (363)
183 PF01422 zf-NF-X1: NF-X1 type 24.4 51 0.0011 20.7 1.3 9 788-796 5-13 (20)
184 cd06326 PBP1_STKc_like Type I 24.2 2.5E+02 0.0055 31.0 8.1 69 5-87 148-216 (336)
185 COG3671 Predicted membrane pro 23.9 2.6E+02 0.0057 26.2 6.3 44 440-484 30-73 (125)
186 PF13829 DUF4191: Domain of un 23.3 82 0.0018 33.1 3.5 51 855-917 23-73 (224)
187 PF12191 stn_TNFRSF12A: Tumour 21.9 34 0.00073 32.2 0.3 54 812-868 34-89 (129)
188 PF04341 DUF485: Protein of un 21.1 3.2E+02 0.007 24.3 6.4 51 438-488 21-72 (91)
No 1
>KOG1056|consensus
Probab=100.00 E-value=9.1e-93 Score=831.08 Aligned_cols=494 Identities=41% Similarity=0.762 Sum_probs=447.4
Q ss_pred hHHHHHHHHhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhH
Q psy1666 41 AYDDIVTKLMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAY 107 (981)
Q Consensus 41 ~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~ 107 (981)
.|+.. +|++|+|.+|++||+.++.+++| |.+.+.|+++++++|||||++++++.... .+.+
T Consensus 167 ry~~F---~RtVP~D~~Qa~Am~~il~~f~W~yVstv~s~~dYGE~Gieaf~~~a~~~~iCIa~s~ki~~~~~---~~~~ 240 (878)
T KOG1056|consen 167 RYDYF---LRTVPSDVFQAQAMVDILKKFNWNYVSTVASEGDYGESGIEAFKEEAAERGICIAFSEKIYQLSI---EQEF 240 (878)
T ss_pred hhhce---eeecCChHHHHHHHHHHHHHhCeeEeeehhcCccchhhhHHHHHHhHHhcCceEEehhhcccccc---hhHH
Confidence 47644 45889999999999999999999 77899999999999999999999987643 5688
Q ss_pred HHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChH
Q psy1666 108 DDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFD 187 (981)
Q Consensus 108 ~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ 187 (981)
+.+++++...++|||+|+|++..+++.+++++.+++++|+++||+||+|+....+........+|++++.++++.+|+|+
T Consensus 241 ~~~l~kl~~~~~a~vvV~F~~~~~~r~~~~aa~~~n~~g~~~wiaSd~W~~~~~~~~~~e~~a~g~i~i~l~~~~v~~F~ 320 (878)
T KOG1056|consen 241 DCVLRKLLETPNARVVVVFCRGEDARRLLKAARRANLTGEFLWIASDGWASQNSPTEAPEREAEGAITIKLASPQVPGFD 320 (878)
T ss_pred HHHHHHHhhcCCCeEEEEecCcchHHHHHHHHHHhCCCcceEEEecchhhccCChhhhhhhhhceeEEEEecCCcchhHH
Confidence 99999998889999999999999999999988999999988999999999877666666668899999999999999999
Q ss_pred HHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCccccc-CCccccccccHHHHHHHHHHHHHHHH
Q psy1666 188 DYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLS-RDTLAFEKQLQFVSDAVMAFSIALDH 266 (981)
Q Consensus 188 ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~-~~~~~~~~~~~~VydAVyAiAhALh~ 266 (981)
+|+++++|.++.+|+|+.| ||++.|+|.++.... .+....+.||+.|... ..+++++++.++|+|||||||||||+
T Consensus 321 ~y~~s~~p~nn~~n~w~~e-~w~~~f~C~l~~~~~--~~~~~~~~Ct~~e~~~~~~~~~q~~k~~~Vi~aVya~A~aLh~ 397 (878)
T KOG1056|consen 321 RYFQSLHPENNRRNPWFAE-FWEDKFNCSLPNSAF--KNENLIRLCTAVERITLDSAYEQDSKVQFVIDAVYAMAHALHN 397 (878)
T ss_pred HHHHhcCccccccCcccch-hhhhcccCCCCcccc--cchhhhhhcccchhhccccchhhhcccccHHHHHHHHHHHHHH
Confidence 9999999999999999999 999999999864321 1233467899998653 45677888999999999999999999
Q ss_pred hHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEECC-eE
Q psy1666 267 MHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLEG-EL 345 (981)
Q Consensus 267 m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~~-~L 345 (981)
|++++|++..+.|++|.+++||+|++|++||+|++..|+ |.||+|||++++|||+||+..+.+ +.|.+||+|+.. +|
T Consensus 398 m~~~lc~~~~~~C~~m~~~dg~~L~~~l~~vnF~~~~~~-v~Fd~~gD~~~~y~I~~~~~~~~~-~~y~~vg~w~~~~~l 475 (878)
T KOG1056|consen 398 MHQDLCPGTSGLCSAMKAIDGSLLLKYLLNVNFTGPAGS-VRFDENGDGPGRYDILNYQLTNGS-YTYKEVGYWSEGLSL 475 (878)
T ss_pred HHHhhcCCccccCcCccccCHHHHHhhhheeEEecCCCc-eeecCCCCCccceeEEEeeccCCC-ccceeeeeecccccc
Confidence 999999999999999999999999999999999998886 999999999999999999976544 899999999852 12
Q ss_pred EEec----------------------------------------------------------------------------
Q psy1666 346 RLNM---------------------------------------------------------------------------- 349 (981)
Q Consensus 346 ~in~---------------------------------------------------------------------------- 349 (981)
.+..
T Consensus 476 ~i~~~~w~~~~~~v~~S~CS~pC~~g~~k~~~~~~~ccw~c~~c~~~eY~~d~~tc~~C~~~~wp~~~~tgc~~~~~~yl 555 (878)
T KOG1056|consen 476 NIEDLDWTTKPSGVPKSVCSEPCLPGQRKKVTKGVTCCWHCTPCMSYEYVNDEFTCSDCQLGQWPNASLTGCFDIPVSYL 555 (878)
T ss_pred cceeeeeccCCCCCccccccCcCCcchhcccccCceeEEEcccCCCcceecCcceeccCCcCcCCCcccCCccccchhhe
Confidence 2110
Q ss_pred ---------------------------------------------------------------------------cchhh
Q psy1666 350 ---------------------------------------------------------------------------FGAGF 354 (981)
Q Consensus 350 ---------------------------------------------------------------------------~~~~~ 354 (981)
+++|+
T Consensus 556 ~W~~~~~i~~l~lA~LGii~tl~vlv~fvr~~~TpvVkasgreLsyiLL~gi~l~y~~tf~~i~eP~~~~C~lrr~~~gl 635 (878)
T KOG1056|consen 556 RWRSPWSIAPLLLAILGIIATLFVLVLFVRYNDTPVVKASGRELSYILLLGIFLCYASTFFFIAEPTDISCRLRRTFLGL 635 (878)
T ss_pred eccccccHHHHHHHHHHHHHHHHhheeEEEecCCceEEecCcEehHHHHHHHHHHHhhhheeEecCCCceeeEeeeecch
Confidence 89999
Q ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCCCCceeccccceeeehhHHHHHHHHHHHhhcccCCCcccccCCCcC-EEEEcC
Q psy1666 355 CFTVVYAALLTKTNRISRIFNAGKRTAKRPNFITPKSQLMICGGLVSVQVLINGVWMLVSPPRAIHHYPSRED-NILVCS 433 (981)
Q Consensus 355 ~ft~~~S~ll~KT~~I~~iF~~~~~~~~~~~~i~~~~q~~iv~~~~~vqv~i~~~Wl~~~PP~~~~~~p~~~~-~il~C~ 433 (981)
+|++||||++||||||+|||..++++.++|+|+++.+|++|+++++.+|++||++|++++||...+.++.+.+ ++|+|+
T Consensus 636 ~f~i~ysalltKtnrI~rif~~~~k~~~~~~~is~~~q~~i~~~l~~iQlvi~~~Wlv~~~p~~~~~~~~~~~~~~L~C~ 715 (878)
T KOG1056|consen 636 GFTICYSALLTKTNRIARIFEFSKKSIQRPRFISPWSQVLITFILIGIQLVICVSWLVVEPPGSVRTYVSRREVVILKCT 715 (878)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcccccccccceeccchHHHHHHHHhhheeEEEEEEEeecCCccccccccccceEEEEec
Confidence 9999999999999999999999988889999999999999999999999999999999999987666666544 789999
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHHHHHHHHHHHHhhhcccccCCcceeeehhHHHHHHHh
Q psy1666 434 SFINASYMIAFGYPIFLIVVCTVYAILTRNIPEAFNESKHIGFTMYTTCVIWLAFVPLYFGTGNHMPLRITTMSVTISLS 513 (981)
Q Consensus 434 ~~s~~~~~~~l~Y~~lL~l~c~~~Af~~R~lP~nfNEAK~ItFsml~~~ivWiafiP~y~~t~g~~~~~~~~~~~~Il~s 513 (981)
+ ++.+|++++||+++|+++||+||||+|++||||||||||+|+||++|++|+||||+|++|.++ ++.+++++++++|
T Consensus 716 ~-~~~~f~~~l~Y~~lL~~~Ct~yA~ktR~~peNFNEaK~I~Ftmy~t~iiWlAfipi~~~t~~~--~~~a~~~is~~lS 792 (878)
T KOG1056|consen 716 E-VDLGFLLSLGYSGLLILSCTVYAFKTRNLPENFNEAKFIGFTMYTTCIIWLAFIPIYFGTDHK--IQDATLCISLSLS 792 (878)
T ss_pred C-cchHHHHHHHHHHHHHHHHHHHHhhccCChhhhhhhhhhhhhHHHHHHHHHHHHHHHhccCcc--eeeeehehhhHhh
Confidence 9 999999999999999999999999999999999999999999999999999999999999995 7899999999999
Q ss_pred hhhheeEEecCCccccCccccccccCCccceeeeEEEeeecCCCCcchhhccccc
Q psy1666 514 ASVTVACLFSPKVRSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNL 568 (981)
Q Consensus 514 ~~~~L~ciF~PK~~~~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l 568 (981)
+.++|+|+|+||||| |.+.|++|.+..|+....+.
T Consensus 793 asv~Lg~lf~PK~yI--------------------Il~~pe~Nv~~~~~~s~~~~ 827 (878)
T KOG1056|consen 793 ASVALGCLFIPKVYI--------------------ILFHPERNVIAEFDPSTLSR 827 (878)
T ss_pred hhhhheeEecCcEEE--------------------EEecCccchHhhcccchhhh
Confidence 999999999999999 99999999988877765553
No 2
>KOG1056|consensus
Probab=100.00 E-value=1.4e-73 Score=669.62 Aligned_cols=402 Identities=43% Similarity=0.840 Sum_probs=367.8
Q ss_pred CCccc--cCccccccccCCccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhhh
Q psy1666 524 PKVRS--DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLRA 601 (981)
Q Consensus 524 PK~~~--~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (981)
+|.++ |+|+....+........+|++++.++++.+++|++|+.+++|.++.+|+||
T Consensus 280 ~~~wiaSd~W~~~~~~~~~~e~~a~g~i~i~l~~~~v~~F~~y~~s~~p~nn~~n~w~---------------------- 337 (878)
T KOG1056|consen 280 EFLWIASDGWASQNSPTEAPEREAEGAITIKLASPQVPGFDRYFQSLHPENNRRNPWF---------------------- 337 (878)
T ss_pred ceEEEecchhhccCChhhhhhhhhceeEEEEecCCcchhHHHHHHhcCccccccCccc----------------------
Confidence 78887 999998888766666899999999999999999999999999999999986
Q ss_pred hhhcchhhhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCCCCCCCCCCCCCcccccC-CccccccchhHHHHHH
Q psy1666 602 RVAAGIVSIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSR-DTLAFEKQLQFVSDAV 680 (981)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~~~~~~~~~Ctg~e~L~~-~~~~~~~~~~~vydAV 680 (981)
.|||++.|+|.+.++... +....+.|++.|.... ..+.++...++|+|||
T Consensus 338 ---------------------------~e~w~~~f~C~l~~~~~~--~~~~~~~Ct~~e~~~~~~~~~q~~k~~~Vi~aV 388 (878)
T KOG1056|consen 338 ---------------------------AEFWEDKFNCSLPNSAFK--NENLIRLCTAVERITLDSAYEQDSKVQFVIDAV 388 (878)
T ss_pred ---------------------------chhhhhcccCCCCccccc--chhhhhhcccchhhccccchhhhcccccHHHHH
Confidence 799999999998654211 1223467999986543 3455566788999999
Q ss_pred HHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCCcEEEEEE
Q psy1666 681 MAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQV 760 (981)
Q Consensus 681 yaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~~~~~~~V 760 (981)
|++|||||+|++++|++..+.|+.+...++|+|++|+++|+|++..|. +.||+|||.+++|||+||+...++ ..+.+|
T Consensus 389 ya~A~aLh~m~~~lc~~~~~~C~~m~~~dg~~L~~~l~~vnF~~~~~~-v~Fd~~gD~~~~y~I~~~~~~~~~-~~y~~v 466 (878)
T KOG1056|consen 389 YAMAHALHNMHQDLCPGTSGLCSAMKAIDGSLLLKYLLNVNFTGPAGS-VRFDENGDGPGRYDILNYQLTNGS-YTYKEV 466 (878)
T ss_pred HHHHHHHHHHHHhhcCCccccCcCccccCHHHHHhhhheeEEecCCCc-eeecCCCCCccceeEEEeeccCCC-ccceee
Confidence 999999999999999998899999988999999999999999999885 999999999999999999976544 789999
Q ss_pred EEEECceEEEeccccccccCCCCCCCccCCccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCCCCCCcc
Q psy1666 761 GEYLEGELRLNMSAIQFKLSHPSPPESVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEGTKPDLL 840 (981)
Q Consensus 761 G~~~~~~l~in~~~i~W~~~~~~~P~S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~~~~n~~ 840 (981)
|+|+. .+.+|.+.+.|.++..++|.|+||++|.||++|..+++.+|||.|.+|+++||.| |..+|.+|+.++|||++
T Consensus 467 g~w~~-~~~l~i~~~~w~~~~~~v~~S~CS~pC~~g~~k~~~~~~~ccw~c~~c~~~eY~~--d~~tc~~C~~~~wp~~~ 543 (878)
T KOG1056|consen 467 GYWSE-GLSLNIEDLDWTTKPSGVPKSVCSEPCLPGQRKKVTKGVTCCWHCTPCMSYEYVN--DEFTCSDCQLGQWPNAS 543 (878)
T ss_pred eeecc-cccccceeeeeccCCCCCccccccCcCCcchhcccccCceeEEEcccCCCcceec--CcceeccCCcCcCCCcc
Confidence 99975 5568999999998888899999999999999999888778999999999999998 99999999999999999
Q ss_pred ccCcccccccccccchhhHHHHHHHHHHHHHHHHHHhhhheeecCcceeeeCCccchHHHHHHHHHHHhhheeeeecCce
Q psy1666 841 RQNCLEIPAMFIEITSTWAIGAMALSSTGILMTLLIVGVFIRHNNTPVVKAAGRELSYVLLFGILLCYLVTFVLVLKPSD 920 (981)
Q Consensus 841 ~~~C~~~~~~~l~~~~~~~i~~~~~s~~~~~~t~~v~~ifi~~r~tpiVka~n~~Ls~~lL~~l~l~fl~~~~fig~p~~ 920 (981)
++.|.+++++|++|+++++++.+++|++|++.|++|+++|++|++|||||++||+|||+||.|+++||.+++.|+++|++
T Consensus 544 ~tgc~~~~~~yl~W~~~~~i~~l~lA~LGii~tl~vlv~fvr~~~TpvVkasgreLsyiLL~gi~l~y~~tf~~i~eP~~ 623 (878)
T KOG1056|consen 544 LTGCFDIPVSYLRWRSPWSIAPLLLAILGIIATLFVLVLFVRYNDTPVVKASGRELSYILLLGIFLCYASTFFFIAEPTD 623 (878)
T ss_pred cCCccccchhheeccccccHHHHHHHHHHHHHHHHhheeEEEecCCceEEecCcEehHHHHHHHHHHHhhhheeEecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeechhhhhhHHHHHHHHHHHHHHHHHHHHHhccCCCCCCCCcchhhhHHHHHHHhhhhcC
Q psy1666 921 LVCAIQRFGAGFCFTVVYAALLTKTNRISRIFNAGKRTAKRPNFITPKSQLMICGGLVSVQ 981 (981)
Q Consensus 921 ~~C~lr~~~f~i~ft~~~s~il~Kt~~v~~~F~~~~~~~~~~~~i~~~~q~~i~~~~~~iq 981 (981)
.+|.+||+.+|++|++|+||+++||+||+|||...++...+++++.+..|++|+.++++||
T Consensus 624 ~~C~lrr~~~gl~f~i~ysalltKtnrI~rif~~~~k~~~~~~~is~~~q~~i~~~l~~iQ 684 (878)
T KOG1056|consen 624 ISCRLRRTFLGLGFTICYSALLTKTNRIARIFEFSKKSIQRPRFISPWSQVLITFILIGIQ 684 (878)
T ss_pred ceeeEeeeecchhHHHHHHHHHHHHHHHHHHHhcccccccccceeccchHHHHHHHHhhhe
Confidence 9999999999999999999999999999999998777778899999988888888888877
No 3
>cd06375 PBP1_mGluR_groupII Ligand binding domain of the group II metabotropic glutamate receptor. Ligand binding domain of the group II metabotropic glutamate receptor, a family that contains mGlu2R and mGlu3R, all of which inhibit adenylyl cyclase. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes
Probab=100.00 E-value=3.1e-43 Score=412.26 Aligned_cols=282 Identities=36% Similarity=0.674 Sum_probs=242.7
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+|+.|++.+|.+||+.++.+++| +.+.+.|++++++.|+||++.+.++.... ..++..++++++
T Consensus 152 fRt~psd~~qa~ai~~ll~~~~W~~Vaii~~~~~yG~~~~~~~~~~~~~~gi~i~~~~~i~~~~~---~~d~~~~l~~l~ 228 (458)
T cd06375 152 ARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNICIATSEKVGRSAD---RKSYDSVIRKLL 228 (458)
T ss_pred EEecCCcHHHHHHHHHHHHHCCCeEEEEEEeCchHHHHHHHHHHHHHHHCCeeEEEEEEecCCCC---HHHHHHHHHHHh
Confidence 46889999999999999999998 44678888999999999999999986543 346778888886
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCC
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTV 195 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p 195 (981)
++++++|||+++...++..+++++.+++++ ++||++++|.............++|++|+.+++.++|+|++|+++++|
T Consensus 229 ~~~~a~vVvl~~~~~~~~~ll~~a~~~g~~--~~wigs~~~~~~~~~~~~~~~~~~G~i~~~~~~~~i~~f~~yl~~l~p 306 (458)
T cd06375 229 QKPNARVVVLFTRSEDARELLAAAKRLNAS--FTWVASDGWGAQESIVKGSEDVAEGAITIELASHPIPDFDRYFQSLTP 306 (458)
T ss_pred ccCCCEEEEEecChHHHHHHHHHHHHcCCc--EEEEEeccccccchhhhccchhhceEEEEEeccccchhHHHHHHhCCc
Confidence 668899999999999999999999999987 499999999865433344456789999999999999999999999999
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCC-ccccccccHHHHHHHHHHHHHHHHhHhhhcCC
Q psy1666 196 ENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRD-TLAFEKQLQFVSDAVMAFSIALDHMHADLCQG 274 (981)
Q Consensus 196 ~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~-~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~ 274 (981)
+++++|||+.| ||++.|+|.++... ...+.|++.+++... .+.+..++++|||||||+|||||+|+++.|++
T Consensus 307 ~~~~~n~w~~e-~w~~~f~c~~~~~~------~~~~~C~~~~~~~~~~~~~~~~~~~~v~~AVyA~AhaLh~~l~~~c~~ 379 (458)
T cd06375 307 ETNTRNPWFKD-FWEQKFQCSLQNRD------CANTTTNDKERLLDKVNYEQESKIMFVVNAVYAMAHALHNMQRDLCPN 379 (458)
T ss_pred CcCCCCcHHHH-HHHHHcCCCCCCCC------ccCCCCCchhcccccCcccccchHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 99999999999 99999999874431 123579988877542 23445678899999999999999999999987
Q ss_pred CCCCCCCCCCCCccHHH-Hhhcceeec-----cCCCCeEEecCCCCCCceeEEEEEEEcCCC-cEEEEEEEEEEC
Q psy1666 275 KVGLCDAMRPTKGPELL-KYLRKVSFQ-----GLSEDHFKFDKDGDGPARYNIIHFKQIRPG-VYQWVQVGEYLE 342 (981)
Q Consensus 275 ~~~~C~~~~~~~~~qLl-~~Lk~V~F~-----g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g-~~~~v~VG~~~~ 342 (981)
..+.|+.+.+++||||+ +|||||+|+ |.+|++|.||+|||++++|||+|||...++ .+.+++||+|+.
T Consensus 380 ~~~~c~~~~~~~~~~l~~~~L~~v~F~~~~~~~~~g~~v~Fd~nGd~~~~YdI~n~q~~~~~~~~~~~~VG~w~~ 454 (458)
T cd06375 380 TTKLCDAMKPLDGKKLYKEYLLNVSFTAPFRPDLADSEVKFDSQGDGLGRYNIFNYQRTGNSYGYRYVGVGAWAN 454 (458)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccccccccCCCCCCeeEECCCCCCCcceEEEEEEEcCCCCcEEEEEEEEEec
Confidence 77889998899999999 599999999 999999999999999999999999976655 788999999964
No 4
>cd06365 PBP1_Pheromone_receptor Ligand-binding domain of the V2R phermone receptor, a member of the family C receptors within the G-protein coupled receptor superfamily. Ligand-binding domain of the V2R phermone receptor, a member of the family C receptors within the G-protein coupled receptor superfamily, which also includes the metabotropic glutamate receptor, the GABAb receptor, the calcium-sensing receptor (CaSR), the T1R taste receptor, and a small group of uncharacterized orphan receptors.
Probab=100.00 E-value=8.9e-43 Score=410.01 Aligned_cols=291 Identities=18% Similarity=0.274 Sum_probs=243.0
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+|+.|++..|++||+.++.+|+| +.+.+.|.++++++||||++.+.++..... ...++..+++++
T Consensus 150 fRt~psd~~q~~ai~~li~~f~W~~Vaiv~~d~~yg~~~~~~~~~~~~~~gi~I~~~~~i~~~~~~-~~~~~~~~l~~i- 227 (469)
T cd06365 150 YQMAPKDTSLPLGMVSLMLHFSWTWVGLVISDDDRGEQFLSDLREEMQRNGICLAFVEKIPVNMQL-YLTRAEKYYNQI- 227 (469)
T ss_pred eEecCCchhHHHHHHHHHHhcCCeEEEEEEecChhHHHHHHHHHHHHHHCCeEEEEEEEecCCchh-hHHHHHHHHHHh-
Confidence 46899999999999999999999 456889999999999999999999865421 123566777776
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCC
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTV 195 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p 195 (981)
+++++||||+++++..+..++.++.+++.+| ++||++++|..+........+.++|++|++++..++|+|++|+++++|
T Consensus 228 ~~~~arvIvl~~~~~~~~~l~~~~~~~~~~~-~~wi~s~~w~~~~~~~~~~~~~~~G~lg~~~~~~~~~~f~~fl~~l~~ 306 (469)
T cd06365 228 MTSSAKVIIIYGDTDSLLEVSFRLWQYLLIG-KVWITTSQWDVTTSPKDFTLNSFHGTLIFSHHHSEIPGFKDFLQTVNP 306 (469)
T ss_pred hcCCCeEEEEEcCcHHHHHHHHHHHHhccCc-eEEEeeccccccccccccccceeeEEEEEEeccCcCcchHHHhhccCc
Confidence 6788999999999988988888888888888 499999999876544455667899999999999999999999999999
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccc-----cccccHHHHHHHHHHHHHHHHhHhh
Q psy1666 196 ENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLA-----FEKQLQFVSDAVMAFSIALDHMHAD 270 (981)
Q Consensus 196 ~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~-----~~~~~~~VydAVyAiAhALh~m~~~ 270 (981)
.++++|||+.| ||++.|+|.++... ....+.|+++++++..... ....+++|||||||+|||||+|+++
T Consensus 307 ~~~~~npw~~e-fwe~~f~c~~~~~~-----~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~v~dAVya~AhALh~~l~c 380 (469)
T cd06365 307 SKYPEDIFLEK-LWWIYFNCSLSKSS-----CKTLKNCLSNASLEWLPLHYFDMAMSEESYNVYNAVYAVAHALHEMLLQ 380 (469)
T ss_pred ccCCCccHHHh-hHhHhcCcccCcCC-----ccccCCCCCCccccccccccccchhhhhHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999 99999999864321 1223579988887643211 2335678999999999999999997
Q ss_pred hcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEEC-----CeE
Q psy1666 271 LCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE-----GEL 345 (981)
Q Consensus 271 lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~-----~~L 345 (981)
.|+.....|..+.+++||||++|||||+|+|.+|++|+||+|||++++|||+|||..+++...+++||+|++ ++|
T Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~~l~~v~F~~~~g~~v~Fd~nGd~~~~YdI~n~q~~~~~~~~~~~VG~~~~~~~~~~~l 460 (469)
T cd06365 381 QVETQSENNGKRLIFLPWQLHSFLKNIQFKNPAGDEVNLNQKRKLDTEYDILNYWNFPQGLGLKVKVGEFSPQAPSGQQL 460 (469)
T ss_pred hccCCCcCCCCCCCccHHHHHHHHHhccccCCCCCEEEecCCCCcCceeeEEEEEECCCCCEEEEEEEEEeCCCCCCcEE
Confidence 775544455556788999999999999999999999999999999999999999976567789999999984 367
Q ss_pred EEe
Q psy1666 346 RLN 348 (981)
Q Consensus 346 ~in 348 (981)
.||
T Consensus 461 ~i~ 463 (469)
T cd06365 461 SIS 463 (469)
T ss_pred EEe
Confidence 776
No 5
>cd06364 PBP1_CaSR Ligand-binding domain of the CaSR calcium-sensing receptor, which is a member of the family C receptors within the G-protein coupled receptor superfamily. Ligand-binding domain of the CaSR calcium-sensing receptor, which is a member of the family C receptors within the G-protein coupled receptor superfamily. CaSR provides feedback control of extracellular calcium homeostasis by responding sensitively to acute fluctuations in extracellular ionized Ca2+ concentration. This ligand-binding domain has homology to the bacterial leucine-isoleucine-valine binding protein (LIVBP) and a leucine binding protein (LBP). CaSR is widely expressed in mammalian tissues and is active in tissues that are not directly involved in extracellular calcium homeostasis. Moreover, CaSR responds to aromatic, aliphatic, and polar amino acids, but not to positively charged or branched chain amino acids, which suggests that changes in plasma amino acid levels are likely to modulate whole body calci
Probab=100.00 E-value=9.1e-41 Score=395.58 Aligned_cols=292 Identities=22% Similarity=0.402 Sum_probs=242.9
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+|+.|++..|.+||+.++.+++| +.+.+.|++++++.||||++.+.++.... ..++..++.++
T Consensus 165 fRt~psd~~q~~Ai~~l~~~f~wk~VaiI~~dd~yG~~~~~~~~~~~~~~Gi~I~~~~~i~~~~~---~~d~~~~l~kl- 240 (510)
T cd06364 165 LRTIPNDEHQATAMADIIEYFRWNWVGTIAADDDYGRPGIEKFREEAEERDICIDFSELISQYSD---EEEIQRVVEVI- 240 (510)
T ss_pred eEcCCChHHHHHHHHHHHHHcCCeEEEEEEecCcchHHHHHHHHHHHHHCCcEEEEEEEeCCCCC---HHHHHHHHHHH-
Confidence 45889999999999999999998 45688899999999999999999986432 34677788777
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCccccccc-CCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVS-DGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~-~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
+.++++|||+++...++..+++++.+++++++ +||++++|..+.... ....+.++|++|+.++..++++|++|+++++
T Consensus 241 k~~~a~vVvl~~~~~~~~~ll~qa~~~g~~~~-iwI~s~~w~~~~~~~~~~~~~~~gg~lg~~~~~~~i~~f~~~l~~l~ 319 (510)
T cd06364 241 QNSTAKVIVVFSSGPDLEPLIKEIVRRNITGK-IWLASEAWASSSLIAMPEYFDVMGGTIGFALKAGQIPGFREFLQKVH 319 (510)
T ss_pred HhcCCeEEEEEeCcHHHHHHHHHHHHhCCCCc-EEEEEchhhcccccccCCccceeeEEEEEEECCCcCccHHHHHHhCC
Confidence 56889999999999999999999999999996 999999998765443 3456788999999999999999999999999
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCC-------------C----CC-CCCCCCCCcccccCCc--cc---cccccH
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTP-------------Y----NS-HYSTECTTHEKLSRDT--LA---FEKQLQ 251 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~-------------~----~~-~~~~~Ctg~e~l~~~~--~~---~~~~~~ 251 (981)
|+++++|+|+.+ ||+..|+|.++....+. + .. ...+.|++++.+.... +. ....++
T Consensus 320 p~~~~~~~~~~~-~we~~f~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~~~~ 398 (510)
T cd06364 320 PKKSSHNGFAKE-FWEETFNCYLEDSPKNALPVDTFLGHEESGDDSENGSTAFRPLCTGDENIASVETPYLDYTHLRISY 398 (510)
T ss_pred cccCCCChHHHH-HHHHhcCCCCCCCcccccccccccccccccccccccccccCCCCCChhhhcccCCccccccchhhHH
Confidence 999999999999 99999999865311100 0 00 1235799998876322 21 223467
Q ss_pred HHHHHHHHHHHHHHHhHhhhcCCC-----CCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEE
Q psy1666 252 FVSDAVMAFSIALDHMHADLCQGK-----VGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQ 326 (981)
Q Consensus 252 ~VydAVyAiAhALh~m~~~lC~~~-----~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~ 326 (981)
+|||||||+|||||+|++ |... ++.|+.+.+++||||++|||||+|+|.+|++|.||+|||++++|||+|||.
T Consensus 399 ~v~~AVyAvAhaLh~~~~--c~~~~~~~~~~~c~~~~~~~~~~l~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~q~ 476 (510)
T cd06364 399 NVYLAVYSIAHALQDIYT--CTPGKGLFTNGSCADIKKVEAWQVLKHLRHLNFTDNMGEQVRFDEGGDLVGNYSIINWHL 476 (510)
T ss_pred HHHHHHHHHHHHHHHHhc--CCCCCCCccCCCCCCCCCCCHHHHHHHHHhcEEecCCCCEEEEecCCCCccceeEEEeee
Confidence 899999999999999997 6432 257999888999999999999999999999999999999999999999998
Q ss_pred cC-CCcEEEEEEEEEEC-----CeEEEe
Q psy1666 327 IR-PGVYQWVQVGEYLE-----GELRLN 348 (981)
Q Consensus 327 ~~-~g~~~~v~VG~~~~-----~~L~in 348 (981)
.+ ++.+.+++||+|++ ++|.||
T Consensus 477 ~~~~~~~~~v~VG~~~~~~~~~~~l~i~ 504 (510)
T cd06364 477 SPEDGSVVFKEVGYYNVYAKKGERLFIN 504 (510)
T ss_pred cCCCCcEEEEEEEEEcCCCCCCceEEec
Confidence 65 67789999999984 367776
No 6
>cd06374 PBP1_mGluR_groupI Ligand binding domain of the group I metabotropic glutamate receptor. Ligand binding domain of the group I metabotropic glutamate receptor, a family containing mGlu1R and mGlu5R, all of which stimulate phospholipase C (PLC) hydrolysis. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes.
Probab=100.00 E-value=2.9e-39 Score=381.54 Aligned_cols=294 Identities=36% Similarity=0.698 Sum_probs=246.3
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+|+.|++..|++||+.++.+++| +.+.+.|++++++.|+||++.+.++.... ..++...+.+++
T Consensus 164 fRt~p~d~~~~~al~~l~~~~~W~~Vaii~~~~~yg~~~~~~~~~~~~~~gi~i~~~~~i~~~~~---~~d~~~~l~~lk 240 (472)
T cd06374 164 LRVVPSDTLQARAMLDIVKRYNWTYVSAVHTEGNYGESGMEAFKELAAHEGLCIAHSDKIYSNAG---EQSFDRLLRKLR 240 (472)
T ss_pred EEcCCChHHHHHHHHHHHHHCCCcEEEEEEecchHHHHHHHHHHHHHHHCCeeEEEEEEecCCCc---hHHHHHHHHHHH
Confidence 35889999999999999999998 44678899999999999999999875432 346778888886
Q ss_pred c-CCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 116 T-KPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 116 ~-~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
. +++++||+++++...+..++.++.++++.++++||++++|...........+.++|++++.++..++++|++|+++++
T Consensus 241 ~~~~da~vvv~~~~~~~~~~~l~~a~~~g~~~~~~wi~s~~~~~~~~~~~~~~~~~~G~l~~~~~~~~~~~F~~~l~~l~ 320 (472)
T cd06374 241 SRLPKARVVVCFCEGMTVRGLLMAMRRLGVGGEFQLIGSDGWADRDDVVEGYEEEAEGGITIKLQSPEVPSFDDYYLKLR 320 (472)
T ss_pred hcCCCcEEEEEEechHHHHHHHHHHHHhcCCCceEEEEecccccchHhhhcchhhhheeEEEEecCCCCccHHHHHHhCC
Confidence 5 478999999998888999999999999988679999999987543334455667999999999999999999999999
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCC
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQG 274 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~ 274 (981)
|+++++|||+.+ ||++.|+|..+.... ......+.|++.++++.. +.....+.+|||||||+|||||+|+++.|++
T Consensus 321 ~~~~~~~~~~~~-~w~~~f~c~~~~~~~--~~~~~~~~c~~~~~~~~~-~~~~~~~~~vyDAVyaiA~ALh~~~~~~~~~ 396 (472)
T cd06374 321 PETNTRNPWFRE-FWQHRFQCRLPGHPQ--ENPNYIKICTGNESLDEQ-YVQDSKMGFVINAIYAMAHGLHNMHQDLCPG 396 (472)
T ss_pred cccCCCChHHHH-HHHHhcCCCcCCccC--cCCccCCCCCCccccccc-ccccceeHHHHHHHHHHHHHHHHHHHhhCCC
Confidence 999999999999 999999998643211 112234579988766432 2233456699999999999999999888976
Q ss_pred CCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEECCeEEEec
Q psy1666 275 KVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLEGELRLNM 349 (981)
Q Consensus 275 ~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~~~L~in~ 349 (981)
..+.|+.+.+.+|++|++||++|+|+|.+|++|.||+|||+.+.|||+|||..+++...+++||+|++++|.||+
T Consensus 397 ~~~~c~~~~~~~~~~l~~~l~~v~F~g~tG~~v~Fd~~G~~~~~ydI~n~~~~~~~~~~~~~VG~w~~~~l~~~~ 471 (472)
T cd06374 397 HVGLCDAMKPIDGRKLLEYLLKTSFSGVSGEEVYFDENGDSPGRYDIMNLQYTEDLRFDYINVGSWHEGDLGIDD 471 (472)
T ss_pred CCCCCcCCCCCCHHHHHHHHHhCcccCCCCCeEEEcCCCCCCCceEEEEEEECCCCCEEEEEEEEEeCCcccccC
Confidence 667899877789999999999999999999999999999999999999999877777899999999987888764
No 7
>cd06376 PBP1_mGluR_groupIII Ligand-binding domain of the group III metabotropic glutamate receptor. Ligand-binding domain of the group III metabotropic glutamate receptor, a family which contains mGlu4R, mGluR6R, mGluR7, and mGluR8; all of which inhibit adenylyl cyclase. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes.
Probab=100.00 E-value=7.8e-39 Score=377.19 Aligned_cols=293 Identities=34% Similarity=0.650 Sum_probs=244.0
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhC-CeeEEEEEEeecCCcchhhhhHHHHHHHH
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKS-SICIAVKEKLVKDSGVAEERAYDDIVTKL 114 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~-gICIA~~~~ip~~~~~~~~~~~~~ii~~l 114 (981)
+|+.|++..|.+||+.++.+++| +.+.+.|.+++++. |+||+..+.++...+ ..++..+++++
T Consensus 150 fR~~p~d~~~~~ai~~~i~~~~w~~Vaii~~~~~yg~~~~~~~~~~~~~~g~~~v~~~~~i~~~~~---~~d~~~~l~~i 226 (463)
T cd06376 150 SRVVPPDSFQAQAMVDIVKALGWNYVSTLASEGNYGESGVEAFTQISREAGGVCIAQSIKIPREPR---PGEFDKIIKRL 226 (463)
T ss_pred EEccCCHHHHHHHHHHHHHHcCCeEEEEEEeCChHHHHHHHHHHHHHHHcCCceEEEEEecCCCCC---HHHHHHHHHHH
Confidence 35789999999999999998888 34567788787776 689999888875443 34677888887
Q ss_pred hcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 115 MTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 115 i~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
++.+++++||++++..++..+++++.++++.|+++||++++|.............++|++++.++..+++||++|+++++
T Consensus 227 k~~~~~~vIvl~~~~~~~~~ll~~a~~~~~~g~~~wig~d~~~~~~~~~~~~~~~~~G~~~~~~~~~~~~~F~~~~~~l~ 306 (463)
T cd06376 227 LETPNARAVIIFANEDDIRRVLEAAKRANQVGHFLWVGSDSWGAKISPILQQEDVAEGAITILPKRASIEGFDAYFTSRT 306 (463)
T ss_pred hccCCCeEEEEecChHHHHHHHHHHHhcCCcCceEEEEeccccccccccccCcceeeeEEEEEeccccchhHHHHHHhCC
Confidence 55578999999999999999999999999998779999999986544333455678999999999999999999999999
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCC-ccccccccHHHHHHHHHHHHHHHHhHhhhcC
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRD-TLAFEKQLQFVSDAVMAFSIALDHMHADLCQ 273 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~-~~~~~~~~~~VydAVyAiAhALh~m~~~lC~ 273 (981)
|+++++|||+.+ +|++.|+|.++..... .....+.|++.+.+... .+.+...+.+|||||||+|||||+|+++.|+
T Consensus 307 ~~~~~~~~~~~~-~w~~~f~c~~~~~~~~--~~~~~~~C~~~~~~~~~~~~~~~~~~~~v~dAVyaiA~ALh~l~~~~c~ 383 (463)
T cd06376 307 LENNRRNVWFAE-FWEENFNCKLTISGSK--KEDTDRKCTGQERIGRDSTYEQEGKVQFVIDAVYAMAHALHSMHKDLCP 383 (463)
T ss_pred cccCCCCcHHHH-HHHHhCCCcccCCCCc--cccccCcCcchhhccccCcccccchhHHHHHHHHHHHHHHHHHHHhhCC
Confidence 999999999999 9999999987522110 01224579998887533 2334457889999999999999999988897
Q ss_pred CCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEECCeEEEe
Q psy1666 274 GKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLEGELRLN 348 (981)
Q Consensus 274 ~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~~~L~in 348 (981)
+..+.|+.+...+||+|++|||+|+|+|.+|++|.||+|||++++|||+|||...++...+++||+|++ ++.||
T Consensus 384 ~~~~~C~~~~~~~~~~l~~~L~~v~F~g~tg~~v~Fd~~G~~~~~Ydi~n~q~~~~~~~~~~~VG~w~~-~l~i~ 457 (463)
T cd06376 384 GYTGVCPEMEPADGKKLLKYIRAVNFNGSAGTPVMFNENGDAPGRYDIFQYQITNTSSPGYRLIGQWTD-ELQLN 457 (463)
T ss_pred CCCCCCccCCCCCHHHHHHHHHhCCccCCCCCeEEeCCCCCCCCceEEEEEEecCCCceeEEEEEEECC-eeEEc
Confidence 666789987788999999999999999999999999999999999999999987677789999999975 66654
No 8
>cd06362 PBP1_mGluR Ligand binding domain of the metabotropic glutamate receptors (mGluR). Ligand binding domain of the metabotropic glutamate receptors (mGluR), which are members of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into cellular responses. mGluRs bind to glutamate and function as an excitatory neurotransmitter; they are involved in learning, memory, anxiety, and the perception of pain. Eight subtypes of mGluRs have been cloned so far, and are classified into three groups according to their sequence similarities, transduction mechanisms, and pharmacological profiles. Group I is composed of mGlu1R and mGlu5R that both stimulate PLC hydrolysis. Group II includes mGlu2R and mGlu3R, which inhibit adenylyl cyclase, as do mGlu4R, mGlu6R, mGlu7R, and mGlu8R, which form group III.
Probab=100.00 E-value=3.5e-35 Score=345.86 Aligned_cols=284 Identities=41% Similarity=0.752 Sum_probs=237.5
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+|+.|++..|..||+.++.+++| +...+.|++++++.|+||+..+.++...+ ..++..++++++
T Consensus 150 fR~~p~d~~~~~a~~~~l~~~~w~~vaii~~~~~~G~~~~~~~~~~~~~~gi~i~~~~~~~~~~~---~~d~~~~l~~l~ 226 (452)
T cd06362 150 SRTVPPDSFQAQAMVDIVKAFNWTYVSTVASEGNYGEKGIEAFEKLAAERGICIAGSEKIPSSAT---EEEFDNIIRKLL 226 (452)
T ss_pred EEecCChHHHHHHHHHHHHHCCCcEEEEEEeCCHHHHHHHHHHHHHHHHCCeeEEEEEEcCCCCC---HHHHHHHHHHHh
Confidence 35779999999999999998887 34578888999999999999999985432 347778888876
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCC
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTV 195 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p 195 (981)
+.+++++||+++....+..+++++.+.+++++++||++++|.............++|++++.++..++++|++|+++++|
T Consensus 227 ~~~~a~viil~~~~~~~~~~~~~a~~~g~~~~~~~i~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~i~~f~~~l~~l~~ 306 (452)
T cd06362 227 SKPNARVVVLFCREDDIRGLLAAAKRLNAEGHFQWIASDGWGARNSVVEGLEDVAEGAITIELQSAEVPGFDEYFLSLTP 306 (452)
T ss_pred hcCCCeEEEEEcChHHHHHHHHHHHHcCCcCceEEEEeccccccchhhcccccccceEEEEEecccccccHHHHhhhCCc
Confidence 65679999999999999999999999999876799999999876544344556789999999999999999999999999
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCC
Q psy1666 196 ENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGK 275 (981)
Q Consensus 196 ~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~ 275 (981)
+++++|+|+.+ ||++.|+|..+.... ......|++++.+.. .+.....+.+|||||||+|||||+|+++.|+..
T Consensus 307 ~~~~~~~~~~~-~w~~~~~c~~~~~~~----~~~~~~c~~~~~~~~-~~~~~~~~~~vyDAV~a~A~AL~~~l~~~~~~~ 380 (452)
T cd06362 307 ENNSRNPWFRE-FWEQKFNCKLTGNGS----TKDNTCCTERILLLS-NYEQESKVQFVIDAVYAMAHALHNMHRDLCPGT 380 (452)
T ss_pred CcCCCChHHHH-HHHHhcCCCcCCCCc----cccCCCCcccccccc-ccccccchhHHHHHHHHHHHHHHHHHHhhCCCC
Confidence 99999999999 999999997543211 111347887766543 223344678999999999999999999889876
Q ss_pred CCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 276 VGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 276 ~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
.+.|+.....+|++|+++|++++|+|.+|+.|.||++||+.+.|||+|||. .++...+++||+|++
T Consensus 381 ~~~c~~~~~~~~~~l~~~l~~v~f~g~tg~~v~Fd~~G~~~~~y~I~~~~~-~~~~~~~~~VG~w~~ 446 (452)
T cd06362 381 TGLCDAMKPIDGRKLLFYLRNVSFSGLAGGPVRFDANGDGPGRYDIFNYQR-TNGKYDYVKVGSWKG 446 (452)
T ss_pred CCCCcCccCCCHHHHHHHHHhCCcCCCCCceEEECCCCCCCCceEEEEEEE-cCCceEEEEEEEEec
Confidence 778987667889999999999999999999999999999999999999996 345678999999975
No 9
>cd06365 PBP1_Pheromone_receptor Ligand-binding domain of the V2R phermone receptor, a member of the family C receptors within the G-protein coupled receptor superfamily. Ligand-binding domain of the V2R phermone receptor, a member of the family C receptors within the G-protein coupled receptor superfamily, which also includes the metabotropic glutamate receptor, the GABAb receptor, the calcium-sensing receptor (CaSR), the T1R taste receptor, and a small group of uncharacterized orphan receptors.
Probab=99.96 E-value=1.7e-29 Score=297.42 Aligned_cols=199 Identities=20% Similarity=0.315 Sum_probs=160.3
Q ss_pred Cccc--cCccccccccCCccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhhhh
Q psy1666 525 KVRS--DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLRAR 602 (981)
Q Consensus 525 K~~~--~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (981)
+.++ ++|+.+..+.....+.++|+|+++++..++|+|++|+++|+|+++++||||
T Consensus 259 ~~wi~s~~w~~~~~~~~~~~~~~~G~lg~~~~~~~~~~f~~fl~~l~~~~~~~npw~----------------------- 315 (469)
T cd06365 259 KVWITTSQWDVTTSPKDFTLNSFHGTLIFSHHHSEIPGFKDFLQTVNPSKYPEDIFL----------------------- 315 (469)
T ss_pred eEEEeeccccccccccccccceeeEEEEEEeccCcCcchHHHhhccCcccCCCccHH-----------------------
Confidence 4455 778776655555677899999999999999999999999999999999975
Q ss_pred hhcchhhhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCCCCCCCCCCCCCcccccCCccc-c----ccchhHHH
Q psy1666 603 VAAGIVSIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLA-F----EKQLQFVS 677 (981)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~~~~~~~~~Ctg~e~L~~~~~~-~----~~~~~~vy 677 (981)
+||||..|+|+++...+ .....|+++++++..... . +..+++||
T Consensus 316 --------------------------~efwe~~f~c~~~~~~~-----~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~v~ 364 (469)
T cd06365 316 --------------------------EKLWWIYFNCSLSKSSC-----KTLKNCLSNASLEWLPLHYFDMAMSEESYNVY 364 (469)
T ss_pred --------------------------HhhHhHhcCcccCcCCc-----cccCCCCCCccccccccccccchhhhhHHHHH
Confidence 79999999998754332 112469998888753221 1 22456899
Q ss_pred HHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCCcEEE
Q psy1666 678 DAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQW 757 (981)
Q Consensus 678 dAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~~~~~ 757 (981)
|||||+|||||+|+.+.|......|.......||||++||+||+|+|.+|++|+||+|||+.+.|||+|||...++...+
T Consensus 365 dAVya~AhALh~~l~c~~~~~~~~~~~~~~~~~~~l~~~l~~v~F~~~~g~~v~Fd~nGd~~~~YdI~n~q~~~~~~~~~ 444 (469)
T cd06365 365 NAVYAVAHALHEMLLQQVETQSENNGKRLIFLPWQLHSFLKNIQFKNPAGDEVNLNQKRKLDTEYDILNYWNFPQGLGLK 444 (469)
T ss_pred HHHHHHHHHHHHHHHhhccCCCcCCCCCCCccHHHHHHHHHhccccCCCCCEEEecCCCCcCceeeEEEEEECCCCCEEE
Confidence 99999999999999644432222333344678999999999999999999999999999999999999999765677889
Q ss_pred EEEEEEEC-----ceEEEecccccc
Q psy1666 758 VQVGEYLE-----GELRLNMSAIQF 777 (981)
Q Consensus 758 ~~VG~~~~-----~~l~in~~~i~W 777 (981)
++||+|+. ++|.||+++|.|
T Consensus 445 ~~VG~~~~~~~~~~~l~i~~~~i~W 469 (469)
T cd06365 445 VKVGEFSPQAPSGQQLSISEEMIEW 469 (469)
T ss_pred EEEEEEeCCCCCCcEEEEehhhccC
Confidence 99999983 479999999998
No 10
>cd06361 PBP1_GPC6A_like Ligand-binding domain of the promiscuous L-alpha-amino acid receptor GPRC6A which is a broad-spectrum amino acid-sensing receptor. This family includes the ligand-binding domain of the promiscuous L-alpha-amino acid receptor GPRC6A which is a broad-spectrum amino acid-sensing receptor, and its fish homolog, the 5.24 chemoreceptor. GPRC6A is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into cellular responses.
Probab=99.96 E-value=4.8e-29 Score=287.72 Aligned_cols=230 Identities=20% Similarity=0.289 Sum_probs=192.4
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchh-hhhHHHHHHHH
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAE-ERAYDDIVTKL 114 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~-~~~~~~ii~~l 114 (981)
+|+.|++.+|++||+.++.+++| +.+.+.|+++++++|+||++.+.++....... .....+.+.++
T Consensus 150 fRt~p~D~~qa~ai~~li~~~~w~~Vaii~~~d~yG~~~~~~f~~~~~~~GicIa~~e~~~~~~~~~~~~~~~~~~~~~~ 229 (403)
T cd06361 150 LRTVPSDFYQTKAMAHLIKKSGWNWVGIIITDDDYGRSALETFIIQAEANGVCIAFKEILPASLSDNTKLNRIIRTTEKI 229 (403)
T ss_pred eECCCchHhHHHHHHHHHHHcCCcEEEEEEecCchHHHHHHHHHHHHHHCCeEEEEEEEecCccCcchhHHHHHHHHHHH
Confidence 46889999999999999999998 55789999999999999999999986432110 11233455566
Q ss_pred hcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccC-CCccceeeEEEEEecCCCCCChHHHHhhc
Q psy1666 115 MTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSD-GSEAEVEGTLSLQPQANPVKGFDDYFLNL 193 (981)
Q Consensus 115 i~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~-~~~~~~~G~l~~~~~~~~ipgF~ef~~~l 193 (981)
+++++++|||+++....+..+++++.++++ + ++||++++|.....+.. .....++|++|+.++..++++|++|++++
T Consensus 230 ik~~~a~vVvv~~~~~~~~~l~~~a~~~g~-~-~~wigs~~w~~~~~~~~~~~~~~~~g~ig~~~~~~~~~~F~~~~~~~ 307 (403)
T cd06361 230 IEENKVNVIVVFARQFHVFLLFNKAIERNI-N-KVWIASDNWSTAKKILTDPNVKKIGKVVGFTFKSGNISSFHQFLKNL 307 (403)
T ss_pred HhcCCCeEEEEEeChHHHHHHHHHHHHhCC-C-eEEEEECcccCccccccCCcccccceEEEEEecCCccchHHHHHHHh
Confidence 678899999999999999999999999998 6 59999999987543333 34467789999999999999999998654
Q ss_pred CCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcC
Q psy1666 194 TVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQ 273 (981)
Q Consensus 194 ~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~ 273 (981)
+ ..+||+||||+|||||++.. |
T Consensus 308 --------------~-----------------------------------------~~~v~~AVyaiA~Al~~~~~--~- 329 (403)
T cd06361 308 --------------L-----------------------------------------IHSIQLAVFALAHAIRDLCQ--E- 329 (403)
T ss_pred --------------h-----------------------------------------HHHHHHHHHHHHHHHHHhcc--C-
Confidence 0 23589999999999999743 2
Q ss_pred CCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEECC
Q psy1666 274 GKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLEG 343 (981)
Q Consensus 274 ~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~~ 343 (981)
+.|+.+.+++||+|+++|++++|+|. |++|.||+|||+++.|||+|||. +++...+++||.|+++
T Consensus 330 ---~~c~~~~~~~~~~l~~~L~~~~f~g~-~~~v~Fd~~gd~~~~y~I~~~~~-~~~~~~~~~vg~~~~~ 394 (403)
T cd06361 330 ---RQCQNPNAFQPWELLGQLKNVTFEDG-GNMYHFDANGDLNLGYDVVLWKE-DNGHMTVTIMAEYDPQ 394 (403)
T ss_pred ---CCCCCCCCcCHHHHHHHHheeEEecC-CceEEECCCCCCCcceEEEEeEe-cCCcEEEEEEEEEeCC
Confidence 45888778899999999999999998 77899999999999999999997 7788899999999974
No 11
>cd06364 PBP1_CaSR Ligand-binding domain of the CaSR calcium-sensing receptor, which is a member of the family C receptors within the G-protein coupled receptor superfamily. Ligand-binding domain of the CaSR calcium-sensing receptor, which is a member of the family C receptors within the G-protein coupled receptor superfamily. CaSR provides feedback control of extracellular calcium homeostasis by responding sensitively to acute fluctuations in extracellular ionized Ca2+ concentration. This ligand-binding domain has homology to the bacterial leucine-isoleucine-valine binding protein (LIVBP) and a leucine binding protein (LBP). CaSR is widely expressed in mammalian tissues and is active in tissues that are not directly involved in extracellular calcium homeostasis. Moreover, CaSR responds to aromatic, aliphatic, and polar amino acids, but not to positively charged or branched chain amino acids, which suggests that changes in plasma amino acid levels are likely to modulate whole body calci
Probab=99.96 E-value=6.1e-29 Score=294.78 Aligned_cols=203 Identities=23% Similarity=0.446 Sum_probs=164.1
Q ss_pred CCccc--cCccccccccC-CccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhh
Q psy1666 524 PKVRS--DGWSARGLVSD-GSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLR 600 (981)
Q Consensus 524 PK~~~--~~w~~~~~~~~-~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (981)
+|+++ ++|..+..+.. .....++|+|++.++..++++|++||.+++|+++++|+|
T Consensus 271 ~~iwI~s~~w~~~~~~~~~~~~~~~gg~lg~~~~~~~i~~f~~~l~~l~p~~~~~~~~---------------------- 328 (510)
T cd06364 271 GKIWLASEAWASSSLIAMPEYFDVMGGTIGFALKAGQIPGFREFLQKVHPKKSSHNGF---------------------- 328 (510)
T ss_pred CcEEEEEchhhcccccccCCccceeeEEEEEEECCCcCccHHHHHHhCCcccCCCChH----------------------
Confidence 57776 78877666654 456889999999999999999999999999999999986
Q ss_pred hhhhcchhhhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCC------------------CCCCCCCCCCCcccc
Q psy1666 601 ARVAAGIVSIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTP------------------YNSHYSTECTTHEKL 662 (981)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~------------------~~~~~~~~Ctg~e~L 662 (981)
+++|||..|+|+++....+. ......+.|++++.+
T Consensus 329 ---------------------------~~~~we~~f~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~ 381 (510)
T cd06364 329 ---------------------------AKEFWEETFNCYLEDSPKNALPVDTFLGHEESGDDSENGSTAFRPLCTGDENI 381 (510)
T ss_pred ---------------------------HHHHHHHhcCCCCCCCcccccccccccccccccccccccccccCCCCCChhhh
Confidence 48999999999875411100 000122479999988
Q ss_pred cCCccc-cc----cchhHHHHHHHHHHHHHHHhHHhhccCCC-----CCCCCCCCCChhhHhhhhccccccCCCCCeEEe
Q psy1666 663 SRDTLA-FE----KQLQFVSDAVMAFSIALDHMHADLCQGKV-----GLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 732 (981)
Q Consensus 663 ~~~~~~-~~----~~~~~vydAVyaiAhALh~~l~~~c~~~~-----~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~F 732 (981)
...... .+ ...++|||||||+|||||+|+. |+... +.|+.+..+.||||++|||||+|++.+|++|.|
T Consensus 382 ~~~~~~~~~~~~~~~~~~v~~AVyAvAhaLh~~~~--c~~~~~~~~~~~c~~~~~~~~~~l~~~L~~v~F~~~~g~~v~F 459 (510)
T cd06364 382 ASVETPYLDYTHLRISYNVYLAVYSIAHALQDIYT--CTPGKGLFTNGSCADIKKVEAWQVLKHLRHLNFTDNMGEQVRF 459 (510)
T ss_pred cccCCccccccchhhHHHHHHHHHHHHHHHHHHhc--CCCCCCCccCCCCCCCCCCCHHHHHHHHHhcEEecCCCCEEEE
Confidence 642222 12 2357899999999999999984 76432 479887678999999999999999999999999
Q ss_pred ccCCCCcceeeEEEeEEcC-CCcEEEEEEEEEEC-----ceEEEecccccc
Q psy1666 733 DKDGDGPARYNIIHFKQIR-PGVYQWVQVGEYLE-----GELRLNMSAIQF 777 (981)
Q Consensus 733 d~~Gd~~~~YdI~n~~~~~-~~~~~~~~VG~~~~-----~~l~in~~~i~W 777 (981)
|+|||+.+.|||+|||..+ ++...+++||+|++ ++|.||+++|.|
T Consensus 460 d~~Gd~~~~YdI~n~q~~~~~~~~~~v~VG~~~~~~~~~~~l~i~~~~i~W 510 (510)
T cd06364 460 DEGGDLVGNYSIINWHLSPEDGSVVFKEVGYYNVYAKKGERLFINESKILW 510 (510)
T ss_pred ecCCCCccceeEEEeeecCCCCcEEEEEEEEEcCCCCCCceEEeccccccC
Confidence 9999999999999999876 67788999999983 589999999999
No 12
>cd06375 PBP1_mGluR_groupII Ligand binding domain of the group II metabotropic glutamate receptor. Ligand binding domain of the group II metabotropic glutamate receptor, a family that contains mGlu2R and mGlu3R, all of which inhibit adenylyl cyclase. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes
Probab=99.96 E-value=9.8e-29 Score=289.91 Aligned_cols=182 Identities=40% Similarity=0.788 Sum_probs=151.3
Q ss_pred cCccccccccCCccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhhhhhhcchh
Q psy1666 529 DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLRARVAAGIV 608 (981)
Q Consensus 529 ~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (981)
++|.....+.....+.++|+|+|.++..++++|++||++|+|+++++||||
T Consensus 265 ~~~~~~~~~~~~~~~~~~G~i~~~~~~~~i~~f~~yl~~l~p~~~~~n~w~----------------------------- 315 (458)
T cd06375 265 DGWGAQESIVKGSEDVAEGAITIELASHPIPDFDRYFQSLTPETNTRNPWF----------------------------- 315 (458)
T ss_pred ccccccchhhhccchhhceEEEEEeccccchhHHHHHHhCCcCcCCCCcHH-----------------------------
Confidence 778754433444557789999999999999999999999999999999975
Q ss_pred hhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCCCCCCCCCCCCCcccccCC-ccccccchhHHHHHHHHHHHHH
Q psy1666 609 SIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRD-TLAFEKQLQFVSDAVMAFSIAL 687 (981)
Q Consensus 609 ~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~~~~~~~~~Ctg~e~L~~~-~~~~~~~~~~vydAVyaiAhAL 687 (981)
+||||..|+|+.+.... ....|++.+.+... .+..+..+++|||||||+||||
T Consensus 316 --------------------~e~w~~~f~c~~~~~~~------~~~~C~~~~~~~~~~~~~~~~~~~~v~~AVyA~AhaL 369 (458)
T cd06375 316 --------------------KDFWEQKFQCSLQNRDC------ANTTTNDKERLLDKVNYEQESKIMFVVNAVYAMAHAL 369 (458)
T ss_pred --------------------HHHHHHHcCCCCCCCCc------cCCCCCchhcccccCcccccchHHHHHHHHHHHHHHH
Confidence 79999999998754331 12469988887652 1222446789999999999999
Q ss_pred HHhHHhhccCCCCCCCCCCCCChhhHh-hhhcccccc-----CCCCCeEEeccCCCCcceeeEEEeEEcCCC-cEEEEEE
Q psy1666 688 DHMHADLCQGKVGLCDAMRPTKGPELL-KYLRKVSFQ-----GLSEDHFKFDKDGDGPARYNIIHFKQIRPG-VYQWVQV 760 (981)
Q Consensus 688 h~~l~~~c~~~~~~c~~~~~~~~~qL~-~~L~~v~F~-----~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~-~~~~~~V 760 (981)
|+|+.+.|+...+.|+.+..++||||+ +||+||+|+ +.+|++|.||+|||+.+.|||+|||...++ ...+++|
T Consensus 370 h~~l~~~c~~~~~~c~~~~~~~~~~l~~~~L~~v~F~~~~~~~~~g~~v~Fd~nGd~~~~YdI~n~q~~~~~~~~~~~~V 449 (458)
T cd06375 370 HNMQRDLCPNTTKLCDAMKPLDGKKLYKEYLLNVSFTAPFRPDLADSEVKFDSQGDGLGRYNIFNYQRTGNSYGYRYVGV 449 (458)
T ss_pred HHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHhccccccccCCCCCCeeEECCCCCCCcceEEEEEEEcCCCCcEEEEEE
Confidence 999987787666779987788999999 599999999 999999999999999999999999976555 7789999
Q ss_pred EEEEC
Q psy1666 761 GEYLE 765 (981)
Q Consensus 761 G~~~~ 765 (981)
|+|+.
T Consensus 450 G~w~~ 454 (458)
T cd06375 450 GAWAN 454 (458)
T ss_pred EEEec
Confidence 99963
No 13
>KOG1055|consensus
Probab=99.96 E-value=2e-29 Score=287.32 Aligned_cols=427 Identities=23% Similarity=0.369 Sum_probs=309.5
Q ss_pred cchHHHHHHHHhcCCCCCCCCCcceeeEEeecchh-------------HHHHHHHHHHhCCeeEEEEEEeecCCcchhhh
Q psy1666 39 ERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETT-------------AFEELEVLLAKSSICIAVKEKLVKDSGVAEER 105 (981)
Q Consensus 39 ~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~-------------~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~ 105 (981)
++.|-..++ +.|||..+...+++++..++|.+ -.++|...+...++-|.+.+.+..+..
T Consensus 152 r~rfp~~fr---t~PS~~~~np~rl~l~~~~~w~rvgt~~q~e~~f~~~~~dl~~~~~~~~ieiv~~qsf~~dp~----- 223 (865)
T KOG1055|consen 152 RKRFPTFFR---THPSANAHNPTRIKLLKKFGWKRVATLQQTEEVFSSTLNDLEARLKEAGIEIVFRQSFSSDPA----- 223 (865)
T ss_pred hhhcchhhh---cCCccccCCcceeeechhcCcceeeeeeeehhhhcchHHHHHHhhhccccEEEEeeccccCHH-----
Confidence 334655555 99999999999999999999943 356777777777887777766654432
Q ss_pred hHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCcccccc--c--------CCCccceeeEE
Q psy1666 106 AYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGLV--S--------DGSEAEVEGTL 174 (981)
Q Consensus 106 ~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~~--~--------~~~~~~~~G~l 174 (981)
..+.++ +..++|+|+-+-.+..++..++++++.++.| +|+|+.. +|....+. . ......++|.+
T Consensus 224 ---~~vk~l-~~~D~RiI~g~f~~~~Arkv~C~~Y~~~myg~ky~w~~~-g~y~d~w~ev~~~~~~ctveem~~A~eg~~ 298 (865)
T KOG1055|consen 224 ---DSVKNL-KRQDARIIVGLFYETEARKVFCEAYKERLYGRKYVWFLI-GWYADNWWEITHPSENCTVEEMTEAAEGHI 298 (865)
T ss_pred ---HHHhhc-cccchhheeccchHhhhhHHHHhhchhhcccceeEEEEE-EeeccchhhccCchhhhhHHHHHHHHhhhe
Confidence 234444 6678999999999999999999999999988 5888854 55433221 0 11223455666
Q ss_pred EEEec---CC---CCCCh--HHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCcccc
Q psy1666 175 SLQPQ---AN---PVKGF--DDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAF 246 (981)
Q Consensus 175 ~~~~~---~~---~ipgF--~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~ 246 (981)
++... +. .+.|- .+|++.+.+.. ...|. ....
T Consensus 299 s~e~~pl~~~~~~tisg~T~~~~l~~~~~~r--------------------------------~~~~~--------~~~~ 338 (865)
T KOG1055|consen 299 TTEFVMLSPANITTISGMTAQEFLEELTKYR--------------------------------KRHPE--------ETGG 338 (865)
T ss_pred eeeeeccccccceeeccchhHHHHHHHHhhh--------------------------------ccccc--------cccC
Confidence 55221 11 12221 23332221110 00110 0001
Q ss_pred ccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCC--CCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEE
Q psy1666 247 EKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCD--AMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHF 324 (981)
Q Consensus 247 ~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~--~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~ 324 (981)
.....+.||||||+|||+...+..+-+....+-+ +.+..-..++++.+++.+|.|.+| .|.|+. ||+.+.-.|-||
T Consensus 339 ~~~~~~ayd~Iwa~ala~n~t~e~l~~~~~~l~~f~y~~k~i~d~i~eamn~tsF~GvsG-~V~F~~-geR~a~t~ieQ~ 416 (865)
T KOG1055|consen 339 FQEAPLAYDAIWALALALNKTMEGLGRSHVRLEDFNYNNKTIADQIYEAMNSTSFEGVSG-HVVFSN-GERMALTLIEQF 416 (865)
T ss_pred cccCchHHHHHHHHHHHHHHHHhcCCccceeccccchhhhHHHHHHHHHhhccccccccc-ceEecc-hhhHHHHHHHHH
Confidence 1235679999999999999987543221111111 122334568999999999999999 699988 999999999998
Q ss_pred EEcCCCcEEEEEEEEEEC--CeEEEec-----------------------------------------------------
Q psy1666 325 KQIRPGVYQWVQVGEYLE--GELRLNM----------------------------------------------------- 349 (981)
Q Consensus 325 q~~~~g~~~~v~VG~~~~--~~L~in~----------------------------------------------------- 349 (981)
|. | .|+++|.|+. +.|.+-+
T Consensus 417 qd---g--~y~k~g~Yds~~D~ls~~n~~~w~~g~ppkd~Tv~~~~~~~~S~~~~~~~~~~s~Lg~~~~~~~l~f~~~~~ 491 (865)
T KOG1055|consen 417 QD---G--KYKKIGYYDSTKDDLSWINTEKWIGGSPPKDSTLIIKTFRFVSQKLYISVSSLSSLGIILAVVFLSFNIKNR 491 (865)
T ss_pred hC---C--ceEeecccccccchhhccccceEeccCCCcccceeehcccccCcchhhhhhHHHHHHHHHHHHhchhhhhhh
Confidence 73 3 6899999983 1222100
Q ss_pred --------------------------------------------------cchhhhHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1666 350 --------------------------------------------------FGAGFCFTVVYAALLTKTNRISRIFNAGKR 379 (981)
Q Consensus 350 --------------------------------------------------~~~~~~ft~~~S~ll~KT~~I~~iF~~~~~ 379 (981)
|.++++||+.++|+|+||+||..+|...+
T Consensus 492 ~q~~i~~s~P~~nni~~~G~~~~~~sv~~lgLd~~~Isv~~f~~lc~~r~w~l~~gft~~~Gamf~K~w~Vh~if~~~~- 570 (865)
T KOG1055|consen 492 NQRYIKMSSPNLNNLIIVGCSLTLASVFLLGLDGYSISVNAFPFLCTARTWILGLGFTLAFGAMFAKTWRVHSIFTNQK- 570 (865)
T ss_pred hhhhhccCCCCCCcceeeccceeeeeeeeccCCcceecHHHHHHHHHHHHHHHhheeecccchhhhhhheeeEeecccc-
Confidence 88999999999999999999999997522
Q ss_pred CCCCCceeccccceeeehhHHHHHHHHHHHhhcccCCCccc----ccCC---CcC-E---EEEcCC-CChHHHHHHHHHH
Q psy1666 380 TAKRPNFITPKSQLMICGGLVSVQVLINGVWMLVSPPRAIH----HYPS---RED-N---ILVCSS-FINASYMIAFGYP 447 (981)
Q Consensus 380 ~~~~~~~i~~~~q~~iv~~~~~vqv~i~~~Wl~~~PP~~~~----~~p~---~~~-~---il~C~~-~s~~~~~~~l~Y~ 447 (981)
-+++-+.+...+.++.++..++++++++|.++||-+.+. ..|. ++. + .-+|++ .+.+|+.++.||.
T Consensus 571 --~~kK~~e~~Kl~~ivg~Ll~iD~~il~~WqivdPl~rt~ekl~~ep~~~~~Dv~I~PelE~Ces~~~~iwlgivya~K 648 (865)
T KOG1055|consen 571 --MWKKVIEDSKLYVIVGLLLAIDVLILAIWQIVDPLHRTEEKLSKEPPKNDRDVSIIPELEHCESEHMTIWLGIVYAYK 648 (865)
T ss_pred --ccccccccceeEeehhHHHHhHHHHhhhhhccChhhhhhhhcCCCCCCcccccccchhhhhhcccccchhhhhhhhhh
Confidence 234456677788899999999999999999999986311 1111 111 1 245975 7889999999999
Q ss_pred HHHHHHHHHHHHhcCCCC-CcchhhhHHHHHHHHHHHHHHHhhhcccccCCcceeeehhHHHHHHHhhhhheeEEecCCc
Q psy1666 448 IFLIVVCTVYAILTRNIP-EAFNESKHIGFTMYTTCVIWLAFVPLYFGTGNHMPLRITTMSVTISLSASVTVACLFSPKV 526 (981)
Q Consensus 448 ~lL~l~c~~~Af~~R~lP-~nfNEAK~ItFsml~~~ivWiafiP~y~~t~g~~~~~~~~~~~~Il~s~~~~L~ciF~PK~ 526 (981)
|+|++++.++||.||++- ..-|++|||+++.|..++.+++--|+-++..++.....+..+.+|..|++..|+.+|.||+
T Consensus 649 glllvfG~FLA~ETR~V~i~~INDskyiG~svyNVfv~cli~a~V~~v~~sq~da~Fa~~sl~Iifc~t~tl~lifvpKv 728 (865)
T KOG1055|consen 649 GLLLLFGCFLAWETRNVSIPAINDSKYIGMSVYNVFVMCLITAPVTLVLSSQKDAAFAFVSLFIIFCSTITLCLVFVPKL 728 (865)
T ss_pred hHHHHHhHHhhhhccccchhhhccccccceeeeeeeEEeeecCceeeeeecccccceehhhhHHHhhhhhhhheecchhh
Confidence 999999999999999999 8999999999999999999999999999888865455566678899999999999999999
Q ss_pred cc
Q psy1666 527 RS 528 (981)
Q Consensus 527 ~~ 528 (981)
+-
T Consensus 729 ~~ 730 (865)
T KOG1055|consen 729 RH 730 (865)
T ss_pred ee
Confidence 76
No 14
>cd06376 PBP1_mGluR_groupIII Ligand-binding domain of the group III metabotropic glutamate receptor. Ligand-binding domain of the group III metabotropic glutamate receptor, a family which contains mGlu4R, mGluR6R, mGluR7, and mGluR8; all of which inhibit adenylyl cyclase. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes.
Probab=99.95 E-value=3.3e-27 Score=278.50 Aligned_cols=197 Identities=39% Similarity=0.770 Sum_probs=162.6
Q ss_pred cCccccccccCCccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhhhhhhcchh
Q psy1666 529 DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLRARVAAGIV 608 (981)
Q Consensus 529 ~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (981)
++|+..........+.++|++++.++..++++|++|+.+++|+++++||||
T Consensus 266 d~~~~~~~~~~~~~~~~~G~~~~~~~~~~~~~F~~~~~~l~~~~~~~~~~~----------------------------- 316 (463)
T cd06376 266 DSWGAKISPILQQEDVAEGAITILPKRASIEGFDAYFTSRTLENNRRNVWF----------------------------- 316 (463)
T ss_pred ccccccccccccCcceeeeEEEEEeccccchhHHHHHHhCCcccCCCCcHH-----------------------------
Confidence 788765545445667899999999999999999999999999999999975
Q ss_pred hhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCCCCCCCCCCCCCcccccCCc-cccccchhHHHHHHHHHHHHH
Q psy1666 609 SIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDT-LAFEKQLQFVSDAVMAFSIAL 687 (981)
Q Consensus 609 ~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~~~~~~~~~Ctg~e~L~~~~-~~~~~~~~~vydAVyaiAhAL 687 (981)
.++|+..|+|.++...... ......|++.+.+.... +..+..+++|||||||+||||
T Consensus 317 --------------------~~~w~~~f~c~~~~~~~~~--~~~~~~C~~~~~~~~~~~~~~~~~~~~v~dAVyaiA~AL 374 (463)
T cd06376 317 --------------------AEFWEENFNCKLTISGSKK--EDTDRKCTGQERIGRDSTYEQEGKVQFVIDAVYAMAHAL 374 (463)
T ss_pred --------------------HHHHHHhCCCcccCCCCcc--ccccCcCcchhhccccCcccccchhHHHHHHHHHHHHHH
Confidence 7999999999875221100 01224799998875422 223445679999999999999
Q ss_pred HHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCCcEEEEEEEEEECce
Q psy1666 688 DHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLEGE 767 (981)
Q Consensus 688 h~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~~~~~~~VG~~~~~~ 767 (981)
|+|+.+.|++..+.|+.....+||+|++|||+|+|+|.+|++|.||++||+.+.|||+|||...++...+++||.|++ +
T Consensus 375 h~l~~~~c~~~~~~C~~~~~~~~~~l~~~L~~v~F~g~tg~~v~Fd~~G~~~~~Ydi~n~q~~~~~~~~~~~VG~w~~-~ 453 (463)
T cd06376 375 HSMHKDLCPGYTGVCPEMEPADGKKLLKYIRAVNFNGSAGTPVMFNENGDAPGRYDIFQYQITNTSSPGYRLIGQWTD-E 453 (463)
T ss_pred HHHHHhhCCCCCCCCccCCCCCHHHHHHHHHhCCccCCCCCeEEeCCCCCCCCceEEEEEEecCCCceeEEEEEEECC-e
Confidence 999977786555679876567899999999999999999999999999999999999999987667788999999975 8
Q ss_pred EEEecccccc
Q psy1666 768 LRLNMSAIQF 777 (981)
Q Consensus 768 l~in~~~i~W 777 (981)
+.||+++|.|
T Consensus 454 l~i~~~~i~W 463 (463)
T cd06376 454 LQLNIEDMQW 463 (463)
T ss_pred eEEccccccC
Confidence 9999999998
No 15
>PF00003 7tm_3: 7 transmembrane sweet-taste receptor of 3 GCPR; InterPro: IPR017978 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes). They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups. We use the term clan to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include the rhodopsin-like GPCRs, the secretin-like GPCRs, the cAMP receptors, the fungal mating pheromone receptors, and the metabotropic glutamate receptor family. There is a specialised database for GPCRs (http://www.gpcr.org/7tm/). GPCR family 3 receptors (also known as family C) are structurally similar to other GPCRs, but do not show any significant sequence similarity and thus represent a distinct group. Structurally they are composed of four elements; an N-terminal signal sequence; a large hydrophilic extracellular agonist-binding region containing several conserved cysteine residues which could be involved in disulphide bonds; a shorter region containing seven transmembrane domains; and a C-terminal cytoplasmic domain of variable length []. Family 3 members include the metabotropic glutamate receptors, the extracellular calcium-sensing receptors, the gamma-amino-butyric acid (GABA) type B receptors, and the vomeronasal type-2 receptors [, , , ]. As these receptors regulate many important physiological processes they are potentially promising targets for drug development. This entry represents the C-terminal region of family 3 GPCR receptor proteins, which contains the seven transmembrane region. The seven TM regions assemble in such a way as to produce a docking pocket into which such molecules as cyclamate and lactisole have been found to bind and consequently confer the taste of sweetness []. ; GO: 0004930 G-protein coupled receptor activity, 0007186 G-protein coupled receptor protein signaling pathway, 0016021 integral to membrane
Probab=99.95 E-value=2.3e-28 Score=262.57 Aligned_cols=175 Identities=38% Similarity=0.640 Sum_probs=154.9
Q ss_pred cchhhhHHHHHHHHHHHHHHHHHHhcCCCCCCCCCceec-cccceeeehhHHHHHHHHHHHhhcccCCCccccc-CCCcC
Q psy1666 350 FGAGFCFTVVYAALLTKTNRISRIFNAGKRTAKRPNFIT-PKSQLMICGGLVSVQVLINGVWMLVSPPRAIHHY-PSRED 427 (981)
Q Consensus 350 ~~~~~~ft~~~S~ll~KT~~I~~iF~~~~~~~~~~~~i~-~~~q~~iv~~~~~vqv~i~~~Wl~~~PP~~~~~~-p~~~~ 427 (981)
++++++|++++|++++|++|++++|+.++. ++++..+ ++.|..+++.++++|+++++.|+.++||.+..+. ....+
T Consensus 61 ~~~~l~f~l~~~~ll~K~~ri~~if~~~~~--~~~~~~~~~~~~~~~~~~~~~v~~ii~~~w~~~~p~~~~~~~~~~~~~ 138 (238)
T PF00003_consen 61 WLFSLGFTLIFSALLAKTWRIYRIFRNPSR--KRRRLISSNRSLLLLVLLLVLVQVIILIIWLILDPPTPVSDIDISSNE 138 (238)
T ss_pred eeeeeehHhhhhHHHHhhhheeeeeccCCC--CCcccccCCcchhhheeeeeeehhhhhhhhhhcccccccccccccceE
Confidence 789999999999999999999999985432 2333344 8999999999999999999999999999642222 33345
Q ss_pred EEEEcCCCChHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHHHHHHHHHHHHhhhcccccCCcceeeehhHH
Q psy1666 428 NILVCSSFINASYMIAFGYPIFLIVVCTVYAILTRNIPEAFNESKHIGFTMYTTCVIWLAFVPLYFGTGNHMPLRITTMS 507 (981)
Q Consensus 428 ~il~C~~~s~~~~~~~l~Y~~lL~l~c~~~Af~~R~lP~nfNEAK~ItFsml~~~ivWiafiP~y~~t~g~~~~~~~~~~ 507 (981)
...+|++++..+++..++|+++|+++|+++||++||+|+||||||||+++||+++++|++++|.|+.+++. .+....+
T Consensus 139 ~~~~C~~~~~~~~~~~~~y~~~Ll~~~~~la~~~R~~~~~~nEa~~I~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 216 (238)
T PF00003_consen 139 IYLSCSSNSNIWLILSLGYNGLLLLIGFFLAFKTRNVPSNFNEARYIAFAIYNITIIWIIFIPLYFVTDGE--WRFLIIS 216 (238)
T ss_pred EEEEecCCccchHHHHHHHHHHHHHHHHHHHHhhCCCCcccchhhhHhHhHHHHHHHHHHhhhheeeccch--HHHHHHH
Confidence 67999767899999999999999999999999999999999999999999999999999999999999987 6678889
Q ss_pred HHHHHhhhhheeEEecCCccc
Q psy1666 508 VTISLSASVTVACLFSPKVRS 528 (981)
Q Consensus 508 ~~Il~s~~~~L~ciF~PK~~~ 528 (981)
++++++++++|+|+|+||+|+
T Consensus 217 ~~~~~~~~~~l~~lF~PKi~~ 237 (238)
T PF00003_consen 217 FGILLCATVTLGLLFIPKIYI 237 (238)
T ss_pred HHHHHHHHHHHHHhhhheEEe
Confidence 999999999999999999996
No 16
>cd06374 PBP1_mGluR_groupI Ligand binding domain of the group I metabotropic glutamate receptor. Ligand binding domain of the group I metabotropic glutamate receptor, a family containing mGlu1R and mGlu5R, all of which stimulate phospholipase C (PLC) hydrolysis. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes.
Probab=99.93 E-value=1.8e-25 Score=264.31 Aligned_cols=196 Identities=40% Similarity=0.829 Sum_probs=155.9
Q ss_pred Cccc--cCccccccccCCccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhhhh
Q psy1666 525 KVRS--DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLRAR 602 (981)
Q Consensus 525 K~~~--~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (981)
+.++ ++|.....+.....+..+|+|++.++..++++|++||++++|+++++||||
T Consensus 274 ~~wi~s~~~~~~~~~~~~~~~~~~G~l~~~~~~~~~~~F~~~l~~l~~~~~~~~~~~----------------------- 330 (472)
T cd06374 274 FQLIGSDGWADRDDVVEGYEEEAEGGITIKLQSPEVPSFDDYYLKLRPETNTRNPWF----------------------- 330 (472)
T ss_pred eEEEEecccccchHhhhcchhhhheeEEEEecCCCCccHHHHHHhCCcccCCCChHH-----------------------
Confidence 3444 777754444444556789999999999999999999999999999999975
Q ss_pred hhcchhhhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCCCCCCCCCCCCCcccccCCccccccchhHHHHHHHH
Q psy1666 603 VAAGIVSIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMA 682 (981)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~~~~~~~~~Ctg~e~L~~~~~~~~~~~~~vydAVya 682 (981)
++||+..|+|.+++.... ...+...|++.++++.. +..+....+|||||||
T Consensus 331 --------------------------~~~w~~~f~c~~~~~~~~--~~~~~~~c~~~~~~~~~-~~~~~~~~~vyDAVya 381 (472)
T cd06374 331 --------------------------REFWQHRFQCRLPGHPQE--NPNYIKICTGNESLDEQ-YVQDSKMGFVINAIYA 381 (472)
T ss_pred --------------------------HHHHHHhcCCCcCCccCc--CCccCCCCCCccccccc-ccccceeHHHHHHHHH
Confidence 799999999987433211 11223469988766432 1112234589999999
Q ss_pred HHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCCcEEEEEEEE
Q psy1666 683 FSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGE 762 (981)
Q Consensus 683 iAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~~~~~~~VG~ 762 (981)
+|||||+|+.+.|......|+......+++|+++|++++|+|.+|++|.||++||+.+.|||+|||...++...+++||+
T Consensus 382 iA~ALh~~~~~~~~~~~~~c~~~~~~~~~~l~~~l~~v~F~g~tG~~v~Fd~~G~~~~~ydI~n~~~~~~~~~~~~~VG~ 461 (472)
T cd06374 382 MAHGLHNMHQDLCPGHVGLCDAMKPIDGRKLLEYLLKTSFSGVSGEEVYFDENGDSPGRYDIMNLQYTEDLRFDYINVGS 461 (472)
T ss_pred HHHHHHHHHHhhCCCCCCCCcCCCCCCHHHHHHHHHhCcccCCCCCeEEEcCCCCCCCceEEEEEEECCCCCEEEEEEEE
Confidence 99999999876775555678875567899999999999999999999999999999999999999986677788999999
Q ss_pred EECceEEEec
Q psy1666 763 YLEGELRLNM 772 (981)
Q Consensus 763 ~~~~~l~in~ 772 (981)
|++.+|.||+
T Consensus 462 w~~~~l~~~~ 471 (472)
T cd06374 462 WHEGDLGIDD 471 (472)
T ss_pred EeCCcccccC
Confidence 9877888864
No 17
>cd06362 PBP1_mGluR Ligand binding domain of the metabotropic glutamate receptors (mGluR). Ligand binding domain of the metabotropic glutamate receptors (mGluR), which are members of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into cellular responses. mGluRs bind to glutamate and function as an excitatory neurotransmitter; they are involved in learning, memory, anxiety, and the perception of pain. Eight subtypes of mGluRs have been cloned so far, and are classified into three groups according to their sequence similarities, transduction mechanisms, and pharmacological profiles. Group I is composed of mGlu1R and mGlu5R that both stimulate PLC hydrolysis. Group II includes mGlu2R and mGlu3R, which inhibit adenylyl cyclase, as do mGlu4R, mGlu6R, mGlu7R, and mGlu8R, which form group III.
Probab=99.88 E-value=3.9e-22 Score=235.03 Aligned_cols=182 Identities=48% Similarity=0.897 Sum_probs=144.8
Q ss_pred cCccccccccCCccceeeeEEEeeecCCCCcchhhcccccCccCCCCCcccccccceeeeeeeccCcchhhhhhhhcchh
Q psy1666 529 DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDTRAYVVFRVILDKPRNMLRARVAAGIV 608 (981)
Q Consensus 529 ~~w~~~~~~~~~~~~~~~G~l~~~~~~~~i~~f~~fl~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (981)
++|...........+..+|++++.++..++++|++|+.+++|+++++|+|
T Consensus 265 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~i~~f~~~l~~l~~~~~~~~~~------------------------------ 314 (452)
T cd06362 265 DGWGARNSVVEGLEDVAEGAITIELQSAEVPGFDEYFLSLTPENNSRNPW------------------------------ 314 (452)
T ss_pred ccccccchhhcccccccceEEEEEecccccccHHHHhhhCCcCcCCCChH------------------------------
Confidence 66765443334455778999999999999999999999999999999886
Q ss_pred hhhhhcccccCCCCCchhhHHHHHHhcCCCcCCCCCCCCCCCCCCCCCCCcccccCCccccccchhHHHHHHHHHHHHHH
Q psy1666 609 SIALSISSLRDATSPTFFSSTEFWEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALD 688 (981)
Q Consensus 609 ~~~~~~~~~~~~~~p~~~~l~efWe~~f~C~~~~~~~~~~~~~~~~~Ctg~e~L~~~~~~~~~~~~~vydAVyaiAhALh 688 (981)
+++||+..|+|..+..... .....|++++.+... +..+....++||||||+|||||
T Consensus 315 -------------------~~~~w~~~~~c~~~~~~~~----~~~~~c~~~~~~~~~-~~~~~~~~~vyDAV~a~A~AL~ 370 (452)
T cd06362 315 -------------------FREFWEQKFNCKLTGNGST----KDNTCCTERILLLSN-YEQESKVQFVIDAVYAMAHALH 370 (452)
T ss_pred -------------------HHHHHHHhcCCCcCCCCcc----ccCCCCccccccccc-cccccchhHHHHHHHHHHHHHH
Confidence 4899999999986543211 112368877665431 1122345799999999999999
Q ss_pred HhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCCcEEEEEEEEEEC
Q psy1666 689 HMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 689 ~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~~~~~~~VG~~~~ 765 (981)
+|+.+.|+.....|+.....++++|+++|++++|+|.+|+.|.||++||+.+.|||+|||. .++...+++||+|++
T Consensus 371 ~~l~~~~~~~~~~c~~~~~~~~~~l~~~l~~v~f~g~tg~~v~Fd~~G~~~~~y~I~~~~~-~~~~~~~~~VG~w~~ 446 (452)
T cd06362 371 NMHRDLCPGTTGLCDAMKPIDGRKLLFYLRNVSFSGLAGGPVRFDANGDGPGRYDIFNYQR-TNGKYDYVKVGSWKG 446 (452)
T ss_pred HHHHhhCCCCCCCCcCccCCCHHHHHHHHHhCCcCCCCCceEEECCCCCCCCceEEEEEEE-cCCceEEEEEEEEec
Confidence 9997777655566876546779999999999999999999999999999999999999996 345678999999974
No 18
>cd06379 PBP1_iGluR_NMDA_NR1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR1, an essential channel-forming subunit of the NMDA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR1, an essential channel-forming subunit of the NMDA receptor. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer ccomposed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. When co-expressed with NR1, the NR3 subunits form receptors that are activated by glycine alone and therefore
Probab=99.85 E-value=6.4e-21 Score=219.28 Aligned_cols=216 Identities=23% Similarity=0.337 Sum_probs=169.7
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCe----eEEEEEEeecCCcchhhhhHHHHH
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSI----CIAVKEKLVKDSGVAEERAYDDIV 111 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gI----CIA~~~~ip~~~~~~~~~~~~~ii 111 (981)
+|+.|++.+|..|++.++.+++| +.+.+.|++.+++.|+ ||+..+.++... .++...+
T Consensus 132 ~R~~psd~~~~~a~~~~l~~~~w~~vaii~~~~~~g~~~~~~~~~~~~~~g~~~~~~v~~~~~~~~~~-----~d~~~~l 206 (377)
T cd06379 132 LRTVPPYSHQADVWLEMLRSFKWNKVILLVSDDHEGRAAQKRFETLLEEREIEFKIKVEKVVEFEPGE-----KNVTSLL 206 (377)
T ss_pred EEecCCHHHHHHHHHHHHHHcCCeEEEEEEEcCcchhHHHHHHHHHHHhcCCccceeeeEEEecCCch-----hhHHHHH
Confidence 46779999999999999999988 2367889999999999 999888886432 3567778
Q ss_pred HHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHH
Q psy1666 112 TKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYF 190 (981)
Q Consensus 112 ~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~ 190 (981)
+++ +.+++++|+++++...+..+++++.+++++|. ++||+++.|.... ....|.+|+++....
T Consensus 207 ~~i-k~~~~~vIvl~~~~~~~~~l~~qa~~~g~~~~~~~wi~t~~~~~~~-------~~~~g~~g~~~~~~~-------- 270 (377)
T cd06379 207 QEA-KELTSRVILLSASEDDAAVIYRNAGMLNMTGEGYVWIVSEQAGAAR-------NAPDGVLGLQLINGK-------- 270 (377)
T ss_pred HHH-hhcCCeEEEEEcCHHHHHHHHHHHHHcCCCCCCEEEEEeccccccc-------cCCCceEEEEECCCC--------
Confidence 776 56789999999999999999999999999874 7999999984321 223577777653210
Q ss_pred hhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhh
Q psy1666 191 LNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHAD 270 (981)
Q Consensus 191 ~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~ 270 (981)
....++|||||++|||||+|+++
T Consensus 271 ---------------------------------------------------------~~~~~~yDAV~~~A~Al~~~~~~ 293 (377)
T cd06379 271 ---------------------------------------------------------NESSHIRDAVAVLASAIQELFEK 293 (377)
T ss_pred ---------------------------------------------------------CHHHHHHHHHHHHHHHHHHHHcC
Confidence 02357999999999999999863
Q ss_pred hc-CCCCCCCCCCC--CCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEECCeEE
Q psy1666 271 LC-QGKVGLCDAMR--PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLEGELR 346 (981)
Q Consensus 271 lC-~~~~~~C~~~~--~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~~~L~ 346 (981)
.+ ......|..+. ..+|++|+++|++++|+|.+| +|.||+|||+. ..|||+||+. ..+++||+|+++.|.
T Consensus 294 ~~~~~~~~~c~~~~~~~~~g~~l~~~l~~v~f~G~tg-~i~Fd~~Gd~~~~~~~I~~~~~-----~~~~~VG~w~~~~l~ 367 (377)
T cd06379 294 ENITEPPRECVGNTVIWETGPLFKRALMSSKYPGETG-RVEFNDDGDRKFANYDIMNIQN-----RKLVQVGLYNGDILR 367 (377)
T ss_pred CCCCCCCccccCCCCCCcchHHHHHHHHhCCcCCccC-ceEECCCCCccCccEEEEEecC-----CCceEeeEEcCcEEE
Confidence 22 22345687642 346889999999999999988 59999999996 6999999983 258999999876666
Q ss_pred Ee
Q psy1666 347 LN 348 (981)
Q Consensus 347 in 348 (981)
++
T Consensus 368 ~~ 369 (377)
T cd06379 368 LN 369 (377)
T ss_pred ec
Confidence 54
No 19
>cd06367 PBP1_iGluR_NMDA N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. The function of the NMDA subtype receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer comprising two NR1 and two NR2 (A, B, C, and D) or NR3 (A and B) subunits
Probab=99.82 E-value=1.3e-19 Score=207.27 Aligned_cols=216 Identities=20% Similarity=0.294 Sum_probs=165.3
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCee--EEEEEEeecCCcchhhhhHHHHHHH
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSIC--IAVKEKLVKDSGVAEERAYDDIVTK 113 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gIC--IA~~~~ip~~~~~~~~~~~~~ii~~ 113 (981)
+|+.|++.+|.+||+.++.+++| +...+.|++.+++.|+| |.....++.... .++...+.+
T Consensus 114 ~R~~p~~~~~~~ai~~ll~~~~w~~vaii~~~~~~g~~~~~~l~~~l~~~g~~~~i~~~~~~~~~~~----~~~~~~l~~ 189 (362)
T cd06367 114 LQTGPSLEQQADVMLEILEEYDWHQFSVVTSRDPGYRDFLDRVETTLEESFVGWEFQLVLTLDLSDD----DGDARLLRQ 189 (362)
T ss_pred EeecCcHHHHHHHHHHHHHHcCCeEEEEEEEcCcccHHHHHHHHHHHHhcccceeeeeeEEeccCCC----cchHHHHHH
Confidence 45889999999999999999998 33578899999999999 666665554321 134455555
Q ss_pred HhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhh
Q psy1666 114 LMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLN 192 (981)
Q Consensus 114 li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~ 192 (981)
+ ++.++++||++++...+..+++++.+++++++ ++||+++.|..... ...+...|.+|+++...
T Consensus 190 l-~~~~~~vivl~~~~~~~~~il~~a~~~g~~~~~~~wI~~~~~~~~~~---~~~~~~~G~~g~~~~~~----------- 254 (362)
T cd06367 190 L-KKLESRVILLYCSKEEAERIFEAAASLGLTGPGYVWIVGELALGSGL---APEGLPVGLLGVGLDTW----------- 254 (362)
T ss_pred H-HhcCCcEEEEeCCHHHHHHHHHHHHHcCCCCCCcEEEECcccccccC---CccCCCCeeEEEEeccc-----------
Confidence 5 55678999999999999999999999988764 79999999975322 22344468888876320
Q ss_pred cCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc
Q psy1666 193 LTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC 272 (981)
Q Consensus 193 l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC 272 (981)
. ....++|||||++|||||+++++..
T Consensus 255 -------------~-----------------------------------------~~~~~~~Dav~~~a~Al~~~~~~~~ 280 (362)
T cd06367 255 -------------Y-----------------------------------------SLEARVRDAVAIVARAAESLLRDKG 280 (362)
T ss_pred -------------c-----------------------------------------cHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 0 0235799999999999999987411
Q ss_pred --CCCCCCCCCCC---CCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 273 --QGKVGLCDAMR---PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 273 --~~~~~~C~~~~---~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
......|.... ..+|..|++||++++|.|.+| +|.||+|||+. +.|||+|++. ...+++||+|++
T Consensus 281 ~~~~~~~~C~~~~~~~~~~g~~l~~~l~~~~f~G~tg-~v~F~~~G~~~~~~~~I~~l~~----~~~~~~VG~W~~ 351 (362)
T cd06367 281 ALPEPPVNCYDTANKRESSGQYLARFLMNVTFDGETG-DVSFNEDGYLSNPKLVIINLRR----NRKWERVGSWEN 351 (362)
T ss_pred CCCCCCCCcCCCCCCCCCchHHHHHHHhcccccCCCC-ceeECCCcccccceEEEEEecC----CCcceEEEEEcC
Confidence 11245687653 356779999999999999999 69999999986 7999999984 346899999975
No 20
>cd06363 PBP1_Taste_receptor Ligand-binding domain of the T1R taste receptor. Ligand-binding domain of the T1R taste receptor. The T1R is a member of the family C receptors within the G-protein coupled receptor superfamily, which also includes the metabotropic glutamate receptors, GABAb receptors, the calcium-sensing receptor (CaSR), the V2R pheromone receptors, and a small group of uncharacterized orphan receptors.
Probab=99.79 E-value=4.9e-18 Score=197.48 Aligned_cols=233 Identities=25% Similarity=0.411 Sum_probs=180.4
Q ss_pred hcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhc
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMT 116 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~ 116 (981)
|+.|++..|..|++.++.+++| +...+.|++.++++|+||+..+.++.... ...++...+.++ +
T Consensus 155 r~~~~~~~~~~al~~~l~~~~~k~vaii~~~~~~g~~~~~~~~~~l~~~gi~i~~~~~~~~~~~--~~~d~~~~l~~i-~ 231 (410)
T cd06363 155 RTVPSDKDQIEAMVQLLQEFGWNWVAFLGSDDEYGRDGLQLFSELIANTGICIAYQGLIPLDTD--PETDYQQILKQI-N 231 (410)
T ss_pred EecCCcHHHHHHHHHHHHHCCCcEEEEEEeCChhHHHHHHHHHHHHHHCCeEEEEEEEecCCCc--hHHHHHHHHHHH-h
Confidence 3567777778888777777776 33467888888999999999999886321 134677888887 5
Q ss_pred CCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccC-CCccceeeEEEEEecCCCCCChHHHHhhcCC
Q psy1666 117 KPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSD-GSEAEVEGTLSLQPQANPVKGFDDYFLNLTV 195 (981)
Q Consensus 117 ~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~-~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p 195 (981)
.+++++|++.+....+..+++++.+.++.++ +||++++|..+..... ......++.+++..+..+.|++++|.+.
T Consensus 232 ~~~~dvIil~~~~~~~~~il~qa~~~g~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~--- 307 (410)
T cd06363 232 QTKVNVIVVFASRQPAEAFFNSVIQQNLTGK-VWIASEAWSLNDELPSLPGIRNIGTVLGVAQQTVTIPGFSDFIYS--- 307 (410)
T ss_pred cCCCeEEEEEcChHHHHHHHHHHHhcCCCCC-EEEEeCcccccccccCCccceeeccEEEEEeCCCCCccHHHHHHH---
Confidence 6789999999999999999999999898876 9999999976543222 1223345678877776677778777642
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCC
Q psy1666 196 ENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGK 275 (981)
Q Consensus 196 ~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~ 275 (981)
....+|||||++|+|||++++ |.
T Consensus 308 -----------------------------------------------------~~~~~YDaV~~~a~Al~~a~~--~~-- 330 (410)
T cd06363 308 -----------------------------------------------------FAFSVYAAVYAVAHALHNVLQ--CG-- 330 (410)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHHHHHhC--CC--
Confidence 123589999999999999975 32
Q ss_pred CCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEEC--CeEEEe
Q psy1666 276 VGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE--GELRLN 348 (981)
Q Consensus 276 ~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~--~~L~in 348 (981)
...|....+.+++.|.++|++++|.|.+| .|.||++||+...|+|++++. +.+...+++||+|++ .+|.+|
T Consensus 331 ~~~~~~~~~~~~~~l~~~L~~~~~~g~~g-~i~fd~~G~~~~~~~i~~~~~-~~~~~~~~~vG~~~~~~~~l~~~ 403 (410)
T cd06363 331 SGGCPKRVPVYPWQLLEELKKVNFTLLGQ-TVRFDENGDPNFGYDIVVWWW-DNSSGTFEEVGSYSFYPIRLTIN 403 (410)
T ss_pred CCCCCCCCCCCHHHHHHHHhccEEecCCc-EEEeCCCCCCccceEEEEEEE-cCCceeEEEEEEEECCCCEEEEe
Confidence 23566545678999999999999998877 799999999878899999986 445679999999996 577775
No 21
>cd06390 PBP1_iGluR_AMPA_GluR1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR1 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR1 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=99.79 E-value=1.3e-18 Score=197.78 Aligned_cols=240 Identities=15% Similarity=0.246 Sum_probs=169.8
Q ss_pred HhcCCCCCCCCCcceeeEEeecc------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhc
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMT 116 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~ 116 (981)
|+..|+ |++||+.+|.+++| ....+.|.+.++++|+||++.+..+.+ ..++...++++ +
T Consensus 98 i~~~P~---~~~Ai~diI~~~~W~~v~iIYd~d~g~~~lq~l~~~~~~~~~~I~~~~~~~~~-----~~d~~~~L~~i-k 168 (364)
T cd06390 98 LQLRPE---LQDALISVIEHYKWQKFVYIYDADRGLSVLQKVLDTAAEKNWQVTAVNILTTT-----EEGYRKLFQDL-D 168 (364)
T ss_pred EEeChh---HHHHHHHHHHHcCCcEEEEEEeCCccHHHHHHHHHhhhccCceeeEEEeecCC-----hHHHHHHHHhc-c
Confidence 456665 89999999999999 345778888888999999998877632 23677888886 6
Q ss_pred CCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEec-cCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 117 KPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSD-GWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 117 ~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~-~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
++++|+||+.++...+..++.++.+.++.+ .+.||.++ +....+. ........|.+|+++.....+.+++|..++
T Consensus 169 ~~~~rvIVl~~~~~~~~~~L~~a~~~~~~~~gy~wI~t~l~~~~~~~--~~~~~~~~nitg~r~~~~~~~~~~~~~~~w- 245 (364)
T cd06390 169 KKKERLIVVDCESERLNAILNQIIKLEKNGIGYHYILANLGFMDIDL--TKFRESGANVTGFQLVNYTDTTVSRIMQQW- 245 (364)
T ss_pred ccCCeEEEEECCHHHHHHHHHHHHHhhccCCceEEEecCCCcccccH--HHHhcCCcCceEEEEecCCCHHHHHHHHHH-
Confidence 778999999999888888888886543333 37999997 3322111 122334568899999877777778876533
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCC
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQG 274 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~ 274 (981)
++.+.-.++.. . ..+.......+|||||++|+|++++....+..
T Consensus 246 ---------------~~~~~~~~~~~-----------------~----~~~~~~~~~l~yDaV~~~A~A~~~l~~~~~~~ 289 (364)
T cd06390 246 ---------------KNFDARDLPRV-----------------D----WKRPKYTSALTYDGVRVMAEAFQNLRKQRIDI 289 (364)
T ss_pred ---------------HhhccccCCCC-----------------C----cCCcchHHHHHHHHHHHHHHHHHHHHHcCCCc
Confidence 22111100000 0 00011235689999999999999997654431
Q ss_pred ----CCCCCCCCC--C-CCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 275 ----KVGLCDAMR--P-TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 275 ----~~~~C~~~~--~-~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
..+.|.... + ..|..|+++|++++|+|.+|+ |.||++|++. ..|||+|.+. + .+++||.|++
T Consensus 290 ~~~~~~~~C~~~~~~~w~~G~~l~~~i~~~~f~GlTG~-i~F~~~G~r~~~~~~I~~~~~--~---g~~~vG~W~~ 359 (364)
T cd06390 290 SRRGNAGDCLANPAVPWGQGIDIQRALQQVRFEGLTGN-VQFNEKGRRTNYTLHVIEMKH--D---GIRKIGYWNE 359 (364)
T ss_pred ccCCCCCCCCCCCCCCCccHHHHHHHHHhhcccccccc-eeeCCCCCcccceEEEEEecC--C---cceEEEEECC
Confidence 224786542 2 347789999999999999996 9999999986 5799999862 2 4899999986
No 22
>cd06378 PBP1_iGluR_NMDA_NR2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer composed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. Among NMDA receptor subtypes, the NR2B subunit containing receptors appear particularly important for pain perception; thus NR2B-selective antagonists may be useful in
Probab=99.76 E-value=5e-18 Score=192.80 Aligned_cols=224 Identities=17% Similarity=0.241 Sum_probs=159.1
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+|+.|++.+|++||+.+|.+|+| +++.+.+++...+.++|+++...++.+... .........+ +
T Consensus 113 lr~~Psd~~q~~Ai~~Ii~~f~W~~v~iV~~~~~g~~~~~~~l~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~l~~-l 189 (362)
T cd06378 113 LQFGPSIEQQAAVMLKIMEEYDWHAFSVVTSRFPGYDDFVSAVRTTVDNSFVGWELQSVLTLDMSD--DDGDARTQRQ-L 189 (362)
T ss_pred EEeCCCHHHHHHHHHHHHHHCCCeEEEEEEEcCCCHHHHHHHHHHHHhhcccceeEEEEEeeccCC--CcchHHHHHH-H
Confidence 67999999999999999999999 245667777766778999998888765431 1123344443 4
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
+++++||||++++...+..++++|.+.+++|+ |+||+++.-....... ..+.-.|.+++..
T Consensus 190 k~~~arViVl~~s~~~a~~if~~A~~~gm~g~~yvWI~t~~~~~~~~~~--~~~~~~G~i~v~~---------------- 251 (362)
T cd06378 190 KKLESQVILLYCSKEEAEYIFRAARSAGLTGPGYVWIVPSLVLGNTDLG--PSEFPVGLISVSY---------------- 251 (362)
T ss_pred HhcCCCEEEEECCHHHHHHHHHHHHHcCCcCCCeEEEecccccCCCccc--cccCCcceEeecc----------------
Confidence 67789999999999999999999999999885 7999996422221110 0111135444331
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc--
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC-- 272 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC-- 272 (981)
+ -|... ....+||||+++|+||++|+++.-
T Consensus 252 -----------~-~w~~~------------------------------------~~a~~~DaV~vva~Al~~l~~~~~~~ 283 (362)
T cd06378 252 -----------D-GWRYS------------------------------------LRARVRDGVAIIATGASAMLRQHGFI 283 (362)
T ss_pred -----------c-ccccc------------------------------------HHHHHHHHHHHHHHHHHHHHhccCCC
Confidence 0 12100 123589999999999999974211
Q ss_pred CCCCCCCCCCC---CCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEECCeEEEe
Q psy1666 273 QGKVGLCDAMR---PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLEGELRLN 348 (981)
Q Consensus 273 ~~~~~~C~~~~---~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~~~L~in 348 (981)
+.....|.... ...|..|++||++|+|+|. .+.||++|++. ..|||+|.+. ...+++||+|+++.|.++
T Consensus 284 ~~~~~~C~~~~~~~~~~G~~l~~~l~~v~~~G~---~i~F~~~G~r~~~~ldIinl~~----~~g~~kVG~W~~~~L~~~ 356 (362)
T cd06378 284 PEAKGSCYGQAEKRDLPPNTLHRYMMNVTWEGR---DLSFTEDGYLVNPKLVVISLNK----ERVWEEVGKWENGSLRLK 356 (362)
T ss_pred CCCCCCcCCCCCCCCCchHHHHHHhhcceECCC---ceeECCCCeEccceEEEEEecC----CCCceEEEEEcCCeEEEe
Confidence 12244686432 2256789999999999885 79999999875 5899999862 125899999998888774
No 23
>cd06391 PBP1_iGluR_delta_2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta2 receptor of an orphan glutamate receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta2 receptor of an orphan glutamate receptor family. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 are closer related to non-NMDA receptors. GluRdelta2 was shown to function as a
Probab=99.70 E-value=1.5e-16 Score=182.96 Aligned_cols=251 Identities=11% Similarity=0.113 Sum_probs=158.3
Q ss_pred CCCCCcceeeEEeecc------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHH-HHHHHhc-CCCcE
Q psy1666 56 RDDPDFIPVLMLFLRE------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDD-IVTKLMT-KPRAR 121 (981)
Q Consensus 56 ~~q~~a~~~lv~f~~~------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~-ii~~li~-~s~a~ 121 (981)
..|.+|++.+|.+++| ..+.+.|.++++++|+||++.. +...........+.. .++++.+ .+++|
T Consensus 123 ~~~~~ai~~li~~f~W~~v~i~~d~~~~~~~l~~l~~~~~~~~i~I~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~r 201 (400)
T cd06391 123 VYLNDVILRVVTEYAWQKFIIFYDTDYDIRGIQEFLDKVSQQGMDVALQK-VENNINKMITGLFRTMRIEELNRYRDTLR 201 (400)
T ss_pred HHHHHHHHHHHHHcCCcEEEEEEeCCccHHHHHHHHHHHHHcCCeEEEEe-cCcchhhhhHHHHHHHHHHHHHhhccccc
Confidence 4588999999999999 3356778888889999999744 221110000001111 1223322 16689
Q ss_pred EEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCC
Q psy1666 122 GVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRR 200 (981)
Q Consensus 122 VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~ 200 (981)
+||++++...+..+++++.+++++|+ |+||.++.-.............++|..+++++....+.+++|+.+..
T Consensus 202 viVl~~~~~~~~~ll~~a~~~gm~~~~y~wi~t~~~~~~~dl~~~~~~~~~~v~~~r~~~~~~~~~~~~~~r~~------ 275 (400)
T cd06391 202 RAILVMNPATAKSFITEVVETNLVAFDCHWIIINEEISDMDVQELVRRSIGRLTIIRQTFPLPQNISQRCFRGN------ 275 (400)
T ss_pred EEEEECCcHHHHHHHHHHHHcCCCCCCeEEEEeCccccccccchHHhcccceEEEeccCCchHHHHHHHHHHHh------
Confidence 99999999999999999999999874 89999865332222222222344667778775554456677664331
Q ss_pred CCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc--CCCCCC
Q psy1666 201 NPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC--QGKVGL 278 (981)
Q Consensus 201 n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC--~~~~~~ 278 (981)
..+.-. .|...+.. ..........+||||+++|+|++++....- ......
T Consensus 276 ----------~~~~~~---------------~~~~~~~~---~~~~~~~~alayDaV~~~A~A~~~l~~~~~~~~~~~~~ 327 (400)
T cd06391 276 ----------HRISSS---------------LCDPKDPF---AQMMEISNLYIYDTVLLLANAFHKKLEDRKWHSMASLS 327 (400)
T ss_pred ----------hhcccc---------------ccCccccc---cccccchhhHHHHHHHHHHHHHHHHHhhccccCCCCcc
Confidence 111000 00000000 000112356799999999999999853111 111234
Q ss_pred CCCC---CCCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 279 CDAM---RPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 279 C~~~---~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
|... .-..|..|+++|++++|+|.+| +|.||++|.+. ..|||+|....+.....+++||+|++
T Consensus 328 c~~~~~~~w~~G~~ll~~i~~~~f~GlTG-~i~f~~~g~r~~~~~dIin~~~~~~~~~g~rkiG~Ws~ 394 (400)
T cd06391 328 CIRKNSKPWQGGRSMLETIKKGGVSGLTG-ELEFNENGGNPNVHFEILGTNYGEDLGRGVRKLGCWNP 394 (400)
T ss_pred cccCCCCCCCChHHHHHHHHhcCccccee-ceEECCCCCccCCceEEEEeeccccCCCcceEEEEEcC
Confidence 6532 1234678999999999999999 59999999885 58999998643332235899999986
No 24
>PF07562 NCD3G: Nine Cysteines Domain of family 3 GPCR; InterPro: IPR011500 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes). They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups. We use the term clan to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include the rhodopsin-like GPCRs, the secretin-like GPCRs, the cAMP receptors, the fungal mating pheromone receptors, and the metabotropic glutamate receptor family. There is a specialised database for GPCRs (http://www.gpcr.org/7tm/). GPCR family 3 receptors (also known as family C) are structurally similar to other GPCRs, but do not show any significant sequence similarity and thus represent a distinct group. Structurally they are composed of four elements; an N-terminal signal sequence; a large hydrophilic extracellular agonist-binding region containing several conserved cysteine residues which could be involved in disulphide bonds; a shorter region containing seven transmembrane domains; and a C-terminal cytoplasmic domain of variable length []. Family 3 members include the metabotropic glutamate receptors, the extracellular calcium-sensing receptors, the gamma-amino-butyric acid (GABA) type B receptors, and the vomeronasal type-2 receptors [, , , ]. As these receptors regulate many important physiological processes they are potentially promising targets for drug development. This entry represents a conserved sequence, found in the extracellular region, that contains several highly-conserved Cys residues that are predicted to form disulphide bridges.; GO: 0004930 G-protein coupled receptor activity, 0007186 G-protein coupled receptor protein signaling pathway; PDB: 2E4X_B 2E4Y_A 2E4U_B 2E4V_B 2E4W_A.
Probab=99.70 E-value=2.5e-18 Score=137.06 Aligned_cols=53 Identities=51% Similarity=1.116 Sum_probs=33.0
Q ss_pred CCccCCccCCCCcEEeeecCc-ceeeccccCCCCceecCccccccccCCCCCCC
Q psy1666 785 PESVCSLPCDIGQAKKYVEGE-SCCWHCFNCSQYQIRLPSDETQCLTCPEGTKP 837 (981)
Q Consensus 785 P~S~Cs~~C~pG~~k~~~~g~-~CC~~C~~C~~g~isn~~d~~~C~~C~~~~~~ 837 (981)
|.|+||++|+||++|..++|. .|||+|++|++|+|+|++|+++|.+||+++||
T Consensus 1 P~S~CS~~C~pG~~k~~~~~~~~CCw~C~~C~~~~is~~~~~~~C~~C~~~~wp 54 (54)
T PF07562_consen 1 PSSVCSEPCPPGQRKKIQKGQPSCCWDCVPCPEGEISNQTDSTSCTKCPEGQWP 54 (54)
T ss_dssp ----SS----TTTEEEE--SSS-S--EEEE--TTEEEE--ETTEEEE--TTEEE
T ss_pred CccccCCCCCCCCEECccCCCcceEEEeecCCCCcEECCCCccccccCCCccCc
Confidence 789999999999999998887 69999999999999999999999999999997
No 25
>PF01094 ANF_receptor: Receptor family ligand binding region The Prosite family is a sub-family of the Pfam family; InterPro: IPR001828 This describes a ligand binding domain and includes extracellular ligand binding domains of a wide range of receptors, as well as the bacterial amino acid binding proteins of known structure [].; PDB: 3SAJ_D 3Q41_B 3QEM_C 3QEK_A 3QEL_C 3MQ4_A 3QLV_G 3OM1_A 3QLU_A 3OM0_A ....
Probab=99.68 E-value=1e-16 Score=181.85 Aligned_cols=266 Identities=22% Similarity=0.330 Sum_probs=179.8
Q ss_pred hHHHHHHHHHhhcCe-EEEEeeeeccCCcccc-cchHHHHHHHHhcCCCCCCCCCcceeeEEeecc---------h----
Q psy1666 8 IAFEELEVLLAKSSI-CIAVKEKLVKDSGVAE-ERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRE---------T---- 72 (981)
Q Consensus 8 ~g~~~~~~~~~~~~~-Cia~~~~i~~~~~~~~-~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~---------~---- 72 (981)
...++....+...|+ .|+..- .++.-.+ +..|...+ |+.|++.+|.+||+.++.+++| +
T Consensus 62 ~~~~~~~~~~~~~~ip~is~~~---~~~~ls~~~~~~~~~~---r~~p~~~~~~~a~~~~l~~~~w~~v~vv~~~~~~~~ 135 (348)
T PF01094_consen 62 SSAEAVASLASEWNIPQISPGS---TSPSLSDRKTRYPTFF---RTVPSDSSQARALVDLLKHFGWTRVSVVYSDDDYGN 135 (348)
T ss_dssp HHHHHHHHHHHHTT-EEEESSG---GSGGGGSTTTTTTTEE---ESSB-HHHHHHHHHHHHHHTTSSEEEEEEESSHHHH
T ss_pred cccchhheeecccccceeeccc---cccccccchhhccccc---cccccHHHHHHHHHHhhhcCCCceeeeecccccccc
Confidence 345666667766666 344210 1111011 11354433 3778888889999999988888 2
Q ss_pred hHHHHHHHHHHh-CCeeEEE-EEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhcc-CCceE
Q psy1666 73 TAFEELEVLLAK-SSICIAV-KEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNA-TGSFS 149 (981)
Q Consensus 73 ~~~~~l~~~~~~-~gICIA~-~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l-~g~~v 149 (981)
...+.|++.+++ .++|+++ ....+... ...++.+.+.+ .++++||||++++...+..++.++.+.++ .+.++
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~--~~~~~rvvil~~~~~~~~~~l~~a~~~~~~~~~~~ 210 (348)
T PF01094_consen 136 SLADSFQDLLRERGGICVAFISVVISSDS---DAEELLKKLKE--IKSGARVVILCSSPEDARQFLEAAYELGMTSGDYV 210 (348)
T ss_dssp HHHHHHHHHHHHHTTCEEEEEEEEETTTS---HHHHHHHHHHH--HTTTTSEEEEESBHHHHHHHHHHHHHTTTSSTTSE
T ss_pred ccchhhhhhhcccccceeccccccccccc---chhhhhhhhhh--ccccceeeeeecccccccccccchhhhhcccccee
Confidence 237788888877 6799999 33333222 12233333333 24789999999999999999999988777 33579
Q ss_pred EEEeccCcccc-cccCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q psy1666 150 WVGSDGWSARG-LVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSH 228 (981)
Q Consensus 150 WI~s~~W~~~~-~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~ 228 (981)
||.++.|.... .........+.|.++++++....+.|++|..++++..+. .+..
T Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~--------------~~~~----------- 265 (348)
T PF01094_consen 211 WILTDLDNSSFWQNNEDFREAFQGVLGFTPPPPSSPEFEDFMKKWKESNNQ--------------SSTS----------- 265 (348)
T ss_dssp EEEETTTTTTHTSTHCHHHCCHTTEEEEEESTTTSHHHHHHHHHHHTTTHT--------------TTTT-----------
T ss_pred EEeecccccccccccccccccccceeeeeeecccccchhhhhcccChhhcc--------------Cccc-----------
Confidence 99998887653 222334556679999999888888999999876543221 0000
Q ss_pred CCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEE
Q psy1666 229 YSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFK 308 (981)
Q Consensus 229 ~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~ 308 (981)
...........++|||||++|||||+++++.|+..... ....+|.+|.++|++++|+|.+| +|.
T Consensus 266 ------------~~~~~~~~~~~~~yDAv~~~a~al~~~~~~~~~~~~~~---~~~~~g~~l~~~l~~~~f~G~tG-~v~ 329 (348)
T PF01094_consen 266 ------------GSDQEPSPYAAYAYDAVYLLAHALNRALQDGGPVTNGR---NPWQNGSQLLKYLRNVSFEGLTG-RVS 329 (348)
T ss_dssp ------------TTTSSGCHHHHHHHHHHHHHHHHHHHHHHHHSTTTSSS---GTSTTHHHHHHHHHTEEEEETTE-EEE
T ss_pred ------------ccccccceeeeeehhhhHHHHHHHHHHHHhccCCCCCc---cccccHHHHHHHHhheeeeCCCC-CEE
Confidence 00011223567899999999999999999877643322 34557889999999999999999 599
Q ss_pred ecC-CCCC-CceeEEEEEE
Q psy1666 309 FDK-DGDG-PARYNIIHFK 325 (981)
Q Consensus 309 FD~-nGD~-~~~YdI~n~q 325 (981)
||+ +||+ ...|+|+|||
T Consensus 330 f~~~~G~~~~~~~~i~~~~ 348 (348)
T PF01094_consen 330 FDSNDGDRTNYDYDILNMQ 348 (348)
T ss_dssp EETTTSBEESEEEEEEEE-
T ss_pred EeCCCCCcCCCEEEEEECC
Confidence 999 9998 4689999986
No 26
>cd06372 PBP1_GC_G_like Ligand-binding domain of membrane guanylyl cyclase G. This group includes the ligand-binding domain of membrane guanylyl cyclase G (GC-G) which is a sperm surface receptor and might function, similar to its sea urchin counterpart, in the early signaling event that regulates the Ca2+ influx/efflux and subsequent motility response in sperm. GC-G appears to be a pseudogene in human. Furthermore, in contrast to the other orphan receptor GCs, GC-G has a broad tissue distribution in rat, including lung, intestine, kidney, and skeletal muscle.
Probab=99.67 E-value=5e-16 Score=179.70 Aligned_cols=237 Identities=15% Similarity=0.214 Sum_probs=155.4
Q ss_pred hcCCCCCCCCCcceeeEEeecchh------------------HHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHH
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRETT------------------AFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIV 111 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~~~------------------~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii 111 (981)
|+.|++.+|..+++.++.+++|.+ ..+.+++.+ +.|++|...+.++.... +....+
T Consensus 116 r~~p~~~~~~~a~~~l~~~~~w~~vaii~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~-----d~~~~~ 189 (391)
T cd06372 116 KLVPPKQKIGEVLQKSLQHFGWKHIGLFGGSSRDSSWDEVDELWKAVENQL-KFHFNITATVRYSSSNP-----DLLQEK 189 (391)
T ss_pred EecCchhhHHHHHHHHHHHCCCeEEEEEEeccccchhhhHHHHHHHHHHHH-hhCEEEEEEEecCCCCh-----HHHHHH
Confidence 467888889999999999988821 122334443 36888888887764321 222222
Q ss_pred HHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEe-----ccCcccccc-c-CCCccceeeEEEEEecCC--
Q psy1666 112 TKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGS-----DGWSARGLV-S-DGSEAEVEGTLSLQPQAN-- 181 (981)
Q Consensus 112 ~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s-----~~W~~~~~~-~-~~~~~~~~G~l~~~~~~~-- 181 (981)
.+. ..+++++||+.++...+..+++++.++++.+ .++||.. +.|...... . .......+|.+++.+...
T Consensus 190 l~~-~~~~~~vii~~~~~~~~~~i~~~a~~~g~~~~~y~~i~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (391)
T cd06372 190 LRY-ISSVARVIILICSSEDAKAILQAAEKLGLMKGKFVFFLLQQFEDNFWKEVLTDDQVQHLPKVYESVFLIAPSSYGG 268 (391)
T ss_pred HHh-hhccceEEEEEcChHHHHHHHHHHHHcCCCCCCEEEEEehhhcCccccccCCCcchHHHHHHHhhEEEEecCCCCC
Confidence 232 2467899999999999999999999999866 4899985 334322110 0 011134578888877542
Q ss_pred --CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHH
Q psy1666 182 --PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMA 259 (981)
Q Consensus 182 --~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyA 259 (981)
+...|.+.++.. +.++| ++|. |.. .........++|||||+
T Consensus 269 ~~~~~~f~~~~~~~----~~~~p----------~~~~----------------~~~-------~~~~~~~a~~~yDav~~ 311 (391)
T cd06372 269 YSGGYEFRKQVYQK----LKRPP----------FQSS----------------LSS-------EEQVSPYSAYLHDAVLL 311 (391)
T ss_pred CcchhHHHHHHHHH----HhcCC----------cccc----------------ccc-------cccchHHHHHHHHHHHH
Confidence 223343333221 11112 1110 100 00112245789999999
Q ss_pred HHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhc---ceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEE
Q psy1666 260 FSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLR---KVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQ 336 (981)
Q Consensus 260 iAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk---~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~ 336 (981)
+|+|||++++ +. ....+|.+|.++|+ +++|+|.+| +|.||+|||+.+.|+|+++|...++ ..+++
T Consensus 312 ~A~Al~~~~~--~g--------~~~~~g~~l~~~l~~~~~~~f~G~tG-~v~fd~~G~r~~~y~i~~~~~~~~~-~~~~~ 379 (391)
T cd06372 312 YALAVKEMLK--AG--------KDFRNGRQLVSTLRGANQVELQGITG-LVLLDEQGKRQMDYSVYALQKSGNS-SLFLP 379 (391)
T ss_pred HHHHHHHHHh--cC--------CCCCCHHHHHHHHhhccCceEeccce-eEEECCCCCcceeEEEEeccccCCc-cceee
Confidence 9999999985 21 12346788999999 699999999 5999999999999999999854332 46999
Q ss_pred EEEEEC
Q psy1666 337 VGEYLE 342 (981)
Q Consensus 337 VG~~~~ 342 (981)
||+|+.
T Consensus 380 vg~~~~ 385 (391)
T cd06372 380 FLHYDS 385 (391)
T ss_pred EEEecc
Confidence 999975
No 27
>cd06370 PBP1_Speract_GC_like Ligand-binding domain of membrane bound guanylyl cyclases. Ligand-binding domain of membrane bound guanylyl cyclases (GCs), which are known to be activated by sperm-activating peptides (SAPs), such as speract or resact. These ligand peptides are released by a range of invertebrates to stimulate the metabolism and motility of spermatozoa and are also potent chemoattractants. These GCs contain a single transmembrane segment, an extracellular ligand binding domain, and intracellular protein kinase-like and cyclase catalytic domains. GCs of insect and nematodes, which exhibit high sequence similarity to the speract receptor are also included in this model.
Probab=99.60 E-value=5.7e-15 Score=171.51 Aligned_cols=233 Identities=15% Similarity=0.178 Sum_probs=147.3
Q ss_pred hcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcc--hhhhhHHHHHHHH
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGV--AEERAYDDIVTKL 114 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~--~~~~~~~~ii~~l 114 (981)
|+.|++..|..+++.++.+++| +...+.|++.+++.|+||...+.++..... ....++.++++++
T Consensus 115 r~~~~~~~~~~a~~~~~~~~~w~~vaii~~~~~~g~~~~~~~~~~~~~~g~~iv~~~~~~~~~~~~~~~~~~~~~~l~~~ 194 (404)
T cd06370 115 RTVPPSIQVVKSVIALLKHFNWNKFSVVYENDSKYSSVFETLKEEAELRNITISHVEYYADFYPPDPIMDNPFEDIIQRT 194 (404)
T ss_pred EcCCCHHHHHHHHHHHHHHCCCcEEEEEEecCcccHHHHHHHHHHHHHcCCEEEEEEEECCCCCchhhhHHHHHHHHHhc
Confidence 4667777788888877777776 556788888888999999999999764210 0123555666554
Q ss_pred hcCCCcEEEEEEcchhhHHHHHHHHHhhccC--CceEEEEecc-------Ccc------------cccccCCCccceeeE
Q psy1666 115 MTKPRARGVIVFGSDQEVAGVMRAVRRLNAT--GSFSWVGSDG-------WSA------------RGLVSDGSEAEVEGT 173 (981)
Q Consensus 115 i~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~--g~~vWI~s~~-------W~~------------~~~~~~~~~~~~~G~ 173 (981)
+..++++|+++....+..+++++.++++. +.++||+.+. |.. ...........++|.
T Consensus 195 --~~~~~~~v~~~~~~~~~~~l~qa~~~g~~~~~~y~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~ 272 (404)
T cd06370 195 --KETTRIYVFIGEANELRQFLMSMLDEGLLESGDYMVLGVDIEYYDRDSQDYYSLHRGFQSREYNRSDDEKALEAMKSV 272 (404)
T ss_pred --cCCCEEEEEEcCHHHHHHHHHHHHHcCCCCCCcEEEEEEchhhccccchhhhhhhhhhccccccccccHHHHHHhHhe
Confidence 23478888888877889899999998886 4578998653 110 000000111234555
Q ss_pred EEEEecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHH
Q psy1666 174 LSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFV 253 (981)
Q Consensus 174 l~~~~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~V 253 (981)
+.+.+... .+.. ++|.+ +|+..++.. +.|...+ .............+.
T Consensus 273 ~~~~~~~~-~~~~---------------~~f~~-~~~~~~~~~--------------~~~~~~~-~~~~~~~~~~~aa~~ 320 (404)
T cd06370 273 LIIVPTPV-SPDY---------------DSFSI-FVRKYNLEP--------------PFNGDLG-ESELVLEIDIEAAYL 320 (404)
T ss_pred EEEecCCC-CchH---------------HHHHH-HHHHhccCC--------------CCccccc-ccccccccceeeehh
Confidence 55443211 2222 22333 343332110 0010000 000000111234679
Q ss_pred HHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEE
Q psy1666 254 SDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQ 326 (981)
Q Consensus 254 ydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~ 326 (981)
|||||++|+|||+++++.. ...+|.+|.++|++++|.|.+|.+|.||++||+.+.|.+++++.
T Consensus 321 yDAv~~~a~Al~~~~~~~~----------~~~~g~~i~~~l~~~~f~GvtG~~v~fd~~G~~~~~y~v~~~~~ 383 (404)
T cd06370 321 YDAVMLYAKALDETLLEGG----------DIYNGTAIVSHILNRTYRSITGFDMYIDENGDAEGNYSVLALQP 383 (404)
T ss_pred HHHHHHHHHHHHHHHHhcC----------CCCCHHHHHHHHhCcccccccCceEEEcCCCCcccceEEEEecc
Confidence 9999999999999976321 12467899999999999999997799999999999999999975
No 28
>cd06387 PBP1_iGluR_AMPA_GluR3 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR3 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR3 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=99.59 E-value=2.5e-14 Score=162.63 Aligned_cols=232 Identities=13% Similarity=0.238 Sum_probs=156.6
Q ss_pred CCCcceeeEEeecc---------hhH---HHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEE
Q psy1666 58 DPDFIPVLMLFLRE---------TTA---FEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIV 125 (981)
Q Consensus 58 q~~a~~~lv~f~~~---------~~~---~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl 125 (981)
+.+|++.+|.+++| +++ .+.|.+.++..+.-|.+....+... ..+++.+++++ ++.+.|+||+
T Consensus 111 l~~Ai~diI~~~~Wr~~~~iYd~d~gl~~Lq~L~~~~~~~~~~V~~~~v~~~~~----~~~~~~~l~el-~~~~~r~iIl 185 (372)
T cd06387 111 LKGAILSLLAHYKWEKFVYLYDTERGFSILQAIMEAAVQNNWQVTARSVGNIKD----VQEFRRIIEEM-DRRQEKRYLI 185 (372)
T ss_pred HHHHHHHHHHhcCCCEEEEEecCchhHHHHHHHHHhhccCCceEEEEEeccCCc----hHHHHHHHHHh-ccccceEEEE
Confidence 67899999999999 333 4455555566787776665443221 22556667665 5567899999
Q ss_pred EcchhhHHHHHHHHHhhccCCc-eEEEEec-cCcccccccCCCccceee---EEEEEecCCCCCChHHHHhhcCCCCCCC
Q psy1666 126 FGSDQEVAGVMRAVRRLNATGS-FSWVGSD-GWSARGLVSDGSEAEVEG---TLSLQPQANPVKGFDDYFLNLTVENNRR 200 (981)
Q Consensus 126 ~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~-~W~~~~~~~~~~~~~~~G---~l~~~~~~~~ipgF~ef~~~l~p~~~~~ 200 (981)
.++.+.+..++..+.+.++.++ +.||.++ +..+.+. .+...| .+|+++.....+.+++|..++
T Consensus 186 d~s~~~~~~il~~a~e~gM~~~~y~~ilt~ld~~~~dl-----~~~~~g~~NItg~rl~~~~~~~~~~f~~~w------- 253 (372)
T cd06387 186 DCEVERINTILEQVVILGKHSRGYHYMLANLGFTDISL-----ERVMHGGANITGFQIVNNENPMVQQFLQRW------- 253 (372)
T ss_pred ECCHHHHHHHHHHHHHcCccccceEEEEecCCcccccH-----HHhccCCcceeEEEEecCCCchHHHHHHHH-------
Confidence 9999999999999998888663 8999986 4333221 122234 899998877777778876533
Q ss_pred CCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcC----CCC
Q psy1666 201 NPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQ----GKV 276 (981)
Q Consensus 201 n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~----~~~ 276 (981)
...+.-..++. + ..........+||||+++|+|++++....-. +..
T Consensus 254 ---------~~~~~~~~~~~--------------~-------~~~l~~~~al~yDaV~~~A~A~~~l~~~~~~~~~~~~~ 303 (372)
T cd06387 254 ---------VRLDEREFPEA--------------K-------NSPLKYTSALTHDAILVIAEAFRYLRRQRVDVSRRGSA 303 (372)
T ss_pred ---------HhCCcccCCCC--------------C-------CCCcchHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCC
Confidence 22111000000 0 0001123567999999999999998542111 123
Q ss_pred CCCCCCC--C-CCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 277 GLCDAMR--P-TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 277 ~~C~~~~--~-~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
+.|.... + ..|..|+++||+++|+|.+| +|.||++|.+. ..|||+|.. ++ ..++||.|++
T Consensus 304 ~~C~~~~~~~W~~G~~l~~~ik~v~~~GLTG-~i~F~~~G~R~~~~ldIinl~--~~---g~~kIG~W~~ 367 (372)
T cd06387 304 GDCLANPAVPWSQGIDIERALKMVQVQGMTG-NIQFDTYGRRTNYTIDVYEMK--PS---GSRKAGYWNE 367 (372)
T ss_pred CCcCCCCCCCccchHHHHHHHHhcccCCCcc-ceeeCCCCCcccceEEEEEec--CC---CceeEEEECC
Confidence 3685422 2 34678999999999999999 59999999985 689999976 22 3799999986
No 29
>PF00003 7tm_3: 7 transmembrane sweet-taste receptor of 3 GCPR; InterPro: IPR017978 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes). They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups. We use the term clan to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include the rhodopsin-like GPCRs, the secretin-like GPCRs, the cAMP receptors, the fungal mating pheromone receptors, and the metabotropic glutamate receptor family. There is a specialised database for GPCRs (http://www.gpcr.org/7tm/). GPCR family 3 receptors (also known as family C) are structurally similar to other GPCRs, but do not show any significant sequence similarity and thus represent a distinct group. Structurally they are composed of four elements; an N-terminal signal sequence; a large hydrophilic extracellular agonist-binding region containing several conserved cysteine residues which could be involved in disulphide bonds; a shorter region containing seven transmembrane domains; and a C-terminal cytoplasmic domain of variable length []. Family 3 members include the metabotropic glutamate receptors, the extracellular calcium-sensing receptors, the gamma-amino-butyric acid (GABA) type B receptors, and the vomeronasal type-2 receptors [, , , ]. As these receptors regulate many important physiological processes they are potentially promising targets for drug development. This entry represents the C-terminal region of family 3 GPCR receptor proteins, which contains the seven transmembrane region. The seven TM regions assemble in such a way as to produce a docking pocket into which such molecules as cyclamate and lactisole have been found to bind and consequently confer the taste of sweetness []. ; GO: 0004930 G-protein coupled receptor activity, 0007186 G-protein coupled receptor protein signaling pathway, 0016021 integral to membrane
Probab=99.59 E-value=4.2e-16 Score=167.47 Aligned_cols=113 Identities=39% Similarity=0.687 Sum_probs=98.2
Q ss_pred HHHHHHHHHhhhheeecCcceeeeCCccchHHHHHHHHHHHhhheeeeecCceeeechhhhhhHHHHHHHHHHHHHHHHH
Q psy1666 868 TGILMTLLIVGVFIRHNNTPVVKAAGRELSYVLLFGILLCYLVTFVLVLKPSDLVCAIQRFGAGFCFTVVYAALLTKTNR 947 (981)
Q Consensus 868 ~~~~~t~~v~~ifi~~r~tpiVka~n~~Ls~~lL~~l~l~fl~~~~fig~p~~~~C~lr~~~f~i~ft~~~s~il~Kt~~ 947 (981)
+|++++++++++|++||+||+||++|+.+++++|+|++++|.++++++++|++.+|.+|+|+++++|++++|++++|++|
T Consensus 1 ~gil~~~~~~i~~~~~r~~~~i~~s~~~l~~~lL~G~~l~~~~~~~~~~~~s~~~C~~r~~~~~l~f~l~~~~ll~K~~r 80 (238)
T PF00003_consen 1 LGILFTIFILIIFIRNRNTPIIRASSPELLYILLLGCLLLYSSVFLFLLPPSDILCTLRRWLFSLGFTLIFSALLAKTWR 80 (238)
T ss_pred ChhhHHHHHHHHHHhhcCCCceecCCHhHHHHHHHHHHHHHHHHHHhccCcCCcEEEEeeeeeeeehHhhhhHHHHhhhh
Confidence 47788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCC----Cc--ch-h-h--hHHHHHHHhhhhc
Q psy1666 948 ISRIFNAGKRTAKR----PN--FI-T-P--KSQLMICGGLVSV 980 (981)
Q Consensus 948 v~~~F~~~~~~~~~----~~--~i-~-~--~~q~~i~~~~~~i 980 (981)
++++|+.++..+.+ .+ .+ + . .+|+++++.|..+
T Consensus 81 i~~if~~~~~~~~~~~~~~~~~~~~~~~~~~v~~ii~~~w~~~ 123 (238)
T PF00003_consen 81 IYRIFRNPSRKRRRLISSNRSLLLLVLLLVLVQVIILIIWLIL 123 (238)
T ss_pred eeeeeccCCCCCcccccCCcchhhheeeeeeehhhhhhhhhhc
Confidence 99999855433221 11 11 1 1 3899999999875
No 30
>cd06386 PBP1_NPR_C_like Ligand-binding domain of type C natriuretic peptide receptor. Ligand-binding domain of type C natriuretic peptide receptor (NPR-C). NPR-C is found in atrial, mesentery, placenta, lung, kidney, venous tissue, aortic smooth muscle, and aortic endothelial cells. The affinity of NPR-C for natriuretic peptides is ANPCNPBNP. The extracellular domain of NPR-C is about 30% identical to NPR-A and NPR-B. However, unlike the cyclase-linked receptors, it contains only 37 intracellular amino acids and no guanylyl cyclase activity. Major function of NPR-C is to clear natriuretic peptides from the circulation or extracellular surroundings through constitutive receptor-mediated internalization and degradation.
Probab=99.54 E-value=5e-14 Score=162.54 Aligned_cols=235 Identities=14% Similarity=0.262 Sum_probs=159.3
Q ss_pred hcCCCCCCCCCcceeeEEeecc-------------hhH---HHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHH
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRE-------------TTA---FEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTK 113 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~-------------~~~---~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~ 113 (981)
|+.|++..|..+++.++.+++| +.. .+.|.+.+++.|+||...+..+... .++.+++++
T Consensus 116 R~~p~~~~~~~a~~~ll~~~~W~~vaiiy~~~~~~~~~~~~~~~l~~~~~~~gi~v~~~~~~~~~~-----~d~~~~l~~ 190 (387)
T cd06386 116 RVAPSYVKMGETFSALFERFHWRSALLVYEDDKQERNCYFTLEGVHHVFQEEGYHMSIYPFDETKD-----LDLDEIIRA 190 (387)
T ss_pred EecCchHHHHHHHHHHHHhCCCeEEEEEEEcCCCCccceehHHHHHHHHHhcCceEEEEecCCCCc-----ccHHHHHHH
Confidence 5779999999999999999998 112 7788889899999998866543221 356777877
Q ss_pred HhcCCCcEEEEEEcchhhHHHHHHHHHhhccC-CceEEEEeccCccc-----ccc-cC-CC---ccceeeEEEEEecCCC
Q psy1666 114 LMTKPRARGVIVFGSDQEVAGVMRAVRRLNAT-GSFSWVGSDGWSAR-----GLV-SD-GS---EAEVEGTLSLQPQANP 182 (981)
Q Consensus 114 li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~-g~~vWI~s~~W~~~-----~~~-~~-~~---~~~~~G~l~~~~~~~~ 182 (981)
+.+ .+ ||||+.++...+..++.++.+.+++ +.|+||..|-.... .+. .+ .. ....+.+.++...+..
T Consensus 191 ik~-~~-rvii~~~~~~~~~~ll~~A~~~gm~~~~yv~i~~d~~~~~~~~~~~w~~~~~~~~~~~~a~~~~~~v~~~~~~ 268 (387)
T cd06386 191 IQA-SE-RVVIMCAGADTIRSIMLAAHRRGLTSGDYIFFNIELFNSSSYGDGSWKRGDKHDFEAKQAYSSLNTVTLLRTV 268 (387)
T ss_pred HHh-cC-cEEEEecCHHHHHHHHHHHHHcCCCCCCEEEEEEecccccccCCCCCccCCCcCHHHHHHHHhheEEeccCCC
Confidence 644 33 9999999999999999999998876 46899998644211 110 00 00 1112223333322222
Q ss_pred CCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHH
Q psy1666 183 VKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSI 262 (981)
Q Consensus 183 ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAh 262 (981)
.|.+++|...+.-. + ....+|. .|.. ........|||||++|+
T Consensus 269 ~~~~~~f~~~~~~~-----------~-~~~~~~~---------------~~~~----------~~~~aa~~yDav~l~A~ 311 (387)
T cd06386 269 KPEFEKFSMEVKSS-----------V-EKAGDLN---------------DCDY----------VNMFVEGFHDAILLYAL 311 (387)
T ss_pred ChHHHHHHHHHHHH-----------H-HhCCCCc---------------cccc----------chHHHHHHHHHHHHHHH
Confidence 46677776543100 0 0000110 0100 01234679999999999
Q ss_pred HHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEE
Q psy1666 263 ALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYL 341 (981)
Q Consensus 263 ALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~ 341 (981)
||++.+.. + ....+|..|.+.|++++|.|.+| .|.||++||+...|+++.++. .+...|+.||.|.
T Consensus 312 Al~~~~~~---g-------~~~~~g~~l~~~l~~~~f~G~tG-~v~~d~~g~r~~~~~v~~~~~--~~~~~~~~~~~~~ 377 (387)
T cd06386 312 ALHEVLKN---G-------YSKKDGTKITQRMWNRTFEGIAG-QVSIDANGDRYGDFSVIAMTD--VEAGTYEVVGNYF 377 (387)
T ss_pred HHHHHhhC---C-------CCCCCHHHHHHHHhCCceeeccc-cEEECCCCCccccEEEEEccC--CCCccEEEEeEEc
Confidence 99998742 1 12357889999999999999999 599999999999999999863 3456899999997
No 31
>cd06361 PBP1_GPC6A_like Ligand-binding domain of the promiscuous L-alpha-amino acid receptor GPRC6A which is a broad-spectrum amino acid-sensing receptor. This family includes the ligand-binding domain of the promiscuous L-alpha-amino acid receptor GPRC6A which is a broad-spectrum amino acid-sensing receptor, and its fish homolog, the 5.24 chemoreceptor. GPRC6A is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into cellular responses.
Probab=99.52 E-value=6.6e-14 Score=161.95 Aligned_cols=83 Identities=25% Similarity=0.385 Sum_probs=72.8
Q ss_pred HHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCCc
Q psy1666 675 FVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGV 754 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~~ 754 (981)
++|+||||+|||||++. +. +.|+.+...+||+|+++|++++|+|. |+++.||+|||+.+.|||+|||. .++.
T Consensus 311 ~v~~AVyaiA~Al~~~~----~~--~~c~~~~~~~~~~l~~~L~~~~f~g~-~~~v~Fd~~gd~~~~y~I~~~~~-~~~~ 382 (403)
T cd06361 311 SIQLAVFALAHAIRDLC----QE--RQCQNPNAFQPWELLGQLKNVTFEDG-GNMYHFDANGDLNLGYDVVLWKE-DNGH 382 (403)
T ss_pred HHHHHHHHHHHHHHHhc----cC--CCCCCCCCcCHHHHHHHHheeEEecC-CceEEECCCCCCCcceEEEEeEe-cCCc
Confidence 58999999999999874 22 34776556789999999999999998 67899999999999999999997 6778
Q ss_pred EEEEEEEEEEC
Q psy1666 755 YQWVQVGEYLE 765 (981)
Q Consensus 755 ~~~~~VG~~~~ 765 (981)
..+++||.|++
T Consensus 383 ~~~~~vg~~~~ 393 (403)
T cd06361 383 MTVTIMAEYDP 393 (403)
T ss_pred EEEEEEEEEeC
Confidence 88999999986
No 32
>KOG1055|consensus
Probab=99.51 E-value=3.6e-15 Score=171.63 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=174.8
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCC--CCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDA--MRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIR 751 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~--~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~ 751 (981)
.+.||||||+|||++..+..+.+.....-+. .......++++.+++.+|.|.+| .|.|.. ||+.+.-+|.|||.
T Consensus 343 ~~ayd~Iwa~ala~n~t~e~l~~~~~~l~~f~y~~k~i~d~i~eamn~tsF~GvsG-~V~F~~-geR~a~t~ieQ~qd-- 418 (865)
T KOG1055|consen 343 PLAYDAIWALALALNKTMEGLGRSHVRLEDFNYNNKTIADQIYEAMNSTSFEGVSG-HVVFSN-GERMALTLIEQFQD-- 418 (865)
T ss_pred chHHHHHHHHHHHHHHHHhcCCccceeccccchhhhHHHHHHHHHhhccccccccc-ceEecc-hhhHHHHHHHHHhC--
Confidence 5799999999999999875432221111111 11223457999999999999999 688987 99999999999873
Q ss_pred CCcEEEEEEEEEEC--ceEEE-eccccccccCCCCCCCccCCccCCCCcEEeeecCcceeeccccCCCCceecCcccccc
Q psy1666 752 PGVYQWVQVGEYLE--GELRL-NMSAIQFKLSHPSPPESVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQC 828 (981)
Q Consensus 752 ~~~~~~~~VG~~~~--~~l~i-n~~~i~W~~~~~~~P~S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C 828 (981)
..++++|.|+. +.|.+ |.+ .|-.+ ++|.- .. +
T Consensus 419 ---g~y~k~g~Yds~~D~ls~~n~~--~w~~g--~ppkd----------~T-------------------v--------- 453 (865)
T KOG1055|consen 419 ---GKYKKIGYYDSTKDDLSWINTE--KWIGG--SPPKD----------ST-------------------L--------- 453 (865)
T ss_pred ---CceEeecccccccchhhccccc--eEecc--CCCcc----------cc-------------------e---------
Confidence 37899999985 23333 222 34433 12310 00 0
Q ss_pred ccCCCCCCCCccccCcccccccccccchhhHHHHHHHHHHHHHHHHHHhhhheeecCcceeeeCCccchHHHHHHHHHHH
Q psy1666 829 LTCPEGTKPDLLRQNCLEIPAMFIEITSTWAIGAMALSSTGILMTLLIVGVFIRHNNTPVVKAAGRELSYVLLFGILLCY 908 (981)
Q Consensus 829 ~~C~~~~~~n~~~~~C~~~~~~~l~~~~~~~i~~~~~s~~~~~~t~~v~~ifi~~r~tpiVka~n~~Ls~~lL~~l~l~f 908 (981)
...++-..+....++..+++++|+....+.+...+++|+...+|++.+++..++..|.++++
T Consensus 454 ------------------~~~~~~~~S~~~~~~~~~~s~Lg~~~~~~~l~f~~~~~~q~~i~~s~P~~nni~~~G~~~~~ 515 (865)
T KOG1055|consen 454 ------------------IIKTFRFVSQKLYISVSSLSSLGIILAVVFLSFNIKNRNQRYIKMSSPNLNNLIIVGCSLTL 515 (865)
T ss_pred ------------------eehcccccCcchhhhhhHHHHHHHHHHHHhchhhhhhhhhhhhccCCCCCCcceeeccceee
Confidence 01112222345567778899999999999999999999999999999999999999999999
Q ss_pred hhheeeeecC-------ceeeechhhhhhHHHHHHHHHHHHHHHHHHHHHhccCCCCCCC---Ccchhh-----hHHHHH
Q psy1666 909 LVTFVLVLKP-------SDLVCAIQRFGAGFCFTVVYAALLTKTNRISRIFNAGKRTAKR---PNFITP-----KSQLMI 973 (981)
Q Consensus 909 l~~~~fig~p-------~~~~C~lr~~~f~i~ft~~~s~il~Kt~~v~~~F~~~~~~~~~---~~~i~~-----~~q~~i 973 (981)
++++++...- -...|..|.|...++||++++++++|||+|..+|...+-+++. .++.++ .+.+++
T Consensus 516 ~sv~~lgLd~~~Isv~~f~~lc~~r~w~l~~gft~~~Gamf~K~w~Vh~if~~~~~~kK~~e~~Kl~~ivg~Ll~iD~~i 595 (865)
T KOG1055|consen 516 ASVFLLGLDGYSISVNAFPFLCTARTWILGLGFTLAFGAMFAKTWRVHSIFTNQKMWKKVIEDSKLYVIVGLLLAIDVLI 595 (865)
T ss_pred eeeeeccCCcceecHHHHHHHHHHHHHHHhheeecccchhhhhhheeeEeeccccccccccccceeEeehhHHHHhHHHH
Confidence 9998876533 2478999999999999999999999999999999763322221 122222 389999
Q ss_pred HHhhhhc
Q psy1666 974 CGGLVSV 980 (981)
Q Consensus 974 ~~~~~~i 980 (981)
+++|-.+
T Consensus 596 l~~Wqiv 602 (865)
T KOG1055|consen 596 LAIWQIV 602 (865)
T ss_pred hhhhhcc
Confidence 9999654
No 33
>cd06392 PBP1_iGluR_delta_1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta1 receptor of an orphan glutamate receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta1 receptor of an orphan glutamate receptor family. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 may be closer related to non-NMDA receptors. In contrast to GluRdelta2, GluRdel
Probab=99.50 E-value=2.3e-13 Score=155.54 Aligned_cols=246 Identities=13% Similarity=0.158 Sum_probs=144.0
Q ss_pred CCCCcceeeEEeecch------------hHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcC--CCcEE
Q psy1666 57 DDPDFIPVLMLFLRET------------TAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTK--PRARG 122 (981)
Q Consensus 57 ~q~~a~~~lv~f~~~~------------~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~--s~a~V 122 (981)
.+.+|++.+|.+++|+ ...+.|.+.+.+.+.-|.+.. +..+.+.......+++..+.+.+ ..-|+
T Consensus 124 ~~~~Ai~dlV~~~~W~~v~~iYD~d~gl~~lq~L~~~~~~~~~~I~~~~-v~~~~~~~~~~~l~~~~~~~L~~~~~~~r~ 202 (400)
T cd06392 124 RLNDVMLKLVTELRWQKFIVFYDSEYDIRGLQSFLDQASRLGLDVSLQK-VDRNISRVFTNLFTTMKTEELNRYRDTLRR 202 (400)
T ss_pred HHHHHHHHHHHhCCCcEEEEEEECcccHHHHHHHHHHHhhcCceEEEEE-cccCcchhhhhHHHHHHHhhhhhccccceE
Confidence 3778999999999992 245566666677787777554 22111000001112222211111 11388
Q ss_pred EEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCcccccccCCCccceeeEEE----EEecCCCCCChHHHHhhcCCCC
Q psy1666 123 VIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGLVSDGSEAEVEGTLS----LQPQANPVKGFDDYFLNLTVEN 197 (981)
Q Consensus 123 IVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~~~~~~~~~~~G~l~----~~~~~~~ipgF~ef~~~l~p~~ 197 (981)
||+.++.+.+..++.+|.+.++.+ .|+||.+ .|...+. ...+..+|.++ ++......+.+.+|..+.
T Consensus 203 iVv~~s~~~~~~il~qA~~lgM~~~~y~wI~t-~~~~~~~---dl~~~~~g~~~niT~~r~~~~~~~~~~~~~~~~---- 274 (400)
T cd06392 203 AILLLSPRGAQTFINEAVETNLASKDSHWVFV-NEEISDT---EILELVHSALGRMTVIRQIFPLSKDNNQRCIRN---- 274 (400)
T ss_pred EEEEcCcHHHHHHHHHHHHhCcccCCeEEEEe-cCCcccc---cHHHHhcccccceeeEEEecCCcHHHHHHHHHH----
Confidence 999999999999999999988865 3899988 4543321 12223345554 555433333233332100
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc--CCC
Q psy1666 198 NRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC--QGK 275 (981)
Q Consensus 198 ~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC--~~~ 275 (981)
. . .|.+.+ |. ..+.. .........++|||||++|+|||+++.+.- ...
T Consensus 275 ------~-~-r~~~~~-~~------------------~~~~~---~~~l~~~aalayDaV~~~A~Al~~ll~~~~~~~~~ 324 (400)
T cd06392 275 ------N-H-RISSLL-CD------------------PQEGY---LQMLQVSNLYLYDSVLMLANAFHRKLEDRKWHSMA 324 (400)
T ss_pred ------H-H-HHHhhh-cc------------------ccccc---ccccchhHHHHHHHHHHHHHHHHHHhhccccCCCC
Confidence 0 0 232111 10 00000 000112456899999999999999763111 111
Q ss_pred CCCCC--CCCCC-CccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 276 VGLCD--AMRPT-KGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 276 ~~~C~--~~~~~-~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
...|. .+.+. .|..|+++|++++|+|.+| +|.||++|.+. ..|||+|.+..+-....+++||+|++
T Consensus 325 ~l~C~~~~~~~w~~G~~ll~~ik~v~f~GLTG-~I~F~~~G~r~~~~ldIi~l~~~~~~g~g~~~iG~W~~ 394 (400)
T cd06392 325 SLNCIRKSTKPWNGGRSMLETIKKGHITGLTG-VMEFKEDGANPHVQFEILGTSYSETFGKDVRRLATWDS 394 (400)
T ss_pred CCccCCCCCCCCCChHHHHHHHHhCCCccCcc-ceeECCCCCCcCCceEEEeccccccCCCCceEeEEecC
Confidence 23573 23333 4678999999999999999 59999999876 58999998743111124799999986
No 34
>cd06385 PBP1_NPR_A Ligand-binding domain of type A natriuretic peptide receptor. Ligand-binding domain of type A natriuretic peptide receptor (NPR-A). NPR-A is one of three known single membrane-spanning natriuretic peptide receptors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. NPR-A is highly expressed in kidney, adrenal, terminal ileum, adipose, aortic, and lung tissues. The rank order of NPR-A activation by natriuretic peptides is ANPBNPCNP. Single allele-inactivating mutations in the promoter of human NPR-A are associated with hypertension and heart failure.
Probab=99.48 E-value=2.8e-13 Score=157.55 Aligned_cols=237 Identities=16% Similarity=0.216 Sum_probs=159.2
Q ss_pred hcCCCCCCCCCcceeeEEeecchh------------------HHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHH
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRETT------------------AFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIV 111 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~~~------------------~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii 111 (981)
|+.|++..|..+++.++.+++|++ ..+.+.+.+++.|+||+..+..+.+ ..++...+
T Consensus 122 R~~p~~~~~~~a~~~~~~~~~w~~va~ii~~~~~~~~~~~~~~~~~l~~~~~~~gi~v~~~~~~~~~-----~~d~~~~l 196 (405)
T cd06385 122 RTGPTHKKLGEFVLHIHQHFGWRSHAMLIYSDNKVDDRPCYFAMEGLYMELKKNNITVVDLVFEEDD-----LINYTTLL 196 (405)
T ss_pred EecCchHHHHHHHHHHHHhCCCeEEEEEEEecCcccccchHHHHHHHHHHHHhCCeEEEEeeccCCc-----hhhHHHHH
Confidence 577777788888877777777621 3477888888999999987644222 23667788
Q ss_pred HHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCccccc--------cc-C----CCccceeeEEEEE
Q psy1666 112 TKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGL--------VS-D----GSEAEVEGTLSLQ 177 (981)
Q Consensus 112 ~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~--------~~-~----~~~~~~~G~l~~~ 177 (981)
+++.. .+++||+.++...+..++.++.++++++ .++||+++.|..... .. . .....+++++...
T Consensus 197 ~~ik~--~~~iii~~~~~~~~~~i~~~a~~~g~~~~~y~~i~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~a~~~v~~~~ 274 (405)
T cd06385 197 QDIKQ--KGRVIYVCCSPDIFRRLMLQFWREGLPSEDYVFFYIDLFGASLQGPDPKRPWYRGDADDAAAREAFQSVKILT 274 (405)
T ss_pred HHHhh--cceEEEEeCCHHHHHHHHHHHHHcCCCCCcEEEEEeecchhhccCCCCCCCCCCCCcccHHHHHhhheeEEEe
Confidence 87643 3599999999999999999999988865 489999876643211 00 0 1123456666654
Q ss_pred ecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHH
Q psy1666 178 PQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAV 257 (981)
Q Consensus 178 ~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAV 257 (981)
......+..++|.+.+.... ...++|.. ..| .........||||
T Consensus 275 ~~~~~~~~~~~f~~~~~~~~------------~~~~~~~~-------------~~~-----------~~~~~aa~~YDav 318 (405)
T cd06385 275 YKEPQNPEYKEFLSDLKTDA------------KEMFNFTV-------------EDS-----------LMNIIAGGFYDGV 318 (405)
T ss_pred CCCCCChhHHHHHHHHHHHh------------hccCCCcc-------------chh-----------hHHHHHHHHHHHH
Confidence 43323345566654331100 00122110 000 0011345689999
Q ss_pred HHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEE
Q psy1666 258 MAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQV 337 (981)
Q Consensus 258 yAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~V 337 (981)
|++|.||++.++..- ...+|.+|.+.|++++|.|.+| +|.||++||+.+.|.+++++...+| .+++|
T Consensus 319 ~l~a~Al~~~~~~~~----------~~~~g~~i~~~l~~~~f~G~tG-~v~fd~~G~r~~~~~~~~~~~~~~g--~~~~v 385 (405)
T cd06385 319 MLYAHALNETMAKGG----------TRPPGTAITQRMWNRTFYGVTG-FVKIDDNGDRETDFALWDMTDTESG--DFQVV 385 (405)
T ss_pred HHHHHHHHHHHhcCC----------CCCCHHHHHHHhhCceEeecee-EEEEcCCCCEeceeEEEEccCCCCC--cEEEE
Confidence 999999999865211 1126788999999999999999 5999999999999999988765555 68999
Q ss_pred EEEEC
Q psy1666 338 GEYLE 342 (981)
Q Consensus 338 G~~~~ 342 (981)
|+|+.
T Consensus 386 ~~~~~ 390 (405)
T cd06385 386 SVYNG 390 (405)
T ss_pred EEEcc
Confidence 99984
No 35
>cd06352 PBP1_NPR_GC_like Ligand-binding domain of membrane guanylyl-cyclase receptors. Ligand-binding domain of membrane guanylyl-cyclase receptors. Membrane guanylyl cyclases (GC) have a single membrane-spanning region and are activated by endogenous and exogenous peptides. This family can be divided into three major subfamilies: the natriuretic peptide receptors (NPRs), sensory organ-specific membrane GCs, and the enterotoxin/guanylin receptors. The binding of peptide ligands to the receptor results in the activation of the cytosolic catalytic domain. Three types of NPRs have been cloned from mammalian tissues: NPR-A/GC-A, NPR-B/ GC-B, and NPR-C. In addition, two of the GCs, GC-D and GC-G, appear to be pseudogenes in humans. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are produced in the heart, and both bind to the NPR-A. NPR-C, also termed the clearance receptor, binds each of the natriuretic peptides and can alter circulating levels of these peptides. The l
Probab=99.44 E-value=9e-13 Score=152.40 Aligned_cols=217 Identities=16% Similarity=0.237 Sum_probs=151.7
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSW 150 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vW 150 (981)
....+.+++++++.|+||+..+.++.... ..++...++++. .+. ++|++.+....+..+++++.++++.+ .++|
T Consensus 152 ~~~~~~~~~~~~~~G~~v~~~~~~~~~~~---~~d~~~~l~~i~-~~~-~vii~~~~~~~~~~~l~q~~~~g~~~~~~~~ 226 (389)
T cd06352 152 FFTLEALEAALREFNLTVSHVVFMEDNSG---AEDLLEILQDIK-RRS-RIIIMCGSSEDVRELLLAAHDLGLTSGDYVF 226 (389)
T ss_pred HHHHHHHHHHHHhcCCeEEEEEEecCCcc---chhHHHHHHHhh-hcc-eEEEEECCHHHHHHHHHHHHHcCCCCCcEEE
Confidence 45567888888899999999999886420 135667777763 444 89999888888999999998888863 4799
Q ss_pred EEeccCcccccc------------cCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCC
Q psy1666 151 VGSDGWSARGLV------------SDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYP 218 (981)
Q Consensus 151 I~s~~W~~~~~~------------~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~ 218 (981)
|+++.|...... .....+..+|++++.+.....|.+++|.+..... +-+..++
T Consensus 227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~f~~~~~~~-----------~~~~~~~---- 291 (389)
T cd06352 227 ILIDLFNYSLPYQNSYPWERGDGDDEKAKEAYDAVLTITLRPPDNPEYEEFSEEVKEA-----------AKRPPFN---- 291 (389)
T ss_pred EEEehhccccccCCCCCcccCCcccHHHHHHHHhheEEEecCCCCchHHHHHHHHHHH-----------HhcccCc----
Confidence 998877654211 0111234678888877666677888888654211 1011112
Q ss_pred CCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhccee
Q psy1666 219 NSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVS 298 (981)
Q Consensus 219 ~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~ 298 (981)
|... ...........|||||++|+|+|++..+.. ...+++++.+.|++++
T Consensus 292 --------------~~~~------~~~~~~~a~~~YDav~~~a~Al~~~~~~~~----------~~~~~~~v~~~l~~~~ 341 (389)
T cd06352 292 --------------TDAE------PEQVSPYAGYLYDAVLLYAHALNETLAEGG----------DYNGGLIITRRMWNRT 341 (389)
T ss_pred --------------cCCC------ccccchhhhhHHHHHHHHHHHHHHHHHhCC----------CCCchHHHHHHhcCcE
Confidence 2200 001122456799999999999999975211 0246788999999999
Q ss_pred eccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 299 FQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 299 F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
|.|.+| .+.||++||+.+.|+|++|+.. ...+..+|.++.
T Consensus 342 f~g~~G-~v~fd~~G~~~~~~~v~~~~~~---~~~~~~~~~~~~ 381 (389)
T cd06352 342 FSGITG-PVTIDENGDREGDYSLLDLDST---GGQLEVVYLYDT 381 (389)
T ss_pred EEeeee-eEEEcCCCCeeeeEEEEEecCC---CceEEEEEeccc
Confidence 999988 6999999999999999999743 246788888864
No 36
>cd06380 PBP1_iGluR_AMPA N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, a member of the glutamate-receptor ion channels (iGluRs). AMPA receptors are the major mediators of excitatory synaptic transmission in the central nervous system. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excita
Probab=99.42 E-value=4.7e-12 Score=146.09 Aligned_cols=221 Identities=14% Similarity=0.227 Sum_probs=134.8
Q ss_pred HHHHHHHHHHhCCeeEEEEE-EeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEE
Q psy1666 74 AFEELEVLLAKSSICIAVKE-KLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWV 151 (981)
Q Consensus 74 ~~~~l~~~~~~~gICIA~~~-~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI 151 (981)
..+.+.+.+++.|.|+.... .++... ...++...+.++ +..++++||+.++...+..+++++.+.++.+ .++||
T Consensus 141 ~~~~~~~~~~~~g~~i~v~~~~~~~~~---~~~d~~~~L~~i-k~~~~~~iil~~~~~~~~~i~~qa~~~gm~~~~y~~i 216 (382)
T cd06380 141 RLQQLLDYLREKDNKWQVTARRVDNVT---DEEEFLRLLEDL-DRRKEKRIVLDCESERLNKILEQIVDVGKNRKGYHYI 216 (382)
T ss_pred HHHHHHHHHhccCCceEEEEEEecCCC---cHHHHHHHHHHh-hcccceEEEEECCHHHHHHHHHHHHHhhhcccceEEE
Confidence 34556667777884443332 222211 124677778776 5567899999999999999999999988865 37888
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYST 231 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~ 231 (981)
.+ +|.............-....++.+.....|..++|.+ .|...++...+..
T Consensus 217 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~----------------~~~~~~~~~~~~~----------- 268 (382)
T cd06380 217 LA-NLGFDDIDLSKFLFGGVNITGFQLVDNTNPTVQKFLQ----------------RWKKLDPREWPGA----------- 268 (382)
T ss_pred Ec-cCCcccccHHHhccCceeeEEEeccCCCCHHHHHHHH----------------HHHhcCccccCcC-----------
Confidence 75 3322211000000001124455443333445666654 2333332211100
Q ss_pred CCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhh----------cCCCCCCCCCCC---CCCccHHHHhhccee
Q psy1666 232 ECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADL----------CQGKVGLCDAMR---PTKGPELLKYLRKVS 298 (981)
Q Consensus 232 ~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~l----------C~~~~~~C~~~~---~~~~~qLl~~Lk~V~ 298 (981)
... .......++|||||++|+||+++.+.. ..+....|.... ..+|.+|.++|++++
T Consensus 269 ------~~~----~~~~~aa~aYDav~~~a~Al~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~g~~i~~~l~~~~ 338 (382)
T cd06380 269 ------GTS----PIKYTAALAHDAVLVMAEAFRSLRRQRGSGRHRIDISRRGNGGDCLANPAVPWEHGIDIERALKKVQ 338 (382)
T ss_pred ------CcC----CcchHHHHHHHHHHHHHHHHHHHHHhccccccccccccCCCCCcCCCCCCCCccchHHHHHHHHhcc
Confidence 000 011134679999999999999986421 111233575431 235778999999999
Q ss_pred eccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 299 FQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 299 F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
|+|.+| +|.||++||+. ..++|+|++. + .+++||.|++
T Consensus 339 ~~G~tG-~i~Fd~~G~~~~~~~~i~~~~~--~---~~~~vg~w~~ 377 (382)
T cd06380 339 FEGLTG-NVQFDEFGQRTNYTLDVVELKT--R---GLRKVGYWNE 377 (382)
T ss_pred cCCccc-ceEECCCCCcccccEEEEEecC--C---CceEEEEECC
Confidence 999999 59999999987 5799999872 2 3789999986
No 37
>cd06373 PBP1_NPR_like Ligand binding domain of natriuretic peptide receptor (NPR) family. Ligand binding domain of natriuretic peptide receptor (NPR) family which consists of three different subtypes: type A natriuretic peptide receptor (NPR-A, or GC-A), type B natriuretic peptide receptors (NPR-B, or GC-B), and type C natriuretic peptide receptor (NPR-C). There are three types of natriuretic peptide (NP) ligands specific to the receptors: atrial NP (ANP), brain or B-type NP (BNP), and C-type NP (CNP). The NP family is thought to have arisen through gene duplication during evolution and plays an essential role in cardiovascular and body fluid homeostasis. ANP and BNP bind mainly to NPR-A, while CNP binds specifically to NPR-B. Both NPR-A and NPR-B have guanylyl cyclase catalytic activity and produces intracellular secondary messenger cGMP in response to peptide-ligand binding. Consequently, the NPR-A activation results in vasodilation and inhibition of vascular smooth muscle cell proli
Probab=99.42 E-value=1e-12 Score=152.27 Aligned_cols=239 Identities=16% Similarity=0.308 Sum_probs=158.2
Q ss_pred HhcCCCCCCCCCcceeeEEeecc----------hh-------HHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHH
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE----------TT-------AFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIV 111 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~----------~~-------~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii 111 (981)
+|+.|++..|..+++.++.+++| +. ..+.+.+.+++.|+||+... +..... ..++...+
T Consensus 120 fr~~p~~~~~~~a~~~~~~~~~w~~vaii~~~~~~~~~~~~~~~~~~~~~~~~~g~~v~~~~-~~~~~~---~~d~~~~l 195 (396)
T cd06373 120 TRTGPSYTKLGEFVLALHEHFNWSRAALLYHDDKNDDRPCYFTLEGVYTVLKEENITVSDFP-FDEDKE---LDDYKELL 195 (396)
T ss_pred eeccccHHHHHHHHHHHHHHcCCeEEEEEEECCCCCcchHHHHHHHHHHHHhhcCceeeEEe-ecCCcc---ccCHHHHH
Confidence 45778888888887777777666 21 35677788888999998554 332210 13566778
Q ss_pred HHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCccc-----ccc---c----CCCccceeeEEEEEe
Q psy1666 112 TKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSAR-----GLV---S----DGSEAEVEGTLSLQP 178 (981)
Q Consensus 112 ~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~-----~~~---~----~~~~~~~~G~l~~~~ 178 (981)
+++.. .. ++|++.+....+..+++++.++++++ .|+||..+-.... .+. . .......+|.+++.+
T Consensus 196 ~~ik~-~~-~vii~~~~~~~~~~~~~qa~~~g~~~~~yv~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~ 273 (396)
T cd06373 196 RDISK-KG-RVVIMCASPDTVREIMLAAHRLGLTSGEYVFFNIDLFGSSLYGGGPWWWERGDEDDEKAKEAYQALMTITL 273 (396)
T ss_pred HHHHh-cC-cEEEEecCHHHHHHHHHHHHHcCCCCCcEEEEEEccchhhhccCCCCcCCCCCcccHHHHHHHHHheEEec
Confidence 77754 33 89999999999999999999888864 5899976533211 111 0 001123446777766
Q ss_pred cCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHH
Q psy1666 179 QANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVM 258 (981)
Q Consensus 179 ~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVy 258 (981)
.....+.+++|.+..... +...+++ |.... .........|||||
T Consensus 274 ~~~~~~~~~~F~~~~~~~------------~~~~~~~-----------------~~~~~-------~~~~~a~~~YDav~ 317 (396)
T cd06373 274 REPDNPEYKEFSLEVKER------------AKKKFNT-----------------TSDDS-------LVNFFAGAFYDAVL 317 (396)
T ss_pred CCCCChHHHHHHHHHHHH------------hhhcCCC-----------------Ccchh-------HHHHHHHHHHHHHH
Confidence 554556677776543211 0001111 00000 01113456899999
Q ss_pred HHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEE
Q psy1666 259 AFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVG 338 (981)
Q Consensus 259 AiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG 338 (981)
++|+||+++.++ .+ ...+|++|.+.|++++|.|.+|. +.||++||+...|.|+++....+| .++.||
T Consensus 318 ~~a~Al~~~~~~--~~--------~~~~~~~i~~~l~~~~f~G~tG~-v~fd~~G~~~~~~~v~~~~~~~~g--~~~~~~ 384 (396)
T cd06373 318 LYALALNETLAE--GG--------DPRDGTNITRRMWNRTFEGITGN-VSIDENGDRESDFSLWDMTDTETG--TFEVVA 384 (396)
T ss_pred HHHHHHHHHHhc--cC--------CCCChHHHHHHhcCCceecccCc-eEeecCCcccceeeeeeccCCCCc--eEEEEe
Confidence 999999999642 11 12578999999999999999995 999999999999999887655555 688999
Q ss_pred EEEC
Q psy1666 339 EYLE 342 (981)
Q Consensus 339 ~~~~ 342 (981)
.|++
T Consensus 385 ~~~~ 388 (396)
T cd06373 385 NYNG 388 (396)
T ss_pred eccc
Confidence 9985
No 38
>cd06389 PBP1_iGluR_AMPA_GluR2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR2 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR2 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=99.41 E-value=6.4e-12 Score=143.92 Aligned_cols=236 Identities=17% Similarity=0.258 Sum_probs=145.4
Q ss_pred CCcceeeEEeecc---------hh---HHHHHHHHHHhCCeeEEEEE--EeecCCcchhhhhHHHHHHHHhcCCCcEEEE
Q psy1666 59 PDFIPVLMLFLRE---------TT---AFEELEVLLAKSSICIAVKE--KLVKDSGVAEERAYDDIVTKLMTKPRARGVI 124 (981)
Q Consensus 59 ~~a~~~lv~f~~~---------~~---~~~~l~~~~~~~gICIA~~~--~ip~~~~~~~~~~~~~ii~~li~~s~a~VIV 124 (981)
..|++.++.+++| +. ..+.|.+.+++.|+-|...+ .+.... ...++...++++ +.++.++||
T Consensus 106 ~~ai~d~i~~~~wk~vailYdsd~gl~~lq~l~~~~~~~g~~V~~~~~~~i~~~~---~~~d~~~~L~~i-k~~~~~~Ii 181 (370)
T cd06389 106 KGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDR---KDEAYRSLFQDL-ENKKERRVI 181 (370)
T ss_pred hhHHHHHHHhcCCcEEEEEecCchHHHHHHHHHHhhccCCceEEEEEeecCCCcc---chHHHHHHHHHh-ccccceEEE
Confidence 4555555555555 33 45666677777785443333 222111 123677788876 677899999
Q ss_pred EEcchhhHHHHHHHHHhhccCCc-eEEEEec-cCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCCCC
Q psy1666 125 VFGSDQEVAGVMRAVRRLNATGS-FSWVGSD-GWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNP 202 (981)
Q Consensus 125 l~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~-~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~n~ 202 (981)
+.++...+..++.++.++++.++ +.||.+. +|.......... .-.+..|+++.....|..++|.+.+
T Consensus 182 l~~~~~~~~~il~qa~~~gm~~~~y~~il~~~~~~~~~l~~~~~--~~~nitg~~~~~~~~~~v~~f~~~~--------- 250 (370)
T cd06389 182 LDCERDKVNDIVDQVITIGKHVKGYHYIIANLGFTDGDLSKIQF--GGANVSGFQIVDYDDPLVSKFIQRW--------- 250 (370)
T ss_pred EECCHHHHHHHHHHHHHhCccccceEEEEccCCccccchhhhcc--CCcceEEEEEecCCCchHHHHHHHH---------
Confidence 99999999999999999888664 6887654 455332210000 0012345554444455566665432
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcC----CCCCC
Q psy1666 203 WFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQ----GKVGL 278 (981)
Q Consensus 203 ~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~----~~~~~ 278 (981)
+....-.+++. + ...........|||||++|.|++++....-. +..+.
T Consensus 251 -------~~~~~~~~~~~--------------~-------~~~~~~~aAl~yDAV~v~a~A~~~l~~~~~~~~~~~~~~~ 302 (370)
T cd06389 251 -------STLEEKEYPGA--------------H-------TKTIKYTSALTYDAVQVMTEAFRNLRKQRIEISRRGNAGD 302 (370)
T ss_pred -------HhcCccccCCC--------------C-------CcCcchHHHHHHHHHHHHHHHHHHHHHcCCCcccCCCCCC
Confidence 11000000000 0 0001113467999999999999998542110 11336
Q ss_pred CCCCC--C-CCccHHHHhhcceeeccCCCCeEEecCCCCCCc-eeEEEEEEEcCCCcEEEEEEEEEECC
Q psy1666 279 CDAMR--P-TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPA-RYNIIHFKQIRPGVYQWVQVGEYLEG 343 (981)
Q Consensus 279 C~~~~--~-~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~-~YdI~n~q~~~~g~~~~v~VG~~~~~ 343 (981)
|.... + .+|..|.++|++++|.|.+| ++.||++|++.. .++|++.+. + .+++||+|++.
T Consensus 303 C~~~~~~~w~~G~~i~~~l~~~~~~GlTG-~i~Fd~~G~r~~~~~~ii~l~~--~---g~~kvG~W~~~ 365 (370)
T cd06389 303 CLANPAVPWGQGVEIERALKQVQVEGLTG-NIKFDQNGKRINYTINVMELKS--N---GPRKIGYWSEV 365 (370)
T ss_pred cCCCCCCCCCCcHHHHHHHHhcccCcccc-ceEeCCCCccccceEEEEEecC--C---cceEEEEEcCC
Confidence 76422 1 24668999999999999999 599999999976 899999862 2 37999999863
No 39
>cd06384 PBP1_NPR_B Ligand-binding domain of type B natriuretic peptide receptor. Ligand-binding domain of type B natriuretic peptide receptor (NPR-B). NPR-B is one of three known single membrane-spanning natriuretic peptide receptors that have been identified. Natriuretic peptides are family of structurally related but genetically distinct hormones/paracrine factors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. Like NPR-A (or GC-A), NPR-B (or GC-B) is a transmembrane guanylyl cyclase, an enzyme that catalyzes the synthesis of cGMP. NPR-B is the predominant natriuretic peptide receptor in the brain. The rank of order activation of NPR-B by natriuretic peptides is CNPANPBNP. Homozygous inactivating mutations in human NPR-B cause a form of short-limbed dwarfism known as acromesomelic dysplasia type Maroteaux.
Probab=99.36 E-value=9.1e-12 Score=144.51 Aligned_cols=237 Identities=14% Similarity=0.208 Sum_probs=154.8
Q ss_pred hcCCCCCCCCCcceeeEEeecchh------------------HHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHH
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRETT------------------AFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIV 111 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~~~------------------~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii 111 (981)
|+.|++..|..++..++.+++|+. ..+.+.+.++++|+||...+....+ ..++..++
T Consensus 122 R~~p~~~~~~~~~~~i~~~~~w~~~vaiiy~~~~~~~~~~~~~~~~~~~~~~~~gi~v~~~~~~~~~-----~~d~~~~l 196 (399)
T cd06384 122 RTGPSTTKLGEFVNHLHEHFNWTSRAALLYLDLKTDDRPHYFISEGVFLALQEENANVSAHPYHIEK-----NSDIIEII 196 (399)
T ss_pred EecCcHHHHHHHHHHHHHhCCCcEEEEEEEecCCccCCcceEehHHHHHHHHhcCceEEEEEEeccc-----hhhHHHHH
Confidence 355666666666655656666531 1344666778899999986654422 23677788
Q ss_pred HHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCccccc----cc----------CCCccceeeEEEE
Q psy1666 112 TKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGL----VS----------DGSEAEVEGTLSL 176 (981)
Q Consensus 112 ~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~----~~----------~~~~~~~~G~l~~ 176 (981)
+++. . +++||++.+....+..+++++.++++.+ .|+||..+.+..... .. ......+++++++
T Consensus 197 ~~ik-~-~~~vIi~~~~~~~~~~i~~qa~~~g~~~~~y~~i~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~v~~~ 274 (399)
T cd06384 197 QFIK-Q-NGRIVYICGPLETFLEIMLQAQREGLTPGDYVFFYLDVFGESLRVKSPRESYKQMNHSSWTVLKEAFKSVFVI 274 (399)
T ss_pred HHHh-h-cccEEEEeCCchHHHHHHHHHHHcCCCCCcEEEEEehhcccccccCCCCccccCCCCcccHHHHHHHhheEEe
Confidence 8874 3 7899999999999999999999988866 489998765442111 00 0111256777777
Q ss_pred EecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHH
Q psy1666 177 QPQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDA 256 (981)
Q Consensus 177 ~~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydA 256 (981)
++.....+.+++|.+.+.-. + ...++|.. . +-.........|||
T Consensus 275 ~~~~~~~~~~~~F~~~~~~~-----------~-~~~~~~~~----------------------~--p~~~~~~aa~~YDa 318 (399)
T cd06384 275 TYREPENPEYKEFQRELHAR-----------A-KEDFGVEL----------------------E--PSLMNFIAGCFYDG 318 (399)
T ss_pred ecCCCCCchHHHHHHHHHHH-----------H-hhhcCCCc----------------------C--cchHhhhhhhhHHH
Confidence 65544345566665433100 0 00122110 0 00001124568999
Q ss_pred HHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEE
Q psy1666 257 VMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQ 336 (981)
Q Consensus 257 VyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~ 336 (981)
||.+|.||.+.++.. + ...++.++.+.|++++|.|.+| .|.||++||+...|.++.++...+| .++.
T Consensus 319 v~l~a~Al~~~~~~~-----~-----~~~~g~~i~~~l~~~~f~GvtG-~v~fd~~G~r~~~~~~~~~~~~~~g--~~~~ 385 (399)
T cd06384 319 VMLYAMALNETLAEG-----G-----SQKDGLNITRKMQDRRFWGVTG-LVSIDKNNDRDIDFDLWAMTDHETG--KYEV 385 (399)
T ss_pred HHHHHHHHHHHHhcC-----C-----CCCCcHhHHHHHhCceeeccee-EEEECCCCCcccceEEEEeecCCCC--eEEE
Confidence 999999999986521 0 1136778999999999999999 4999999999989999766544555 5899
Q ss_pred EEEEEC
Q psy1666 337 VGEYLE 342 (981)
Q Consensus 337 VG~~~~ 342 (981)
||+|+.
T Consensus 386 v~~~~~ 391 (399)
T cd06384 386 VAHYNG 391 (399)
T ss_pred EEEEcC
Confidence 999974
No 40
>cd06393 PBP1_iGluR_Kainate_GluR5_7 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR5-7 subunits of Kainate receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR5-7 subunits of Kainate receptor. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. There are five types of kainate receptors, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeric receptor channels activated
Probab=99.36 E-value=9.2e-12 Score=143.66 Aligned_cols=241 Identities=16% Similarity=0.191 Sum_probs=147.2
Q ss_pred cCCCCCCCCCcceeeEEeecc---------hhH---HHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCC
Q psy1666 51 TKPRARDDPDFIPVLMLFLRE---------TTA---FEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKP 118 (981)
Q Consensus 51 ~~psa~~q~~a~~~lv~f~~~---------~~~---~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s 118 (981)
..|++..+..|++.++.+++| .++ .+.|.+.+++.|+||.. +.++... .++...++++ +.+
T Consensus 119 ~~~~~~~~~~a~~~~~~~~~wk~vaily~~~~g~~~l~~~~~~~~~~g~~v~~-~~~~~~~-----~d~~~~L~~i-k~~ 191 (384)
T cd06393 119 LYPDYASLSHAILDLVQYLKWRSATVVYDDSTGLIRLQELIMAPSRYNIRLKI-RQLPTDS-----DDARPLLKEM-KRG 191 (384)
T ss_pred eccCHHHHHHHHHHHHHHcCCcEEEEEEeCchhHHHHHHHHHhhhccCceEEE-EECCCCc-----hHHHHHHHHH-hhc
Confidence 445555566666666666666 222 23577777788999986 4454322 3677778776 455
Q ss_pred CcEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceee--EEEEEecCCCCCChHHHHhhcCC
Q psy1666 119 RARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEG--TLSLQPQANPVKGFDDYFLNLTV 195 (981)
Q Consensus 119 ~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G--~l~~~~~~~~ipgF~ef~~~l~p 195 (981)
+.++||+.++...+..+++++.++++.++ +.|+.++. ..... ....-..+| ..++.+.....+.+++|.+.+.-
T Consensus 192 ~~~~iil~~~~~~~~~il~qa~~~gm~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~it~~~~~~~~~~~~~~f~~~~~~ 268 (384)
T cd06393 192 REFRIIFDCSHQMAAQILKQAMAMGMMTEYYHFIFTTL-DLYAL--DLEPYRYSGVNLTGFRILNVDNPHVSSIVEKWSM 268 (384)
T ss_pred CceEEEEECCHHHHHHHHHHHHHhccccCceEEEEccC-ccccc--cchhhhcCcceEEEEEecCCCcHHHHHHHHHHHh
Confidence 67888999999999999999999888653 56775421 11110 000000123 36666665566677777654321
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCC
Q psy1666 196 ENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGK 275 (981)
Q Consensus 196 ~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~ 275 (981)
..+...|+-. .... +..........|||||++|+|+++..+. ...
T Consensus 269 ~~~~~~p~~~-------------------------------~~~~--~~~~~~~aal~yDav~~~a~A~~~~~~~--~~~ 313 (384)
T cd06393 269 ERLQAAPKPE-------------------------------TGLL--DGVMMTDAALLYDAVHMVSVCYQRAPQM--TVN 313 (384)
T ss_pred hhhccccccc-------------------------------cccc--cccccchhHHhhhhHHHHHHHHhhhhhc--CCC
Confidence 1110000000 0000 0001123567999999999999976431 111
Q ss_pred CCCCCCCCCC-CccHHHHhhcceeeccCCCCeEEecC-CCCC-CceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 276 VGLCDAMRPT-KGPELLKYLRKVSFQGLSEDHFKFDK-DGDG-PARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 276 ~~~C~~~~~~-~~~qLl~~Lk~V~F~g~~G~~V~FD~-nGD~-~~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
.-.|....+. .|..|.++|++++|.|.+| .+.||+ +|.+ .-.|||+|... + .+++||.|++
T Consensus 314 ~~~c~~~~~w~~G~~i~~~l~~~~~~GltG-~i~Fd~~~g~r~~~~~~i~~~~~--~---g~~~vg~W~~ 377 (384)
T cd06393 314 SLQCHRHKAWRFGGRFMNFIKEAQWEGLTG-RIVFNKTSGLRTDFDLDIISLKE--D---GLEKVGVWNP 377 (384)
T ss_pred CCCCCCCCCCcccHHHHHHHhheeeccccc-ceEecCCCCeeeeeEEEEEEecC--C---cceeeEEEcC
Confidence 2347643322 3457999999999999999 499996 5665 46899999862 2 4799999986
No 41
>cd06350 PBP1_GPCR_family_C_like Ligand-binding domain of membrane-bound glutamate receptors that mediate excitatory transmission on the cellular surface through initial binding of glutamate and are categorized into ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). Ligand-binding domain of membrane-bound glutamate receptors that mediate excitatory transmission on the cellular surface through initial binding of glutamate and are categorized into ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). The metabotropic glutamate receptors (mGluR) are key receptors in the modulation of excitatory synaptic transmission in the central nervous system. The mGluRs are coupled to G proteins and are thus distinct from the iGluRs which internally contain ligand-gated ion channels. The mGluR structure is divided into three regions: the extracellular region, the seven-spanning transmembrane region and the cytoplasmic region. The extr
Probab=99.35 E-value=6.2e-12 Score=143.03 Aligned_cols=185 Identities=28% Similarity=0.433 Sum_probs=142.8
Q ss_pred hcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhc
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMT 116 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~ 116 (981)
|+.|++.+|..+++.++..++| ....+.|++.+++.|+||+..+.++.... ..++...++++ +
T Consensus 139 r~~p~~~~~~~a~~~~~~~~~~~~v~~l~~~~~~g~~~~~~~~~~~~~~gi~v~~~~~~~~~~~---~~d~~~~l~~l-~ 214 (348)
T cd06350 139 RTVPSDTSQALAIVALLKHFGWTWVGLVYSDDDYGRSGLSDLEEELEKNGICIAFVEAIPPSST---EEDIKRILKKL-K 214 (348)
T ss_pred EecCCcHHHHHHHHHHHHHCCCeEEEEEEecchhHHHHHHHHHHHHHHCCCcEEEEEEccCCCc---HHHHHHHHHHH-H
Confidence 4778888899999888888777 44678888999999999999999986421 23566777776 5
Q ss_pred CCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEec---CCCCCChHHHHhhc
Q psy1666 117 KPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQ---ANPVKGFDDYFLNL 193 (981)
Q Consensus 117 ~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~---~~~ipgF~ef~~~l 193 (981)
.+++++|++++...++..+++++.++++.++ .|+++++|.............++|.++..+. ..+.++|++|++.
T Consensus 215 ~~~~~vvv~~~~~~~~~~~~~~a~~~g~~~~-~~i~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~f~~~~~~- 292 (348)
T cd06350 215 SSTARVIVVFGDEDDALRLFCEAYKLGMTGK-YWIISTDWDTSTCLLLFTLDAFQGVLGFSGHAPRSGEIPGFKDFLRK- 292 (348)
T ss_pred hCCCcEEEEEeCcHHHHHHHHHHHHhCCCCe-EEEEEccccCccccccCCcceeeeEEEEEEEeecCCcCCChHHHHHH-
Confidence 6678999999999999999999999988554 7888989987632222233455677666543 3567778777642
Q ss_pred CCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcC
Q psy1666 194 TVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQ 273 (981)
Q Consensus 194 ~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~ 273 (981)
...++|||||+
T Consensus 293 -------------------------------------------------------~~~~~YDav~~-------------- 303 (348)
T cd06350 293 -------------------------------------------------------YAYNVYDAVYA-------------- 303 (348)
T ss_pred -------------------------------------------------------HHHHHHhheeE--------------
Confidence 12468999988
Q ss_pred CCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 274 GKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 274 ~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
+|.||++||+.+.|+|.+|+..+ ++..+++||.|++
T Consensus 304 --------------------------------~v~f~~~gd~~~~~~i~~~~~~~-~~~~~~~vg~~~~ 339 (348)
T cd06350 304 --------------------------------EVKFDENGDRLASYDIINWQIFP-GGGGFVKVGFWDP 339 (348)
T ss_pred --------------------------------EEEecCCCCcccceeEEEEEEcC-CcEEEEEEEEEcC
Confidence 59999999999999999998755 6788999999985
No 42
>cd06388 PBP1_iGluR_AMPA_GluR4 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR4 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR4 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=99.35 E-value=2.2e-11 Score=139.34 Aligned_cols=229 Identities=14% Similarity=0.230 Sum_probs=146.3
Q ss_pred CCcceeeEEeecc---------h---hHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEE
Q psy1666 59 PDFIPVLMLFLRE---------T---TAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVF 126 (981)
Q Consensus 59 ~~a~~~lv~f~~~---------~---~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~ 126 (981)
..|++.++.+++| . ...+.|.+.+++.|+-|...+..+.+ ..++...++++ +.++.++||+.
T Consensus 112 ~~a~~~~i~~~~wk~vaiiYd~~~~~~~lq~l~~~~~~~g~~v~~~~~~~~~-----~~d~~~~L~~i-k~~~~~~iil~ 185 (371)
T cd06388 112 RGALLSLLDHYEWNRFVFLYDTDRGYSILQAIMEKAGQNGWQVSAICVENFN-----DASYRRLLEDL-DRRQEKKFVID 185 (371)
T ss_pred hhHHHHHHHhcCceEEEEEecCCccHHHHHHHHHhhHhcCCeeeeEEeccCC-----cHHHHHHHHHh-cccccEEEEEE
Confidence 3455555555555 2 23567777777889877665543321 13677777776 66788999999
Q ss_pred cchhhHHHHHHHHHhhccCCc-eEEEEec-cCcccccccCCCccceee---EEEEEecCCCCCChHHHHhhcCCCCCCCC
Q psy1666 127 GSDQEVAGVMRAVRRLNATGS-FSWVGSD-GWSARGLVSDGSEAEVEG---TLSLQPQANPVKGFDDYFLNLTVENNRRN 201 (981)
Q Consensus 127 ~s~~~a~~~~~~~~~~~l~g~-~vWI~s~-~W~~~~~~~~~~~~~~~G---~l~~~~~~~~ipgF~ef~~~l~p~~~~~n 201 (981)
++...+..++.++.+.++.++ +.||.+. +|..... .+...| ..|+.+.....|..++|.+.+
T Consensus 186 ~~~~~~~~il~qa~~~gm~~~~y~~il~~~~~~~~~l-----~~~~~g~~nitg~~~~~~~~~~v~~~~~~~-------- 252 (371)
T cd06388 186 CEIERLQNILEQIVSVGKHVKGYHYIIANLGFKDISL-----ERFMHGGANVTGFQLVDFNTPMVTKLMQRW-------- 252 (371)
T ss_pred CCHHHHHHHHHHHHhcCccccceEEEEccCccccccH-----HHHhccCCceEEEEeecCCChhHHHHHHHH--------
Confidence 999999999999999888653 6888764 3443221 111122 556666544456677765432
Q ss_pred CccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcC----CCCC
Q psy1666 202 PWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQ----GKVG 277 (981)
Q Consensus 202 ~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~----~~~~ 277 (981)
.+.+.-.+++. .+ .........|||||++|.|++++....-. +..+
T Consensus 253 --------~~~~~~~~~~~-----------~~-----------~~~~~aAl~YDaV~l~a~A~~~l~~~~~~~~~~~~~~ 302 (371)
T cd06388 253 --------KKLDQREYPGS-----------ES-----------PPKYTSALTYDGVLVMAEAFRNLRRQKIDISRRGNAG 302 (371)
T ss_pred --------HhcCccccCCC-----------CC-----------CccchHHHHHHHHHHHHHHHHHHHhcCCCcccCCCCC
Confidence 21111000000 00 01113567999999999999997431111 1123
Q ss_pred CCCCCC--C-CCccHHHHhhcceeeccCCCCeEEecCCCCCCc-eeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 278 LCDAMR--P-TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPA-RYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 278 ~C~~~~--~-~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~-~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
.|.... + -.|..|.++|++++|+|.+| .+.||++|++.. .++|++.+ .+ .+++||+|++
T Consensus 303 ~C~~~~~~~w~~G~~i~~~lk~~~~~GlTG-~i~Fd~~G~r~~~~l~Ii~l~--~~---g~~kvG~W~~ 365 (371)
T cd06388 303 DCLANPAAPWGQGIDMERTLKQVRIQGLTG-NIQFDHYGRRVNYTMDVFELK--SN---GPRKIGYWND 365 (371)
T ss_pred CcCCCCCCCCcccHHHHHHHHhcCcCCCcc-ceeECCCCCcccceEEEEEcc--CC---CceEEEEEcC
Confidence 675321 1 23456999999999999999 699999999977 89999986 22 3799999986
No 43
>cd06371 PBP1_sensory_GC_DEF_like Ligand-binding domain of membrane guanylyl cyclases (GC-D, GC-E, and GC-F) that are specifically expressed in sensory tissues. This group includes the ligand-binding domain of membrane guanylyl cyclases (GC-D, GC-E, and GC-F) that are specifically expressed in sensory tissues. They share a similar topology with an N-terminal extracellular ligand-binding domain, a single transmembrane domain, and a C-terminal cytosolic region that contains kinase-like and catalytic domains. GC-D is specifically expressed in a subpopulation of olfactory sensory neurons. GC-E and GC-F are colocalized within the same photoreceptor cells of the retina and have important roles in phototransduction. Unlike the other family members, GC-E and GC-F have no known extracellular ligands. Instead, they are activated under low calcium conditions by guanylyl cyclase activating proteins called GCAPs. GC-D expressing neurons have been implicated in pheromone detection and GC-D is phyloge
Probab=99.25 E-value=1.7e-10 Score=132.88 Aligned_cols=210 Identities=14% Similarity=0.225 Sum_probs=136.6
Q ss_pred CcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEE
Q psy1666 60 DFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVF 126 (981)
Q Consensus 60 ~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~ 126 (981)
.+++.++.+++| ....+.+.+.+++.|+||...+.++.+. .++..+++++.....++|||+.
T Consensus 121 ~~~~~~~~~~~w~~vaii~~~~~~~~~~~~~l~~~l~~~gi~v~~~~~~~~~~-----~d~~~~L~~lk~~~~~~viv~~ 195 (382)
T cd06371 121 RVLFTVLRYFRWAHVAIVSSPQDIWVETAQKLASALRAHGLPVGLVTSMGPDE-----KGAREALKKVRSADRVRVVIMC 195 (382)
T ss_pred HHHHHHHHHCCCeEEEEEEecccchHHHHHHHHHHHHHCCCcEEEEEEecCCH-----HHHHHHHHHHhcCCCcEEEEEE
Confidence 455566666666 2247888888889999999998887543 3678888887554457998887
Q ss_pred cch-----hhHHHHHHHHHhhccCC-ceEEEEeccCcccc-----cccC-----CCccceeeEEEEEecCCCCCChHHHH
Q psy1666 127 GSD-----QEVAGVMRAVRRLNATG-SFSWVGSDGWSARG-----LVSD-----GSEAEVEGTLSLQPQANPVKGFDDYF 190 (981)
Q Consensus 127 ~s~-----~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~-----~~~~-----~~~~~~~G~l~~~~~~~~ipgF~ef~ 190 (981)
+.. ..+..+++++.++++++ .++||++++...+. .... ......++.+++++.. +...|.+-+
T Consensus 196 ~~~~~~~~~~~~~i~~qa~~~Gm~~~~y~~i~~d~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~-~~~~~~~~f 274 (382)
T cd06371 196 MHSVLIGGEEQRLLLETALEMGMTDGRYVFIPYDTLLYSLPYRNVSYPALRNNSKLRRAYDAVLTITMDS-GEQSFYEAF 274 (382)
T ss_pred eeccccCcHHHHHHHHHHHHcCCcCCcEEEEEeccccccCCCCCccccCCCCCHHHHHHhHhhEEEEecC-CCCcHHHHH
Confidence 655 56778899999998874 57999988543110 0010 0013456666666543 222332222
Q ss_pred hhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhh
Q psy1666 191 LNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHAD 270 (981)
Q Consensus 191 ~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~ 270 (981)
...... ...| |+. . +..........|||||++|+||++..+.
T Consensus 275 ~~~~~~--~~~~-----~~~-----------------------------~--~~~~~~~~~~~YDav~~~a~Al~~a~~~ 316 (382)
T cd06371 275 RAAQER--GEIP-----SDL-----------------------------E--PEQVSPLFGTIYNSIYLLAHAVENARAA 316 (382)
T ss_pred HHHHhc--CCCC-----CCC-----------------------------C--ccccchhHHHHHHHHHHHHHHHHHHHHh
Confidence 111000 0000 000 0 0001112346899999999999998742
Q ss_pred hcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEE
Q psy1666 271 LCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFK 325 (981)
Q Consensus 271 lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q 325 (981)
+ .+.++.+|.+.|++++|+|.+|. |.||++||+...|.|++++
T Consensus 317 ---g--------~~~d~~~l~~~l~~~~f~GvtG~-v~fd~~g~~~~~~~v~~~~ 359 (382)
T cd06371 317 ---G--------GGVSGANLAQHTRNLEFQGFNQR-LRTDSGGGGQAPYVVLDTD 359 (382)
T ss_pred ---C--------CCccHHHHHHHHhCccccccceE-EEecCCCCcccceEEEecC
Confidence 1 12467899999999999999995 9999999999999999886
No 44
>cd06383 PBP1_iGluR_AMPA_Like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excitatory synaptic current.
Probab=99.25 E-value=1.2e-11 Score=141.05 Aligned_cols=222 Identities=13% Similarity=0.106 Sum_probs=134.0
Q ss_pred HhcCCCCCCCCCcceeeEEeecch---------hH-----HHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHH
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRET---------TA-----FEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKL 114 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~~---------~~-----~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~l 114 (981)
+++.|++..|++||+.+|.+++|. ++ .+.+++...+.+.|+. +... .++.+.++++
T Consensus 111 ir~~Ps~~~~~~Ai~dlI~~f~W~~v~iIYddd~gl~~~l~~~l~~~~~~~~~~v~-----~~~~-----~~~~~~Lk~l 180 (368)
T cd06383 111 IQLMPPADDIVEAIRDIVSYYNITNAAILYDDDFVMDHKYKSLLQNWPTRHVITII-----NSII-----DEVREQIKRL 180 (368)
T ss_pred EEEeCChHHHHHHHHHHHHHCCCcEEEEEEEcCchhhHHHHHHHHhHHhcCCEEEE-----eccc-----hhHHHHHHHH
Confidence 358899999999999999999991 22 2334434445566653 1111 2455677776
Q ss_pred hcCCCcEEEEEEcch-hhHHHHHHHHHhhccCCc-eEEEEeccCccccc-ccCCCccceeeEEEEEecCCCCCChHHHHh
Q psy1666 115 MTKPRARGVIVFGSD-QEVAGVMRAVRRLNATGS-FSWVGSDGWSARGL-VSDGSEAEVEGTLSLQPQANPVKGFDDYFL 191 (981)
Q Consensus 115 i~~s~a~VIVl~~s~-~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~-~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~ 191 (981)
+++++++||++++. +.+..+++++.+++++|+ +.||.+ +|..... ... ....-....|+++........+++++
T Consensus 181 -k~~~~~rIIi~~s~~~~~~~il~qA~~lgm~~~~y~wilt-~ld~~~~dl~~-~~~~~~Nitgfrl~~~~~~~~~~~~~ 257 (368)
T cd06383 181 -RNLDIKNIFILGSTEEIIRYVLDQALAEGFMGRKYAWFLG-NPDLGIYDDLS-CQLRNASIFVTRPMMDYQSSVRGALL 257 (368)
T ss_pred -HhCCCeEEEEEeCCHHHHHHHHHHHHHcCCcCCceEEEEc-CCCchhhhhhh-hccccCcEEEeeccccchhhhcccee
Confidence 45567666776775 899999999999998774 899987 5554321 111 00001134566664333322344443
Q ss_pred hcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhh-
Q psy1666 192 NLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHAD- 270 (981)
Q Consensus 192 ~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~- 270 (981)
++.+. ++... . .......+...||||+++|.|+++|...
T Consensus 258 ~~~~~-----~~~~~------~-----------------------------~~~~~~~~aL~~Dav~~~~~a~~~l~~~~ 297 (368)
T cd06383 258 RTDEP-----TLRPV------F-----------------------------YFEWAFRLFLAYDAVLAVGEWPRRMRKKR 297 (368)
T ss_pred eccCC-----ccCch------h-----------------------------HHHHHHHHHHHHHHHHHhccccchhheee
Confidence 32100 00000 0 0000113457899999999999987321
Q ss_pred ---hcCCCCC-CCCCCCCCCcc-----HHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEE
Q psy1666 271 ---LCQGKVG-LCDAMRPTKGP-----ELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFK 325 (981)
Q Consensus 271 ---lC~~~~~-~C~~~~~~~~~-----qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q 325 (981)
.|.+... .|....+.-|| .+.+|||.++|+|.+| .|.||++|-+ ..|++--|+
T Consensus 298 ~~~~~~~~~~~~~~g~~~~~~w~~~g~~~~~~~k~~~~~gltG-~i~f~~~g~R-~~~~l~~~~ 359 (368)
T cd06383 298 VEDGSTGTSVLPGFGISPESPLMTLQSSPFNGSSEIKFEMLAG-RVAIDEGSSV-STKTIGSWS 359 (368)
T ss_pred ccCCCcCccccCCCCCCcccchhhcccccccCccceeEeeecC-eEEEecCcee-eeeeeeeEe
Confidence 1322111 45543323456 8999999999999999 5999998854 667776665
No 45
>cd06379 PBP1_iGluR_NMDA_NR1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR1, an essential channel-forming subunit of the NMDA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR1, an essential channel-forming subunit of the NMDA receptor. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer ccomposed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. When co-expressed with NR1, the NR3 subunits form receptors that are activated by glycine alone and therefore
Probab=99.17 E-value=6.4e-11 Score=136.37 Aligned_cols=99 Identities=26% Similarity=0.404 Sum_probs=79.8
Q ss_pred hHHHHHHHHHHHHHHHhHHhhc-cCCCCCCCCCC--CCChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEeEE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLC-QGKVGLCDAMR--PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQ 749 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c-~~~~~~c~~~~--~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~~~ 749 (981)
.++|||||++|||||+++...+ ......|.... ...+++|+++|++++|+|.+| +|.||+|||+. ..|||+|++.
T Consensus 274 ~~~yDAV~~~A~Al~~~~~~~~~~~~~~~c~~~~~~~~~g~~l~~~l~~v~f~G~tg-~i~Fd~~Gd~~~~~~~I~~~~~ 352 (377)
T cd06379 274 SHIRDAVAVLASAIQELFEKENITEPPRECVGNTVIWETGPLFKRALMSSKYPGETG-RVEFNDDGDRKFANYDIMNIQN 352 (377)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCCCccccCCCCCCcchHHHHHHHHhCCcCCccC-ceEECCCCCccCccEEEEEecC
Confidence 4799999999999999974111 11224576432 235678999999999999988 69999999997 7999999983
Q ss_pred cCCCcEEEEEEEEEECceEEEeccccccc
Q psy1666 750 IRPGVYQWVQVGEYLEGELRLNMSAIQFK 778 (981)
Q Consensus 750 ~~~~~~~~~~VG~~~~~~l~in~~~i~W~ 778 (981)
..+++||.|+++.|.++++.|.|+
T Consensus 353 -----~~~~~VG~w~~~~l~~~~~~i~W~ 376 (377)
T cd06379 353 -----RKLVQVGLYNGDILRLNDRSIIWP 376 (377)
T ss_pred -----CCceEeeEEcCcEEEecCceeeCC
Confidence 257999999987899999999996
No 46
>cd06377 PBP1_iGluR_NMDA_NR3 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR3 subunit of NMDA receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR3 subunit of NMDA receptor family. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer composed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. Among NMDA receptor subtypes, the NR2B subunit containing receptors appear particularly important for pain perception; thus NR2B-selective antagonists may be useful in
Probab=99.14 E-value=4.5e-10 Score=126.55 Aligned_cols=223 Identities=14% Similarity=0.195 Sum_probs=137.0
Q ss_pred HhcCCCCCCCCCcceeeEEeecc---------hhHHHHHHHHHHhCCe-eEEEEEEeecCC-cchhhhhH-HHHHHHHhc
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE---------TTAFEELEVLLAKSSI-CIAVKEKLVKDS-GVAEERAY-DDIVTKLMT 116 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~---------~~~~~~l~~~~~~~gI-CIA~~~~ip~~~-~~~~~~~~-~~ii~~li~ 116 (981)
|+..|+..+|..|++.+|.+++| +++...|++.++..+. =+.....+.... +..+..++ ...++++ +
T Consensus 129 L~l~P~~~~l~~a~~~ll~~~~W~~f~~iy~~~~gl~~lq~l~~~~~~~~~~~~i~v~~~~~~~~d~~~~~~~~L~~i-~ 207 (382)
T cd06377 129 MSWASPLSTLLDVLLSVLQRNGWEDVSLVLCRERDPTGLLLLWTNHARFHLGSVLNLSRNDPSTADLLDFLRAQLELL-K 207 (382)
T ss_pred EEecCCHHHHHHHHHHHHHHCCCcEEEEEEecCcCHHHHHHHHHHhcccccCceEEEEeccCccCChhHHHHHHHHHh-h
Confidence 55689999999999999999999 3345555555544332 001112221110 00011233 5566655 6
Q ss_pred CCC-cEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCC
Q psy1666 117 KPR-ARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTV 195 (981)
Q Consensus 117 ~s~-a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p 195 (981)
++. +++|++.++.+.+..+++.+. .+ |.||.++.-+.......+.. -|.++
T Consensus 208 ~~~~~~~ill~cs~e~~~~il~~~~----~~-y~wIv~~~~~le~~~~~g~n---igLl~-------------------- 259 (382)
T cd06377 208 DPPGPAVVLFGCDVARARRVLELTP----PG-PHWILGDPLPPEALRTEGLP---PGLLA-------------------- 259 (382)
T ss_pred cccCceEEEEECCHHHHHHHHHhhc----cc-eEEEEcCCcChhhccCCCCC---ceEEE--------------------
Confidence 777 899999999998888885543 34 79998752111111000000 01110
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhH---h--h
Q psy1666 196 ENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMH---A--D 270 (981)
Q Consensus 196 ~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~---~--~ 270 (981)
| .+ .++ ......+||||+.+|.|++.|. . .
T Consensus 260 -------~-~~-~~~------------------------------------~~l~ali~DAV~lvA~a~~~l~~~~~~~~ 294 (382)
T cd06377 260 -------H-GE-TTQ------------------------------------PPLEAYVQDALELVARAVGSATLVQPELA 294 (382)
T ss_pred -------E-ee-ccc------------------------------------ccHHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 0 00 000 0114679999999999999873 1 1
Q ss_pred hcCCCCCCCCCC----CCCCccHHHHhhcceeeccCCCCeEEecCCCC--CCceeEEEEEEEcCCCcEEEEEEEEEEC-C
Q psy1666 271 LCQGKVGLCDAM----RPTKGPELLKYLRKVSFQGLSEDHFKFDKDGD--GPARYNIIHFKQIRPGVYQWVQVGEYLE-G 343 (981)
Q Consensus 271 lC~~~~~~C~~~----~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD--~~~~YdI~n~q~~~~g~~~~v~VG~~~~-~ 343 (981)
+-+ ....|... ....|..|.+||++|+|+|.+| +|.|++.+. ..-..||++.+.++.|...|++||+|++ +
T Consensus 295 l~~-~~~~C~~~~~~~~W~~G~~l~~~Lknv~~eGlTG-~I~F~~g~R~~~~~~l~I~~L~~~~~G~~~W~kVG~W~~~~ 372 (382)
T cd06377 295 LIP-ATVNCMDLPTKGNESSGQYLARFLANTSFDGRTG-PVWVTGSSQVHSSRHFKVWSLRRDPVGQPTWTTVGSWQGGR 372 (382)
T ss_pred cCC-CCCCcccCCCCCCCCchHHHHHHHHhCcccccce-eEEEccCeeecccceEEEEEeccccCCCccceEEEEecCCC
Confidence 112 23578643 2346778999999999999999 599965444 3457899999876677668899999997 4
Q ss_pred eEEE
Q psy1666 344 ELRL 347 (981)
Q Consensus 344 ~L~i 347 (981)
.+.+
T Consensus 373 ~~~~ 376 (382)
T cd06377 373 KIVM 376 (382)
T ss_pred ceec
Confidence 5543
No 47
>cd06381 PBP1_iGluR_delta_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of an orphan family of delta receptors, GluRdelta1 and GluRdelta2. This CD represents the N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of an orphan family of delta receptors, GluRdelta1 and GluRdelta2. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 are more homologous to non-NMDA receptors. G
Probab=99.10 E-value=5.9e-10 Score=127.06 Aligned_cols=159 Identities=13% Similarity=0.117 Sum_probs=109.4
Q ss_pred CCCcEEEEEEcchhhHHHHHHHHHhhccC--CceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 117 KPRARGVIVFGSDQEVAGVMRAVRRLNAT--GSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 117 ~s~a~VIVl~~s~~~a~~~~~~~~~~~l~--g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
+++.++||+.++...+..++.++.+.+++ | +.|+++++|...............|.+|+++-....+..++|.....
T Consensus 197 ~~~~~~vIl~~~~~~~~~~l~~a~~~gm~~~~-~~wi~~~~l~~~~~~l~~~~~~~~nitgfrl~~~~~~~~~~~~~~~~ 275 (363)
T cd06381 197 RDTLRRALLLLSPNGAYTFIDASVETNLAIKD-SHWFLINEEISDTEIDELVRYAHGRMTVIRQTFSKEKTNQRCLRNNH 275 (363)
T ss_pred cccceEEEEEcCcHHHHHHHHHHHHcCCCcCc-eEEEEeccccccchhhHHHhhcCccEEEEEEecCCcCchHHHHHHHH
Confidence 55677899999999999999999999887 5 79999999998654444445566788999885443344454432211
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCC
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQG 274 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~ 274 (981)
+ .|+.. |.- + .+ ... .........|||||++
T Consensus 276 -----------~-~~~~~--~~~-------------~--~~--~~~----~~~~~~al~yDaV~~~-------------- 306 (363)
T cd06381 276 -----------R-ISSLL--CDP-------------K--DG--YLQ----MLEISNLYIYDSVLLL-------------- 306 (363)
T ss_pred -----------H-HHHhh--cCC-------------C--CC--CCC----ChhHHHHHHHHHHHHH--------------
Confidence 1 34311 110 0 00 000 0111356799999999
Q ss_pred CCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 275 KVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 275 ~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
++|||+++|+|.+| .|.||++|.+. -.+||+.....+...-..++||+|++
T Consensus 307 ----------------~~~~~~~~~~GLTG-~i~F~~~g~r~~~~l~i~~~~~~~~~~~~~~~~~~w~~ 358 (363)
T cd06381 307 ----------------LETIKKGPITGLTG-KLEFNEGGDNSNVQFEILGTGYSETLGKDGRWLATWNP 358 (363)
T ss_pred ----------------HHHHHhcCccCcce-eEEeCCCCCccccEEEEEEeccCCccccceEEeeeccC
Confidence 57899999999999 59999999985 58999998743322335688999986
No 48
>KOG4440|consensus
Probab=99.05 E-value=4.6e-10 Score=125.44 Aligned_cols=149 Identities=26% Similarity=0.347 Sum_probs=100.7
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcC
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLT 194 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~ 194 (981)
+...+||+++.+++++|..++..|-..|++|+ ++||.++.-.....+ -+|.||+++..+..
T Consensus 221 k~~~~rv~~~~as~dDA~~ifr~Ag~lnmTG~G~VWiV~E~a~~~nn~-------PdG~LGlqL~~~~~----------- 282 (993)
T KOG4440|consen 221 KELEARVIILSASEDDAATIFRAAGMLNMTGSGYVWIVGERAISGNNL-------PDGILGLQLINGKN----------- 282 (993)
T ss_pred hhhhheeEEeecccchHHHHHHhhhhhcccCceEEEEEeccccccCCC-------CCceeeeEeecCcc-----------
Confidence 34568999999999999999999988999874 799999775433221 26888877633211
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc-C
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC-Q 273 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC-~ 273 (981)
....+-|+|+.+|.|+|+|++..- .
T Consensus 283 ------------------------------------------------------~~~hirDsv~vlasAv~e~~~~e~I~ 308 (993)
T KOG4440|consen 283 ------------------------------------------------------ESAHIRDSVGVLASAVHELLEKENIT 308 (993)
T ss_pred ------------------------------------------------------ccceehhhHHHHHHHHHHHHhhccCC
Confidence 012357899999999999997432 1
Q ss_pred CCCCCCCCCC-CCCcc-HHHHhhcceee-ccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEE
Q psy1666 274 GKVGLCDAMR-PTKGP-ELLKYLRKVSF-QGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYL 341 (981)
Q Consensus 274 ~~~~~C~~~~-~~~~~-qLl~~Lk~V~F-~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~ 341 (981)
..+..|.+.. .-..| .|..+++.... .|.+| +|.||++||+. +.|||+|+.+. ...+-+|.|+
T Consensus 309 ~~P~~c~d~~~~w~~g~~l~~~l~s~~~~~g~Tg-rV~Fnd~gdRi~a~YdiiN~hq~----rk~Vg~~~yd 375 (993)
T KOG4440|consen 309 DPPRGCVDNTNIWKTGPLLKRVLMSSKYADGVTG-RVEFNDDGDRIFANYDIINLHQN----RKLVGVGIYD 375 (993)
T ss_pred CCCCcccCccchhcccHHHHHHHhhhcccCCcce-eEEEcCCCceeeccceeEehhhh----hhhhhhcccc
Confidence 1233444332 22334 45567766444 45666 69999999997 69999999532 1334455555
No 49
>cd06367 PBP1_iGluR_NMDA N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. The function of the NMDA subtype receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer comprising two NR1 and two NR2 (A, B, C, and D) or NR3 (A and B) subunits
Probab=98.99 E-value=9.5e-10 Score=125.95 Aligned_cols=98 Identities=24% Similarity=0.370 Sum_probs=77.1
Q ss_pred hHHHHHHHHHHHHHHHhHHhhc--cCCCCCCCCCC---CCChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEe
Q psy1666 674 QFVSDAVMAFSIALDHMHADLC--QGKVGLCDAMR---PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHF 747 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c--~~~~~~c~~~~---~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~ 747 (981)
.++|||||++|||||+++.+.. ......|.... ...+..|+++|++++|.|.+| .|.||+|||+. ..|||+|+
T Consensus 259 ~~~~Dav~~~a~Al~~~~~~~~~~~~~~~~C~~~~~~~~~~g~~l~~~l~~~~f~G~tg-~v~F~~~G~~~~~~~~I~~l 337 (362)
T cd06367 259 ARVRDAVAIVARAAESLLRDKGALPEPPVNCYDTANKRESSGQYLARFLMNVTFDGETG-DVSFNEDGYLSNPKLVIINL 337 (362)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCCCCCcCCCCCCCCCchHHHHHHHhcccccCCCC-ceeECCCcccccceEEEEEe
Confidence 4799999999999999975211 11234576542 133457999999999999999 79999999986 79999999
Q ss_pred EEcCCCcEEEEEEEEEECceEEEeccccccc
Q psy1666 748 KQIRPGVYQWVQVGEYLEGELRLNMSAIQFK 778 (981)
Q Consensus 748 ~~~~~~~~~~~~VG~~~~~~l~in~~~i~W~ 778 (981)
+. ...+++||+|++ +.++.+.|.|+
T Consensus 338 ~~----~~~~~~VG~W~~--~~~~~~~i~w~ 362 (362)
T cd06367 338 RR----NRKWERVGSWEN--GKLVMRYIVWP 362 (362)
T ss_pred cC----CCcceEEEEEcC--CceecCcCCCC
Confidence 84 346899999964 77899999995
No 50
>cd06366 PBP1_GABAb_receptor Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA). Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA). GABA is the major inhibitory neurotransmitter in the mammalian CNS and, like glutamate and other transmitters, acts via both ligand gated ion channels (GABAa receptors) and G-protein coupled receptors (GABAb). GABAa receptors are members of the ionotropic receptor superfamily which includes alpha-adrenergic and glycine receptors. The GABAb receptor is a member of a receptor superfamily which includes the mGlu receptors. The GABAb receptor is coupled to G alpha_i proteins, and activation causes a decrease in calcium, an increase in potassium membrane conductance, and inhibition of cAMP formation. The response is thus inhibitory and leads to hyperpolarization and decreased neurotransmitter release, for example.
Probab=98.93 E-value=4e-09 Score=120.17 Aligned_cols=207 Identities=17% Similarity=0.251 Sum_probs=137.2
Q ss_pred cCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcC
Q psy1666 51 TKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTK 117 (981)
Q Consensus 51 ~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~ 117 (981)
+.|++..|..+++.++..++| ....+.+++.+++.|+||...+.++.... ..++...+.++ +.
T Consensus 115 ~~p~~~~~~~a~~~~~~~~~~~~v~ii~~~~~~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~~---~~d~~~~l~~i-~~ 190 (350)
T cd06366 115 TTPSDSSQNPAIAALLKKFGWRRVATIYEDDDYGSGGLPDLVDALQEAGIEISYRAAFPPSAN---DDDITDALKKL-KE 190 (350)
T ss_pred cccchHhHHHHHHHHHHHCCCcEEEEEEEcCcccchhHHHHHHHHHHcCCEEEEEeccCCCCC---hhHHHHHHHHH-hc
Confidence 445555555555555544444 44678888899999999999998876421 23677778776 45
Q ss_pred CCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCcccc-----cccCCCccceeeEEEEEecCCC-CCChHHHH
Q psy1666 118 PRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARG-----LVSDGSEAEVEGTLSLQPQANP-VKGFDDYF 190 (981)
Q Consensus 118 s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~-----~~~~~~~~~~~G~l~~~~~~~~-ipgF~ef~ 190 (981)
+++++|++.+...++..+++++.++++.+ .++||.++.|.... ..........+|.+++.+.... .|.+++|.
T Consensus 191 ~~~dvvi~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~gv~~~~~~~~~~~~~~~~f~ 270 (350)
T cd06366 191 KDSRVIVVHFSPDLARRVFCEAYKLGMMGKGYVWILTDWLSSNWWSSSDCTDEEMLEAMQGVIGVRSYVPNSSMTLQEFT 270 (350)
T ss_pred CCCeEEEEECChHHHHHHHHHHHHcCCcCCCEEEEECcchhhhhccCCCCChHHHHHhhceEEEEeecccccCccHHHHH
Confidence 66899999999999999999999988865 37999987665321 1111122456788888876555 67788887
Q ss_pred hhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhh
Q psy1666 191 LNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHAD 270 (981)
Q Consensus 191 ~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~ 270 (981)
+.. ...+.-..+ . ...........|||||.
T Consensus 271 ~~~----------------~~~~~~~~~------------~-----------~~~p~~~a~~~YDav~~----------- 300 (350)
T cd06366 271 SRW----------------RKRFGNENP------------E-----------LTEPSIYALYAYDAVWA----------- 300 (350)
T ss_pred HHH----------------HHHhcccCc------------C-----------cCCCCcccchhhhheee-----------
Confidence 543 111110000 0 00001123457888777
Q ss_pred hcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 271 LCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 271 lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
+++|.|.+| +|.||++|++. ..|+++++. + ..+++||+|++
T Consensus 301 -------------------------~~~~~G~~G-~v~fd~~~~~~~~~~~~~~~~---~--~~~~~vg~~~~ 342 (350)
T cd06366 301 -------------------------STNFNGLSG-PVQFDGGRRLASPAFEIINII---G--KGYRKIGFWSS 342 (350)
T ss_pred -------------------------eceEEeeee-eEEEcCCCccCCcceEEEEec---C--CceEEEEEEeC
Confidence 457889999 59999999984 678887763 2 36899999985
No 51
>cd06363 PBP1_Taste_receptor Ligand-binding domain of the T1R taste receptor. Ligand-binding domain of the T1R taste receptor. The T1R is a member of the family C receptors within the G-protein coupled receptor superfamily, which also includes the metabotropic glutamate receptors, GABAb receptors, the calcium-sensing receptor (CaSR), the V2R pheromone receptors, and a small group of uncharacterized orphan receptors.
Probab=98.88 E-value=8.8e-09 Score=120.04 Aligned_cols=99 Identities=31% Similarity=0.414 Sum_probs=82.4
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPG 753 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~ 753 (981)
..+|||||++|+|||+++. |.. ..|.......++.|.++|++++|.+.+| .+.||++||+...|+|+++|. +.+
T Consensus 310 ~~~YDaV~~~a~Al~~a~~--~~~--~~~~~~~~~~~~~l~~~L~~~~~~g~~g-~i~fd~~G~~~~~~~i~~~~~-~~~ 383 (410)
T cd06363 310 FSVYAAVYAVAHALHNVLQ--CGS--GGCPKRVPVYPWQLLEELKKVNFTLLGQ-TVRFDENGDPNFGYDIVVWWW-DNS 383 (410)
T ss_pred HHHHHHHHHHHHHHHHHhC--CCC--CCCCCCCCCCHHHHHHHHhccEEecCCc-EEEeCCCCCCccceEEEEEEE-cCC
Confidence 3589999999999999973 322 3455333567889999999999998877 899999999888999999986 345
Q ss_pred cEEEEEEEEEEC--ceEEEeccccccc
Q psy1666 754 VYQWVQVGEYLE--GELRLNMSAIQFK 778 (981)
Q Consensus 754 ~~~~~~VG~~~~--~~l~in~~~i~W~ 778 (981)
...+++||+|++ ++|.+|+++|.|.
T Consensus 384 ~~~~~~vG~~~~~~~~l~~~~~~i~w~ 410 (410)
T cd06363 384 SGTFEEVGSYSFYPIRLTINRSKIQWH 410 (410)
T ss_pred ceeEEEEEEEECCCCEEEEehHhcccC
Confidence 678999999995 7999999999995
No 52
>cd06342 PBP1_ABC_LIVBP_like Type I periplasmic ligand-binding domain of ABC (Atpase Binding Cassette)-type active transport systems that are involved in the transport of all three branched chain aliphatic amino acids (leucine, isoleucine and valine). This subgroup includes the type I periplasmic ligand-binding domain of ABC (Atpase Binding Cassette)-type active transport systems that are involved in the transport of all three branched chain aliphatic amino acids (leucine, isoleucine and valine). This subgroup also includes a leucine-specific binding protein (or LivK), which is very similar in sequence and structure to leucine-isoleucine-valine binding protein (LIVBP). ABC-type active transport systems are transmembrane proteins that function in the transport of diverse sets of substrates across extra- and intracellular membranes, including carbohydrates, amino acids, inorganic ions, dipeptides and oligopeptides, metabolic products, lipids and sterols, and heme, to name a few.
Probab=98.75 E-value=3.1e-08 Score=111.84 Aligned_cols=183 Identities=19% Similarity=0.300 Sum_probs=124.5
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +++++.+|++.+...++..+++++.+.++.. .|+
T Consensus 149 ~~~~~~~~~~~~~~g~~v~~~~~~~~~~-----~d~~~~l~~i-~~~~~~~vi~~~~~~~~~~~~~~~~~~g~~~--~~~ 220 (334)
T cd06342 149 QGLADEFKKALKAAGGKVVAREGTTDGA-----TDFSAILTKI-KAANPDAVFFGGYYPEAGPLVRQMRQLGLKA--PFM 220 (334)
T ss_pred hHHHHHHHHHHHHcCCEEEEEecCCCCC-----ccHHHHHHHH-HhcCCCEEEEcCcchhHHHHHHHHHHcCCCC--cEE
Confidence 4456778888888999999998887543 2566677775 4556788888888888888998988888754 688
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCC--CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQAN--PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
+++.|...... .......+|.+...+... ..|..++|.+. |++.+. .
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~~~~~~~~f~~~----------------~~~~~~----~---------- 269 (334)
T cd06342 221 GGDGLCDPEFI-KIAGDAAEGTYATFPGGPLEKMPAGKAFVAR----------------YKAKFG----D---------- 269 (334)
T ss_pred ecCccCCHHHH-HHhhHhhCCcEEEecCCCCCCChHHHHHHHH----------------HHHHhC----C----------
Confidence 88777643322 111234467665544321 23334444332 221111 0
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
.........|||++++++|++++- ..++..|.+.|++++|.|..| ++.|
T Consensus 270 ---------------~~~~~~~~~yda~~~~~~al~~~~---------------~~~~~~v~~~l~~~~~~g~~g-~i~f 318 (334)
T cd06342 270 ---------------PPGAYAPYAYDAANVLAEAIKKAG---------------STDPAKVADALRKVDFDGVTG-KISF 318 (334)
T ss_pred ---------------CCchhHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHHhCCCCCcce-eeEE
Confidence 001134578999999999998761 235678999999999999999 6999
Q ss_pred cCCCCC-CceeEEEEE
Q psy1666 310 DKDGDG-PARYNIIHF 324 (981)
Q Consensus 310 D~nGD~-~~~YdI~n~ 324 (981)
|++|+. ...|+|+||
T Consensus 319 ~~~g~~~~~~~~~~~~ 334 (334)
T cd06342 319 DAKGDLKGAAVTVYQV 334 (334)
T ss_pred CCCCCcccCcEEEEeC
Confidence 999998 468999876
No 53
>cd06369 PBP1_GC_C_enterotoxin_receptor Ligand-binding domain of the membrane guanylyl cyclase C. Ligand-binding domain of the membrane guanylyl cyclase C (GC-C or StaR). StaR is a key receptor for the STa (Escherichia coli Heat Stable enterotoxin), a potent stimulant of intestinal chloride and bicarbonate secretion that cause acute secretory diarrhea. The catalytic domain of the STa/guanylin receptor type membrane GC is highly similar to those of the natriuretic peptide receptor (NPR) type and sensory organ-specific type membrane GCs (GC-D, GC-E and GC-F). The GC-C receptor is mainly expressed in the intestine of most vertebrates, but is also found in the kidney and other organs. Moreover, GC-C is activated by guanylin and uroguanylin, endogenous peptide ligands synthesized in the intestine and kidney. Consequently, the receptor activation results in increased cGMP levels and phosphorylation of the CFTR chloride channel and secretion.
Probab=98.67 E-value=4.8e-07 Score=99.93 Aligned_cols=168 Identities=12% Similarity=0.182 Sum_probs=111.4
Q ss_pred hHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCC
Q psy1666 106 AYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKG 185 (981)
Q Consensus 106 ~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipg 185 (981)
++++++++. +.++||||+.++.++.+.++.... ..|.+++|.-|-+..+..........++.++.+++...+.+.
T Consensus 197 ~~~~il~~~--~~~sRIiImCG~p~~ir~lm~~~~---~~gDYVf~~IDlF~~sy~~d~~a~~amqsVLvIT~~~p~~~~ 271 (380)
T cd06369 197 ELQKLLTDK--NRKSNVIIMCGTPEDIVNLKGDRA---VAEDIVIILIDLFNDVYYENTTSPPYMRNVLVLTLPPRNSTN 271 (380)
T ss_pred hHHHHHHHh--ccCccEEEEeCCHHHHHHHHhcCc---cCCCEEEEEEecccchhccCcchHHHHhceEEEecCCCCCcc
Confidence 566666653 456899999999999999886522 236689998877654332112233455666666653321111
Q ss_pred hHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHH
Q psy1666 186 FDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALD 265 (981)
Q Consensus 186 F~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh 265 (981)
.++ . ..+ +..+. ...+..-||||.-.||||+
T Consensus 272 ~~~-------------------~--~~f----------------------n~~l~------~~~aa~fyDaVLLYa~AL~ 302 (380)
T cd06369 272 NSS-------------------F--TTD----------------------NSLLK------DDYVAAYHDGVLLFGHVLK 302 (380)
T ss_pred ccc-------------------C--CCC----------------------CcchH------HHHHHHHHHHHHHHHHHHH
Confidence 000 0 000 00111 1345678999999999999
Q ss_pred HhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 266 HMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 266 ~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
+.++.. . . .++.++-+.++|.+|+|.+|. |.+|+|||+.+.|.++-.. .++..|..||+|+.
T Consensus 303 EtL~~G---~-------~-~~~~~I~~~m~NrTF~GitG~-V~IDeNGDRd~dfsLl~ms---~~tg~y~vV~~y~t 364 (380)
T cd06369 303 KFLESQ---E-------G-VQTFSFINEFRNISFEGAGGP-YTLDEYGDRDVNFTLLYTS---TDTSKYKVLFEFDT 364 (380)
T ss_pred HHHHhC---C-------C-CCcHHHHHHHhCcceecCCCc-eEeCCCCCccCceEEEEee---CCCCCeEEEEEEEC
Confidence 998631 1 1 123678888999999999996 9999999999999998763 33457899999984
No 54
>cd06382 PBP1_iGluR_Kainate N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the kainate receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the kainate receptors, non-NMDA ionotropic receptors which respond to the neurotransmitter glutamate. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Kainate receptors have five subunits, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeri
Probab=98.59 E-value=1.5e-07 Score=106.27 Aligned_cols=201 Identities=14% Similarity=0.156 Sum_probs=122.7
Q ss_pred hcCCCCCCCCCcceeeEEeecc---------hhHHHHHHHHHHhCCee---EEEEEEeecCCcchhhhhHHHHHHHHhcC
Q psy1666 50 MTKPRARDDPDFIPVLMLFLRE---------TTAFEELEVLLAKSSIC---IAVKEKLVKDSGVAEERAYDDIVTKLMTK 117 (981)
Q Consensus 50 ~~~psa~~q~~a~~~lv~f~~~---------~~~~~~l~~~~~~~gIC---IA~~~~ip~~~~~~~~~~~~~ii~~li~~ 117 (981)
|+.|++..|..+++.++..++| .+..+.+++.+++.|.+ |.. +.++.. . ++...+.++ +.
T Consensus 108 r~~p~~~~~~~a~~~~~~~~~w~~vavl~~~~~~~~~l~~~~~~~~~~g~~v~~-~~~~~~-----~-d~~~~l~~i-~~ 179 (327)
T cd06382 108 NLYPSNADLSRAYADIVKSFNWKSFTIIYESAEGLLRLQELLQAFGISGITITV-RQLDDD-----L-DYRPLLKEI-KN 179 (327)
T ss_pred EeCCCHHHHHHHHHHHHHhcCCcEEEEEecChHHHHHHHHHHHhhccCCCeEEE-EEccCC-----c-cHHHHHHHH-Hh
Confidence 4556666666666666666655 33556677777777764 332 333321 1 567778776 56
Q ss_pred CCcEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCC
Q psy1666 118 PRARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVE 196 (981)
Q Consensus 118 s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~ 196 (981)
+++++|++.+....+..++.++.+.++.+. ++|+.+............ .....+..++.+...+.|..++|.+..
T Consensus 180 ~~~d~vv~~~~~~~~~~~~~qa~~~g~~~~~~~~i~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~f~~~~--- 255 (327)
T cd06382 180 SGDNRIIIDCSADILIELLKQAQQVGMMSEYYHYIITNLDLHTLDLEDY-RYSGVNITGFRLVDPDSPEVKEVIRSL--- 255 (327)
T ss_pred cCceEEEEECCHHHHHHHHHHHHHhCccccceEEEEecCCccccchhhh-ccCceeEEEEEEecCCchhHHHHHHHH---
Confidence 678999999999999999999999988774 689886443322211111 111225666666555566677776533
Q ss_pred CCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCC
Q psy1666 197 NNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKV 276 (981)
Q Consensus 197 ~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~ 276 (981)
+..++-..+.. .... ........||||+++
T Consensus 256 -------------~~~~~~~~~~~-----------------~~~~----p~~~~a~~yDav~~~---------------- 285 (327)
T cd06382 256 -------------ELSWDEGCRIL-----------------PSTG----VTTESALMYDAVYLF---------------- 285 (327)
T ss_pred -------------HhhcccccccC-----------------CCCC----cchhhhhhhceEEEe----------------
Confidence 22221000000 0000 011234567777666
Q ss_pred CCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 277 GLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 277 ~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
|.+|. |.||++||+. -.|||+|.+ + ..+++||.|++
T Consensus 286 ------------------------g~tG~-v~f~~~g~r~~~~~~~~~~~---~--~~~~~vg~w~~ 322 (327)
T cd06382 286 ------------------------GLTGR-IEFDSSGQRSNFTLDVIELT---E--SGLRKVGTWNS 322 (327)
T ss_pred ------------------------ecccc-eeeCCCCCEeeeEEEEEecc---c--cCceEEEEECC
Confidence 68885 9999999986 479999875 1 24789999985
No 55
>cd06394 PBP1_iGluR_Kainate_KA1_2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the KA1 and KA2 subunits of Kainate receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the KA1 and KA2 subunits of Kainate receptor. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. There are five types of kainate receptors, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeric receptor channels act
Probab=98.55 E-value=6e-08 Score=108.96 Aligned_cols=137 Identities=11% Similarity=0.125 Sum_probs=87.9
Q ss_pred HhcCCCCCCCCCcceeeEEeecc---------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCC
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE---------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPR 119 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~---------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~ 119 (981)
++..|++..|++|++.+|.+++| .++...|++.++..++ ....++.... ....++...++++ +.++
T Consensus 112 i~l~P~~~~~~~Ai~dli~~~~W~~v~~iYe~d~~l~~L~~~l~~~~~---~~~~i~~~~~-~~~~d~~~~L~~i-k~~~ 186 (333)
T cd06394 112 VNLHPSNEDISVAVAGILNSFNYPTASLICAKAECLLRLEELLRQFLI---SKETLSVRML-DDSRDPTPLLKEI-RDDK 186 (333)
T ss_pred EEecCCHHHHHHHHHHHHHhcCCCEEEEEEeCcHHHHHHHHHHHhhcc---cCCceeeEEc-cCcccHHHHHHHH-HhcC
Confidence 55668888899999999999999 4456777776655433 2233332111 0123566777776 5678
Q ss_pred cEEEEEEcchhhHHHHHHHHHhhccCCc-eEEEEeccCcccc-cccCCCccceeeEEEEEecCCCCCChHHHHhh
Q psy1666 120 ARGVIVFGSDQEVAGVMRAVRRLNATGS-FSWVGSDGWSARG-LVSDGSEAEVEGTLSLQPQANPVKGFDDYFLN 192 (981)
Q Consensus 120 a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vWI~s~~W~~~~-~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~ 192 (981)
.++||+.++.+.+..++.++.+.++.++ +.||.+ +|.... .+.+..... --..++++-....|..++|.+.
T Consensus 187 ~~~iVv~~~~~~a~~il~qa~~lGm~~~~y~~i~T-~l~~~~~~L~~~~~~~-~niTgF~l~d~~~~~v~~f~~~ 259 (333)
T cd06394 187 TATIIIDANASMSHTILLKASELGMTSAFYKYILT-TMDFPLLRLDSIVDDR-SNILGFSMFNQSHAFYQEFIRS 259 (333)
T ss_pred CCEEEEECChHHHHHHHHHHHHcCCCCCceEEEEe-cCCcccccHHHhhcCC-cceEEEEeecCCcHHHHHHHHH
Confidence 8999999999999999999999888653 788866 333221 111100011 1245666655555667777764
No 56
>cd06372 PBP1_GC_G_like Ligand-binding domain of membrane guanylyl cyclase G. This group includes the ligand-binding domain of membrane guanylyl cyclase G (GC-G) which is a sperm surface receptor and might function, similar to its sea urchin counterpart, in the early signaling event that regulates the Ca2+ influx/efflux and subsequent motility response in sperm. GC-G appears to be a pseudogene in human. Furthermore, in contrast to the other orphan receptor GCs, GC-G has a broad tissue distribution in rat, including lung, intestine, kidney, and skeletal muscle.
Probab=98.35 E-value=8.9e-07 Score=102.54 Aligned_cols=81 Identities=20% Similarity=0.376 Sum_probs=65.5
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhc---cccccCCCCCeEEeccCCCCcceeeEEEeEE
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLR---KVSFQGLSEDHFKFDKDGDGPARYNIIHFKQ 749 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~---~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~ 749 (981)
..++|||||++|+|||+++. +.. ...++.+|.++|+ +++|+|.+| .|.||+|||+.+.|+|+++|.
T Consensus 302 a~~~yDav~~~A~Al~~~~~--~g~--------~~~~g~~l~~~l~~~~~~~f~G~tG-~v~fd~~G~r~~~y~i~~~~~ 370 (391)
T cd06372 302 SAYLHDAVLLYALAVKEMLK--AGK--------DFRNGRQLVSTLRGANQVELQGITG-LVLLDEQGKRQMDYSVYALQK 370 (391)
T ss_pred HHHHHHHHHHHHHHHHHHHh--cCC--------CCCCHHHHHHHHhhccCceEeccce-eEEECCCCCcceeEEEEeccc
Confidence 35899999999999999874 221 0123567999999 699999999 699999999999999999986
Q ss_pred cCCCcEEEEEEEEEEC
Q psy1666 750 IRPGVYQWVQVGEYLE 765 (981)
Q Consensus 750 ~~~~~~~~~~VG~~~~ 765 (981)
..++ ..+++||+|+.
T Consensus 371 ~~~~-~~~~~vg~~~~ 385 (391)
T cd06372 371 SGNS-SLFLPFLHYDS 385 (391)
T ss_pred cCCc-cceeeEEEecc
Confidence 4332 46899999975
No 57
>cd06338 PBP1_ABC_ligand_binding_like_5 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT); however their ligand specificity has not been determined experimentally.
Probab=98.33 E-value=2.3e-06 Score=97.24 Aligned_cols=184 Identities=12% Similarity=0.138 Sum_probs=118.3
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +..++++|++.+....+..+++++.+.++..+ ...
T Consensus 155 ~~~~~~~~~~~~~~g~~v~~~~~~~~~~-----~d~~~~v~~l-~~~~~d~i~~~~~~~~~~~~~~~~~~~g~~~~-~~~ 227 (345)
T cd06338 155 QDVAEGAREKAEAAGLEVVYDETYPPGT-----ADLSPLISKA-KAAGPDAVVVAGHFPDAVLLVRQMKELGYNPK-ALY 227 (345)
T ss_pred HHHHHHHHHHHHHcCCEEEEEeccCCCc-----cchHHHHHHH-HhcCCCEEEECCcchhHHHHHHHHHHcCCCCC-EEE
Confidence 4456778888889999999888776433 2566777776 45668889988888889999989888888765 322
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC--CC-----CCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA--NP-----VKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTP 224 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~--~~-----ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~ 224 (981)
.+.++........ .....+|.++..+.. .+ .|..++|.+. ++..+.-
T Consensus 228 ~~~~~~~~~~~~~-~g~~~~g~~~~~~~~~~~~~~~~~~~~~~~f~~~----------------~~~~~~~--------- 281 (345)
T cd06338 228 MTVGPAFPAFVKA-LGADAEGVFGPTQWTPALDYKDDLFPSAAEFAAA----------------YKEKYGK--------- 281 (345)
T ss_pred EecCCCcHHHHHH-HhhhhCceeecceeccCcccccccCccHHHHHHH----------------HHHHhCC---------
Confidence 2333322211111 112235665543311 11 2445555432 1111110
Q ss_pred CCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCC
Q psy1666 225 YNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSE 304 (981)
Q Consensus 225 ~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G 304 (981)
.........|||++++++|+.+.- ..++..+.+.|++++|.|..|
T Consensus 282 --------------------~p~~~~~~~y~a~~~~~~a~~~ag---------------~~~~~~v~~al~~~~~~~~~G 326 (345)
T cd06338 282 --------------------APDYHAAGAYAAGQVLQEAVERAG---------------SLDPAAVRDALASNDFDTFYG 326 (345)
T ss_pred --------------------CCCcccHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHHhCCCccccc
Confidence 000123457999999999997642 124677999999999999998
Q ss_pred CeEEecCCCCCCceeEEEEE
Q psy1666 305 DHFKFDKDGDGPARYNIIHF 324 (981)
Q Consensus 305 ~~V~FD~nGD~~~~YdI~n~ 324 (981)
++.||++||....+-|++|
T Consensus 327 -~~~f~~~~~~~~~~~~~~~ 345 (345)
T cd06338 327 -PIKFDETGQNNHPMTVVQW 345 (345)
T ss_pred -CeeECCCCCcCCCceeeeC
Confidence 6999999998777666665
No 58
>cd06390 PBP1_iGluR_AMPA_GluR1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR1 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR1 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=98.32 E-value=1.3e-06 Score=99.71 Aligned_cols=86 Identities=21% Similarity=0.387 Sum_probs=64.8
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCC----CCCCCCCCC---CChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGK----VGLCDAMRP---TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNII 745 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~----~~~c~~~~~---~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~ 745 (981)
-.+|||||++|+|++++..+.+... .+.|..... ..+..|+++|++++|+|.+|+ +.||++|++. ..|||+
T Consensus 266 ~l~yDaV~~~A~A~~~l~~~~~~~~~~~~~~~C~~~~~~~w~~G~~l~~~i~~~~f~GlTG~-i~F~~~G~r~~~~~~I~ 344 (364)
T cd06390 266 ALTYDGVRVMAEAFQNLRKQRIDISRRGNAGDCLANPAVPWGQGIDIQRALQQVRFEGLTGN-VQFNEKGRRTNYTLHVI 344 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCcccCCCCCCCCCCCCCCCccHHHHHHHHHhhcccccccc-eeeCCCCCcccceEEEE
Confidence 4799999999999999864333211 135754211 124479999999999999995 9999999886 579999
Q ss_pred EeEEcCCCcEEEEEEEEEEC
Q psy1666 746 HFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 746 n~~~~~~~~~~~~~VG~~~~ 765 (981)
|.+. + .+++||.|++
T Consensus 345 ~~~~--~---g~~~vG~W~~ 359 (364)
T cd06390 345 EMKH--D---GIRKIGYWNE 359 (364)
T ss_pred EecC--C---cceEEEEECC
Confidence 9752 2 3789999975
No 59
>cd06378 PBP1_iGluR_NMDA_NR2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer composed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. Among NMDA receptor subtypes, the NR2B subunit containing receptors appear particularly important for pain perception; thus NR2B-selective antagonists may be useful in
Probab=98.26 E-value=2.7e-06 Score=97.11 Aligned_cols=95 Identities=22% Similarity=0.365 Sum_probs=69.6
Q ss_pred HHHHHHHHHHHHHHHhHHhhc--cCCCCCCCCCCC---CChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEeE
Q psy1666 675 FVSDAVMAFSIALDHMHADLC--QGKVGLCDAMRP---TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFK 748 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c--~~~~~~c~~~~~---~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~~ 748 (981)
.+||||+.+|+|+++|+.+.- ......|..... ..+..|++||++++|+|. .+.||++|++. ..|||+|.+
T Consensus 261 ~~~DaV~vva~Al~~l~~~~~~~~~~~~~C~~~~~~~~~~G~~l~~~l~~v~~~G~---~i~F~~~G~r~~~~ldIinl~ 337 (362)
T cd06378 261 RVRDGVAIIATGASAMLRQHGFIPEAKGSCYGQAEKRDLPPNTLHRYMMNVTWEGR---DLSFTEDGYLVNPKLVVISLN 337 (362)
T ss_pred HHHHHHHHHHHHHHHHHhccCCCCCCCCCcCCCCCCCCCchHHHHHHhhcceECCC---ceeECCCCeEccceEEEEEec
Confidence 589999999999999964211 112235754211 124479999999999884 79999999766 699999986
Q ss_pred EcCCCcEEEEEEEEEECceEEEeccccccc
Q psy1666 749 QIRPGVYQWVQVGEYLEGELRLNMSAIQFK 778 (981)
Q Consensus 749 ~~~~~~~~~~~VG~~~~~~l~in~~~i~W~ 778 (981)
. ...+++||.|+.++|.++ ...|+
T Consensus 338 ~----~~g~~kVG~W~~~~L~~~--~~~wp 361 (362)
T cd06378 338 K----ERVWEEVGKWENGSLRLK--YPVWP 361 (362)
T ss_pred C----CCCceEEEEEcCCeEEEe--cCCCC
Confidence 2 135789999998888884 45675
No 60
>KOG1053|consensus
Probab=98.17 E-value=2e-05 Score=92.61 Aligned_cols=220 Identities=18% Similarity=0.218 Sum_probs=131.4
Q ss_pred cCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcC
Q psy1666 51 TKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTK 117 (981)
Q Consensus 51 ~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~ 117 (981)
--|+-.+|+.+|+.++--++| +.....+++...+.-+=-+....+.-+.+ ..+.....+..+++
T Consensus 153 lg~Sieqqa~Vml~iL~~ydW~~Fs~vtt~~pg~~~f~~~ir~~~d~s~vgwe~i~v~~l~~s---~~d~~a~~q~qLkk 229 (1258)
T KOG1053|consen 153 LGPSIEQQAQVMLKILEEYDWYNFSLVTTQFPGNRTFVSLIRQTNDNSHVGWEMINVLTLDPS---TDDLLAKLQAQLKK 229 (1258)
T ss_pred eCCcHHHHHHHHHHHHHHcCcceeEEEEeecCchHHHHHHHHHhhhhccccceeeeeeecCCC---CCchHHHHHHHHHh
Confidence 336777788888888888887 44555555554432221122222222222 11222333333455
Q ss_pred CCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCC
Q psy1666 118 PRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVE 196 (981)
Q Consensus 118 s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~ 196 (981)
-++.||+++|+.+.+..+|.++.+.+++| .++||.+..-. | ..+ +| ++|=..|-.-
T Consensus 230 i~a~VillyC~~eea~~IF~~A~q~Gl~g~~y~Wi~pqlv~--------------g---~~~----~p--a~~P~GLisv 286 (1258)
T KOG1053|consen 230 IQAPVILLYCSREEAERIFEEAEQAGLTGPGYVWIVPQLVE--------------G---LEP----RP--AEFPLGLISV 286 (1258)
T ss_pred cCCcEEEEEecHHHHHHHHHHHHhcCCcCCceEEEeehhcc--------------C---CCC----CC--ccCccceeee
Confidence 56899999999999999999999999987 58999862211 1 000 11 0000000000
Q ss_pred CCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc--CC
Q psy1666 197 NNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC--QG 274 (981)
Q Consensus 197 ~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC--~~ 274 (981)
.+ + -| +++.-.+|-|+|-.+|.|-+.|+...- +.
T Consensus 287 ~~-------~-~w------------------------------------~~~l~~rVrdgvaiva~aa~s~~~~~~~lp~ 322 (1258)
T KOG1053|consen 287 SY-------D-TW------------------------------------RYSLEARVRDGVAIVARAASSMLRIHGFLPE 322 (1258)
T ss_pred ec-------c-ch------------------------------------hhhHHHHHhhhHHHHHHHHHHHHhhcccCCC
Confidence 00 0 01 112235799999999999999987432 23
Q ss_pred CCCCCCCC---CCCCccHHHHhhcceeeccCCCCeEEecCCCCCCc--eeEEEEEEEcCCCcEEEEEEEEEECCeEEEe
Q psy1666 275 KVGLCDAM---RPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPA--RYNIIHFKQIRPGVYQWVQVGEYLEGELRLN 348 (981)
Q Consensus 275 ~~~~C~~~---~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~--~YdI~n~q~~~~g~~~~v~VG~~~~~~L~in 348 (981)
....|-.. +...+..|+.||.||.|.| ..++|+++|-... .+-| ..++...|.+||.|..+.|.+.
T Consensus 323 ~~~~C~~~~~~~~~~~~~l~r~l~NvT~~g---~~lsf~~~g~~v~p~lvvI-----~l~~~r~We~VG~We~~~L~M~ 393 (1258)
T KOG1053|consen 323 PKMDCREQEETRLTSGETLHRFLANVTWDG---RDLSFNEDGYLVHPNLVVI-----DLNRDRTWERVGSWENGTLVMK 393 (1258)
T ss_pred cccccccccCccccchhhhhhhhheeeecc---cceeecCCceeeccceEEE-----ecCCCcchheeceecCCeEEEe
Confidence 35567532 2234567899999999986 4599999885432 2222 4455668999999997776654
No 61
>cd06392 PBP1_iGluR_delta_1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta1 receptor of an orphan glutamate receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta1 receptor of an orphan glutamate receptor family. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 may be closer related to non-NMDA receptors. In contrast to GluRdelta2, GluRdel
Probab=98.17 E-value=3.5e-06 Score=96.77 Aligned_cols=90 Identities=19% Similarity=0.313 Sum_probs=64.0
Q ss_pred hHHHHHHHHHHHHHHHhHHhhcc--CCCCCCCC--CCC-CChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEe
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQ--GKVGLCDA--MRP-TKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHF 747 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~--~~~~~c~~--~~~-~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~ 747 (981)
-.+|||||++|+|||+++.+.-. .....|.. ..+ ..+..|+++|++++|+|.+| +|.||++|.+. ..|||+|.
T Consensus 298 alayDaV~~~A~Al~~ll~~~~~~~~~~l~C~~~~~~~w~~G~~ll~~ik~v~f~GLTG-~I~F~~~G~r~~~~ldIi~l 376 (400)
T cd06392 298 LYLYDSVLMLANAFHRKLEDRKWHSMASLNCIRKSTKPWNGGRSMLETIKKGHITGLTG-VMEFKEDGANPHVQFEILGT 376 (400)
T ss_pred HHHHHHHHHHHHHHHHHhhccccCCCCCCccCCCCCCCCCChHHHHHHHHhCCCccCcc-ceeECCCCCCcCCceEEEec
Confidence 47999999999999987531111 11124632 111 12346999999999999999 79999999666 69999998
Q ss_pred EEc-CCCcEEEEEEEEEEC
Q psy1666 748 KQI-RPGVYQWVQVGEYLE 765 (981)
Q Consensus 748 ~~~-~~~~~~~~~VG~~~~ 765 (981)
+.. --| ..+++||.|++
T Consensus 377 ~~~~~~g-~g~~~iG~W~~ 394 (400)
T cd06392 377 SYSETFG-KDVRRLATWDS 394 (400)
T ss_pred cccccCC-CCceEeEEecC
Confidence 632 112 24799999975
No 62
>cd06368 PBP1_iGluR_non_NMDA_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the non-NMDA (N-methyl-d-asparate) subtypes of ionotropic glutamate receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the non-NMDA (N-methyl-d-asparate) subtypes of ionotropic glutamate receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Glutamate mediates the majority of excitatory synaptic transmission in the central nervous system via two broad classes of ionotropic receptors, characterized by their response to glutamate agonists: N-methyl-d -aspartate (NMDA) and non-NMDA receptors. NMDA receptors
Probab=98.15 E-value=5.4e-06 Score=93.28 Aligned_cols=74 Identities=12% Similarity=0.246 Sum_probs=54.1
Q ss_pred HHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEE
Q psy1666 74 AFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVG 152 (981)
Q Consensus 74 ~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~ 152 (981)
..+.+.+.++++|++|...+..+.. .++...+.++ +..++++|++.+...++..+++++.++++.+ .+.||.
T Consensus 142 ~l~~~~~~~~~~g~~v~~~~~~~~~------~d~~~~l~~i-~~~~~d~Vi~~~~~~~~~~i~~qa~~~g~~~~~~~~i~ 214 (324)
T cd06368 142 RLQELLDALSPKGIQVTVRRLDDDT------DMYRPLLKEI-KREKERRIILDCSPERLKEFLEQAVEVGMMSEYYHYIL 214 (324)
T ss_pred HHHHHHHhhccCCceEEEEEecCCc------hHHHHHHHHH-hhccCceEEEECCHHHHHHHHHHHHHhccccCCcEEEE
Confidence 3455556666779999877643321 1566777776 5567889999999999999999999988854 368997
Q ss_pred ec
Q psy1666 153 SD 154 (981)
Q Consensus 153 s~ 154 (981)
++
T Consensus 215 ~~ 216 (324)
T cd06368 215 TN 216 (324)
T ss_pred cc
Confidence 64
No 63
>PF01094 ANF_receptor: Receptor family ligand binding region The Prosite family is a sub-family of the Pfam family; InterPro: IPR001828 This describes a ligand binding domain and includes extracellular ligand binding domains of a wide range of receptors, as well as the bacterial amino acid binding proteins of known structure [].; PDB: 3SAJ_D 3Q41_B 3QEM_C 3QEK_A 3QEL_C 3MQ4_A 3QLV_G 3OM1_A 3QLU_A 3OM0_A ....
Probab=98.15 E-value=3e-06 Score=95.91 Aligned_cols=73 Identities=36% Similarity=0.524 Sum_probs=57.2
Q ss_pred chhHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEecc-CCCC-cceeeEEEeE
Q psy1666 672 QLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDK-DGDG-PARYNIIHFK 748 (981)
Q Consensus 672 ~~~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~-~Gd~-~~~YdI~n~~ 748 (981)
...++|||||++|||||+++++.|...... .....+.++.++|++++|+|.+| ++.||+ +|++ ...|+|+|||
T Consensus 274 ~~~~~yDAv~~~a~al~~~~~~~~~~~~~~---~~~~~g~~l~~~l~~~~f~G~tG-~v~f~~~~G~~~~~~~~i~~~~ 348 (348)
T PF01094_consen 274 YAAYAYDAVYLLAHALNRALQDGGPVTNGR---NPWQNGSQLLKYLRNVSFEGLTG-RVSFDSNDGDRTNYDYDILNMQ 348 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSTTTSSS---GTSTTHHHHHHHHHTEEEEETTE-EEEEETTTSBEESEEEEEEEE-
T ss_pred eeeeehhhhHHHHHHHHHHHHhccCCCCCc---cccccHHHHHHHHhheeeeCCCC-CEEEeCCCCCcCCCEEEEEECC
Confidence 345899999999999999987665432211 11334668999999999999999 699999 8998 5799999986
No 64
>cd06346 PBP1_ABC_ligand_binding_like_11 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=98.14 E-value=7.1e-06 Score=91.91 Aligned_cols=111 Identities=11% Similarity=0.185 Sum_probs=75.0
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +.+++.+|++.+...++..+++++.++++.. .|+
T Consensus 151 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~v~~l-~~~~pd~v~~~~~~~~~~~~~~~~~~~G~~~--~~~ 222 (312)
T cd06346 151 VGLADAFTKAFEALGGTVTNVVAHEEGK-----SSYSSEVAAA-AAGGPDALVVIGYPETGSGILRSAYEQGLFD--KFL 222 (312)
T ss_pred hHHHHHHHHHHHHcCCEEEEEEeeCCCC-----CCHHHHHHHH-HhcCCCEEEEecccchHHHHHHHHHHcCCCC--ceE
Confidence 4456778888889999999988887543 2566777776 4567788888888878888998888888854 478
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHh
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFL 191 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~ 191 (981)
+++++..............+|.++..+.... |..++|.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~-~~~~~f~~ 261 (312)
T cd06346 223 LTDGMKSDSFLPADGGYILAGSYGTSPGAGG-PGLEAFTS 261 (312)
T ss_pred eeccccChHHHHhhhHHHhCCcEEccCCCCc-hhHHHHHH
Confidence 7777665443222212345677766553322 55555553
No 65
>cd06348 PBP1_ABC_ligand_binding_like_13 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=98.12 E-value=4.4e-05 Score=86.75 Aligned_cols=185 Identities=16% Similarity=0.195 Sum_probs=118.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +.+++.+|++.+....+..+++++.+.++.++ |+
T Consensus 151 ~~~~~~~~~~~~~~g~~v~~~~~~~~~~-----~d~~~~v~~i-~~~~~d~vi~~~~~~~~~~~~~~~~~~g~~~~--~~ 222 (344)
T cd06348 151 VSETEIFQKALRDQGLNLVTVQTFQTGD-----TDFQAQITAV-LNSKPDLIVISALAADGGNLVRQLRELGYNGL--IV 222 (344)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEeeCCCC-----CCHHHHHHHH-HhcCCCEEEECCcchhHHHHHHHHHHcCCCCc--ee
Confidence 4567788888889999999988887543 2566777776 56678888888888888889998888888763 56
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCC--CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQAN--PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
+++++..... ........+|.+...+... +.|..++|.+ .|+..+.-
T Consensus 223 ~~~~~~~~~~-~~~~g~~~~g~~~~~~~~~~~~~~~~~~f~~----------------~~~~~~g~-------------- 271 (344)
T cd06348 223 GGNGFNTPNV-FPVCQAACDGVLVAQAYSPENDTPVNRDFVE----------------AYKKKYGK-------------- 271 (344)
T ss_pred ccccccCHHH-HHhhhHhhcCeEEEeeccCCCCCHHHHHHHH----------------HHHHHHCC--------------
Confidence 6655543332 1222234456665544321 1122233322 22222210
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
.........|||++++++|++++.. ++ ....|+ .+-.+..|.++|++++|.|.+| +|.|
T Consensus 272 ---------------~p~~~~~~~yda~~~~~~A~~~a~~--~~-~~~~~~--~~~~~~~l~~~l~~~~~~g~~G-~v~f 330 (344)
T cd06348 272 ---------------APPQFSAQAFDAVQVVAEALKRLNQ--KQ-KLAELP--LPELRTALNAALLSGQYDTPLG-EISF 330 (344)
T ss_pred ---------------CccHHHHHHHHHHHHHHHHHHHhcC--CC-ccccch--hhhHHHHHHHHHhccCCcccee-eeEE
Confidence 0011234689999999999998853 21 111121 1112457889999999999999 7999
Q ss_pred cCCCCCC
Q psy1666 310 DKDGDGP 316 (981)
Q Consensus 310 D~nGD~~ 316 (981)
|++|++.
T Consensus 331 ~~~g~~~ 337 (344)
T cd06348 331 TPDGEVL 337 (344)
T ss_pred CCCCCcc
Confidence 9999864
No 66
>cd06345 PBP1_ABC_ligand_binding_like_10 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=98.11 E-value=1.5e-05 Score=90.57 Aligned_cols=178 Identities=13% Similarity=0.100 Sum_probs=109.9
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++.... ++...+.++ +.+++.+|++.+.......++.++.+.++..+ ++
T Consensus 158 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~~-----d~~~~v~~l-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~~--~~ 229 (344)
T cd06345 158 KGIDAGIKALLPEAGLEVVSVERFSPDTT-----DFTPILQQI-KAADPDVIIAGFSGNVGVLFTQQWAEQKVPIP--TI 229 (344)
T ss_pred hHHHHHHHHHHHHcCCeEEEEEecCCCCC-----chHHHHHHH-HhcCCCEEEEeecCchHHHHHHHHHHcCCCCc--eE
Confidence 45667888888889999999888875432 466677776 45567888888887778888888888877543 44
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC----CCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA----NPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNS 227 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~----~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~ 227 (981)
+...|..............+|.++..... ...|..++|.+ . +.+.+.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~--------------~--y~~~~g~------------ 281 (344)
T cd06345 230 GISVEGNSPAFWKATNGAGNYVITAESGAPGVEAITDKTVPFTE--------------A--YEAKFGG------------ 281 (344)
T ss_pred EecCCcCCHHHHHhhchhcceEEeecccccCccCCCHHHHHHHH--------------H--HHHHhCC------------
Confidence 44444422221111122334544332211 01122223321 1 1111110
Q ss_pred CCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeE
Q psy1666 228 HYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHF 307 (981)
Q Consensus 228 ~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V 307 (981)
.........|||++.+++|+.+.- ..++..+.+.|++++|.|..| +|
T Consensus 282 -----------------~p~~~~~~~yda~~~l~~A~~~ag---------------~~~~~~i~~al~~~~~~g~~G-~i 328 (344)
T cd06345 282 -----------------PPNYMGASTYDSIYILAEAIERAG---------------STDGDALVEALEKTDFVGTAG-RI 328 (344)
T ss_pred -----------------CCcccchHHHHHHHHHHHHHHHhc---------------CCCHHHHHHHHHhCCCcCCce-eE
Confidence 001123457999999999997642 124567999999999999998 69
Q ss_pred EecCCCCCCce
Q psy1666 308 KFDKDGDGPAR 318 (981)
Q Consensus 308 ~FD~nGD~~~~ 318 (981)
.||++||+.+.
T Consensus 329 ~f~~~g~~~~~ 339 (344)
T cd06345 329 QFYGDDSAFAH 339 (344)
T ss_pred EECCCCCcCcC
Confidence 99999998653
No 67
>cd06391 PBP1_iGluR_delta_2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta2 receptor of an orphan glutamate receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta2 receptor of an orphan glutamate receptor family. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 are closer related to non-NMDA receptors. GluRdelta2 was shown to function as a
Probab=98.11 E-value=6.6e-06 Score=95.15 Aligned_cols=91 Identities=16% Similarity=0.221 Sum_probs=64.8
Q ss_pred hHHHHHHHHHHHHHHHhHHhhcc--CCCCCCCCCC---CCChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEe
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQ--GKVGLCDAMR---PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHF 747 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~--~~~~~c~~~~---~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~ 747 (981)
-.+||||+++|+|++++....-. .....|.... -..+..|+++|++++|+|.+| ++.||++|.+. ..|||+|.
T Consensus 298 alayDaV~~~A~A~~~l~~~~~~~~~~~~~c~~~~~~~w~~G~~ll~~i~~~~f~GlTG-~i~f~~~g~r~~~~~dIin~ 376 (400)
T cd06391 298 LYIYDTVLLLANAFHKKLEDRKWHSMASLSCIRKNSKPWQGGRSMLETIKKGGVSGLTG-ELEFNENGGNPNVHFEILGT 376 (400)
T ss_pred hHHHHHHHHHHHHHHHHHhhccccCCCCcccccCCCCCCCChHHHHHHHHhcCccccee-ceEECCCCCccCCceEEEEe
Confidence 47999999999999987521111 1122464311 112347999999999999999 79999999775 69999998
Q ss_pred EEcCCCcEEEEEEEEEEC
Q psy1666 748 KQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 748 ~~~~~~~~~~~~VG~~~~ 765 (981)
...+.....+++||.|++
T Consensus 377 ~~~~~~~~g~rkiG~Ws~ 394 (400)
T cd06391 377 NYGEDLGRGVRKLGCWNP 394 (400)
T ss_pred eccccCCCcceEEEEEcC
Confidence 643332234799999975
No 68
>cd06377 PBP1_iGluR_NMDA_NR3 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR3 subunit of NMDA receptor family. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR3 subunit of NMDA receptor family. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer composed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. Among NMDA receptor subtypes, the NR2B subunit containing receptors appear particularly important for pain perception; thus NR2B-selective antagonists may be useful in
Probab=98.08 E-value=1e-05 Score=91.56 Aligned_cols=97 Identities=15% Similarity=0.266 Sum_probs=68.9
Q ss_pred hhHHHHHHHHHHHHHHHhHH----hhccCCCCCCCCC----CCCChhhHhhhhccccccCCCCCeEEeccCCC--Cccee
Q psy1666 673 LQFVSDAVMAFSIALDHMHA----DLCQGKVGLCDAM----RPTKGPELLKYLRKVSFQGLSEDHFKFDKDGD--GPARY 742 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~----~~c~~~~~~c~~~----~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd--~~~~Y 742 (981)
...+||||+.+|.|++++.. ..-......|... .-..+..|.+||++++|+|.+| .|.|++.+. .....
T Consensus 269 ~ali~DAV~lvA~a~~~l~~~~~~~~l~~~~~~C~~~~~~~~W~~G~~l~~~Lknv~~eGlTG-~I~F~~g~R~~~~~~l 347 (382)
T cd06377 269 EAYVQDALELVARAVGSATLVQPELALIPATVNCMDLPTKGNESSGQYLARFLANTSFDGRTG-PVWVTGSSQVHSSRHF 347 (382)
T ss_pred HHHHHHHHHHHHHHHHHhhhcccccccCCCCCCcccCCCCCCCCchHHHHHHHHhCcccccce-eEEEccCeeecccceE
Confidence 34799999999999998731 0111122467542 1112346999999999999999 799975444 35688
Q ss_pred eEEEeEEcCCCcEEEEEEEEEEC-ceEEE
Q psy1666 743 NIIHFKQIRPGVYQWVQVGEYLE-GELRL 770 (981)
Q Consensus 743 dI~n~~~~~~~~~~~~~VG~~~~-~~l~i 770 (981)
||++.+..++|...|++||+|++ +.+.+
T Consensus 348 ~I~~L~~~~~G~~~W~kVG~W~~~~~~~~ 376 (382)
T cd06377 348 KVWSLRRDPVGQPTWTTVGSWQGGRKIVM 376 (382)
T ss_pred EEEEeccccCCCccceEEEEecCCCceec
Confidence 99999876667668899999986 44444
No 69
>cd06370 PBP1_Speract_GC_like Ligand-binding domain of membrane bound guanylyl cyclases. Ligand-binding domain of membrane bound guanylyl cyclases (GCs), which are known to be activated by sperm-activating peptides (SAPs), such as speract or resact. These ligand peptides are released by a range of invertebrates to stimulate the metabolism and motility of spermatozoa and are also potent chemoattractants. These GCs contain a single transmembrane segment, an extracellular ligand binding domain, and intracellular protein kinase-like and cyclase catalytic domains. GCs of insect and nematodes, which exhibit high sequence similarity to the speract receptor are also included in this model.
Probab=98.00 E-value=7.7e-06 Score=95.18 Aligned_cols=67 Identities=22% Similarity=0.471 Sum_probs=56.1
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEc
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQI 750 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~ 750 (981)
.+.|||||++|+|||+++.+. . . ..++.+|.++|++++|.|.+|+.|.||++||+...|.+++++..
T Consensus 318 a~~yDAv~~~a~Al~~~~~~~--~-----~---~~~g~~i~~~l~~~~f~GvtG~~v~fd~~G~~~~~y~v~~~~~~ 384 (404)
T cd06370 318 AYLYDAVMLYAKALDETLLEG--G-----D---IYNGTAIVSHILNRTYRSITGFDMYIDENGDAEGNYSVLALQPI 384 (404)
T ss_pred ehhHHHHHHHHHHHHHHHHhc--C-----C---CCCHHHHHHHHhCcccccccCceEEEcCCCCcccceEEEEeccc
Confidence 479999999999999987421 1 0 13467899999999999999978999999999999999998753
No 70
>cd06387 PBP1_iGluR_AMPA_GluR3 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR3 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR3 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=97.99 E-value=1.5e-05 Score=91.18 Aligned_cols=86 Identities=21% Similarity=0.337 Sum_probs=63.3
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhcc----CCCCCCCCCCCCChh----hHhhhhccccccCCCCCeEEeccCCCCc-ceee
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQ----GKVGLCDAMRPTKGP----ELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYN 743 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~----~~~~~c~~~~~~~~~----qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~Yd 743 (981)
...+|||||++|+|++++....-. +..+.|... ...|| .|+++|++++|+|.+| .+.||++|.+. ..||
T Consensus 273 ~al~yDaV~~~A~A~~~l~~~~~~~~~~~~~~~C~~~-~~~~W~~G~~l~~~ik~v~~~GLTG-~i~F~~~G~R~~~~ld 350 (372)
T cd06387 273 SALTHDAILVIAEAFRYLRRQRVDVSRRGSAGDCLAN-PAVPWSQGIDIERALKMVQVQGMTG-NIQFDTYGRRTNYTID 350 (372)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCcCCC-CCCCccchHHHHHHHHhcccCCCcc-ceeeCCCCCcccceEE
Confidence 347999999999999998531111 112256432 12234 6999999999999999 79999999876 6999
Q ss_pred EEEeEEcCCCcEEEEEEEEEEC
Q psy1666 744 IIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 744 I~n~~~~~~~~~~~~~VG~~~~ 765 (981)
|+|.. ++ ..++||.|++
T Consensus 351 Iinl~--~~---g~~kIG~W~~ 367 (372)
T cd06387 351 VYEMK--PS---GSRKAGYWNE 367 (372)
T ss_pred EEEec--CC---CceeEEEECC
Confidence 99975 22 3689999975
No 71
>PRK15404 leucine ABC transporter subunit substrate-binding protein LivK; Provisional
Probab=97.94 E-value=0.00032 Score=80.54 Aligned_cols=185 Identities=15% Similarity=0.235 Sum_probs=119.9
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|.+|...+.+|.... ++...+.++ +.+++.+|++.+...++..+++++..+++.. .|+
T Consensus 175 ~~~~~~~~~~~~~~G~~v~~~~~~~~g~~-----D~~~~v~~l-~~~~~d~v~~~~~~~~~~~~~k~~~~~G~~~--~~i 246 (369)
T PRK15404 175 EGLARSVKDGLKKAGANVVFFEGITAGDK-----DFSALIAKL-KKENVDFVYYGGYHPEMGQILRQAREAGLKT--QFM 246 (369)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEeeCCCCC-----chHHHHHHH-HhcCCCEEEECCCchHHHHHHHHHHHCCCCC--eEE
Confidence 56677888889999999998888876432 566677776 4566777777666667777888888877754 578
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC-CCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA-NPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYS 230 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~-~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~ 230 (981)
+++.+..+.. .....+..+|.++..+.. ...|..++|.+. |+..+. ..
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~Gv~~~~~~~~~~~~~~~~f~~~----------------~~~~~~----~~---------- 295 (369)
T PRK15404 247 GPEGVGNKSL-SNIAGPASEGMLVTLPKRYDQDPANKAIVDA----------------FKAKKQ----DP---------- 295 (369)
T ss_pred ecCcCCCHHH-HHhhhhhhcCcEEEccCCCccChhHHHHHHH----------------HHHhcC----CC----------
Confidence 7754443322 111123446666544321 112333333321 111110 00
Q ss_pred CCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEec
Q psy1666 231 TECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFD 310 (981)
Q Consensus 231 ~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD 310 (981)
........|+++++++.||.+.= ..++..|.+.|++.+|.|..| ++.||
T Consensus 296 ---------------~~~~~~~~Y~~~~~l~~Al~~aG---------------~~~~~~l~~al~~~~~~~~~G-~~~~~ 344 (369)
T PRK15404 296 ---------------SGPFVWTTYAAVQSLAAGINRAG---------------SDDPAKVAKYLKANTFDTVIG-PLSWD 344 (369)
T ss_pred ---------------CccchHHHHHHHHHHHHHHHhhC---------------CCCHHHHHHHHHhCCCCcceE-eeEEC
Confidence 00123458999999999996531 124678999999999999999 69999
Q ss_pred CCCCCC-ceeEEEEEEE
Q psy1666 311 KDGDGP-ARYNIIHFKQ 326 (981)
Q Consensus 311 ~nGD~~-~~YdI~n~q~ 326 (981)
++||.. ..|.|.+|+.
T Consensus 345 ~~g~~~~~~~~i~~~~~ 361 (369)
T PRK15404 345 EKGDLKGFEFGVFEWHA 361 (369)
T ss_pred CCCCcccCCEEEEEEEc
Confidence 999984 6899998873
No 72
>KOG1054|consensus
Probab=97.93 E-value=0.00042 Score=78.56 Aligned_cols=231 Identities=16% Similarity=0.234 Sum_probs=125.5
Q ss_pred CcceeeEEeecc---------hhHHHHH---HHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEc
Q psy1666 60 DFIPVLMLFLRE---------TTAFEEL---EVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFG 127 (981)
Q Consensus 60 ~a~~~lv~f~~~---------~~~~~~l---~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~ 127 (981)
.|++.++-|++| +++...| -+.+..+|.-|.....-... +..++...++.+ .....|-+++-+
T Consensus 140 ~al~s~i~hy~W~~fv~lyD~~rg~s~Lqai~~~a~~~nw~VtA~~v~~~~----d~~~yr~~f~~l-~~r~e~rv~iDc 214 (897)
T KOG1054|consen 140 GALLSLIDHYKWEKFVYLYDTDRGLSILQAIMEAAAQNNWQVTAINVGNIN----DVKEYRMLFEML-DRRQENRVLIDC 214 (897)
T ss_pred HHHHHHHHhcccceEEEEEcccchHHHHHHHHHHHHhcCceEEEEEcCCcc----cHHHHHHHHHHH-hccccceEEEEc
Confidence 566677777777 4444444 44455667766554433221 123466666655 344455567777
Q ss_pred chhhHHHHHHHHHhhc--cCCceEEEEe-ccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCCCCcc
Q psy1666 128 SDQEVAGVMRAVRRLN--ATGSFSWVGS-DGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWF 204 (981)
Q Consensus 128 s~~~a~~~~~~~~~~~--l~g~~vWI~s-~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~n~~~ 204 (981)
..+....++..+.+.+ ..| |-.|.. -+....+. .. ....--..-||.+-+...|--++|++..
T Consensus 215 e~~~~~~il~q~i~~~k~~~~-YHYvlaNl~f~d~dl-~~-f~~g~aNitgFqivn~~~~~~~k~~~~~----------- 280 (897)
T KOG1054|consen 215 ESERRNRILLQVIELGKHVKG-YHYVLANLGFTDIDL-ER-FQHGGANITGFQIVNKNNPMVKKFIQRW----------- 280 (897)
T ss_pred ccHHHHHHHHHHHHHhhhccc-eEEEEeeCCCchhhH-HH-HhcCCcceeEEEEecCCChHHHHHHHHH-----------
Confidence 6666666666665432 244 233322 12211110 00 0000012345555444444456666532
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhc----CCCCCCCC
Q psy1666 205 VDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLC----QGKVGLCD 280 (981)
Q Consensus 205 ~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC----~~~~~~C~ 280 (981)
.+.-.-..++. ++ + + ..-.+...||||..+|+|++.+.++.- .+..|.|.
T Consensus 281 -----~~l~~~~~~g~--------------~~---~--~--~k~tsAlthDailV~~eaf~~~~~q~~~~~rRG~~GD~~ 334 (897)
T KOG1054|consen 281 -----KELDEREYPGA--------------SN---D--P--IKYTSALTHDAILVMAEAFRSLRRQRIDISRRGNAGDCL 334 (897)
T ss_pred -----hhhcccccCCC--------------CC---C--C--cchhhhhhhhHHHHHHHHHHHHHHhhhchhccCCCcccc
Confidence 21100000000 00 0 0 011345789999999999999887532 23467787
Q ss_pred CCCCCCc----cHHHHhhcceeeccCCCCeEEecCCCCCCc-eeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 281 AMRPTKG----PELLKYLRKVSFQGLSEDHFKFDKDGDGPA-RYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 281 ~~~~~~~----~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~-~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
..+ ..| ..+-..||+|.++|.+|+ |.||+.|.+.- .-||+... +++ ..+||.|++
T Consensus 335 an~-~~p~~qG~~I~ralk~v~~eGLTGn-iqFd~~G~R~Nyt~~i~elk--~~~---~rk~~~W~e 394 (897)
T KOG1054|consen 335 ANP-AVPWEQGIDIERALKQVQVEGLTGN-IQFDKYGRRTNYTIDIVELK--SNG---SRKVGYWNE 394 (897)
T ss_pred CCC-CCchhcchhHHHHHHheeecccccc-eeecccCccccceEEEEEec--cCC---cceeeeecc
Confidence 543 444 468899999999999995 99999998742 34455543 343 578999985
No 73
>cd06385 PBP1_NPR_A Ligand-binding domain of type A natriuretic peptide receptor. Ligand-binding domain of type A natriuretic peptide receptor (NPR-A). NPR-A is one of three known single membrane-spanning natriuretic peptide receptors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. NPR-A is highly expressed in kidney, adrenal, terminal ileum, adipose, aortic, and lung tissues. The rank order of NPR-A activation by natriuretic peptides is ANPBNPCNP. Single allele-inactivating mutations in the promoter of human NPR-A are associated with hypertension and heart failure.
Probab=97.91 E-value=2.8e-05 Score=90.48 Aligned_cols=91 Identities=22% Similarity=0.344 Sum_probs=70.7
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPG 753 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~ 753 (981)
...|||||++|.||++.+.+. + . ..++..+.+.|++++|.|.+| .|.||++||+.+.|.+++++...++
T Consensus 312 a~~YDav~l~a~Al~~~~~~~--~-----~---~~~g~~i~~~l~~~~f~G~tG-~v~fd~~G~r~~~~~~~~~~~~~~g 380 (405)
T cd06385 312 GGFYDGVMLYAHALNETMAKG--G-----T---RPPGTAITQRMWNRTFYGVTG-FVKIDDNGDRETDFALWDMTDTESG 380 (405)
T ss_pred HHHHHHHHHHHHHHHHHHhcC--C-----C---CCCHHHHHHHhhCceEeecee-EEEEcCCCCEeceeEEEEccCCCCC
Confidence 368999999999999886421 1 0 124667999999999999999 6999999999999999888755444
Q ss_pred cEEEEEEEEEEC--ceEEEec-ccccc
Q psy1666 754 VYQWVQVGEYLE--GELRLNM-SAIQF 777 (981)
Q Consensus 754 ~~~~~~VG~~~~--~~l~in~-~~i~W 777 (981)
.++.||.|+. .++.+.. +.|.|
T Consensus 381 --~~~~v~~~~~~~~~~~~~~~~~i~w 405 (405)
T cd06385 381 --DFQVVSVYNGTQKQLVAVPGRKIQW 405 (405)
T ss_pred --cEEEEEEEcccCcEEEEcCCcccCC
Confidence 6889999984 4566633 66666
No 74
>cd06389 PBP1_iGluR_AMPA_GluR2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR2 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR2 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=97.90 E-value=2.5e-05 Score=89.62 Aligned_cols=86 Identities=26% Similarity=0.410 Sum_probs=64.4
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhcc----CCCCCCCCCCCCChh----hHhhhhccccccCCCCCeEEeccCCCCcc-eee
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQ----GKVGLCDAMRPTKGP----ELLKYLRKVSFQGLSEDHFKFDKDGDGPA-RYN 743 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~----~~~~~c~~~~~~~~~----qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~-~Yd 743 (981)
....|||||.+|.|++++....-. .+...|... +..|| .|.++|++++|.|.+| .+.||++|++.. .++
T Consensus 270 aAl~yDAV~v~a~A~~~l~~~~~~~~~~~~~~~C~~~-~~~~w~~G~~i~~~l~~~~~~GlTG-~i~Fd~~G~r~~~~~~ 347 (370)
T cd06389 270 SALTYDAVQVMTEAFRNLRKQRIEISRRGNAGDCLAN-PAVPWGQGVEIERALKQVQVEGLTG-NIKFDQNGKRINYTIN 347 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCcccCCCCCCcCCC-CCCCCCCcHHHHHHHHhcccCcccc-ceEeCCCCccccceEE
Confidence 347999999999999988421100 112256532 22334 6999999999999999 799999999987 899
Q ss_pred EEEeEEcCCCcEEEEEEEEEEC
Q psy1666 744 IIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 744 I~n~~~~~~~~~~~~~VG~~~~ 765 (981)
|++.+. + .+++||.|++
T Consensus 348 ii~l~~--~---g~~kvG~W~~ 364 (370)
T cd06389 348 VMELKS--N---GPRKIGYWSE 364 (370)
T ss_pred EEEecC--C---cceEEEEEcC
Confidence 999862 2 3689999985
No 75
>KOG4440|consensus
Probab=97.82 E-value=2.1e-05 Score=89.04 Aligned_cols=103 Identities=23% Similarity=0.256 Sum_probs=69.9
Q ss_pred hHHHHHHHHHHHHHHHhHHhhc-cC-CCCCCCCCCCCChh-hHhhhhcc-ccccCCCCCeEEeccCCCCc-ceeeEEEeE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLC-QG-KVGLCDAMRPTKGP-ELLKYLRK-VSFQGLSEDHFKFDKDGDGP-ARYNIIHFK 748 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c-~~-~~~~c~~~~~~~~~-qL~~~L~~-v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~~ 748 (981)
..+-|+|+.+|.|+|+|+.+.- .. +.+-|+.......| .|.++|+. -.-.|.+| +|.||++||+. +.|||+|+.
T Consensus 285 ~hirDsv~vlasAv~e~~~~e~I~~~P~~c~d~~~~w~~g~~l~~~l~s~~~~~g~Tg-rV~Fnd~gdRi~a~YdiiN~h 363 (993)
T KOG4440|consen 285 AHIRDSVGVLASAVHELLEKENITDPPRGCVDNTNIWKTGPLLKRVLMSSKYADGVTG-RVEFNDDGDRIFANYDIINLH 363 (993)
T ss_pred ceehhhHHHHHHHHHHHHhhccCCCCCCcccCccchhcccHHHHHHHhhhcccCCcce-eEEEcCCCceeeccceeEehh
Confidence 3578999999999999985321 11 12233433222333 35566665 33456666 79999999999 699999984
Q ss_pred EcCCCcEEEEEEEEEECceEEEeccccccccCC
Q psy1666 749 QIRPGVYQWVQVGEYLEGELRLNMSAIQFKLSH 781 (981)
Q Consensus 749 ~~~~~~~~~~~VG~~~~~~l~in~~~i~W~~~~ 781 (981)
+ +.+.|-+|.|+...+..|+++|.|+++.
T Consensus 364 q----~rk~Vg~~~yd~~r~~~nd~~IiWpGg~ 392 (993)
T KOG4440|consen 364 Q----NRKLVGVGIYDGTRVIPNDRKIIWPGGE 392 (993)
T ss_pred h----hhhhhhhccccceeeccCCceeecCCCC
Confidence 2 1244566777766777788999998773
No 76
>cd06380 PBP1_iGluR_AMPA N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, a member of the glutamate-receptor ion channels (iGluRs). AMPA receptors are the major mediators of excitatory synaptic transmission in the central nervous system. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excita
Probab=97.76 E-value=6.6e-05 Score=86.68 Aligned_cols=86 Identities=26% Similarity=0.419 Sum_probs=63.7
Q ss_pred hHHHHHHHHHHHHHHHhHHhh----------ccCCCCCCCCCC---CCChhhHhhhhccccccCCCCCeEEeccCCCCc-
Q psy1666 674 QFVSDAVMAFSIALDHMHADL----------CQGKVGLCDAMR---PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP- 739 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~----------c~~~~~~c~~~~---~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~- 739 (981)
..+|||||++|+|++++.... .......|.... ..++.++.++|++++|.|.+| .+.||++|++.
T Consensus 278 a~aYDav~~~a~Al~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~g~~i~~~l~~~~~~G~tG-~i~Fd~~G~~~~ 356 (382)
T cd06380 278 ALAHDAVLVMAEAFRSLRRQRGSGRHRIDISRRGNGGDCLANPAVPWEHGIDIERALKKVQFEGLTG-NVQFDEFGQRTN 356 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhccccccccccccCCCCCcCCCCCCCCccchHHHHHHHHhcccCCccc-ceEECCCCCccc
Confidence 479999999999999885321 111122465321 123557999999999999998 69999999987
Q ss_pred ceeeEEEeEEcCCCcEEEEEEEEEEC
Q psy1666 740 ARYNIIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 740 ~~YdI~n~~~~~~~~~~~~~VG~~~~ 765 (981)
..++|++++. + .+++||.|++
T Consensus 357 ~~~~i~~~~~--~---~~~~vg~w~~ 377 (382)
T cd06380 357 YTLDVVELKT--R---GLRKVGYWNE 377 (382)
T ss_pred ccEEEEEecC--C---CceEEEEECC
Confidence 5799999872 1 3789999975
No 77
>cd06388 PBP1_iGluR_AMPA_GluR4 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR4 subunit of the AMPA receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR4 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).
Probab=97.76 E-value=6.1e-05 Score=86.41 Aligned_cols=86 Identities=21% Similarity=0.375 Sum_probs=63.7
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhcc----CCCCCCCCCCCCChh----hHhhhhccccccCCCCCeEEeccCCCCcc-eee
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQ----GKVGLCDAMRPTKGP----ELLKYLRKVSFQGLSEDHFKFDKDGDGPA-RYN 743 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~----~~~~~c~~~~~~~~~----qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~-~Yd 743 (981)
...+|||||++|.|++++....-. +....|... +..|| .|.++|++++|+|.+| .+.||++|++.. .++
T Consensus 271 aAl~YDaV~l~a~A~~~l~~~~~~~~~~~~~~~C~~~-~~~~w~~G~~i~~~lk~~~~~GlTG-~i~Fd~~G~r~~~~l~ 348 (371)
T cd06388 271 SALTYDGVLVMAEAFRNLRRQKIDISRRGNAGDCLAN-PAAPWGQGIDMERTLKQVRIQGLTG-NIQFDHYGRRVNYTMD 348 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCcCCC-CCCCCcccHHHHHHHHhcCcCCCcc-ceeECCCCCcccceEE
Confidence 347999999999999987421111 011256432 23344 5999999999999999 799999999987 999
Q ss_pred EEEeEEcCCCcEEEEEEEEEEC
Q psy1666 744 IIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 744 I~n~~~~~~~~~~~~~VG~~~~ 765 (981)
|++.+. + ..++||+|++
T Consensus 349 Ii~l~~--~---g~~kvG~W~~ 365 (371)
T cd06388 349 VFELKS--N---GPRKIGYWND 365 (371)
T ss_pred EEEccC--C---CceEEEEEcC
Confidence 998752 2 3689999985
No 78
>cd06373 PBP1_NPR_like Ligand binding domain of natriuretic peptide receptor (NPR) family. Ligand binding domain of natriuretic peptide receptor (NPR) family which consists of three different subtypes: type A natriuretic peptide receptor (NPR-A, or GC-A), type B natriuretic peptide receptors (NPR-B, or GC-B), and type C natriuretic peptide receptor (NPR-C). There are three types of natriuretic peptide (NP) ligands specific to the receptors: atrial NP (ANP), brain or B-type NP (BNP), and C-type NP (CNP). The NP family is thought to have arisen through gene duplication during evolution and plays an essential role in cardiovascular and body fluid homeostasis. ANP and BNP bind mainly to NPR-A, while CNP binds specifically to NPR-B. Both NPR-A and NPR-B have guanylyl cyclase catalytic activity and produces intracellular secondary messenger cGMP in response to peptide-ligand binding. Consequently, the NPR-A activation results in vasodilation and inhibition of vascular smooth muscle cell proli
Probab=97.74 E-value=5.6e-05 Score=87.71 Aligned_cols=79 Identities=22% Similarity=0.477 Sum_probs=63.9
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPG 753 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~ 753 (981)
...|||||++|+||++++. +... ..++++|.+.|++++|.|.+| .+.||++||+...|.+++++...++
T Consensus 310 ~~~YDav~~~a~Al~~~~~--~~~~--------~~~~~~i~~~l~~~~f~G~tG-~v~fd~~G~~~~~~~v~~~~~~~~g 378 (396)
T cd06373 310 GAFYDAVLLYALALNETLA--EGGD--------PRDGTNITRRMWNRTFEGITG-NVSIDENGDRESDFSLWDMTDTETG 378 (396)
T ss_pred HHHHHHHHHHHHHHHHHHh--ccCC--------CCChHHHHHHhcCCceecccC-ceEeecCCcccceeeeeeccCCCCc
Confidence 4689999999999999863 2110 135788999999999999999 5999999999999999877544444
Q ss_pred cEEEEEEEEEEC
Q psy1666 754 VYQWVQVGEYLE 765 (981)
Q Consensus 754 ~~~~~~VG~~~~ 765 (981)
.++.+|.|++
T Consensus 379 --~~~~~~~~~~ 388 (396)
T cd06373 379 --TFEVVANYNG 388 (396)
T ss_pred --eEEEEeeccc
Confidence 6789999976
No 79
>cd06351 PBP1_iGluR_N_LIVBP_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NMDA, AMPA, and kainate receptor subtypes of ionotropic glutamate receptors (iGluRs). N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NMDA, AMPA, and kainate receptor subtypes of ionotropic glutamate receptors (iGluRs). While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Glutamate mediates the majority of excitatory synaptic transmission in the central nervous system via two broad classes of ionotropic receptors characterized by their response to glutamate agonists: N-methyl-aspartate (NMDA) and non-NMDA receptors
Probab=97.71 E-value=8.2e-05 Score=83.53 Aligned_cols=137 Identities=14% Similarity=0.241 Sum_probs=83.5
Q ss_pred HhcCCCCCCCCCcceeeEEeecc---------hhHHHHHHHHHHh---CCeeEEEEEEeecCCcchhhhhHHHHHHHHhc
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE---------TTAFEELEVLLAK---SSICIAVKEKLVKDSGVAEERAYDDIVTKLMT 116 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~---------~~~~~~l~~~~~~---~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~ 116 (981)
++..|++.+|.+|++.++.+++| .++...+++.+++ .+.++..... +... .++.+.++++ +
T Consensus 110 ~~~~p~~~~~~~a~~~~l~~~~w~~v~iiy~~~~~~~~l~~~~~~~~~~~~~v~~~~~-~~~~-----~~~~~~l~~l-~ 182 (328)
T cd06351 110 LQLYPSLEDLADALLDLLEYYNWTKFAIIYDSDEGLSRLQELLDESGIKGIQVTVRRL-DLDD-----DNYRQLLKEL-K 182 (328)
T ss_pred EEecCCHHHHHHHHHHHHHHcCCcEEEEEEeCchHHHHHHHHHHhhcccCceEEEEEe-cCCc-----hhHHHHHHHH-h
Confidence 34678888888888888888887 2234444444433 3456665433 2221 1456666665 4
Q ss_pred CCCc-EEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhc
Q psy1666 117 KPRA-RGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNL 193 (981)
Q Consensus 117 ~s~a-~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l 193 (981)
+..+ +||+..+....+..++.++.+.++.+ .+.||.++. .....-.........|.+|+.+.....+.+++|..++
T Consensus 183 ~~~~~~vil~~~~~~~~~~~l~~a~~~gm~~~~~~~i~~~~-~~~~~d~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~ 260 (328)
T cd06351 183 RSESRRIILDCSSEEEAKEILEQAVELGMMGYGYHWILTNL-DLSDIDLEPFQYGPANITGFRLVDPDSPDVSQFLQRW 260 (328)
T ss_pred hcccceEEEECCcHHHHHHHHHHHHHhccccCCcEEEEecC-CccccchhhhccCCcceEEEEEeCCCchHHHHHHHhh
Confidence 4556 66665555588888999999888864 479998853 2221101122223358888888776666677766543
No 80
>cd06386 PBP1_NPR_C_like Ligand-binding domain of type C natriuretic peptide receptor. Ligand-binding domain of type C natriuretic peptide receptor (NPR-C). NPR-C is found in atrial, mesentery, placenta, lung, kidney, venous tissue, aortic smooth muscle, and aortic endothelial cells. The affinity of NPR-C for natriuretic peptides is ANPCNPBNP. The extracellular domain of NPR-C is about 30% identical to NPR-A and NPR-B. However, unlike the cyclase-linked receptors, it contains only 37 intracellular amino acids and no guanylyl cyclase activity. Major function of NPR-C is to clear natriuretic peptides from the circulation or extracellular surroundings through constitutive receptor-mediated internalization and degradation.
Probab=97.66 E-value=0.00015 Score=83.87 Aligned_cols=79 Identities=19% Similarity=0.434 Sum_probs=64.4
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPG 753 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~ 753 (981)
...|||||++|+||++.+.+ + . ...++..|.+.|++++|.|.+| .+.||++||+...|.++.++. .+
T Consensus 300 a~~yDav~l~A~Al~~~~~~---g--~-----~~~~g~~l~~~l~~~~f~G~tG-~v~~d~~g~r~~~~~v~~~~~--~~ 366 (387)
T cd06386 300 EGFHDAILLYALALHEVLKN---G--Y-----SKKDGTKITQRMWNRTFEGIAG-QVSIDANGDRYGDFSVIAMTD--VE 366 (387)
T ss_pred HHHHHHHHHHHHHHHHHhhC---C--C-----CCCCHHHHHHHHhCCceeeccc-cEEECCCCCccccEEEEEccC--CC
Confidence 47999999999999988631 1 0 1234567889999999999999 699999999999999999864 34
Q ss_pred cEEEEEEEEEEC
Q psy1666 754 VYQWVQVGEYLE 765 (981)
Q Consensus 754 ~~~~~~VG~~~~ 765 (981)
+..++.||.|..
T Consensus 367 ~~~~~~~~~~~~ 378 (387)
T cd06386 367 AGTYEVVGNYFG 378 (387)
T ss_pred CccEEEEeEEcc
Confidence 567899999963
No 81
>cd06340 PBP1_ABC_ligand_binding_like_6 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=97.65 E-value=0.00018 Score=81.96 Aligned_cols=177 Identities=14% Similarity=0.138 Sum_probs=107.5
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +.+++.+|++.+....+..+++++.+.++.++ .+.
T Consensus 158 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~i~~l-~~~~~d~v~~~~~~~~~~~~~~~~~~~G~~~~-~~~ 230 (347)
T cd06340 158 TSVAEAIKKFAKERGFEIVEDISYPANA-----RDLTSEVLKL-KAANPDAILPASYTNDAILLVRTMKEQRVEPK-AVY 230 (347)
T ss_pred HHHHHHHHHHHHHcCCEEEEeeccCCCC-----cchHHHHHHH-HhcCCCEEEEcccchhHHHHHHHHHHcCCCCc-EEE
Confidence 4456777888889999999988887543 2566677776 55678888888888888889988888888765 333
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCCC-CCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQANP-VKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYS 230 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~-ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~ 230 (981)
....+..............+|.+...+.... .|..++|... +...+.-
T Consensus 231 ~~~~~~~~~~~~~~~g~~~~g~~~~~~~~~~~~~~~~~f~~~----------------y~~~~~~--------------- 279 (347)
T cd06340 231 SVGGGAEDPSFVKALGKDAEGILTRNEWSDPKDPMAKDLNKR----------------FKARFGV--------------- 279 (347)
T ss_pred ecCCCcCcHHHHHHhhHhhheEEeccccCCCCChHHHHHHHH----------------HHHHhCC---------------
Confidence 3323222222111112334677765443221 2333444321 1111110
Q ss_pred CCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHH--Hhhcceeec---cCCCC
Q psy1666 231 TECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELL--KYLRKVSFQ---GLSED 305 (981)
Q Consensus 231 ~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl--~~Lk~V~F~---g~~G~ 305 (981)
.........|||++.+++|+++.- ..++..+. ..|+...+. +..|
T Consensus 280 --------------~~~~~~~~~Y~a~~~l~~A~~~ag---------------~~~~~~v~~~~~~~~~~~~~~~~~~g- 329 (347)
T cd06340 280 --------------DLSGNSARAYTAVLVIADALERAG---------------SADPEKIRDLAALASTSGEDLIMPYG- 329 (347)
T ss_pred --------------CCChHHHHHHHHHHHHHHHHHHhc---------------CCCHHHHHHHHHhccCCccccccCCC-
Confidence 001123467999999999998752 12345555 366666654 3455
Q ss_pred eEEecCCCCCC
Q psy1666 306 HFKFDKDGDGP 316 (981)
Q Consensus 306 ~V~FD~nGD~~ 316 (981)
++.||++||..
T Consensus 330 ~~~f~~~g~~~ 340 (347)
T cd06340 330 PIKFDAKGQNT 340 (347)
T ss_pred CeeECCCCCcc
Confidence 69999999974
No 82
>cd06347 PBP1_ABC_ligand_binding_like_12 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=97.63 E-value=0.00052 Score=77.36 Aligned_cols=176 Identities=17% Similarity=0.237 Sum_probs=110.8
Q ss_pred HHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEe
Q psy1666 74 AFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGS 153 (981)
Q Consensus 74 ~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s 153 (981)
..+.+++.+++.|+|+...+.++.... ++...+.++ ++.++.+|++.+.......++.++.+.++.. .|+++
T Consensus 152 ~~~~~~~~~~~~g~~v~~~~~~~~~~~-----d~~~~~~~~-~~~~~d~i~~~~~~~~~~~~~~~~~~~g~~~--~i~~~ 223 (334)
T cd06347 152 LAKAFKEAFKKLGGEIVAEETFNAGDT-----DFSAQLTKI-KAKNPDVIFLPGYYTEVGLIAKQARELGIKV--PILGG 223 (334)
T ss_pred HHHHHHHHHHHcCCEEEEEEEecCCCC-----cHHHHHHHH-HhcCCCEEEEcCchhhHHHHHHHHHHcCCCC--cEEec
Confidence 356777788889999999888875432 466677776 4456788888888888888888887777643 68888
Q ss_pred ccCcccccccCCCccceeeEEEEEecCC--CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCC
Q psy1666 154 DGWSARGLVSDGSEAEVEGTLSLQPQAN--PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYST 231 (981)
Q Consensus 154 ~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~ 231 (981)
+.|...... .......+|.+...+... ..|..++|... |...+. ..
T Consensus 224 ~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~~~~~~~~f~~~----------------~~~~~~-~~-------------- 271 (334)
T cd06347 224 DGWDSPKLE-EAGGAAAEGVYFTTHFSADDPTPKAKKFVKA----------------YKAKYG-KE-------------- 271 (334)
T ss_pred ccccCHHHH-HHHHHHhCCcEEecccCCCCCCHHHHHHHHH----------------HHHHHC-CC--------------
Confidence 889765331 111223455544433211 12333333321 111111 00
Q ss_pred CCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcce-eeccCCCCeEEec
Q psy1666 232 ECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKV-SFQGLSEDHFKFD 310 (981)
Q Consensus 232 ~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V-~F~g~~G~~V~FD 310 (981)
.......-||||+.++.||.+.- ..++..+.+.|++. +|+|..| .+.||
T Consensus 272 --------------~~~~~~~~yda~~~~~~Al~~ag---------------~~~~~~v~~~l~~~~~~~g~~G-~v~f~ 321 (334)
T cd06347 272 --------------PDAFAALGYDAYYLLADAIERAG---------------STDPEAIRDALAKTKDFDGVTG-KITID 321 (334)
T ss_pred --------------cchhHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHHhCCCccccee-eeEEC
Confidence 00123457999999999986531 11456788887764 7999999 69999
Q ss_pred CCCCCCcee
Q psy1666 311 KDGDGPARY 319 (981)
Q Consensus 311 ~nGD~~~~Y 319 (981)
.+|+....|
T Consensus 322 ~~g~~~~~~ 330 (334)
T cd06347 322 ENGNPVKSA 330 (334)
T ss_pred CCCCcCCCc
Confidence 999876444
No 83
>cd06360 PBP1_alkylbenzenes_like Type I periplasmic binding component of active transport systems that are predicted be involved in anaerobic biodegradation of alkylbenzenes such as toluene and ethylbenzene. This group includes the type I periplasmic binding component of active transport systems that are predicted be involved in anaerobic biodegradation of alkylbenzenes such as toluene and ethylbenzene; their substrate specificity is not well characterized, however.
Probab=97.62 E-value=0.0014 Score=74.02 Aligned_cols=180 Identities=11% Similarity=0.114 Sum_probs=112.4
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+.+...+.++... .++...+.+++ ++++.+|++......+..++.++.+.++.++..|+
T Consensus 148 ~~~~~~~~~~~~~~G~~v~~~~~~~~~~-----~d~~~~v~~~~-~~~pd~v~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 221 (336)
T cd06360 148 YEVVEGFKEAFTEAGGKIVKELWVPFGT-----SDFASYLAQIP-DDVPDAVFVFFAGGDAIKFVKQYDAAGLKAKIPLI 221 (336)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEecCCCC-----cchHHHHHHHH-hcCCCEEEEecccccHHHHHHHHHHcCCccCCeEE
Confidence 3445677888888999998877776543 25667777764 45566777777777788889888888886554677
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCC--CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQAN--PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
+++.+....... ......+|.+...+... ..|..++|.+. ++..+. .
T Consensus 222 ~~~~~~~~~~~~-~~g~~~~g~~~~~~~~~~~~~~~~~~f~~~----------------y~~~~~----~---------- 270 (336)
T cd06360 222 GSGFLTDGTTLG-AAGEAAEGVITALHYADTLDNPANQAFVKA----------------YRAAYP----D---------- 270 (336)
T ss_pred ecccccCHHHHH-hhHhhhcCceeccccCCCCCCHHHHHHHHH----------------HHHHhC----C----------
Confidence 765554332211 11123456655443211 22334444321 111110 0
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
.........|||++.++.|+.+.-. ...++..+.+.|++.+|.|..| ++.|
T Consensus 271 ---------------~~~~~~~~~yda~~~~~~A~~~a~~-------------~~~~~~~v~~al~~~~~~~~~g-~~~f 321 (336)
T cd06360 271 ---------------TPSVYAVQGYDAGQALILALEAVGG-------------DLSDGQALIAAMAAAKIDSPRG-PFTL 321 (336)
T ss_pred ---------------CccHHHHHHHHHHHHHHHHHHHhCC-------------CCCCHHHHHHHHhcCCccCCCc-ceEE
Confidence 0011245689999999999976521 1124567999999999999888 6999
Q ss_pred cCCCCCCc
Q psy1666 310 DKDGDGPA 317 (981)
Q Consensus 310 D~nGD~~~ 317 (981)
|++|+...
T Consensus 322 ~~~~~~~~ 329 (336)
T cd06360 322 DKAHNPIQ 329 (336)
T ss_pred CCCCCccc
Confidence 99999754
No 84
>cd06269 PBP1_glutamate_receptors_like Family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domain of the ionotropic glutamate receptors. This CD represents the ligand-binding domain of the family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domain of the ionotropic glutamate receptors, all of which are structurally similar and related to the periplasmic-binding fold type I family. The family C GPCRs consist of metabotropic glutamate receptor (mGluR) receptors, a calcium-sensing receptor (CaSR), gamma-aminobutyric receptors (GABAb), the promiscuous L-alpha-amino acid receptor GPR6A, families of taste and pheromone receptors, and orphan receptors. Truncated splicing va
Probab=97.43 E-value=0.00028 Score=77.46 Aligned_cols=105 Identities=24% Similarity=0.399 Sum_probs=83.8
Q ss_pred HhcCCCCCCCCCcceeeEEeecc-------------hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHh
Q psy1666 49 LMTKPRARDDPDFIPVLMLFLRE-------------TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLM 115 (981)
Q Consensus 49 l~~~psa~~q~~a~~~lv~f~~~-------------~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li 115 (981)
+++.|++..|.+|++.++.+++| ....+.+++.+.+.|+|+...+.++... .++.+.++++
T Consensus 118 ~~~~p~~~~~~~a~~~~l~~~~w~~v~~v~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~-----~~~~~~l~~l- 191 (298)
T cd06269 118 LRTVPSDSSQAQAIVDLLKHFGWTWVGLVYSDDDYGRRLLELLEEELEKNGICVAFVESIPDGS-----EDIRRLLKEL- 191 (298)
T ss_pred EecCCCcHHHHHHHHHHHHHCCCeEEEEEEecchhhHHHHHHHHHHHHHCCeeEEEEEEcCCCH-----HHHHHHHHHH-
Confidence 34778888999999999999988 4457788888888899999999887542 2455666665
Q ss_pred cCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCccc
Q psy1666 116 TKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSAR 159 (981)
Q Consensus 116 ~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~ 159 (981)
+.+.++|||+++....+..+++++.+.++.+.+.||.++.|...
T Consensus 192 ~~~~~~viv~~~~~~~~~~~l~~a~~~g~~~~~~~i~~~~~~~~ 235 (298)
T cd06269 192 KSSTARVIVVFSSEEDALRLLEEAVELGMMTGYHWIITDLWLTS 235 (298)
T ss_pred HhcCCcEEEEEechHHHHHHHHHHHHcCCCCCeEEEEEChhhcc
Confidence 45566999999998889999999998887444699999999764
No 85
>cd06336 PBP1_ABC_ligand_binding_like_3 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This group includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters (HAAT), such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=97.29 E-value=0.0012 Score=75.17 Aligned_cols=70 Identities=17% Similarity=0.199 Sum_probs=55.3
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchh-hHHHHHHHHHhhccCCc
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQ-EVAGVMRAVRRLNATGS 147 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~-~a~~~~~~~~~~~l~g~ 147 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +.+++.+|++.+... ++..+++++.++++.+.
T Consensus 152 ~~~~~~~~~~l~~~G~~vv~~~~~~~~~-----~D~s~~i~~i-~~~~~d~v~~~~~~~~~~~~~~~~~~~~g~~~~ 222 (347)
T cd06336 152 QPWVAAYKAAWEAAGGKVVSEEPYDPGT-----TDFSPIVTKL-LAEKPDVIFLGGPSPAPAALVIKQARELGFKGG 222 (347)
T ss_pred HHHHHHHHHHHHHcCCEEeeecccCCCC-----cchHHHHHHH-HhcCCCEEEEcCCCchHHHHHHHHHHHcCCCcc
Confidence 5567778888889999999888887543 2566777776 456788888888777 88999999988888774
No 86
>cd06352 PBP1_NPR_GC_like Ligand-binding domain of membrane guanylyl-cyclase receptors. Ligand-binding domain of membrane guanylyl-cyclase receptors. Membrane guanylyl cyclases (GC) have a single membrane-spanning region and are activated by endogenous and exogenous peptides. This family can be divided into three major subfamilies: the natriuretic peptide receptors (NPRs), sensory organ-specific membrane GCs, and the enterotoxin/guanylin receptors. The binding of peptide ligands to the receptor results in the activation of the cytosolic catalytic domain. Three types of NPRs have been cloned from mammalian tissues: NPR-A/GC-A, NPR-B/ GC-B, and NPR-C. In addition, two of the GCs, GC-D and GC-G, appear to be pseudogenes in humans. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are produced in the heart, and both bind to the NPR-A. NPR-C, also termed the clearance receptor, binds each of the natriuretic peptides and can alter circulating levels of these peptides. The l
Probab=97.28 E-value=0.00055 Score=79.18 Aligned_cols=79 Identities=22% Similarity=0.325 Sum_probs=62.4
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCC
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRP 752 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~ 752 (981)
....|||||++|+|+|++.. +... ...+.++.+.|++++|.|.+| .+.||++|++...|+|++++..
T Consensus 303 a~~~YDav~~~a~Al~~~~~--~~~~--------~~~~~~v~~~l~~~~f~g~~G-~v~fd~~G~~~~~~~v~~~~~~-- 369 (389)
T cd06352 303 AGYLYDAVLLYAHALNETLA--EGGD--------YNGGLIITRRMWNRTFSGITG-PVTIDENGDREGDYSLLDLDST-- 369 (389)
T ss_pred hhhHHHHHHHHHHHHHHHHH--hCCC--------CCchHHHHHHhcCcEEEeeee-eEEEcCCCCeeeeEEEEEecCC--
Confidence 34799999999999999863 2110 124677999999999999988 7999999999999999999743
Q ss_pred CcEEEEEEEEEEC
Q psy1666 753 GVYQWVQVGEYLE 765 (981)
Q Consensus 753 ~~~~~~~VG~~~~ 765 (981)
...+..+|.++.
T Consensus 370 -~~~~~~~~~~~~ 381 (389)
T cd06352 370 -GGQLEVVYLYDT 381 (389)
T ss_pred -CceEEEEEeccc
Confidence 245677777753
No 87
>cd06384 PBP1_NPR_B Ligand-binding domain of type B natriuretic peptide receptor. Ligand-binding domain of type B natriuretic peptide receptor (NPR-B). NPR-B is one of three known single membrane-spanning natriuretic peptide receptors that have been identified. Natriuretic peptides are family of structurally related but genetically distinct hormones/paracrine factors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. Like NPR-A (or GC-A), NPR-B (or GC-B) is a transmembrane guanylyl cyclase, an enzyme that catalyzes the synthesis of cGMP. NPR-B is the predominant natriuretic peptide receptor in the brain. The rank of order activation of NPR-B by natriuretic peptides is CNPANPBNP. Homozygous inactivating mutations in human NPR-B cause a form of short-limbed dwarfism known as acromesomelic dysplasia type Maroteaux.
Probab=97.24 E-value=0.00093 Score=77.63 Aligned_cols=79 Identities=20% Similarity=0.402 Sum_probs=62.4
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPG 753 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~ 753 (981)
...|||||.+|.||.+.+.+ .+. ..++.++.+.|++++|.|.+| .+.||++||+...|.++.++...++
T Consensus 313 a~~YDav~l~a~Al~~~~~~--~~~--------~~~g~~i~~~l~~~~f~GvtG-~v~fd~~G~r~~~~~~~~~~~~~~g 381 (399)
T cd06384 313 GCFYDGVMLYAMALNETLAE--GGS--------QKDGLNITRKMQDRRFWGVTG-LVSIDKNNDRDIDFDLWAMTDHETG 381 (399)
T ss_pred hhhHHHHHHHHHHHHHHHhc--CCC--------CCCcHhHHHHHhCceeeccee-EEEECCCCCcccceEEEEeecCCCC
Confidence 46999999999999987632 110 124557999999999999999 6999999999989988766444444
Q ss_pred cEEEEEEEEEEC
Q psy1666 754 VYQWVQVGEYLE 765 (981)
Q Consensus 754 ~~~~~~VG~~~~ 765 (981)
.++.||+|+.
T Consensus 382 --~~~~v~~~~~ 391 (399)
T cd06384 382 --KYEVVAHYNG 391 (399)
T ss_pred --eEEEEEEEcC
Confidence 5889999975
No 88
>cd06369 PBP1_GC_C_enterotoxin_receptor Ligand-binding domain of the membrane guanylyl cyclase C. Ligand-binding domain of the membrane guanylyl cyclase C (GC-C or StaR). StaR is a key receptor for the STa (Escherichia coli Heat Stable enterotoxin), a potent stimulant of intestinal chloride and bicarbonate secretion that cause acute secretory diarrhea. The catalytic domain of the STa/guanylin receptor type membrane GC is highly similar to those of the natriuretic peptide receptor (NPR) type and sensory organ-specific type membrane GCs (GC-D, GC-E and GC-F). The GC-C receptor is mainly expressed in the intestine of most vertebrates, but is also found in the kidney and other organs. Moreover, GC-C is activated by guanylin and uroguanylin, endogenous peptide ligands synthesized in the intestine and kidney. Consequently, the receptor activation results in increased cGMP levels and phosphorylation of the CFTR chloride channel and secretion.
Probab=97.21 E-value=0.0011 Score=73.77 Aligned_cols=78 Identities=15% Similarity=0.299 Sum_probs=62.4
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCC
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRP 752 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~ 752 (981)
....||||.-.||||++.+.+. . . . ...++.+.++|.+|+|.+|. |.+|+|||+...|.++-.- .
T Consensus 287 aa~fyDaVLLYa~AL~EtL~~G--~------~--~-~~~~I~~~m~NrTF~GitG~-V~IDeNGDRd~dfsLl~ms---~ 351 (380)
T cd06369 287 VAAYHDGVLLFGHVLKKFLESQ--E------G--V-QTFSFINEFRNISFEGAGGP-YTLDEYGDRDVNFTLLYTS---T 351 (380)
T ss_pred HHHHHHHHHHHHHHHHHHHHhC--C------C--C-CcHHHHHHHhCcceecCCCc-eEeCCCCCccCceEEEEee---C
Confidence 3478999999999999998521 1 1 1 12467788999999999995 9999999999999998762 3
Q ss_pred CcEEEEEEEEEEC
Q psy1666 753 GVYQWVQVGEYLE 765 (981)
Q Consensus 753 ~~~~~~~VG~~~~ 765 (981)
.+..+..||+|+.
T Consensus 352 ~tg~y~vV~~y~t 364 (380)
T cd06369 352 DTSKYKVLFEFDT 364 (380)
T ss_pred CCCCeEEEEEEEC
Confidence 3467889999985
No 89
>cd06393 PBP1_iGluR_Kainate_GluR5_7 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR5-7 subunits of Kainate receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR5-7 subunits of Kainate receptor. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. There are five types of kainate receptors, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeric receptor channels activated
Probab=97.17 E-value=0.00084 Score=77.61 Aligned_cols=82 Identities=20% Similarity=0.347 Sum_probs=60.6
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChh----hHhhhhccccccCCCCCeEEecc-CCCC-cceeeEEE
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGP----ELLKYLRKVSFQGLSEDHFKFDK-DGDG-PARYNIIH 746 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~----qL~~~L~~v~F~~~~g~~v~Fd~-~Gd~-~~~YdI~n 746 (981)
....|||||++|+|+++... . ......|+.. .|| .+.++|++++|.|.+| .+.||+ +|.+ .-.|||+|
T Consensus 290 aal~yDav~~~a~A~~~~~~-~-~~~~~~c~~~---~~w~~G~~i~~~l~~~~~~GltG-~i~Fd~~~g~r~~~~~~i~~ 363 (384)
T cd06393 290 AALLYDAVHMVSVCYQRAPQ-M-TVNSLQCHRH---KAWRFGGRFMNFIKEAQWEGLTG-RIVFNKTSGLRTDFDLDIIS 363 (384)
T ss_pred hHHhhhhHHHHHHHHhhhhh-c-CCCCCCCCCC---CCCcccHHHHHHHhheeeccccc-ceEecCCCCeeeeeEEEEEE
Confidence 34799999999999986532 1 1112246542 245 6999999999999999 699996 5664 57999999
Q ss_pred eEEcCCCcEEEEEEEEEEC
Q psy1666 747 FKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 747 ~~~~~~~~~~~~~VG~~~~ 765 (981)
... + .+++||.|++
T Consensus 364 ~~~--~---g~~~vg~W~~ 377 (384)
T cd06393 364 LKE--D---GLEKVGVWNP 377 (384)
T ss_pred ecC--C---cceeeEEEcC
Confidence 862 2 4689999985
No 90
>cd06343 PBP1_ABC_ligand_binding_like_8 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=97.17 E-value=0.03 Score=64.02 Aligned_cols=189 Identities=12% Similarity=0.097 Sum_probs=114.9
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++.... ++...+.++ +..++.+|++.+....+..++.++.+.++..+ |+
T Consensus 158 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~~-----d~~~~v~~i-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~~--~~ 229 (362)
T cd06343 158 KDYLKGLKDGLGDAGLEIVAETSYEVTEP-----DFDSQVAKL-KAAGADVVVLATTPKFAAQAIRKAAELGWKPT--FL 229 (362)
T ss_pred HHHHHHHHHHHHHcCCeEEEEeeecCCCc-----cHHHHHHHH-HhcCCCEEEEEcCcHHHHHHHHHHHHcCCCce--EE
Confidence 45678888889999999999998886432 556667776 45677888898888888889999988888763 56
Q ss_pred EeccCccccc-ccCCCccceeeEEEEEecC-------CCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCC
Q psy1666 152 GSDGWSARGL-VSDGSEAEVEGTLSLQPQA-------NPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRT 223 (981)
Q Consensus 152 ~s~~W~~~~~-~~~~~~~~~~G~l~~~~~~-------~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~ 223 (981)
.++.+..... +........+|.++..... ...|..++|.+.. +..+. ..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~p~~~~~~~~~~f~~~~----------------~~~~~----~~--- 286 (362)
T cd06343 230 LSSVSASVASVLKPAGLEAAEGVIAAAYLKDPTDPAWADDPGVKEFIAFY----------------KKYFP----EG--- 286 (362)
T ss_pred EEecccccHHHHHHhhhHhhCceEEEEEecCCCccccccCHHHHHHHHHH----------------HHhcC----CC---
Confidence 6655543321 2211122345665543321 1223334443321 00110 00
Q ss_pred CCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceee---c
Q psy1666 224 PYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSF---Q 300 (981)
Q Consensus 224 ~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F---~ 300 (981)
..........|||+..+++|+.+.- ...++..+.+.|+++++ .
T Consensus 287 --------------------~~~~~~~~~~y~a~~~~~~a~~~ag--------------~~~~~~~v~~aL~~~~~~~~~ 332 (362)
T cd06343 287 --------------------DPPDTYAVYGYAAAETLVKVLKQAG--------------DDLTRENIMKQAESLKDVLPD 332 (362)
T ss_pred --------------------CCCchhhhHHHHHHHHHHHHHHHhC--------------CCCCHHHHHHHHHhCCCCCcc
Confidence 0001122457999999999996541 12356779999999997 3
Q ss_pred cCCCCeEEecCC-CCCCceeEEEEEE
Q psy1666 301 GLSEDHFKFDKD-GDGPARYNIIHFK 325 (981)
Q Consensus 301 g~~G~~V~FD~n-GD~~~~YdI~n~q 325 (981)
+..+.++.|+.+ +.+...+.|+.++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~i~~~~ 358 (362)
T cd06343 333 LLPGIRINTSPDDHLPIEQMQLMRFE 358 (362)
T ss_pred ccCccceecCccccccceeEEEEEEe
Confidence 334457999854 3444456666654
No 91
>cd06355 PBP1_FmdD_like Periplasmic component (FmdD) of an active transport system for short-chain amides and urea (FmdDEF). This group includes the periplasmic component (FmdD) of an active transport system for short-chain amides and urea (FmdDEF), found in Methylophilus methylotrophus, and its homologs from other bacteria. FmdD, a type I periplasmic binding protein, is induced by short-chain amides and urea and repressed by excess ammonia, while FmdE and FmdF are hydrophobic transmembrane proteins. FmdDEF is predicted to be an ATP-dependent transporter and closely resembles the periplasmic binding protein and the two transmembrane proteins present in various hydrophobic amino acid-binding transport systems.
Probab=97.06 E-value=0.026 Score=64.18 Aligned_cols=187 Identities=11% Similarity=0.056 Sum_probs=111.0
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCc-eEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGS-FSW 150 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~-~vW 150 (981)
+...+.+++.+++.|+-|...+.+|... .++...+.++ +..++.+|++......+..+++++.+.++.++ ..+
T Consensus 147 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~D~~~~v~~l-~~~~pd~v~~~~~~~~~~~~~~~~~~~G~~~~~~~~ 220 (348)
T cd06355 147 RTANKILKAQLESLGGEVVGEEYLPLGH-----TDFQSIINKI-KAAKPDVVVSTVNGDSNVAFFKQLKAAGITASKVPV 220 (348)
T ss_pred HHHHHHHHHHHHHcCCeEEeeEEecCCh-----hhHHHHHHHH-HHhCCCEEEEeccCCchHHHHHHHHHcCCCccCCee
Confidence 4566778888888999988888887543 3666777776 45567778887777778888988888888764 244
Q ss_pred EEeccCcccccccCCCccceeeEEEEEe--cCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q psy1666 151 VGSDGWSARGLVSDGSEAEVEGTLSLQP--QANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSH 228 (981)
Q Consensus 151 I~s~~W~~~~~~~~~~~~~~~G~l~~~~--~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~ 228 (981)
+++ ++.... ..........|.+.... ...+.|..++|.+. |-+ .+.-
T Consensus 221 ~~~-~~~~~~-~~~~g~~~~~g~~~~~~~~~~~~~~~~~~f~~~---------------y~~-~~g~------------- 269 (348)
T cd06355 221 LSF-SVAEEE-LRGIGPENLAGHYAAWNYFQSVDTPENKKFVAA---------------FKA-RYGQ------------- 269 (348)
T ss_pred EEc-cccHHH-HhhcChHhhcCCEEeccchhhcCCHHHHHHHHH---------------HHH-HcCC-------------
Confidence 543 332211 11111122345443221 11123333444321 111 1100
Q ss_pred CCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEE
Q psy1666 229 YSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFK 308 (981)
Q Consensus 229 ~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~ 308 (981)
+ + .........|||++.++.||.+.- ..++..+.+.|++.+|.+..| ++.
T Consensus 270 --------~-----~-~~~~~a~~~Y~a~~~~~~Al~~ag---------------~~~~~~i~~aL~~~~~~~~~g-~~~ 319 (348)
T cd06355 270 --------D-----R-VTNDPMEAAYIGVYLWKQAVEKAG---------------SFDVDKVRAALPGQSFDAPEG-PVT 319 (348)
T ss_pred --------C-----C-CCCcHHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHhccCcccCCCc-ceE
Confidence 0 0 001123457999999999997541 135678999999999998877 699
Q ss_pred ecCC-CCCCceeEEEEEE
Q psy1666 309 FDKD-GDGPARYNIIHFK 325 (981)
Q Consensus 309 FD~n-GD~~~~YdI~n~q 325 (981)
||++ ++....+.|.+++
T Consensus 320 f~~~~~~~~~~~~i~~~~ 337 (348)
T cd06355 320 VDPANHHLWKPVRIGRIQ 337 (348)
T ss_pred eecCCCeeeeeeEEEEEc
Confidence 9984 3444445555553
No 92
>cd06332 PBP1_aromatic_compounds_like Type I periplasmic binding proteins of active transport systems that are predicted to be involved in transport of aromatic compounds such as 2-nitrobenzoic acid and alkylbenzenes. This group includes the type I periplasmic binding proteins of active transport systems that are predicted to be involved in transport of aromatic compounds such as 2-nitrobenzoic acid and alkylbenzenes; their substrate specificities are not well characterized, however. Members also exhibit close similarity to active transport systems for short chain amides and/or urea found in bacteria and archaea.
Probab=97.03 E-value=0.016 Score=65.07 Aligned_cols=155 Identities=12% Similarity=0.130 Sum_probs=93.8
Q ss_pred hHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCC--CC
Q psy1666 106 AYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQAN--PV 183 (981)
Q Consensus 106 ~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~i 183 (981)
++...+.++ +.+++.+|++......+..++.++.++++.++..++++..|...... .......+|.+...+... ..
T Consensus 174 d~~~~i~~l-~~~~~d~i~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~~~ 251 (333)
T cd06332 174 DFSAELAQI-RAAKPDAVFVFLPGGMAVNFVKQYDQAGLKKKIPLYGPGFLTDQDTL-PAQGDAAVGVLTALHWAPDLDN 251 (333)
T ss_pred chHHHHHHH-HhcCCCEEEEecccchHHHHHHHHHHcCcccCCceeccCCCCCHHHH-HhhchhhcCeeeeeccCCCCCC
Confidence 455567665 45667777777776778888988888888555467777666543222 222234466665544211 12
Q ss_pred CChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHH
Q psy1666 184 KGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIA 263 (981)
Q Consensus 184 pgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhA 263 (981)
|..++|.+. ++..++- .........|||++.+|.|
T Consensus 252 ~~~~~f~~~----------------~~~~~~~-----------------------------~~~~~~~~~yda~~~~~~a 286 (333)
T cd06332 252 PANKRFVAA----------------YKAAYGR-----------------------------VPSVYAAQGYDAAQLLDAA 286 (333)
T ss_pred HHHHHHHHH----------------HHHHhCC-----------------------------CCcHHHHHHHHHHHHHHHH
Confidence 333343321 1111110 0011234689999999999
Q ss_pred HHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEE
Q psy1666 264 LDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNI 321 (981)
Q Consensus 264 Lh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI 321 (981)
+.+.=. ...++..|.+.|++.+|.|..| .+.||++|+....+-+
T Consensus 287 ~~~ag~-------------~~~~~~~v~~al~~~~~~~~~g-~i~f~~~~~~~~~~~~ 330 (333)
T cd06332 287 LRAVGG-------------DLSDKDALRAALRAADFDSPRG-PFKFNPNHNPIQDFYL 330 (333)
T ss_pred HHHhcC-------------CCCCHHHHHHHHhcCceecCcc-ceeECCCCCcccceeE
Confidence 977510 1234567999999999999888 5999999997554433
No 93
>cd06331 PBP1_AmiC_like Type I periplasmic components of amide-binding protein (AmiC) and the active transport system for short-chain and urea (FmdDEF). This group includes the type I periplasmic components of amide-binding protein (AmiC) and the active transport system for short-chain and urea (FmdDEF), found in bacteria and Archaea. AmiC controls expression of the amidase operon by a ligand-triggered conformational switch. In the absence of ligand or presence of butyramide (repressor), AmiC (the ligand sensor and negative regulator) adopts an open conformation and inhibits the transcription antitermination function of AmiR by direct protein-protein interaction. In the presence of inducing ligands such as acetamide, AmiC adopts a closed conformation which disrupts a silencing AmiC-AmiR complex and the expression of amidase and other genes of the operon is induced. FmdDEF is predicted to be an ATP-dependent transporter and closely resembles the periplasmic binding protein and the two t
Probab=97.00 E-value=0.022 Score=64.26 Aligned_cols=179 Identities=12% Similarity=0.076 Sum_probs=111.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|..|...+.++... .++...+.++ +..++.+|++.+...++..++.++...++.++.+++
T Consensus 146 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~v~~~-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 219 (333)
T cd06331 146 RESNRIARALLEELGGEVVGEEYLPLGT-----SDFGSVIEKI-KAAGPDVVLSTLVGDSNVAFYRQFAAAGLDADRIPI 219 (333)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEEecCCc-----ccHHHHHHHH-HHcCCCEEEEecCCCChHHHHHHHHHcCCCcCCCee
Confidence 4466888888888999999888888543 2567777776 455677888888888888888888888876322455
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC--CCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA--NPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~--~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
.+..+.... +........+|.+...+.. ...+..++|... ++..+.-.
T Consensus 220 ~~~~~~~~~-~~~~~~~~~~g~~~~~~~~~~~~~~~~~~f~~~----------------~~~~~~~~------------- 269 (333)
T cd06331 220 LSLTLDENE-LAAIGAEAAEGHYSAASYFQSLDTPENKAFVAR----------------YRARYGDD------------- 269 (333)
T ss_pred EEcccchhh-hhccChhhhCCcEeechhhhhcCChhHHHHHHH----------------HHHHcCCC-------------
Confidence 443333222 2221122345666544321 112223333321 11111100
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
. .........|||+.+++.|+++.- ..++..|.+.|++++|+|..| .+.|
T Consensus 270 -------------~-~~~~~~~~~yda~~~~~~A~~~ag---------------~~~~~~l~~al~~~~~~~~~G-~i~f 319 (333)
T cd06331 270 -------------A-VINSPAEAAYEAVYLWAAAVEKAG---------------STDPEAVRAALEGVSFDAPQG-PVRI 319 (333)
T ss_pred -------------c-CCCchhHHHHHHHHHHHHHHHHcC---------------CCCHHHHHHHhhcCcccCCCC-ceEe
Confidence 0 001124568999999999997531 135678999999999999999 5999
Q ss_pred cCCCCCC
Q psy1666 310 DKDGDGP 316 (981)
Q Consensus 310 D~nGD~~ 316 (981)
|+++...
T Consensus 320 ~~~~~~~ 326 (333)
T cd06331 320 DPDNHHT 326 (333)
T ss_pred cCCCCcc
Confidence 9877664
No 94
>cd06344 PBP1_ABC_ligand_binding_like_9 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters, such as leucine/isoleucine/valine binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=97.00 E-value=0.0031 Score=71.27 Aligned_cols=175 Identities=15% Similarity=0.175 Sum_probs=99.3
Q ss_pred hhHHHHHHHHHHh-CCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEE
Q psy1666 72 TTAFEELEVLLAK-SSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSW 150 (981)
Q Consensus 72 ~~~~~~l~~~~~~-~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vW 150 (981)
+...+.+++.+++ .|+++.....++... .++...+.+++ ..++.+|++.+.......++.++...+. +..|
T Consensus 149 ~~~~~~~~~~~~~~~g~~v~~~~~~~~~~-----~~~~~~v~~i~-~~~~d~v~~~~~~~~~~~~~~~~~~~~~--~~~i 220 (332)
T cd06344 149 QSLKQEFTSALLERGGGIVVTPCDLSSPD-----FNANTAVSQAI-NNGATVLVLFPDTDTLDKALEVAKANKG--RLTL 220 (332)
T ss_pred HHHHHHHHHHHHHhcCCeeeeeccCCCCC-----CCHHHHHHHHH-hcCCCEEEEeCChhHHHHHHHHHHhcCC--CceE
Confidence 5556678888878 588887654443211 13445666664 4567888888777666666666554443 2356
Q ss_pred EEeccCcccccccCCCccceeeEEEEEecCCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCC
Q psy1666 151 VGSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYS 230 (981)
Q Consensus 151 I~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~ 230 (981)
++++.|........ .....+|.++..+.....|.-++|.+. ++..+. .
T Consensus 221 ~~~~~~~~~~~~~~-~~~~~~G~~~~~~~~~~~~~~~~f~~~----------------~~~~~~----~----------- 268 (332)
T cd06344 221 LGGDSLYTPDTLLD-GGKDLEGLVLAVPWHPLASPNSPFAKL----------------AQQLWG----G----------- 268 (332)
T ss_pred EecccccCHHHHHh-chhhhcCeEEEEecccccccchHHHHH----------------HHHHhc----C-----------
Confidence 77777655433211 122346776665533222222333221 111110 0
Q ss_pred CCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHH-HhhcceeeccCCCCeEEe
Q psy1666 231 TECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELL-KYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 231 ~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl-~~Lk~V~F~g~~G~~V~F 309 (981)
.........|||++++++|+...- ..++..+. ..+++..|.|..| ++.|
T Consensus 269 --------------~~~~~a~~~Yda~~~l~~A~~~ag---------------~~~~~~~~~~~~~~~~~~g~~g-~i~f 318 (332)
T cd06344 269 --------------DVSWRTATAYDATKALIAALSQGP---------------TREGVQQVELSLRNFSVQGATG-KIKF 318 (332)
T ss_pred --------------CchHHHHhHHHHHHHHHHHHHhCC---------------ChhhhhhhhhhcccccccCCCc-eeEe
Confidence 001123468999999999996431 11222333 5677788988887 7999
Q ss_pred cCCCCCC
Q psy1666 310 DKDGDGP 316 (981)
Q Consensus 310 D~nGD~~ 316 (981)
|++||..
T Consensus 319 ~~~g~~~ 325 (332)
T cd06344 319 LPSGDRN 325 (332)
T ss_pred CCCCccc
Confidence 9999974
No 95
>cd06357 PBP1_AmiC Periplasmic binding domain of amidase (AmiC) that belongs to the type I periplasmic binding fold protein family. This group includes the periplasmic binding domain of amidase (AmiC) that belongs to the type I periplasmic binding fold protein family. AmiC controls expression of the amidase operon by the ligand-triggered conformational switch. In the absence of ligand or presence of butyramide (repressor), AmiC (the ligand sensor and negative regulator) adopts an open conformation and inhibits the transcription antitermination function of AmiR by direct protein-protein interaction. In the presence of inducing ligands such as acetamide, AmiC adopts a closed conformation which disrupts a silencing AmiC-AmiR complex and the expression of amidase and other genes of the operon are induced.
Probab=96.88 E-value=0.067 Score=61.20 Aligned_cols=180 Identities=13% Similarity=0.089 Sum_probs=109.4
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+-|.....++...+ ..++...+.++ +.+++.+|++.+....+..++.++.++++.++...+
T Consensus 146 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~~---~~d~s~~v~~l-~~~~pd~V~~~~~~~~~~~~~~~~~~~G~~~~~~~~ 221 (360)
T cd06357 146 YESNRIMRDLLEQRGGEVLGERYLPLGAS---DEDFARIVEEI-REAQPDFIFSTLVGQSSYAFYRAYAAAGFDPARMPI 221 (360)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEEecCCCc---hhhHHHHHHHH-HHcCCCEEEEeCCCCChHHHHHHHHHcCCCccCcee
Confidence 55677888888889988776555554311 23566777776 455677888888888888889888888887654444
Q ss_pred EeccCcccccccCCCccceeeEEEEEec--CCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQ--ANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~--~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
.+..+.... .........+|.++..+. ....|..++|... ++..+.-
T Consensus 222 ~~~~~~~~~-~~~~~g~~~~g~~~~~~~~~~~~~p~~~~f~~~----------------~~~~~g~-------------- 270 (360)
T cd06357 222 ASLTTSEAE-VAAMGAEAAAGHITAAPYFSSIDTPANRAFVAR----------------YRARFGE-------------- 270 (360)
T ss_pred EEeeccHHH-HhhcchHhhCCcEEecccccccCChhHHHHHHH----------------HHHHcCC--------------
Confidence 443322211 111112345676665442 1123445555432 1111110
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
+ . .........|||++++++|+.+.- ..++..+.+.|++++|.+..| .+.|
T Consensus 271 -------~-----~-~~~~~~~~~yda~~~l~~Al~~ag---------------~~~~~~v~~aL~~~~~~~~~g-~~~f 321 (360)
T cd06357 271 -------D-----A-PVSACAEAAYFQVHLFARALQRAG---------------SDDPEDVLAALLGFSFDAPQG-PVRI 321 (360)
T ss_pred -------C-----C-CCCcHHHHHHHHHHHHHHHHHHcC---------------CCCHHHHHHHhccCcccCCCc-ceEE
Confidence 0 0 000123467999999999997641 123567899999999998777 6999
Q ss_pred cCCCCC
Q psy1666 310 DKDGDG 315 (981)
Q Consensus 310 D~nGD~ 315 (981)
|..++.
T Consensus 322 ~~~~~~ 327 (360)
T cd06357 322 DPDNNH 327 (360)
T ss_pred eCCCCe
Confidence 987653
No 96
>cd06327 PBP1_SBP_like_1 Periplasmic solute-binding domain of active transport proteins that belong to the type I periplasmic binding fold protein family. Periplasmic solute-binding domain of active transport proteins that belong to the type I periplasmic binding fold protein family. Solute binding proteins are the primary specific receptors that initiate uptake of a broad range of solutes, including amino acids, peptides and inorganic ions. The members are predicted to have a similar function to an active transport system for short chain amides and urea by sequence comparison and phylogenetic analysis. Moreover, this binding domain has high sequence identity to the family of hydrophobic amino acid transporters (HAAT), and thus may also be involved in transport of amino acids.
Probab=96.80 E-value=0.022 Score=64.32 Aligned_cols=176 Identities=6% Similarity=0.014 Sum_probs=107.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|++|...+.++... .++...+.++ +..++.+|++.+....+..+++++.+.++.++..|+
T Consensus 149 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~v~~l-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 222 (334)
T cd06327 149 HSLERDARKVVKANGGKVVGSVRHPLGT-----SDFSSYLLQA-QASGADVLVLANAGADTVNAIKQAAEFGLTKGQKLA 222 (334)
T ss_pred HHHHHHHHHHHHhcCCEEcCcccCCCCC-----ccHHHHHHHH-HhCCCCEEEEeccchhHHHHHHHHHHhCCccCCcEE
Confidence 5567888888889999998888887543 2566777776 455678888888888888899999888886442333
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC--CCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA--NPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~--~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
+...+. ...........+|.+...+.. .+.|..++|.... +..+.-
T Consensus 223 ~~~~~~--~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~f~~~~----------------~~~~g~-------------- 270 (334)
T cd06327 223 GLLLFL--TDVHSLGLDAAQGLYLTTAWYWDLPNDETRAFVKRF----------------QAKYGK-------------- 270 (334)
T ss_pred EecccH--HHHHhhchhhhcCeEEeeeccccCCCHHHHHHHHHH----------------HHHHCc--------------
Confidence 332221 111111122345665554431 1233344443211 111100
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
.........|||++++++|+.+.- ..++..+.+.|+++.+.+.-+.+++|
T Consensus 271 ---------------~p~~~~~~~Y~~~~~~~~A~~~ag---------------~~~~~~v~~al~~~~~~~~~~g~~~~ 320 (334)
T cd06327 271 ---------------MPSMVQAGAYSAVLHYLKAVEAAG---------------TDDADKVVAKMKETPIYDLFAGNGYI 320 (334)
T ss_pred ---------------CCCcHHHHHHHHHHHHHHHHHHHC---------------CCChHHHHHhccccceeccCCCCcee
Confidence 001123468999999999997662 12456788999998653333447999
Q ss_pred cC-CCCC
Q psy1666 310 DK-DGDG 315 (981)
Q Consensus 310 D~-nGD~ 315 (981)
++ +|+.
T Consensus 321 ~~~~~~~ 327 (334)
T cd06327 321 RACDHQM 327 (334)
T ss_pred eccccch
Confidence 76 6654
No 97
>cd06359 PBP1_Nba_like Type I periplasmic binding component of active transport systems that are predicted to be involved in 2-nitrobenzoic acid degradation pathway. This group includes the type I periplasmic binding component of active transport systems that are predicted to be involved in 2-nitrobenzoic acid degradation pathway; their substrate specificities are not well characterized.
Probab=96.78 E-value=0.035 Score=62.69 Aligned_cols=157 Identities=11% Similarity=0.118 Sum_probs=93.6
Q ss_pred hHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecC--CCC
Q psy1666 106 AYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQA--NPV 183 (981)
Q Consensus 106 ~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~--~~i 183 (981)
++...+.++ +.+++.+|++......+..++.++...++.++..++++..+...... .......+|.+...+.. ...
T Consensus 174 d~~~~i~~l-~~~~pd~v~~~~~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~-~~~g~~~~g~~~~~~~~~~~~~ 251 (333)
T cd06359 174 DFSAELAQI-RAAKPDAVFVFLPGGMGVNFVKQYRQAGLKKDIPLYSPGFSDEEDTL-PAVGDAALGLYNTAQWAPDLDN 251 (333)
T ss_pred chHHHHHHH-HhCCCCEEEEEccCccHHHHHHHHHHcCcccCCeeeccCcccCHHHH-HhcchhhcCeeeccccCCCCCC
Confidence 566677776 55667777777777777888888888887544356665544432221 11123345665544321 123
Q ss_pred CChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHH
Q psy1666 184 KGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIA 263 (981)
Q Consensus 184 pgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhA 263 (981)
|..++|.... ...+. . .........|||++++|+|
T Consensus 252 ~~~~~f~~~~----------------~~~~~--------------------------~---~~~~~~~~~yda~~~~~~A 286 (333)
T cd06359 252 PANKKFVADF----------------EKKYG--------------------------R---LPTLYAAQAYDAAQLLDSA 286 (333)
T ss_pred HHHHHHHHHH----------------HHHhC--------------------------C---CCcHHHHHHHHHHHHHHHH
Confidence 3344443321 11110 0 0011234689999999999
Q ss_pred HHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEecCCCCCCceeEEEE
Q psy1666 264 LDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIH 323 (981)
Q Consensus 264 Lh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD~nGD~~~~YdI~n 323 (981)
+.+.-. ...++..+.+.|++.+|.|..| .+.||.+|+....+.++.
T Consensus 287 ~~~ag~-------------~~~~~~~v~~al~~~~~~~~~G-~~~~~~~~~~~~~~~~~~ 332 (333)
T cd06359 287 VRKVGG-------------NLSDKDALRAALRAADFKSVRG-AFRFGTNHFPIQDFYLRE 332 (333)
T ss_pred HHHhcC-------------CCCCHHHHHHHHhcCccccCcc-ceEECCCCCcceeEEEEe
Confidence 976410 1125678999999999999888 699999988765554443
No 98
>cd06349 PBP1_ABC_ligand_binding_like_14 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in the uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=96.75 E-value=0.044 Score=62.00 Aligned_cols=184 Identities=14% Similarity=0.162 Sum_probs=108.3
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+||...+.++.... ++...+.++ +.+++.+|++.+....+..++.++.+.++..+ ++
T Consensus 149 ~~~~~~~~~~~~~~g~~v~~~~~~~~~~~-----d~~~~v~~l-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~~--~~ 220 (340)
T cd06349 149 RTSADIFVKAAEKLGGQVVAHEEYVPGEK-----DFRPTITRL-RDANPDAIILISYYNDGAPIARQARAVGLDIP--VV 220 (340)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEEeCCCCC-----cHHHHHHHH-HhcCCCEEEEccccchHHHHHHHHHHcCCCCc--EE
Confidence 45678888888899999998888775432 566677776 55678888888888888888988888877653 55
Q ss_pred EeccCcccccccCCCccceeeEEEEEec--CCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQ--ANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~--~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
+...+.....+.. .....+|.+...+. ..+.|..++|.+.. ...+.-
T Consensus 221 ~~~~~~~~~~~~~-~~~~~~g~~~~~~~~~~~~~~~~~~f~~~~----------------~~~~~~-------------- 269 (340)
T cd06349 221 ASSSVYSPKFIEL-GGDAVEGVYTPTAFFPGDPRPEVQSFVSAY----------------EAKYGA-------------- 269 (340)
T ss_pred ccCCcCCHHHHHH-hHHHhCCcEEecccCCCCCCHHHHHHHHHH----------------HHHHCC--------------
Confidence 5544433222211 11234566554332 12233344444321 111110
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHh-hcceeeccCCCCeEE
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKY-LRKVSFQGLSEDHFK 308 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~-Lk~V~F~g~~G~~V~ 308 (981)
.........|||++.++.|+.+.- +.++...... +.+..+.+..| .+.
T Consensus 270 ---------------~p~~~~~~~y~~~~~~~~a~~~ag---------------~~~~~~~~~~~~~~~~~~~~~g-~i~ 318 (340)
T cd06349 270 ---------------QPDAFAAQAYDAVGILAAAVRRAG---------------TDRRAARDGFAKAEDVYSGVTG-STK 318 (340)
T ss_pred ---------------CcchhhhhHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHHhccCcccceE-eEE
Confidence 000123458999999999997531 0111222222 24455667777 599
Q ss_pred ecCC-CCCCceeEEEEEE
Q psy1666 309 FDKD-GDGPARYNIIHFK 325 (981)
Q Consensus 309 FD~n-GD~~~~YdI~n~q 325 (981)
||.+ ++....|-++..+
T Consensus 319 ~~~~~~~~~~~~~~~~~~ 336 (340)
T cd06349 319 FDPNTRRVIKRFVPLVVR 336 (340)
T ss_pred ECCCCCCccCceEEEEEe
Confidence 9986 6666666666543
No 99
>cd06358 PBP1_NHase Type I periplasmic-binding protein of the nitrile hydratase (NHase) system that selectively converts nitriles to corresponding amides. This group includes the type I periplasmic-binding protein of the nitrile hydratase (NHase) system that selectively converts nitriles to corresponding amides, which are subsequently converted by amidases to yield free carboxylic acids and ammonia. NHases from bacteria and fungi have been purified and characterized. In Rhodococcus sp., the nitrile hydratase operon consists of six genes encoding NHase regulator 2, NHase regulator 1, amidase, NHase alpha subunit, NHase beta subunit, and NHase activator. The operon produces a constitutive hydratase that has a broad substrate spectrum: aliphatic and aromatic nitriles, mononitriles and dinitriles, hydroxynitriles and amino-nitriles, and a constitutive amidase of equally low substrate specificity. NHases are metalloenzymes containing either cobalt or iron, and therefore can be classified int
Probab=96.57 E-value=0.062 Score=60.66 Aligned_cols=177 Identities=11% Similarity=0.099 Sum_probs=103.5
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+-|.....++... .++...+.+++ +.+..+|++.........++.++.+.++.++ |+
T Consensus 146 ~~~~~~~~~~~~~~G~~v~~~~~~~~~~-----~d~~~~v~~l~-~~~pd~v~~~~~~~~~~~~~~~~~~~G~~~~--~~ 217 (333)
T cd06358 146 RGSLAAAKRYIAELGGEVVGEEYVPLGT-----TDFTSVLERIA-ASGADAVLSTLVGQDAVAFNRQFAAAGLRDR--IL 217 (333)
T ss_pred HHHHHHHHHHHHHcCCEEeeeeeecCCh-----HHHHHHHHHHH-HcCCCEEEEeCCCCchHHHHHHHHHcCCCcc--Cc
Confidence 4566778888889999888888887543 35666777764 4455677766666666778888888888764 33
Q ss_pred E-eccCcccccccCCCccceeeEEEEEec--CCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q psy1666 152 G-SDGWSARGLVSDGSEAEVEGTLSLQPQ--ANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSH 228 (981)
Q Consensus 152 ~-s~~W~~~~~~~~~~~~~~~G~l~~~~~--~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~ 228 (981)
. +..|.... .........+|.+...+. ....|..++|.+. +...+.-
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~g~~~~~~~~~~~~~~~~~~f~~~----------------~~~~~g~------------- 267 (333)
T cd06358 218 RLSPLMDENM-LLASGAEAAEGLYSSSGYFASLQTPANAAFLAR----------------YRARFGD------------- 267 (333)
T ss_pred eeecccCHHH-HHhcChHhhCCcEEeccchhhcCCHHHHHHHHH----------------HHHHcCC-------------
Confidence 2 22333221 111111223555443221 1122333444321 1111110
Q ss_pred CCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEE
Q psy1666 229 YSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFK 308 (981)
Q Consensus 229 ~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~ 308 (981)
+ ...........|||+..++.|+.+. .+.++..|.+.|++++|.|..| ++.
T Consensus 268 --------~-----~~~~~~~~~~~yda~~~~~~A~~~a---------------g~~~~~~v~~al~~~~~~~~~G-~~~ 318 (333)
T cd06358 268 --------D-----APPLNSLSESCYEAVHALAAAAERA---------------GSLDPEALIAALEDVSYDGPRG-TVT 318 (333)
T ss_pred --------C-----CCCCChHHHHHHHHHHHHHHHHHHh---------------CCCCHHHHHHHhccCeeeCCCc-ceE
Confidence 0 0000112345799999999999642 1235678999999999999888 599
Q ss_pred ecCCCCC
Q psy1666 309 FDKDGDG 315 (981)
Q Consensus 309 FD~nGD~ 315 (981)
|++++..
T Consensus 319 ~~~~~~~ 325 (333)
T cd06358 319 MRGRHAR 325 (333)
T ss_pred Ecccccc
Confidence 9987654
No 100
>cd06381 PBP1_iGluR_delta_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of an orphan family of delta receptors, GluRdelta1 and GluRdelta2. This CD represents the N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of an orphan family of delta receptors, GluRdelta1 and GluRdelta2. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 are more homologous to non-NMDA receptors. G
Probab=96.56 E-value=0.007 Score=69.25 Aligned_cols=62 Identities=16% Similarity=0.293 Sum_probs=47.8
Q ss_pred hhHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEeEEcC
Q psy1666 673 LQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQIR 751 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~~~~~ 751 (981)
.-.+|||||++ .++||++.|+|.+| .|.||++|.+. -.+||+......
T Consensus 296 ~al~yDaV~~~------------------------------~~~~~~~~~~GLTG-~i~F~~~g~r~~~~l~i~~~~~~~ 344 (363)
T cd06381 296 NLYIYDSVLLL------------------------------LETIKKGPITGLTG-KLEFNEGGDNSNVQFEILGTGYSE 344 (363)
T ss_pred HHHHHHHHHHH------------------------------HHHHHhcCccCcce-eEEeCCCCCccccEEEEEEeccCC
Confidence 45799999999 57889999999999 79999999986 589998876322
Q ss_pred CCcEEEEEEEEEEC
Q psy1666 752 PGVYQWVQVGEYLE 765 (981)
Q Consensus 752 ~~~~~~~~VG~~~~ 765 (981)
......+++|.|++
T Consensus 345 ~~~~~~~~~~~w~~ 358 (363)
T cd06381 345 TLGKDGRWLATWNP 358 (363)
T ss_pred ccccceEEeeeccC
Confidence 11223467888875
No 101
>PF13458 Peripla_BP_6: Periplasmic binding protein; PDB: 4EVS_A 4EY3_A 4EYG_B 4EYK_A 3H5L_B 3TD9_A 3EAF_A 1Z18_A 1Z17_A 2LIV_A ....
Probab=96.41 E-value=0.049 Score=61.49 Aligned_cols=212 Identities=13% Similarity=0.146 Sum_probs=127.2
Q ss_pred hHHHHHHHHhcC-CCCCCCCCcceeeEEeecc---hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhc
Q psy1666 41 AYDDIVTKLMTK-PRARDDPDFIPVLMLFLRE---TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMT 116 (981)
Q Consensus 41 ~~~~i~~~l~~~-psa~~q~~a~~~lv~f~~~---~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~ 116 (981)
....+++.+++. +..+ +.++.-+. +...+.+++.+++.|+-|.....++.+.. ++...+.++.
T Consensus 121 ~~~~~~~~~~~~~g~~~-------v~iv~~~~~~g~~~~~~~~~~~~~~G~~vv~~~~~~~~~~-----d~~~~~~~l~- 187 (343)
T PF13458_consen 121 QAAALAEYLAKKLGAKK-------VAIVYPDDPYGRSLAEAFRKALEAAGGKVVGEIRYPPGDT-----DFSALVQQLK- 187 (343)
T ss_dssp HHHHHHHHHHHTTTTSE-------EEEEEESSHHHHHHHHHHHHHHHHTTCEEEEEEEE-TTSS-----HHHHHHHHHH-
T ss_pred HHHHHHHHHHHHcCCcE-------EEEEecCchhhhHHHHHHHHHHhhcCceeccceecccccc-----cchHHHHHHh-
Confidence 355666666543 3233 33333332 55677888899999998877777775442 5667777764
Q ss_pred CCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEEEeccCcccccccCCCccceeeEEEEEecCC--CCCChHHHHhhcC
Q psy1666 117 KPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWVGSDGWSARGLVSDGSEAEVEGTLSLQPQAN--PVKGFDDYFLNLT 194 (981)
Q Consensus 117 ~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~ipgF~ef~~~l~ 194 (981)
+.++.+|++.+....+..++.++.+.+..++.+++...+..... +........+|.+...+... ..|.-++|.+.
T Consensus 188 ~~~~d~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~g~~~~~~~~~~~~~~~~~~f~~~-- 264 (343)
T PF13458_consen 188 SAGPDVVVLAGDPADAAAFLRQLRQLGLKPPRIPLFGTSLDDAS-LQQLGGDALEGVYIVSPWFPDPDSPAVKQFQER-- 264 (343)
T ss_dssp HTTTSEEEEESTHHHHHHHHHHHHHTTGCSCTEEEEEGGGSSHH-HHHHHGGGGTTEEEEESGGGTGGSHHHHHHHHH--
T ss_pred hcCCCEEEEeccchhHHHHHHHHHhhccccccceeeccccCcHH-HHHhhhhhccCceeecccCCCCCCHHHHHHHHH--
Confidence 35667788888888899999999888777643556543322211 11111223456666655321 12333444332
Q ss_pred CCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCC
Q psy1666 195 VENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQG 274 (981)
Q Consensus 195 p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~ 274 (981)
|.+ .+.- .+ .........|||+..++.||++.-
T Consensus 265 -------------~~~-~~~~--------------------------~~-~~~~~~~~~yda~~~~~~al~~~g------ 297 (343)
T PF13458_consen 265 -------------YRA-AYGE--------------------------EP-PPSLYAAQGYDAARLLAQALERAG------ 297 (343)
T ss_dssp -------------HHH-HHSS--------------------------TG-GTCHHHHHHHHHHHHHHHHHHHHT------
T ss_pred -------------HHH-HcCC--------------------------CC-CCchhHHHHHHHHHHHHHHHHHhC------
Confidence 111 1100 00 001123468999999999998761
Q ss_pred CCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEec-CCCCCCceeEEEEEE
Q psy1666 275 KVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFD-KDGDGPARYNIIHFK 325 (981)
Q Consensus 275 ~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~FD-~nGD~~~~YdI~n~q 325 (981)
+.++.++.+.|+++.|.|..| ++.|+ .+|.....+.|++++
T Consensus 298 ---------~~~~~~v~~al~~~~~~g~~g-~~~~~~~~~~~~~~~~i~~v~ 339 (343)
T PF13458_consen 298 ---------SLDREAVREALESLKYDGLFG-PISFDPPDHQANKPVYIVQVK 339 (343)
T ss_dssp ---------SHHHHHHHHHHHTSEEEETTE-EEEEETTTSBEEEEEEEEEEE
T ss_pred ---------CCCHHHHHHHHHhCCCccccc-ceEEeCCCCccccCeEEEEEe
Confidence 245678999999999999888 57775 444444567777765
No 102
>TIGR03407 urea_ABC_UrtA urea ABC transporter, urea binding protein. Members of this protein family are ABC transporter substrate-binding proteins associated with urea transport and metabolism. This protein is found in a conserved five-gene transport operon typically found adjacent to urease genes. It was shown in Cyanobacteria that disruption leads to the loss of high-affinity urea transport activity. Members of this protein family tend to have the twin-arginine signal for Sec-independent transport across the plasma membrane.
Probab=96.31 E-value=0.21 Score=57.12 Aligned_cols=187 Identities=9% Similarity=0.033 Sum_probs=107.0
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCce-EE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSF-SW 150 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~-vW 150 (981)
+...+.+++.+++.|+-|...+.++... .++...+.++ +.+++.+|++.........++.++.+.++..+. .+
T Consensus 148 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~D~s~~v~~l-~~~~pDav~~~~~~~~~~~~~~~~~~~G~~~~~~~~ 221 (359)
T TIGR03407 148 RTANKIIKAYLKSLGGTVVGEDYTPLGH-----TDFQTIINKI-KAFKPDVVFNTLNGDSNVAFFKQLKNAGITAKDVPV 221 (359)
T ss_pred HHHHHHHHHHHHHcCCEEEeeEEecCCh-----HhHHHHHHHH-HHhCCCEEEEeccCCCHHHHHHHHHHcCCCccCCcE
Confidence 4566778888899999888888777533 3566777776 445566666655566667788888888876532 24
Q ss_pred EEeccCcccccccCCCccceeeEEEEEec--CCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q psy1666 151 VGSDGWSARGLVSDGSEAEVEGTLSLQPQ--ANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSH 228 (981)
Q Consensus 151 I~s~~W~~~~~~~~~~~~~~~G~l~~~~~--~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~ 228 (981)
+++..+. ...........+|..+.... ..+.|..++|.+. |-+ .+. .
T Consensus 222 ~~~~~~~--~~~~~~g~~~~~G~~~~~~~~~~~~~~~~~~f~~~---------------~~~-~~~----~--------- 270 (359)
T TIGR03407 222 VSFSVAE--EEIRGIGPENLVGHLAAWNYFQSVDTPANKKFVKA---------------FKA-KYG----D--------- 270 (359)
T ss_pred EEeecCH--HHHhhcChHhhCCeEEeccchhcCCCHHHHHHHHH---------------HHH-HcC----C---------
Confidence 4432221 11111111234555432111 1122333443321 111 110 0
Q ss_pred CCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEE
Q psy1666 229 YSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFK 308 (981)
Q Consensus 229 ~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~ 308 (981)
. . ........-||||+.++.|+.+.- ..++..+.+.|++.+|.+..| ++.
T Consensus 271 ---------~----~-~~~~~~~~~y~a~~~~~~A~~~ag---------------~~~~~~i~~al~~~~~~~~~G-~i~ 320 (359)
T TIGR03407 271 ---------D----R-VTNDPMEAAYLGVYLWKAAVEKAG---------------SFDVDAVRDAAIGIEFDAPEG-KVK 320 (359)
T ss_pred ---------C----C-CCCcHHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHhcCCcccCCCc-cEE
Confidence 0 0 000012346999999999997641 135678999999999998888 799
Q ss_pred ecC-CCCCCceeEEEEEE
Q psy1666 309 FDK-DGDGPARYNIIHFK 325 (981)
Q Consensus 309 FD~-nGD~~~~YdI~n~q 325 (981)
||+ +++....+.+.+++
T Consensus 321 f~~~~~~~~~~~~~~~~~ 338 (359)
T TIGR03407 321 VDGKNHHLTKTVRIGEIR 338 (359)
T ss_pred EeCCCCeeeeeeEEEEEc
Confidence 997 55544455555553
No 103
>cd06330 PBP1_Arsenic_SBP_like Periplasmic solute-binding domain of active transport proteins. Periplasmic solute-binding domain of active transport proteins found in bacteria and Archaea that is predicted to be involved in the efflux of toxic compounds. Members of this subgroup include proteins from Herminiimonas arsenicoxydans, which is resistant to arsenic and various heavy metals such as cadmium and zinc. Moreover, they show significant sequence similarity to the cluster of AmiC and active transport systems for short-chain amides and urea (FmdDEF), and thus are likely to exhibit a ligand-binding mode similar to that of the amide sensor protein AmiC from Pseudomonas aeruginosa.
Probab=96.20 E-value=0.086 Score=59.75 Aligned_cols=178 Identities=11% Similarity=0.064 Sum_probs=100.6
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+|+........... ..++...+.++ +..++.+|++.+...+...+++++.+.++.+...|+
T Consensus 152 ~~~~~~~~~~~~~~g~~~~~v~~~~~~~~---~~d~~~~v~~i-~~~~~d~ii~~~~~~~~~~~~~~~~~~g~~~~~~~~ 227 (346)
T cd06330 152 QDAWADFKAALKRLRPDVEVVSEQWPKLG---APDYGSEITAL-LAAKPDAIFSSLWGGDLVTFVRQANARGLFDGTTVV 227 (346)
T ss_pred HHHHHHHHHHHHHhCCCCeecccccCCCC---CcccHHHHHHH-HhcCCCEEEEecccccHHHHHHHHHhcCcccCceEE
Confidence 44567788888888888766543221111 23566777776 345577778777777788889888888876545788
Q ss_pred EeccCcccccccCCCccceeeEEEEEec--CC--CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQ--AN--PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNS 227 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~--~~--~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~ 227 (981)
++..+... +........+|.+.-... .. ..|.-++|.. .|+..++ .
T Consensus 228 ~~~~~~~~--~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~f~~----------------~~~~~~g-~----------- 277 (346)
T cd06330 228 LTLTGAPE--LAPLGDEMPEGVIIGGRGPYFIPPDTPENKAFVD----------------AYQEKYG-D----------- 277 (346)
T ss_pred eeccchhh--hhhhhcccCCceEEeccccCCCCCCChHHHHHHH----------------HHHHHHC-C-----------
Confidence 76543322 111112223444322111 00 1122223322 1222221 0
Q ss_pred CCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeE
Q psy1666 228 HYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHF 307 (981)
Q Consensus 228 ~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V 307 (981)
.........|||+..++.|+.+...+ + ..... ..|.+.|+++.|.|..| .+
T Consensus 278 -----------------~p~~~~~~~y~a~~~l~~a~~~a~~~--~--------~~~~~-~~v~~al~~~~~~~~~G-~~ 328 (346)
T cd06330 278 -----------------YPTYGAYGAYQAVMALAAAVEKAGAT--D--------GGAPP-EQIAAALEGLSFETPGG-PI 328 (346)
T ss_pred -----------------CCChHHHHHHHHHHHHHHHHHHhcCC--C--------CCCcH-HHHHHHHcCCCccCCCC-ce
Confidence 00012346799999999999876421 0 00001 45899999999999888 69
Q ss_pred EecCC
Q psy1666 308 KFDKD 312 (981)
Q Consensus 308 ~FD~n 312 (981)
.||++
T Consensus 329 ~f~~~ 333 (346)
T cd06330 329 TMRAA 333 (346)
T ss_pred eeecC
Confidence 99874
No 104
>COG0683 LivK ABC-type branched-chain amino acid transport systems, periplasmic component [Amino acid transport and metabolism]
Probab=96.20 E-value=0.29 Score=56.16 Aligned_cols=190 Identities=14% Similarity=0.123 Sum_probs=111.9
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|.-+...+.++.... ++..++.++ +.+++.+|++.+...+...+++++..+++.++..+.
T Consensus 162 ~~~~~~~~~~l~~~G~~~~~~~~~~~~~~-----~~~~~v~~i-~~~~~d~v~~~~~~~~~~~~~r~~~~~G~~~~~~~~ 235 (366)
T COG0683 162 EGLADAFKAALKALGGEVVVEEVYAPGDT-----DFSALVAKI-KAAGPDAVLVGGYGPDAALFLRQAREQGLKAKLIGG 235 (366)
T ss_pred hhHHHHHHHHHHhCCCeEEEEEeeCCCCC-----ChHHHHHHH-HhcCCCEEEECCCCccchHHHHHHHHcCCCCccccc
Confidence 66788899999999987555555544332 366777776 555667888888888899999999988887753433
Q ss_pred EeccCcccccccCCCcccee--eEEEEEec-CCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVE--GTLSLQPQ-ANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSH 228 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~--G~l~~~~~-~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~ 228 (981)
. +..+....... ..... +.+..... ....|.-+.|++. +...+. .
T Consensus 236 ~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~p~~~~f~~~----------------~~~~~g-~------------ 283 (366)
T COG0683 236 D--GAGTAEFEEIA-GAGGAGAGLLATAYSTPDDSPANKKFVEA----------------YKAKYG-D------------ 283 (366)
T ss_pred c--ccCchhhhhhc-ccCccccEEEEecccccccCcchHHHHHH----------------HHHHhC-C------------
Confidence 2 22221111000 00011 22222111 1112222223221 121111 0
Q ss_pred CCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhccee-eccCCCCeE
Q psy1666 229 YSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVS-FQGLSEDHF 307 (981)
Q Consensus 229 ~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~-F~g~~G~~V 307 (981)
+..........|+||+.++.|+.+.-. ..++.++.+.|+... |.+..| .+
T Consensus 284 --------------~~~~~~~~~~~y~a~~~~~~ai~~a~~--------------~~d~~~v~~al~~~~~~~~~~G-~v 334 (366)
T COG0683 284 --------------PAAPSYFAAAAYDAVKLLAKAIEKAGK--------------SSDREAVAEALKGGKFFDTAGG-PV 334 (366)
T ss_pred --------------CCCcccchHHHHHHHHHHHHHHHHHhc--------------CCCHHHHHHHHhhCCCCccCCc-ce
Confidence 000111345689999999999977741 112567889999887 455666 59
Q ss_pred EecCCCCCC-ceeEEEEEEEcC
Q psy1666 308 KFDKDGDGP-ARYNIIHFKQIR 328 (981)
Q Consensus 308 ~FD~nGD~~-~~YdI~n~q~~~ 328 (981)
.||++||.. ..|.|..|+...
T Consensus 335 ~~~~~~~~~~~~~~i~~~~~~~ 356 (366)
T COG0683 335 TFDEKGDRGSKPVYVGQVQKGG 356 (366)
T ss_pred eECCCCCcCCCceEEEEEEecC
Confidence 999999975 689999998543
No 105
>cd06371 PBP1_sensory_GC_DEF_like Ligand-binding domain of membrane guanylyl cyclases (GC-D, GC-E, and GC-F) that are specifically expressed in sensory tissues. This group includes the ligand-binding domain of membrane guanylyl cyclases (GC-D, GC-E, and GC-F) that are specifically expressed in sensory tissues. They share a similar topology with an N-terminal extracellular ligand-binding domain, a single transmembrane domain, and a C-terminal cytosolic region that contains kinase-like and catalytic domains. GC-D is specifically expressed in a subpopulation of olfactory sensory neurons. GC-E and GC-F are colocalized within the same photoreceptor cells of the retina and have important roles in phototransduction. Unlike the other family members, GC-E and GC-F have no known extracellular ligands. Instead, they are activated under low calcium conditions by guanylyl cyclase activating proteins called GCAPs. GC-D expressing neurons have been implicated in pheromone detection and GC-D is phyloge
Probab=96.05 E-value=0.015 Score=67.24 Aligned_cols=63 Identities=22% Similarity=0.466 Sum_probs=52.7
Q ss_pred HHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEE
Q psy1666 675 FVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQ 749 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~ 749 (981)
..|||||++|+||++...+ .. ..++.++.+.|++.+|.|.+| .+.||++||+...|.++++..
T Consensus 298 ~~YDav~~~a~Al~~a~~~--g~---------~~d~~~l~~~l~~~~f~GvtG-~v~fd~~g~~~~~~~v~~~~~ 360 (382)
T cd06371 298 TIYNSIYLLAHAVENARAA--GG---------GVSGANLAQHTRNLEFQGFNQ-RLRTDSGGGGQAPYVVLDTDG 360 (382)
T ss_pred HHHHHHHHHHHHHHHHHHh--CC---------CccHHHHHHHHhCccccccce-EEEecCCCCcccceEEEecCC
Confidence 5899999999999988631 10 134678999999999999999 699999999999999988753
No 106
>cd06329 PBP1_SBP_like_3 Periplasmic solute-binding domain of active transport proteins. Periplasmic solute-binding domain of active transport proteins found in bacteria and Archaea. Members of this group are initial receptors in the process of active transport across cellular membrane, but their substrate specificities are not known in detail. However, they closely resemble the group of AmiC and active transport systems for short-chain amides and urea (FmdDEF), and thus are likely to exhibit a ligand-binding mode similar to that of the amide sensor protein AmiC from Pseudomonas aeruginosa. Moreover, this binding domain has high sequence identity to the family of hydrophobic amino acid transporters (HAAT), and thus it may also be involved in transport of amino acids.
Probab=96.05 E-value=0.17 Score=57.38 Aligned_cols=170 Identities=8% Similarity=0.015 Sum_probs=102.4
Q ss_pred hhHHHHHHHHHHh--CCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceE
Q psy1666 72 TTAFEELEVLLAK--SSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFS 149 (981)
Q Consensus 72 ~~~~~~l~~~~~~--~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~v 149 (981)
+...+.+++.+++ .|++|...+.++... ..++...+.++ +..++.+|++......+..++.++.+.++.. -
T Consensus 157 ~~~~~~~~~~~~~~~~G~~vv~~~~~~~~~----~~d~~~~i~~l-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~--~ 229 (342)
T cd06329 157 QDVAAAFKAMLAAKRPDIQIVGEDLHPLGK----VKDFSPYVAKI-KASGADTVITGNWGNDLLLLVKQAADAGLKL--P 229 (342)
T ss_pred HHHHHHHHHHHHhhcCCcEEeceeccCCCC----CCchHHHHHHH-HHcCCCEEEEcccCchHHHHHHHHHHcCCCc--e
Confidence 5567888888888 999998888777543 02455667666 4556677777776667788888888888765 3
Q ss_pred EEEeccCcccccccCCCccceeeEEEEEecCC--CCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCC
Q psy1666 150 WVGSDGWSARGLVSDGSEAEVEGTLSLQPQAN--PVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNS 227 (981)
Q Consensus 150 WI~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~--~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~ 227 (981)
|++...+... +........+|.+...+... ..|.-++|.+. |++.+. .
T Consensus 230 ~~~~~~~~~~--~~~~~g~~~~g~~~~~~~~~~~~~~~~~~f~~~----------------~~~~~~----~-------- 279 (342)
T cd06329 230 FYTPYLDQPG--NPAALGEAGLGLVVAVAYWHPNDTPANRAFVEA----------------FKAKYG----R-------- 279 (342)
T ss_pred EEeccccchh--HHHhhcccccceEEeeeccCCCCCHHHHHHHHH----------------HHHHhC----C--------
Confidence 5555333222 11111223355554433211 12223333321 111111 0
Q ss_pred CCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeE
Q psy1666 228 HYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHF 307 (981)
Q Consensus 228 ~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V 307 (981)
.........||++.+++.|+...- ..++..+.+.|++++|.+..| ++
T Consensus 280 -----------------~~~~~~~~~y~~~~~~~~a~~~ag---------------~~~~~~v~~al~~~~~~~~~g-~~ 326 (342)
T cd06329 280 -----------------VPDYYEGQAYNGIQMLADAIEKAG---------------STDPEAVAKALEGMEVDTPVG-PV 326 (342)
T ss_pred -----------------CCCchHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHhCCccccCCC-Ce
Confidence 000123457999999999997531 234677999999999999888 69
Q ss_pred EecC
Q psy1666 308 KFDK 311 (981)
Q Consensus 308 ~FD~ 311 (981)
.|+.
T Consensus 327 ~~~~ 330 (342)
T cd06329 327 TMRA 330 (342)
T ss_pred EEcc
Confidence 9984
No 107
>TIGR03669 urea_ABC_arch urea ABC transporter, substrate-binding protein, archaeal type. Members of this protein family are identified as the substrate-binding protein of a urea ABC transport system by similarity to a known urea transporter from Corynebacterium glutamicum, operon structure, proximity of its operons to urease (urea-utilization protein) operons, and by Partial Phylogenetic Profiling vs. urea utilization.
Probab=95.75 E-value=0.34 Score=55.77 Aligned_cols=187 Identities=7% Similarity=0.001 Sum_probs=105.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+-|...+.+|... .++...+.++ +.+++.+|++.....+...+++++.+.++... ++
T Consensus 147 ~~~~~~~~~~~~~~G~~vv~~~~~~~g~-----~Df~~~l~~i-~~~~pD~V~~~~~g~~~~~~~kq~~~~G~~~~--~~ 218 (374)
T TIGR03669 147 QLSADWVRVIAKENGAEVVGEEFIPLSV-----SQFSSTIQNI-QKADPDFVMSMLVGANHASFYEQAASANLNLP--MG 218 (374)
T ss_pred HHHHHHHHHHHHHcCCeEEeEEecCCCc-----chHHHHHHHH-HHcCCCEEEEcCcCCcHHHHHHHHHHcCCCCc--cc
Confidence 3345667777788999887777777543 3566777776 55667777776666667778888887777543 22
Q ss_pred EeccCcccccccCCCccceeeEEEEEec--CCCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQ--ANPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~--~~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
.+..................|.++..+. ..+.|..++|.+. | +..+. ..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~F~~~---------------y-~~~~g----~~--------- 269 (374)
T TIGR03669 219 TSTAMAQGYEHKRFEPPALKDVYAGVNYMEEIDTPENEAFVER---------------F-YAKFP----DA--------- 269 (374)
T ss_pred chhhhhhhhhhhhcCchhhCCcEEeeeccccCCCHHHHHHHHH---------------H-HHHcC----CC---------
Confidence 2211111101000111122344333221 1123334444432 1 11111 00
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcc-eeeccCCCCeEE
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRK-VSFQGLSEDHFK 308 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~-V~F~g~~G~~V~ 308 (981)
+ .........|||++++++|+.+.- ..++..+.+.|++ .+|.+..| ++.
T Consensus 270 -------------p-~~~~~a~~~Yda~~~l~~Ai~~AG---------------s~d~~av~~aL~~~~~~~~~~G-~i~ 319 (374)
T TIGR03669 270 -------------P-YINQEAENNYFSVYMYKQAVEEAG---------------TTDQDAVRDVLESGVEMDAPEG-KVC 319 (374)
T ss_pred -------------C-CCChHHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHHcCCeEECCCc-cEE
Confidence 0 000123457999999999997541 2467789999986 67888887 699
Q ss_pred ecCCCCCC-ceeEEEEEE
Q psy1666 309 FDKDGDGP-ARYNIIHFK 325 (981)
Q Consensus 309 FD~nGD~~-~~YdI~n~q 325 (981)
||+++... ..+.|.+++
T Consensus 320 fd~~~~~~~~~~~v~~~~ 337 (374)
T TIGR03669 320 IDGATHHMSHTMRLARAD 337 (374)
T ss_pred EcCCCCeeeeeeEEEEEc
Confidence 99765433 345566664
No 108
>cd06383 PBP1_iGluR_AMPA_Like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excitatory synaptic current.
Probab=95.48 E-value=0.011 Score=67.74 Aligned_cols=75 Identities=17% Similarity=0.141 Sum_probs=53.3
Q ss_pred hhHHHHHHHHHHHHHHHhHH----hhccCCCC-CCCCCCCCChh-----hHhhhhccccccCCCCCeEEeccCCCCccee
Q psy1666 673 LQFVSDAVMAFSIALDHMHA----DLCQGKVG-LCDAMRPTKGP-----ELLKYLRKVSFQGLSEDHFKFDKDGDGPARY 742 (981)
Q Consensus 673 ~~~vydAVyaiAhALh~~l~----~~c~~~~~-~c~~~~~~~~~-----qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~Y 742 (981)
...+||||+++|.|++++.. ..|.+... .|.......|| .+.+|||.++|+|.+| .|.||++|. ...|
T Consensus 276 ~aL~~Dav~~~~~a~~~l~~~~~~~~~~~~~~~~~~g~~~~~~w~~~g~~~~~~~k~~~~~gltG-~i~f~~~g~-R~~~ 353 (368)
T cd06383 276 LFLAYDAVLAVGEWPRRMRKKRVEDGSTGTSVLPGFGISPESPLMTLQSSPFNGSSEIKFEMLAG-RVAIDEGSS-VSTK 353 (368)
T ss_pred HHHHHHHHHHhccccchhheeeccCCCcCccccCCCCCCcccchhhcccccccCccceeEeeecC-eEEEecCce-eeee
Confidence 34799999999999998731 12221111 34432223467 8999999999999999 799998885 4578
Q ss_pred eEEEeEE
Q psy1666 743 NIIHFKQ 749 (981)
Q Consensus 743 dI~n~~~ 749 (981)
++.-|.-
T Consensus 354 ~l~~~~~ 360 (368)
T cd06383 354 TIGSWSA 360 (368)
T ss_pred eeeeEec
Confidence 8877764
No 109
>PF07699 GCC2_GCC3: GCC2 and GCC3; InterPro: IPR011641 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. This entry represents various ephrin type A and B receptors, which have tyrosine kinase activity.
Probab=95.25 E-value=0.01 Score=46.25 Aligned_cols=28 Identities=25% Similarity=0.669 Sum_probs=24.7
Q ss_pred ccccCCCCceecCccccccccCCCCCCC
Q psy1666 810 HCFNCSQYQIRLPSDETQCLTCPEGTKP 837 (981)
Q Consensus 810 ~C~~C~~g~isn~~d~~~C~~C~~~~~~ 837 (981)
.|.+||.|+|.+...+..|++||.+..-
T Consensus 10 ~C~~Cp~GtYq~~~g~~~C~~Cp~g~~T 37 (48)
T PF07699_consen 10 KCQPCPKGTYQDEEGQTSCTPCPPGSTT 37 (48)
T ss_pred ccCCCCCCccCCccCCccCccCcCCCcc
Confidence 6999999999999999999999998543
No 110
>KOG1054|consensus
Probab=94.89 E-value=0.099 Score=60.05 Aligned_cols=86 Identities=26% Similarity=0.410 Sum_probs=60.8
Q ss_pred hHHHHHHHHHHHHHHHhHHhhc----cCCCCCCCCCCCCChh----hHhhhhccccccCCCCCeEEeccCCCCcceeeEE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLC----QGKVGLCDAMRPTKGP----ELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNII 745 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c----~~~~~~c~~~~~~~~~----qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~ 745 (981)
...||||..+|+|++.++++.- .+..+.|... +..|| .+-+.||+|.+.|.+| .|.||+.|.+. +|++-
T Consensus 301 AlthDailV~~eaf~~~~~q~~~~~rRG~~GD~~an-~~~p~~qG~~I~ralk~v~~eGLTG-niqFd~~G~R~-Nyt~~ 377 (897)
T KOG1054|consen 301 ALTHDAILVMAEAFRSLRRQRIDISRRGNAGDCLAN-PAVPWEQGIDIERALKQVQVEGLTG-NIQFDKYGRRT-NYTID 377 (897)
T ss_pred hhhhhHHHHHHHHHHHHHHhhhchhccCCCccccCC-CCCchhcchhHHHHHHheeeccccc-ceeecccCccc-cceEE
Confidence 4689999999999999864321 1223456543 35566 4789999999999999 69999999876 45543
Q ss_pred EeEEcCCCcEEEEEEEEEEC
Q psy1666 746 HFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 746 n~~~~~~~~~~~~~VG~~~~ 765 (981)
-....+++ ..++|.|++
T Consensus 378 i~elk~~~---~rk~~~W~e 394 (897)
T KOG1054|consen 378 IVELKSNG---SRKVGYWNE 394 (897)
T ss_pred EEEeccCC---cceeeeecc
Confidence 33333344 578899974
No 111
>PTZ00382 Variant-specific surface protein (VSP); Provisional
Probab=94.28 E-value=0.042 Score=49.60 Aligned_cols=86 Identities=20% Similarity=0.285 Sum_probs=41.7
Q ss_pred ccCCccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCCCCCCccccCccccccc--ccccchhhHHHHHH
Q psy1666 787 SVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEGTKPDLLRQNCLEIPAM--FIEITSTWAIGAMA 864 (981)
Q Consensus 787 S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~~~~n~~~~~C~~~~~~--~l~~~~~~~i~~~~ 864 (981)
.+|. .|.+|+.+....+ .|++|++..=.+=.....|..|-+++.++. +.|+..... -|+-.-..+|++.+
T Consensus 4 ~~Ct-~C~~g~~~~~~~~-----~C~~C~~~~C~~C~~~~~C~~C~~GY~~~~--~~Cv~~st~~~~ls~gaiagi~vg~ 75 (96)
T PTZ00382 4 AVCT-SCDSDKKPNKDGS-----GCVLCSVGNCKSCVVDGVCGECNSGFSLDN--GKCVSSGANRSGLSTGAIAGISVAV 75 (96)
T ss_pred cccC-cCCCCCccCCCCC-----cCCcCCCCCCcCCCCCCccccCcCCcccCC--CcccccccCCCCcccccEEEEEeeh
Confidence 4674 4899986653222 134444211111112245888888888754 567643322 11212233445555
Q ss_pred HHHHHHHHHHHHhhhh
Q psy1666 865 LSSTGILMTLLIVGVF 880 (981)
Q Consensus 865 ~s~~~~~~t~~v~~if 880 (981)
+.+++.++.+++++++
T Consensus 76 ~~~v~~lv~~l~w~f~ 91 (96)
T PTZ00382 76 VAVVGGLVGFLCWWFV 91 (96)
T ss_pred hhHHHHHHHHHhheeE
Confidence 5555555555554433
No 112
>cd06339 PBP1_YraM_LppC_lipoprotein_like Periplasmic binding component of lipoprotein LppC, an immunodominant antigen. This subgroup includes periplasmic binding component of lipoprotein LppC, an immunodominant antigen, whose molecular function is not characterized. Members of this subgroup are predicted to be involved in transport of lipid compounds, and they are sequence similar to the family of ABC-type hydrophobic amino acid transporters (HAAT).
Probab=94.19 E-value=1.1 Score=50.53 Aligned_cols=84 Identities=8% Similarity=0.107 Sum_probs=50.5
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcC--------------------CCcEEEEEEcchh-
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTK--------------------PRARGVIVFGSDQ- 130 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~--------------------s~a~VIVl~~s~~- 130 (981)
+...+.|++.+++.|+-|...+.++... .++...+.++... .++..|++.+...
T Consensus 138 ~~~~~~f~~~~~~~G~~vv~~~~~~~~~-----~d~~~~i~~i~~~~~~~~~~~~~~~~~~~~~~~~~~d~v~~~~~~~~ 212 (336)
T cd06339 138 QRVADAFRQAWQQLGGTVVAIESYDPSP-----TDLSDAIRRLLGVDDSEQRIAQLKSLESEPRRRQDIDAIDAVALPDG 212 (336)
T ss_pred HHHHHHHHHHHHHcCCceeeeEecCCCH-----HHHHHHHHHHhccccchhhhhhhhhcccCccccCCCCcEEEEecChh
Confidence 4556778888888999988888877533 3666777776442 0444555544443
Q ss_pred hHHHHHHHHHhhcc-CCceEEEEeccCcccc
Q psy1666 131 EVAGVMRAVRRLNA-TGSFSWVGSDGWSARG 160 (981)
Q Consensus 131 ~a~~~~~~~~~~~l-~g~~vWI~s~~W~~~~ 160 (981)
.+..+...+...+. ..+..++++++|....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 243 (336)
T cd06339 213 EARLIKPQLLFYYGVPGDVPLYGTSRWYSGT 243 (336)
T ss_pred hhhhhcchhhhhccCcCCCCEEEeccccCCC
Confidence 44434333333332 0123688998888653
No 113
>cd06337 PBP1_ABC_ligand_binding_like_4 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters, such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=93.70 E-value=0.76 Score=52.45 Aligned_cols=62 Identities=10% Similarity=0.112 Sum_probs=46.1
Q ss_pred HHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCc
Q psy1666 80 VLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGS 147 (981)
Q Consensus 80 ~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~ 147 (981)
+..++.|+-|...+.++.... ++...+.++ +.+++.+|++.+...++..+++++..+++..+
T Consensus 170 ~~~~~~G~~vv~~~~~~~~~~-----D~~~~v~~i-k~a~pD~v~~~~~~~~~~~~~~~~~~~G~~~~ 231 (357)
T cd06337 170 AALADAGYKLVDPGRFEPGTD-----DFSSQINAF-KREGVDIVTGFAIPPDFATFWRQAAQAGFKPK 231 (357)
T ss_pred HHHHhCCcEEecccccCCCCC-----cHHHHHHHH-HhcCCCEEEeCCCccHHHHHHHHHHHCCCCCC
Confidence 455668998888887775432 566777776 56778888888888888888888888888664
No 114
>PHA02637 TNF-alpha-receptor-like protein; Provisional
Probab=93.60 E-value=0.053 Score=50.51 Aligned_cols=46 Identities=20% Similarity=0.456 Sum_probs=31.5
Q ss_pred ccCCccCCCCcEEeeecCcceeeccccCCCCceecCcc-ccccccCC
Q psy1666 787 SVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSD-ETQCLTCP 832 (981)
Q Consensus 787 S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d-~~~C~~C~ 832 (981)
..|-..|+||++....=...==-.|.|||+|+|+...| .+.|.+|.
T Consensus 41 ~~CC~kCPPGt~v~~~Ct~~t~T~C~PCp~GTYTe~~N~~~~C~~C~ 87 (127)
T PHA02637 41 NLCCLSCPPGTYASRLCDIKTNTQCTPCGSGTFTSHNNHLPACLSCN 87 (127)
T ss_pred CeEcCCCCCCCEEeCcCCCCCCcccccCCCCCeeccCCCCCcccccC
Confidence 56999999999886421100002799999999977664 55688885
No 115
>cd06328 PBP1_SBP_like_2 Periplasmic solute-binding domain of active transport proteins found in gram-negative and gram-positive bacteria. Periplasmic solute-binding domain of active transport proteins found in gram-negative and gram-positive bacteria. Members of this group are initial receptors in the process of active transport across cellular membrane, but their substrate specificities are not known in detail. However, they closely resemble the group of AmiC and active transport systems for short-chain amides and urea (FmdDEF), and thus are likely to exhibit a ligand-binding mode similar to that of the amide sensor protein AmiC from Pseudomonas aeruginosa. Moreover, this binding domain has high sequence identity to the family of hydrophobic amino acid transporters (HAAT), and thus it may also be involved in transport of amino acids.
Probab=93.33 E-value=1.6 Score=49.12 Aligned_cols=68 Identities=12% Similarity=0.133 Sum_probs=43.3
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchh-hHHHHHHHHHhhccC
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQ-EVAGVMRAVRRLNAT 145 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~-~a~~~~~~~~~~~l~ 145 (981)
+...+.+++.++++|++|...+.++... .++...+.+++ .+++.+|++..... .+...+..+...+..
T Consensus 150 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~v~~l~-~~~pd~V~~~~~~~~~~~~~~~~~~~~g~~ 218 (333)
T cd06328 150 RDGVAAFKAALEKLGAAIVTEEYAPTDT-----TDFTPYAQRLL-DALKKVLFVIWAGAGGPWPKLQQMGVLGYG 218 (333)
T ss_pred HHHHHHHHHHHHhCCCEEeeeeeCCCCC-----cchHHHHHHHH-hcCCCEEEEEecCchhHHHHHHHhhhhcCC
Confidence 5667888889999999999888887643 25667777764 44555555433222 444455555444433
No 116
>cd06356 PBP1_Amide_Urea_BP_like Periplasmic component (FmdD) of an active transport system for short-chain amides and urea (FmdDEF). This group includes the type I periplasmic-binding proteins that are predicted to have a function similar to that of an active transport system for short chain amides and/or urea in bacteria and Archaea, by sequence comparison and phylogenetic analysis.
Probab=93.24 E-value=1.7 Score=48.92 Aligned_cols=90 Identities=11% Similarity=0.103 Sum_probs=58.7
Q ss_pred HHHHHHHHhcCCCCCCCCCcceeeEEeecc---hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCC
Q psy1666 42 YDDIVTKLMTKPRARDDPDFIPVLMLFLRE---TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKP 118 (981)
Q Consensus 42 ~~~i~~~l~~~psa~~q~~a~~~lv~f~~~---~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s 118 (981)
...+++-+.+....+ +.+++.+. +...+.+++.+++.|+-+...+.++... .++...+.++ +.+
T Consensus 120 ~~~~~~~~~~~~~~~-------vail~~d~~~g~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~v~~l-~~~ 186 (334)
T cd06356 120 FSTLVPYMMEKYGKK-------VYTIAADYNFGQISAEWVRKIVEENGGEVVGEEFIPLDV-----SDFGSTIQKI-QAA 186 (334)
T ss_pred HHHHHHHHHHccCCe-------EEEECCCchhhHHHHHHHHHHHHHcCCEEEeeeecCCCc-----hhHHHHHHHH-Hhc
Confidence 445566665433333 33444332 4456778888889999888888877543 2566777776 455
Q ss_pred CcEEEEEEcchhhHHHHHHHHHhhcc
Q psy1666 119 RARGVIVFGSDQEVAGVMRAVRRLNA 144 (981)
Q Consensus 119 ~a~VIVl~~s~~~a~~~~~~~~~~~l 144 (981)
++.+|++.........++.++...++
T Consensus 187 ~pd~v~~~~~~~~~~~~~~~~~~~G~ 212 (334)
T cd06356 187 KPDFVMSILVGANHLSFYRQWAAAGL 212 (334)
T ss_pred CCCEEEEeccCCcHHHHHHHHHHcCC
Confidence 67777776666667778888877777
No 117
>cd04509 PBP1_ABC_transporter_GCPR_C_like Family C of G-protein coupled receptors and their close homologs, the type I periplasmic-binding proteins of ATP-binding cassette transporter-like systems. This CD includes members of the family C of G-protein coupled receptors and their close homologs, the type I periplasmic-binding proteins of ATP-binding cassette transporter-like systems. The family C GPCR includes glutamate/glycine-gated ion channels such as the NMDA receptor, G-protein-coupled receptors, metabotropic glutamate, GABA-B, calcium sensing, phermone receptors, and atrial natriuretic peptide-guanylate cyclase receptors. The glutamate receptors that form cation-selective ion channels, iGluR, can be classified into three different subgroups according to their binding-affinity for the agonists NMDA (N-methyl-D-asparate), AMPA (alpha-amino-3-dihydro-5-methyl-3-oxo-4-isoxazolepropionic acid), and kainate. L-glutamate is a major neurotransmitter in the brain of vertebrates and acts th
Probab=93.02 E-value=0.8 Score=49.85 Aligned_cols=108 Identities=15% Similarity=0.211 Sum_probs=72.8
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
....+.+++.+++.|+++.....++... .++...++++. +..+++|++......+..++.++.+.++.+.+.|+
T Consensus 150 ~~~~~~~~~~~~~~g~~i~~~~~~~~~~-----~~~~~~~~~l~-~~~~~~v~~~~~~~~~~~~~~~~~~~g~~~~~~~i 223 (299)
T cd04509 150 RGLLEAFKAAFKKKGGTVVGEEYYPLGT-----TDFTSLLQKLK-AAKPDVIVLCGSGEDAATILKQAAEAGLTGGYPIL 223 (299)
T ss_pred HHHHHHHHHHHHHcCCEEEEEecCCCCC-----ccHHHHHHHHH-hcCCCEEEEcccchHHHHHHHHHHHcCCCCCCcEE
Confidence 4456778888889999998776665432 24455666653 34467888877768888899888888776556899
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCCCCCCh
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQANPVKGF 186 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~ipgF 186 (981)
+.+.|...... .......+|.++..+.....+..
T Consensus 224 ~~~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~~~~ 257 (299)
T cd04509 224 GITLGLSDVLL-EAGGEAAEGVLTGTPYFPGDPPP 257 (299)
T ss_pred ecccccCHHHH-HHhHHhhcCcEEeeccCCCCCCh
Confidence 99888754332 11224456888877765544444
No 118
>cd06342 PBP1_ABC_LIVBP_like Type I periplasmic ligand-binding domain of ABC (Atpase Binding Cassette)-type active transport systems that are involved in the transport of all three branched chain aliphatic amino acids (leucine, isoleucine and valine). This subgroup includes the type I periplasmic ligand-binding domain of ABC (Atpase Binding Cassette)-type active transport systems that are involved in the transport of all three branched chain aliphatic amino acids (leucine, isoleucine and valine). This subgroup also includes a leucine-specific binding protein (or LivK), which is very similar in sequence and structure to leucine-isoleucine-valine binding protein (LIVBP). ABC-type active transport systems are transmembrane proteins that function in the transport of diverse sets of substrates across extra- and intracellular membranes, including carbohydrates, amino acids, inorganic ions, dipeptides and oligopeptides, metabolic products, lipids and sterols, and heme, to name a few.
Probab=92.49 E-value=0.2 Score=56.33 Aligned_cols=58 Identities=26% Similarity=0.418 Sum_probs=48.3
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEe
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHF 747 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~ 747 (981)
...|||++.+++|+++.- ..++..+.+.|+++.|.|.+| .+.||++|+.. ..|+|.||
T Consensus 276 ~~~yda~~~~~~al~~~~---------------~~~~~~v~~~l~~~~~~g~~g-~i~f~~~g~~~~~~~~~~~~ 334 (334)
T cd06342 276 PYAYDAANVLAEAIKKAG---------------STDPAKVADALRKVDFDGVTG-KISFDAKGDLKGAAVTVYQV 334 (334)
T ss_pred HHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHHHhCCCCCcce-eeEECCCCCcccCcEEEEeC
Confidence 478999999999998651 123567999999999999998 69999999874 68999876
No 119
>cd06335 PBP1_ABC_ligand_binding_like_2 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters, such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=91.78 E-value=3.8 Score=46.42 Aligned_cols=69 Identities=14% Similarity=0.134 Sum_probs=53.2
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCC
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATG 146 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g 146 (981)
+...+.+++.+++.|+++...+.++.... ++...+.++ +++.+.+|++.+....+..+++++.++++..
T Consensus 152 ~~~~~~~~~~~~~~G~~v~~~~~~~~~~~-----d~s~~i~~i-~~~~~d~v~~~~~~~~~~~~~~~~~~~g~~~ 220 (347)
T cd06335 152 RSNRKDLTAALAARGLKPVAVEWFNWGDK-----DMTAQLLRA-KAAGADAIIIVGNGPEGAQIANGMAKLGWKV 220 (347)
T ss_pred hhHHHHHHHHHHHcCCeeEEEeeecCCCc-----cHHHHHHHH-HhCCCCEEEEEecChHHHHHHHHHHHcCCCC
Confidence 55678888888899999999888875432 566677776 4556788888888888888898888887754
No 120
>PF13433 Peripla_BP_5: Periplasmic binding protein domain; PDB: 1QNL_A 1QO0_A 1PEA_A.
Probab=91.74 E-value=1 Score=50.66 Aligned_cols=174 Identities=10% Similarity=0.073 Sum_probs=92.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
....+.+++.+++.|.-|.-...+|-.. .++..+++++... +..+|+--...+....|+.+....++..+..=|
T Consensus 148 re~Nri~r~~l~~~GgevvgE~Y~plg~-----td~~~ii~~I~~~-~Pd~V~stlvG~s~~aF~r~~~~aG~~~~~~Pi 221 (363)
T PF13433_consen 148 RESNRIIRDLLEARGGEVVGERYLPLGA-----TDFDPIIAEIKAA-KPDFVFSTLVGDSNVAFYRAYAAAGLDPERIPI 221 (363)
T ss_dssp HHHHHHHHHHHHHTT-EEEEEEEE-S-H-----HHHHHHHHHHHHH-T-SEEEEE--TTCHHHHHHHHHHHH-SSS---E
T ss_pred HHHHHHHHHHHHHcCCEEEEEEEecCCc-----hhHHHHHHHHHhh-CCCEEEEeCcCCcHHHHHHHHHHcCCCcccCeE
Confidence 4456777888888899898999998643 3677888877433 344555333345566778777777877653445
Q ss_pred EeccCcccccccCCCccceeeEEEEEecCCCC--CChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQANPV--KGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHY 229 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~~~i--pgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~ 229 (981)
+|-+-+... +.........|.++..+.-..+ |.=++|.+ -|...+...
T Consensus 222 ~S~~~~E~E-~~~~g~~~~~Gh~~~~~YFqsidtp~N~~Fv~----------------~~~~~~g~~------------- 271 (363)
T PF13433_consen 222 ASLSTSEAE-LAAMGAEAAAGHYTSAPYFQSIDTPENQAFVA----------------RFRARYGDD------------- 271 (363)
T ss_dssp EESS--HHH-HTTS-HHHHTT-EEEES--TT-SSHHHHHHHH----------------HHHTTS-TT-------------
T ss_pred EEEecCHHH-HhhcChhhcCCcEEeehhhhhCCcHHHHHHHH----------------HHHHHhCCC-------------
Confidence 553332211 1111222445667665532211 11223322 123222110
Q ss_pred CCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccHHHHhhcceeeccCCCCeEEe
Q psy1666 230 STECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKF 309 (981)
Q Consensus 230 ~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~qLl~~Lk~V~F~g~~G~~V~F 309 (981)
.. ..+..-..|.+|+.+|.|+++.- ..++.++.+.|..++|.++.|. |++
T Consensus 272 --------~v------~s~~~eaaY~~v~l~a~Av~~ag---------------s~d~~~vr~al~g~~~~aP~G~-v~i 321 (363)
T PF13433_consen 272 --------RV------TSDPMEAAYFQVHLWAQAVEKAG---------------SDDPEAVREALAGQSFDAPQGR-VRI 321 (363)
T ss_dssp ------------------HHHHHHHHHHHHHHHHHHHHT---------------S--HHHHHHHHTT--EEETTEE-EEE
T ss_pred --------CC------CCcHHHHHHHHHHHHHHHHHHhC---------------CCCHHHHHHHhcCCeecCCCcc-eEE
Confidence 00 01122358999999999997761 3467899999999999999995 999
Q ss_pred cC
Q psy1666 310 DK 311 (981)
Q Consensus 310 D~ 311 (981)
|.
T Consensus 322 d~ 323 (363)
T PF13433_consen 322 DP 323 (363)
T ss_dssp -T
T ss_pred cC
Confidence 86
No 121
>cd06326 PBP1_STKc_like Type I periplasmic binding domain of uncharacterized extracellular ligand-binding proteins. The type I periplasmic binding domain of uncharacterized extracellular ligand-binding proteins, some of which contain a conserved catalytic serine/threonine protein kinase (STKc) domain in the N-terminal region. Members of this group are sequence-similar to the branched-chain amino acid ABC transporter leucine-isoleucine-valine-binding protein (LIVBP); their ligand specificity has not been determined experimentally, however.
Probab=91.52 E-value=6.4 Score=44.11 Aligned_cols=70 Identities=19% Similarity=0.301 Sum_probs=50.0
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCc
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGS 147 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~ 147 (981)
+...+.+++.+++.|+++.....++... .++...+.+++. +.+.+|++......+..++.++.++++..+
T Consensus 150 ~~~~~~~~~~~~~~G~~~~~~~~~~~~~-----~d~~~~~~~l~~-~~~dav~~~~~~~~a~~~i~~~~~~G~~~~ 219 (336)
T cd06326 150 KDGLAGVEKALAARGLKPVATASYERNT-----ADVAAAVAQLAA-ARPQAVIMVGAYKAAAAFIRALRKAGGGAQ 219 (336)
T ss_pred HHHHHHHHHHHHHcCCCeEEEEeecCCc-----ccHHHHHHHHHh-cCCCEEEEEcCcHHHHHHHHHHHhcCCCCc
Confidence 5566788888889999887766666432 245566666644 456777887777778889988888887654
No 122
>cd06350 PBP1_GPCR_family_C_like Ligand-binding domain of membrane-bound glutamate receptors that mediate excitatory transmission on the cellular surface through initial binding of glutamate and are categorized into ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). Ligand-binding domain of membrane-bound glutamate receptors that mediate excitatory transmission on the cellular surface through initial binding of glutamate and are categorized into ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). The metabotropic glutamate receptors (mGluR) are key receptors in the modulation of excitatory synaptic transmission in the central nervous system. The mGluRs are coupled to G proteins and are thus distinct from the iGluRs which internally contain ligand-gated ion channels. The mGluR structure is divided into three regions: the extracellular region, the seven-spanning transmembrane region and the cytoplasmic region. The extr
Probab=90.70 E-value=0.73 Score=52.12 Aligned_cols=71 Identities=30% Similarity=0.343 Sum_probs=56.8
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++..+.++|++++++.|+||+.++.++.... ..++..++++|+.. +++ +++++....++...+++. ++
T Consensus 172 ~g~~~~~~~~~~~~~~gi~v~~~~~~~~~~~---~~d~~~~l~~l~~~-~~~-------vvv~~~~~~~~~~~~~~a-~~ 239 (348)
T cd06350 172 YGRSGLSDLEEELEKNGICIAFVEAIPPSST---EEDIKRILKKLKSS-TAR-------VIVVFGDEDDALRLFCEA-YK 239 (348)
T ss_pred hHHHHHHHHHHHHHHCCCcEEEEEEccCCCc---HHHHHHHHHHHHhC-CCc-------EEEEEeCcHHHHHHHHHH-HH
Confidence 5778899999999999999999999986532 23699999999875 568 888888888877777654 66
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 240 ~g~ 242 (348)
T cd06350 240 LGM 242 (348)
T ss_pred hCC
Confidence 666
No 123
>cd06334 PBP1_ABC_ligand_binding_like_1 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters, such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=89.69 E-value=4.7 Score=45.91 Aligned_cols=110 Identities=13% Similarity=0.154 Sum_probs=70.2
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+.|...+.+|.... ++...+.++ +..++.+|++.+...++..+++++.++++.. .|+
T Consensus 154 ~~~~~~~~~~~~~~G~~vv~~~~~~~~~~-----D~~~~v~~i-~~~~pd~V~~~~~~~~~~~~~~~~~~~G~~~--~~~ 225 (351)
T cd06334 154 KEPIEALKALAEKLGFEVVLEPVPPPGPN-----DQKAQWLQI-RRSGPDYVILWGWGVMNPVAIKEAKRVGLDD--KFI 225 (351)
T ss_pred hhhHHHHHHHHHHcCCeeeeeccCCCCcc-----cHHHHHHHH-HHcCCCEEEEecccchHHHHHHHHHHcCCCc--eEE
Confidence 55677888888999999988888775432 566777776 4567888888888888888999998888754 355
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC--CCCCChHHHH
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA--NPVKGFDDYF 190 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~--~~ipgF~ef~ 190 (981)
++ .|..............+|+++..+.. ...|..++|.
T Consensus 226 ~~-~~~~~~~~~~~~g~~~~g~~~~~~~~~~~~~p~~~~f~ 265 (351)
T cd06334 226 GN-WWSGDEEDVKPAGDAAKGYKGVTPFAGGADDPVGKEIV 265 (351)
T ss_pred Ee-eccCcHHHHHHhhhhhcCcEEeecccCCCCchHHHHHH
Confidence 44 44332222222223346666554422 2334445544
No 124
>KOG1052|consensus
Probab=89.15 E-value=6.9 Score=48.70 Aligned_cols=173 Identities=13% Similarity=0.163 Sum_probs=95.9
Q ss_pred CCCcEEEEEEcchhhHHHHHHHHHhhccCC-ceEEEEeccCccccccc--CCCccceeeEEEEEecCCCCCChHHHHhhc
Q psy1666 117 KPRARGVIVFGSDQEVAGVMRAVRRLNATG-SFSWVGSDGWSARGLVS--DGSEAEVEGTLSLQPQANPVKGFDDYFLNL 193 (981)
Q Consensus 117 ~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g-~~vWI~s~~W~~~~~~~--~~~~~~~~G~l~~~~~~~~ipgF~ef~~~l 193 (981)
....+++++......+..++..+.+.++.+ .++|+.+..-....... ....+..+|.++...+...-...++|-.
T Consensus 11 ~~~~~~~v~~~~~~~~~~~~~~a~~~~~~~~~~~~i~t~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~s~~~~~~~~-- 88 (656)
T KOG1052|consen 11 AMRTRVFVLHMFPILALAIFSQAEELGMMQFGYVWILTNLLTDALDLDELYSLIDVMNGVLGLRGHIPRSELLQNFVT-- 88 (656)
T ss_pred ccCceEEEEeCCHHHHHHHHHHHHHhCccccCeEEEEEecchhhhcccccccchhheeeEEeeccCCCccHHHHHHHH--
Confidence 345688888888777888888887777654 47999874322211111 1222333455544332222211222211
Q ss_pred CCCCCCCCCccccccccccCCCCCCCCCCCCCCCCCCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcC
Q psy1666 194 TVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSHYSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQ 273 (981)
Q Consensus 194 ~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~ 273 (981)
.|... +. .........|||++++|.|.+++.. ..
T Consensus 89 --------------~~~~~-~~-----------------------------~~~~~~~~~~D~~~~~a~~~~~~~~--~~ 122 (656)
T KOG1052|consen 89 --------------RWQTS-NV-----------------------------ELLVYALWAYDAIQALARAVESLLN--IG 122 (656)
T ss_pred --------------HHhhc-cc-----------------------------cccchhhHHHHHHHHHHHHHHHhhc--CC
Confidence 12211 00 0011245789999999999998874 11
Q ss_pred CCCCCCCC-CCCCCccHHHHhhcceeeccCCCC--eEEecCCCCCC-ceeEEEEEEEcCCCcEEEEEEEEEEC
Q psy1666 274 GKVGLCDA-MRPTKGPELLKYLRKVSFQGLSED--HFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 342 (981)
Q Consensus 274 ~~~~~C~~-~~~~~~~qLl~~Lk~V~F~g~~G~--~V~FD~nGD~~-~~YdI~n~q~~~~g~~~~v~VG~~~~ 342 (981)
...-.|.. ....++..+.+++++..-.+..|. .+.++.+|... -.|+|+|.... + ...||.|++
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~n~~~~--~---~~~ig~W~~ 190 (656)
T KOG1052|consen 123 NLSLSCGRNNSWLDALGVFNFGKKLLVVNLSGVTGQFQFFRGGLLEYFKYEILNLNGS--G---ERRIGYWYP 190 (656)
T ss_pred CCceecCCCCcccchhHHHHHHHhhhhhccccceeEEEecCCCccccceEEEEEecCc--C---ceeEEEecC
Confidence 12234553 233566678888888776655433 35555444443 47999987532 2 234999986
No 125
>cd06341 PBP1_ABC_ligand_binding_like_7 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=89.00 E-value=12 Score=41.93 Aligned_cols=174 Identities=15% Similarity=0.029 Sum_probs=97.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.++++|+-+.....++... .++...+.++. ..+..+|++......+..++..+.++++.+.. +
T Consensus 147 ~~~~~~~~~~~~~~G~~v~~~~~~~~~~-----~d~~~~~~~i~-~~~pdaV~~~~~~~~a~~~~~~~~~~G~~~~~--~ 218 (341)
T cd06341 147 SAAAALLARSLAAAGVSVAGIVVITATA-----PDPTPQAQQAA-AAGADAIITVLDAAVCASVLKAVRAAGLTPKV--V 218 (341)
T ss_pred HHHHHHHHHHHHHcCCccccccccCCCC-----CCHHHHHHHHH-hcCCCEEEEecChHHHHHHHHHHHHcCCCCCE--E
Confidence 4456778888888998766555554432 24556677764 34577777777676888899999888887652 2
Q ss_pred EeccCcccccccCCCccceeeEEEEEecC---CCCCChHHHHhhcCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQA---NPVKGFDDYFLNLTVENNRRNPWFVDPPLEDHFRCKYPNSSRTPYNSH 228 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~~---~~ipgF~ef~~~l~p~~~~~n~~~~~~fw~~~f~C~~~~~~~~~~~~~ 228 (981)
.+........ ........+|.+...+.. ...|..++|.+-. ++ |... ++
T Consensus 219 ~~~~~~~~~~-~~~~g~~~~g~~~~~~~~~~~~~~p~~~~~~~~~-----------~~-~~~~-~~-------------- 270 (341)
T cd06341 219 LSGTCYDPAL-LAAPGPALAGVYIAVFYRPFESGTPAVALYLAAM-----------AR-YAPQ-LD-------------- 270 (341)
T ss_pred EecCCCCHHH-HHhcCcccCceEEEeeeccccCCCHHHHHHHHHH-----------HH-hCCC-CC--------------
Confidence 2322222221 122223456766544321 2234444443210 00 1100 00
Q ss_pred CCCCCCCcccccCCccccccccHHHHHHHHHHHHHHHHhHhhhcCCCCCCCCCCCCCCccH-HHHhhcceeeccCCCCeE
Q psy1666 229 YSTECTTHEKLSRDTLAFEKQLQFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPE-LLKYLRKVSFQGLSEDHF 307 (981)
Q Consensus 229 ~~~~Ctg~e~l~~~~~~~~~~~~~VydAVyAiAhALh~m~~~lC~~~~~~C~~~~~~~~~q-Ll~~Lk~V~F~g~~G~~V 307 (981)
..........|||++.+++|+.+.-. ...+.. +.+.|+++.+....|-.+
T Consensus 271 ---------------~~~~~~~~~~yda~~~~~~a~~~ag~--------------~~~~~~~v~~al~~~~~~~~~g~~~ 321 (341)
T cd06341 271 ---------------PPEQGFALIGYIAADLFLRGLSGAGG--------------CPTRASQFLRALRAVTDYDAGGLTP 321 (341)
T ss_pred ---------------CCcchHHHHHHHHHHHHHHHHHhcCC--------------CCChHHHHHHHhhcCCCCCCCCccc
Confidence 00011245689999999999977521 123445 899999987665555444
Q ss_pred Eec
Q psy1666 308 KFD 310 (981)
Q Consensus 308 ~FD 310 (981)
.+|
T Consensus 322 ~~~ 324 (341)
T cd06341 322 PCD 324 (341)
T ss_pred Ccc
Confidence 444
No 126
>cd00185 TNFR Tumor necrosis factor receptor (TNFR) domain; superfamily of TNF-like receptor domains. When bound to TNF-like cytokines, TNFRs trigger multiple signal transduction pathways, they are involved in inflammation response, apoptosis, autoimmunity and organogenesis. TNFRs domains are elongated with generally three tandem repeats of cysteine-rich domains (CRDs). They fit in the grooves between protomers within the ligand trimer. Some TNFRs, such as NGFR and HveA, bind ligands with no structural similarity to TNF and do not bind ligand trimers.
Probab=85.86 E-value=0.59 Score=42.57 Aligned_cols=44 Identities=18% Similarity=0.314 Sum_probs=25.7
Q ss_pred cCCccCCCCcEEeeecCcceeeccccCCCCceecCccc-cccccC
Q psy1666 788 VCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDE-TQCLTC 831 (981)
Q Consensus 788 ~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~-~~C~~C 831 (981)
.|-..|+||++....=+..==-.|.+|++|+|++..+. ..|.+|
T Consensus 12 ~cC~~C~pG~~~~~~C~~~~~t~C~~C~~g~ys~~~~~~~~C~~c 56 (98)
T cd00185 12 LCCDQCPPGTYLSKDCTPGSDTVCEPCPPGTYTDSWNHLPKCLSC 56 (98)
T ss_pred CCCCCCCCCccCCCcCCCCCCCeecCCCCCCcccCCCCCCcCCcC
Confidence 56678888876543201001135778888888877664 344444
No 127
>KOG0196|consensus
Probab=84.94 E-value=0.62 Score=56.22 Aligned_cols=41 Identities=22% Similarity=0.420 Sum_probs=24.8
Q ss_pred ccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCCCC
Q psy1666 791 LPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEGTK 836 (981)
Q Consensus 791 ~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~~~ 836 (981)
+.|++|++|..... -.|.+||.++.+....+..|. |-++++
T Consensus 277 ~aCp~G~yK~~~~~----~~C~~CP~~S~s~~ega~~C~-C~~gyy 317 (996)
T KOG0196|consen 277 QACPPGTYKASQGD----SLCLPCPPNSHSSSEGATSCT-CENGYY 317 (996)
T ss_pred eeCCCCcccCCCCC----CCCCCCCCCCCCCCCCCCccc-ccCCcc
Confidence 45777777654311 146677777776666666663 666654
No 128
>KOG4418|consensus
Probab=84.58 E-value=0.045 Score=60.05 Aligned_cols=171 Identities=18% Similarity=0.206 Sum_probs=105.5
Q ss_pred cchhhhHHHHHHHHHHHHHHHHHHhcCCCCC-CCC-----CceeccccceeeehhHHHHHHHHHHHhhcccCCCcc--cc
Q psy1666 350 FGAGFCFTVVYAALLTKTNRISRIFNAGKRT-AKR-----PNFITPKSQLMICGGLVSVQVLINGVWMLVSPPRAI--HH 421 (981)
Q Consensus 350 ~~~~~~ft~~~S~ll~KT~~I~~iF~~~~~~-~~~-----~~~i~~~~q~~iv~~~~~vqv~i~~~Wl~~~PP~~~--~~ 421 (981)
|+--.+|++.|.++|-||+|+.-+|+....+ .+. -.++++...... ++...|...+||... ..
T Consensus 16 w~rH~gF~iTyt~lLlkiwr~S~~~nv~sa~~~kltde~lL~~l~~i~~~~~---------~~l~~wtls~ppd~ev~rl 86 (438)
T KOG4418|consen 16 WWRHHGFIITYTYLLLKIWRTSGARNVVSAGGQKLTDEELLSSLDQIYPCGH---------VVLAEWTLSTPPDLEVPRL 86 (438)
T ss_pred HHHhhchhhhhhhhHhhcccccceeeccccccccccHHHHHhhccccccccc---------eeeeeEeecCCchhhhHhH
Confidence 6667899999999999999999999864322 121 123333322222 245689999998531 00
Q ss_pred cCCCcCEEEEcCC-CChHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHHHHHHHHHHHHhhhcccccCCc--
Q psy1666 422 YPSREDNILVCSS-FINASYMIAFGYPIFLIVVCTVYAILTRNIPEAFNESKHIGFTMYTTCVIWLAFVPLYFGTGNH-- 498 (981)
Q Consensus 422 ~p~~~~~il~C~~-~s~~~~~~~l~Y~~lL~l~c~~~Af~~R~lP~nfNEAK~ItFsml~~~ivWiafiP~y~~t~g~-- 498 (981)
+.. --+..|.. -.+..+... -.+-..-++=+.|+.|+-|.-|||+|+|+...|.-...-.+-....+.....
T Consensus 87 ~~q--Lkff~ck~~wwD~~ll~k---evfflawG~rvsimrR~aes~ynesR~cS~aiyn~al~~~a~~v~hv~l~ppa~ 161 (438)
T KOG4418|consen 87 IQQ--LKFFACKSKWWDPQLLDK---EVFFLAWGFRVSIMRRIAESFYNESRNCSGAIYNNALEYRARKVQHVSLRPPAM 161 (438)
T ss_pred HHH--HHHHHhhcccCCchhhhh---hhheeccCcceEEEEecccccchhhhhccHhhHhHHHHHHhhheeeEEecCCCC
Confidence 000 01234543 112222111 0122233455678889999999999999999998888877776655554432
Q ss_pred ceeeehhHHHHHHHhhhhheeEEecCCccccCcccc
Q psy1666 499 MPLRITTMSVTISLSASVTVACLFSPKVRSDGWSAR 534 (981)
Q Consensus 499 ~~~~~~~~~~~Il~s~~~~L~ciF~PK~~~~~w~~~ 534 (981)
..+.......-+-++.+-.++..|.||..-..|.-.
T Consensus 162 pdyly~~~fl~tql~~t~t~as~fd~ki~rt~~~q~ 197 (438)
T KOG4418|consen 162 PDYLYAMLFLTTQLLMTWTVASWFDTKIWRTAWPQC 197 (438)
T ss_pred ccHHHHHHHHHHHHHHHHhHHhhcccccchhccchh
Confidence 223333334456677788899999999988777643
No 129
>PF07699 GCC2_GCC3: GCC2 and GCC3; InterPro: IPR011641 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. This entry represents various ephrin type A and B receptors, which have tyrosine kinase activity.
Probab=80.73 E-value=1 Score=35.05 Aligned_cols=32 Identities=25% Similarity=0.505 Sum_probs=21.9
Q ss_pred ccCCCCcEEeeecCcceeeccccCCCCceecCcccc
Q psy1666 791 LPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDET 826 (981)
Q Consensus 791 ~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~ 826 (981)
.+|+.|+++.. +|.. .|.+||.|.++..+.+.
T Consensus 12 ~~Cp~GtYq~~-~g~~---~C~~Cp~g~~T~~~Gs~ 43 (48)
T PF07699_consen 12 QPCPKGTYQDE-EGQT---SCTPCPPGSTTSSEGST 43 (48)
T ss_pred CCCCCCccCCc-cCCc---cCccCcCCCccCCcCCc
Confidence 46888888753 3333 78889988877665544
No 130
>cd06338 PBP1_ABC_ligand_binding_like_5 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT); however their ligand specificity has not been determined experimentally.
Probab=78.73 E-value=2.9 Score=47.16 Aligned_cols=57 Identities=14% Similarity=0.194 Sum_probs=45.5
Q ss_pred HHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEe
Q psy1666 675 FVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHF 747 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~ 747 (981)
..|+|++++++|+.+. . ..++..+.+.|+++.|.+..| .+.||++||....+-+++|
T Consensus 289 ~~y~a~~~~~~a~~~a-----g----------~~~~~~v~~al~~~~~~~~~G-~~~f~~~~~~~~~~~~~~~ 345 (345)
T cd06338 289 GAYAAGQVLQEAVERA-----G----------SLDPAAVRDALASNDFDTFYG-PIKFDETGQNNHPMTVVQW 345 (345)
T ss_pred HHHHHHHHHHHHHHHh-----C----------CCCHHHHHHHHHhCCCccccc-CeeECCCCCcCCCceeeeC
Confidence 5799999999999643 1 123557889999999999998 7999999998776666654
No 131
>cd06345 PBP1_ABC_ligand_binding_like_10 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=77.19 E-value=3.1 Score=47.03 Aligned_cols=51 Identities=24% Similarity=0.360 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcce
Q psy1666 675 FVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPAR 741 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~ 741 (981)
..|||++.+++|+.+. . ...+..+.+.|+++.|.+..| .+.||++||+...
T Consensus 289 ~~yda~~~l~~A~~~a-----g----------~~~~~~i~~al~~~~~~g~~G-~i~f~~~g~~~~~ 339 (344)
T cd06345 289 STYDSIYILAEAIERA-----G----------STDGDALVEALEKTDFVGTAG-RIQFYGDDSAFAH 339 (344)
T ss_pred HHHHHHHHHHHHHHHh-----c----------CCCHHHHHHHHHhCCCcCCce-eEEECCCCCcCcC
Confidence 5799999999999743 1 112456889999999999998 7999999998754
No 132
>PHA02637 TNF-alpha-receptor-like protein; Provisional
Probab=77.15 E-value=2.9 Score=39.30 Aligned_cols=48 Identities=25% Similarity=0.481 Sum_probs=33.3
Q ss_pred CCCccCCccCCCCcEEeeecCcceeeccccCCCCceecCc----cccccccCCCCCCC
Q psy1666 784 PPESVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPS----DETQCLTCPEGTKP 837 (981)
Q Consensus 784 ~P~S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~----d~~~C~~C~~~~~~ 837 (981)
+|.......|..|.++ .+..||- .||.|++.... ....|.+||++++.
T Consensus 23 ~Py~~~~~~C~e~EY~---~~~~CC~---kCPPGt~v~~~Ct~~t~T~C~PCp~GTYT 74 (127)
T PHA02637 23 APHAPSDGKCKDNEYK---RHNLCCL---SCPPGTYASRLCDIKTNTQCTPCGSGTFT 74 (127)
T ss_pred CCCCCCCCCCCCCcCc---CCCeEcC---CCCCCCEEeCcCCCCCCcccccCCCCCee
Confidence 5777777789999763 3335765 67888875432 35689999999764
No 133
>KOG1053|consensus
Probab=77.00 E-value=6.5 Score=48.13 Aligned_cols=97 Identities=21% Similarity=0.236 Sum_probs=64.9
Q ss_pred hHHHHHHHHHHHHHHHhHHhhc--cCCCCCCCCCC---CCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLC--QGKVGLCDAMR---PTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFK 748 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c--~~~~~~c~~~~---~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~ 748 (981)
..|-|+|-.+|.|-+.|+.+.- +.....|.... ......|++||.|+.|.| ..+.|+++|-....- +..
T Consensus 297 ~rVrdgvaiva~aa~s~~~~~~~lp~~~~~C~~~~~~~~~~~~~l~r~l~NvT~~g---~~lsf~~~g~~v~p~---lvv 370 (1258)
T KOG1053|consen 297 ARVRDGVAIVARAASSMLRIHGFLPEPKMDCREQEETRLTSGETLHRFLANVTWDG---RDLSFNEDGYLVHPN---LVV 370 (1258)
T ss_pred HHHhhhHHHHHHHHHHHHhhcccCCCcccccccccCccccchhhhhhhhheeeecc---cceeecCCceeeccc---eEE
Confidence 4799999999999999974221 22334565322 123446899999999986 468999888543211 112
Q ss_pred EcCCCcEEEEEEEEEECceEEEeccccccc
Q psy1666 749 QIRPGVYQWVQVGEYLEGELRLNMSAIQFK 778 (981)
Q Consensus 749 ~~~~~~~~~~~VG~~~~~~l~in~~~i~W~ 778 (981)
...++...|.+||.|..+.|.+.. -.|.
T Consensus 371 I~l~~~r~We~VG~We~~~L~M~y--~vWP 398 (1258)
T KOG1053|consen 371 IDLNRDRTWERVGSWENGTLVMKY--PVWP 398 (1258)
T ss_pred EecCCCcchheeceecCCeEEEec--cccc
Confidence 245666789999999877777754 3565
No 134
>PRK15404 leucine ABC transporter subunit substrate-binding protein LivK; Provisional
Probab=76.99 E-value=4.6 Score=46.35 Aligned_cols=59 Identities=15% Similarity=0.349 Sum_probs=47.8
Q ss_pred HHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCc-ceeeEEEeEE
Q psy1666 675 FVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGP-ARYNIIHFKQ 749 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~-~~YdI~n~~~ 749 (981)
..|+++++++.|+... . ..++..|.+.|++..|.+..| ++.||++|+.. ..|.|.+|+.
T Consensus 302 ~~Y~~~~~l~~Al~~a-----G----------~~~~~~l~~al~~~~~~~~~G-~~~~~~~g~~~~~~~~i~~~~~ 361 (369)
T PRK15404 302 TTYAAVQSLAAGINRA-----G----------SDDPAKVAKYLKANTFDTVIG-PLSWDEKGDLKGFEFGVFEWHA 361 (369)
T ss_pred HHHHHHHHHHHHHHhh-----C----------CCCHHHHHHHHHhCCCCcceE-eeEECCCCCcccCCEEEEEEEc
Confidence 5899999999999532 1 123567999999999999998 79999999884 7899998874
No 135
>COG5472 Predicted small integral membrane protein [Function unknown]
Probab=76.07 E-value=4.1 Score=37.97 Aligned_cols=40 Identities=23% Similarity=0.452 Sum_probs=30.4
Q ss_pred HHHHHHHHHHHHhcCCCC-CcchhhhHHHHHHHHH-HHHHHH
Q psy1666 448 IFLIVVCTVYAILTRNIP-EAFNESKHIGFTMYTT-CVIWLA 487 (981)
Q Consensus 448 ~lL~l~c~~~Af~~R~lP-~nfNEAK~ItFsml~~-~ivWia 487 (981)
+.+..++-+--|++|||| ..||.||-+...-++. |+.|..
T Consensus 77 ~~~~~~ggi~M~~AR~LpA~~F~rAK~~~~~g~tL~flLWFF 118 (164)
T COG5472 77 AVFCWVGGIGMLIARKLPAKVFNRAKGIAIIGLTLGFLLWFF 118 (164)
T ss_pred HHHHHhcchHHHHhccCCHHHHhhccchhhhhhHHHHHHHHH
Confidence 345555666789999999 8999999887666666 777754
No 136
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=75.40 E-value=1.4 Score=46.67 Aligned_cols=44 Identities=23% Similarity=0.454 Sum_probs=31.4
Q ss_pred ccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCCC
Q psy1666 791 LPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEGT 835 (981)
Q Consensus 791 ~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~~ 835 (981)
++|+|||-|.......|=-=|+-|+.|+||- .+...|..|+...
T Consensus 220 dsC~PGfG~N~~~h~~C~~CCVvCsPgTysp-~~~~~C~~C~~~~ 263 (271)
T PF07354_consen 220 DSCRPGFGKNDILHSDCPSCCVVCSPGTYSP-DDDVHCQQCNSSR 263 (271)
T ss_pred eccCCCCCcCcccCCCCCCeeEECCCcccCC-CCCceEEecCcce
Confidence 3699999887654444555567788999974 3566899998643
No 137
>PF12191 stn_TNFRSF12A: Tumour necrosis factor receptor stn_TNFRSF12A_TNFR domain; InterPro: IPR022316 The tumour necrosis factor (TNF) receptor (TNFR) superfamily comprises more than 20 type-I transmembrane proteins. Family members are defined based on similarity in their extracellular domain - a region that contains many cysteine residues arranged in a specific repetitive pattern []. The cysteines allow formation of an extended rod-like structure, responsible for ligand binding []. Upon receptor activation, different intracellular signalling complexes are assembled for different members of the TNFR superfamily, depending on their intracellular domains and sequences []. Activation of TNFRs can therefore induce a range of disparate effects, including cell proliferation, differentiation, survival, or apoptotic cell death, depending upon the receptor involved []. TNFRs are widely distributed and play important roles in many crucial biological processes, such as lymphoid and neuronal development, innate and adaptive immunity, and maintenance of cellular homeostasis []. Drugs that manipulate their signalling have potential roles in the prevention and treatment of many diseases, such as viral infections, coronary heart disease, transplant rejection, and immune disease []. TNF receptor 12 (also known as TWEAK receptor, and fibroblast growth factor-inducible-14 (Fn14)) has been implicated in endothelial cell growth and migration []. The receptor may also play a role in cell-matrix interactions [].; PDB: 2KN0_A 2RPJ_A 2KMZ_A 2EQP_A.
Probab=75.38 E-value=2.2 Score=39.82 Aligned_cols=38 Identities=26% Similarity=0.675 Sum_probs=23.5
Q ss_pred CccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCC
Q psy1666 790 SLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEG 834 (981)
Q Consensus 790 s~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~ 834 (981)
+.+|++|+.-...- .=|=+|.-|+.. .+.+.|..|+.-
T Consensus 33 ~~~Cp~G~sWs~dL--dkCm~CssC~~~-----P~S~~C~~C~a~ 70 (129)
T PF12191_consen 33 TTPCPRGSSWSADL--DKCMSCSSCPAY-----PKSPFCQGCPAA 70 (129)
T ss_dssp CSSS-SSEEEETTT--TEEEECCCHCC------TT-CCCCCHSS-
T ss_pred CCCCCCCCcCcccc--cccccCccCCCC-----CCCccccCCCCC
Confidence 46788997544322 356788888864 466789999863
No 138
>cd06268 PBP1_ABC_transporter_LIVBP_like Periplasmic binding domain of ATP-binding cassette transporter-like systems that belong to the type I periplasmic binding fold protein superfamily. Periplasmic binding domain of ATP-binding cassette transporter-like systems that belong to the type I periplasmic binding fold protein superfamily. They are mostly present in archaea and eubacteria, and are primarily involved in scavenging solutes from the environment. ABC-type transporters couple ATP hydrolysis with the uptake and efflux of a wide range of substrates across bacterial membranes, including amino acids, peptides, lipids and sterols, and various drugs. These systems are comprised of transmembrane domains, nucleotide binding domains, and in most bacterial uptake systems, periplasmic binding proteins (PBPs) which transfer the ligand to the extracellular gate of the transmembrane domains. These PBPs bind their substrates selectively and with high affinity. Members of this group include ABC
Probab=75.11 E-value=21 Score=38.52 Aligned_cols=99 Identities=19% Similarity=0.260 Sum_probs=64.0
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
....+.+++.++++|+++.....++... .+....+++++. .+..+|++......+..++.++.++++. ..|+
T Consensus 149 ~~~~~~~~~~~~~~g~~i~~~~~~~~~~-----~~~~~~~~~l~~-~~~~~vi~~~~~~~~~~~~~~~~~~g~~--~~~~ 220 (298)
T cd06268 149 RGLAAAFREALKKLGGEVVAEETYPPGA-----TDFSPLIAKLKA-AGPDAVFLAGYGGDAALFLKQAREAGLK--VPIV 220 (298)
T ss_pred HHHHHHHHHHHHHcCCEEEEEeccCCCC-----ccHHHHHHHHHh-cCCCEEEEccccchHHHHHHHHHHcCCC--CcEE
Confidence 4456778888888999887776665432 244556666643 3566777777767788888888887773 3688
Q ss_pred EeccCcccccccCCCccceeeEEEEEec
Q psy1666 152 GSDGWSARGLVSDGSEAEVEGTLSLQPQ 179 (981)
Q Consensus 152 ~s~~W~~~~~~~~~~~~~~~G~l~~~~~ 179 (981)
+.+.|...... ....+..+|.+...+.
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~g~~~~~~~ 247 (298)
T cd06268 221 GGDGAAAPALL-ELAGDAAEGVLGTTPY 247 (298)
T ss_pred ecCccCCHHHH-HhhhHhhCCcEEeccC
Confidence 88888754332 1122334566666553
No 139
>cd06269 PBP1_glutamate_receptors_like Family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domain of the ionotropic glutamate receptors. This CD represents the ligand-binding domain of the family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domain of the ionotropic glutamate receptors, all of which are structurally similar and related to the periplasmic-binding fold type I family. The family C GPCRs consist of metabotropic glutamate receptor (mGluR) receptors, a calcium-sensing receptor (CaSR), gamma-aminobutyric receptors (GABAb), the promiscuous L-alpha-amino acid receptor GPR6A, families of taste and pheromone receptors, and orphan receptors. Truncated splicing va
Probab=73.24 E-value=12 Score=40.61 Aligned_cols=69 Identities=28% Similarity=0.356 Sum_probs=52.9
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++..+.+.|++..++.|+|+...+.++... ..+..++++|+.. .++ ++|.+...+++...+++. .+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~-----~~~~~~l~~l~~~-~~~-------viv~~~~~~~~~~~l~~a-~~ 217 (298)
T cd06269 152 YGRRLLELLEEELEKNGICVAFVESIPDGS-----EDIRRLLKELKSS-TAR-------VIVVFSSEEDALRLLEEA-VE 217 (298)
T ss_pred hhHHHHHHHHHHHHHCCeeEEEEEEcCCCH-----HHHHHHHHHHHhc-CCc-------EEEEEechHHHHHHHHHH-HH
Confidence 577888889999988899999999987542 2688999999765 447 888887777777777654 55
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 218 ~g~ 220 (298)
T cd06269 218 LGM 220 (298)
T ss_pred cCC
Confidence 555
No 140
>cd00185 TNFR Tumor necrosis factor receptor (TNFR) domain; superfamily of TNF-like receptor domains. When bound to TNF-like cytokines, TNFRs trigger multiple signal transduction pathways, they are involved in inflammation response, apoptosis, autoimmunity and organogenesis. TNFRs domains are elongated with generally three tandem repeats of cysteine-rich domains (CRDs). They fit in the grooves between protomers within the ligand trimer. Some TNFRs, such as NGFR and HveA, bind ligands with no structural similarity to TNF and do not bind ligand trimers.
Probab=71.19 E-value=4.4 Score=36.87 Aligned_cols=49 Identities=31% Similarity=0.634 Sum_probs=32.7
Q ss_pred CCCCcEEeeecCcceeeccccCCCCceecCc----cccccccCCCCCCCCccc--cCccc
Q psy1666 793 CDIGQAKKYVEGESCCWHCFNCSQYQIRLPS----DETQCLTCPEGTKPDLLR--QNCLE 846 (981)
Q Consensus 793 C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~----d~~~C~~C~~~~~~n~~~--~~C~~ 846 (981)
|++|++.. ..+ .| |..||.|++.... ....|.+||++++.+... ..|.+
T Consensus 1 c~~~~y~~-~~~-~c---C~~C~pG~~~~~~C~~~~~t~C~~C~~g~ys~~~~~~~~C~~ 55 (98)
T cd00185 1 CREGEYYY-TGG-LC---CDQCPPGTYLSKDCTPGSDTVCEPCPPGTYTDSWNHLPKCLS 55 (98)
T ss_pred CCCcceEc-CCC-CC---CCCCCCCccCCCcCCCCCCCeecCCCCCCcccCCCCCCcCCc
Confidence 66777664 122 45 5678999886653 346799999998877544 35654
No 141
>cd06366 PBP1_GABAb_receptor Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA). Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA). GABA is the major inhibitory neurotransmitter in the mammalian CNS and, like glutamate and other transmitters, acts via both ligand gated ion channels (GABAa receptors) and G-protein coupled receptors (GABAb). GABAa receptors are members of the ionotropic receptor superfamily which includes alpha-adrenergic and glycine receptors. The GABAb receptor is a member of a receptor superfamily which includes the mGlu receptors. The GABAb receptor is coupled to G alpha_i proteins, and activation causes a decrease in calcium, an increase in potassium membrane conductance, and inhibition of cAMP formation. The response is thus inhibitory and leads to hyperpolarization and decreased neurotransmitter release, for example.
Probab=68.74 E-value=15 Score=41.42 Aligned_cols=72 Identities=17% Similarity=0.154 Sum_probs=53.6
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....++|.+.+++.|+||...+.++...+ ..+|..++++|+.. +++ ++++.....++...+++. .+
T Consensus 147 ~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~~---~~d~~~~l~~i~~~-~~d-------vvi~~~~~~~~~~~~~~a-~~ 214 (350)
T cd06366 147 YGSGGLPDLVDALQEAGIEISYRAAFPPSAN---DDDITDALKKLKEK-DSR-------VIVVHFSPDLARRVFCEA-YK 214 (350)
T ss_pred ccchhHHHHHHHHHHcCCEEEEEeccCCCCC---hhHHHHHHHHHhcC-CCe-------EEEEECChHHHHHHHHHH-HH
Confidence 4556789999999999999999998875421 23799999999764 567 777777777777766544 56
Q ss_pred CCee
Q psy1666 85 SSIC 88 (981)
Q Consensus 85 ~gIC 88 (981)
.|..
T Consensus 215 ~g~~ 218 (350)
T cd06366 215 LGMM 218 (350)
T ss_pred cCCc
Confidence 6763
No 142
>KOG0196|consensus
Probab=67.98 E-value=3.5 Score=50.17 Aligned_cols=56 Identities=20% Similarity=0.462 Sum_probs=43.7
Q ss_pred CCCccCCccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCCCCC-CccccCccc
Q psy1666 784 PPESVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEGTKP-DLLRQNCLE 846 (981)
Q Consensus 784 ~P~S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~~~~-n~~~~~C~~ 846 (981)
+|...| .|.+||....... .|..||.|.|....+...|.+||....+ ++..+.|.=
T Consensus 256 vpiG~C--~C~aGye~~~~~~-----~C~aCp~G~yK~~~~~~~C~~CP~~S~s~~ega~~C~C 312 (996)
T KOG0196|consen 256 VPIGGC--VCKAGYEEAENGK-----ACQACPPGTYKASQGDSLCLPCPPNSHSSSEGATSCTC 312 (996)
T ss_pred EEcCce--eecCCCCcccCCC-----cceeCCCCcccCCCCCCCCCCCCCCCCCCCCCCCcccc
Confidence 455566 4999998755443 7899999999888788899999998766 777777753
No 143
>PTZ00087 thrombosponding-related protein; Provisional
Probab=63.57 E-value=14 Score=39.02 Aligned_cols=34 Identities=18% Similarity=0.205 Sum_probs=25.6
Q ss_pred eEEEeccccccccCCCCCCCccCCccCC--CCcEEeeec
Q psy1666 767 ELRLNMSAIQFKLSHPSPPESVCSLPCD--IGQAKKYVE 803 (981)
Q Consensus 767 ~l~in~~~i~W~~~~~~~P~S~Cs~~C~--pG~~k~~~~ 803 (981)
+|.|.+....|..- .+=|.||.+|. .|.+...+.
T Consensus 223 ~l~iek~~~~WSeW---SeWS~CSkTCGgggGVQtRtRt 258 (340)
T PTZ00087 223 SLIIEKKNMFYTEW---GEWSNCSMECDHPDNVQIRERK 258 (340)
T ss_pred eEEEEcCCCCCCCC---CCCCCcCcccCCCCCeEeEEEe
Confidence 67787777778654 36789999999 577776654
No 144
>cd00064 FU Furin-like repeats. Cysteine rich region. Exact function of the domain is not known. Furin is a serine-kinase dependent proprotein processor. Other members of this family include endoproteases and cell surface receptors.
Probab=62.41 E-value=5.6 Score=30.89 Aligned_cols=32 Identities=34% Similarity=0.713 Sum_probs=24.8
Q ss_pred ccccCCCCceecCccccccc-cCCCCCCCCccccCc
Q psy1666 810 HCFNCSQYQIRLPSDETQCL-TCPEGTKPDLLRQNC 844 (981)
Q Consensus 810 ~C~~C~~g~isn~~d~~~C~-~C~~~~~~n~~~~~C 844 (981)
+|..|++|.+ .+..+|. .||++++.+.....|
T Consensus 16 ~C~~C~~~~~---~~~~~Cv~~C~~~~~~~~~~~~C 48 (49)
T cd00064 16 QCTSCRHGFY---LDGGTCVSECPEGTYADTEGGVC 48 (49)
T ss_pred cCccCcCccC---CCCCcccccCCCCceecCcCCcC
Confidence 6888898877 4566787 899998888666655
No 145
>cd06346 PBP1_ABC_ligand_binding_like_11 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=60.28 E-value=33 Score=38.07 Aligned_cols=69 Identities=7% Similarity=-0.049 Sum_probs=49.3
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....++|++.+++.|++|...+.++.. ..+|..++.+|+.. +.. +|++.....++...+++ +++
T Consensus 149 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~-----~~d~~~~v~~l~~~-~pd-------~v~~~~~~~~~~~~~~~-~~~ 214 (312)
T cd06346 149 YGVGLADAFTKAFEALGGTVTNVVAHEEG-----KSSYSSEVAAAAAG-GPD-------ALVVIGYPETGSGILRS-AYE 214 (312)
T ss_pred hhhHHHHHHHHHHHHcCCEEEEEEeeCCC-----CCCHHHHHHHHHhc-CCC-------EEEEecccchHHHHHHH-HHH
Confidence 56677899999999999999998888744 33799999999764 445 55554444555555554 456
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 215 ~G~ 217 (312)
T cd06346 215 QGL 217 (312)
T ss_pred cCC
Confidence 665
No 146
>cd06368 PBP1_iGluR_non_NMDA_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the non-NMDA (N-methyl-d-asparate) subtypes of ionotropic glutamate receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the non-NMDA (N-methyl-d-asparate) subtypes of ionotropic glutamate receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Glutamate mediates the majority of excitatory synaptic transmission in the central nervous system via two broad classes of ionotropic receptors, characterized by their response to glutamate agonists: N-methyl-d -aspartate (NMDA) and non-NMDA receptors. NMDA receptors
Probab=57.55 E-value=29 Score=38.51 Aligned_cols=68 Identities=18% Similarity=0.194 Sum_probs=50.2
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
.+..+++++.+++.+.|+++...+..+ . . . +|..++.+|+.. +++ +|+++....++...+++. .+
T Consensus 138 ~~~~~l~~~~~~~~~~g~~v~~~~~~~-~-~---~-d~~~~l~~i~~~-~~d-------~Vi~~~~~~~~~~i~~qa-~~ 202 (324)
T cd06368 138 EGLLRLQELLDALSPKGIQVTVRRLDD-D-T---D-MYRPLLKEIKRE-KER-------RIILDCSPERLKEFLEQA-VE 202 (324)
T ss_pred HhHHHHHHHHHhhccCCceEEEEEecC-C-c---h-HHHHHHHHHhhc-cCc-------eEEEECCHHHHHHHHHHH-HH
Confidence 466788999999888899999765433 1 1 2 598999999764 566 778888888777776644 56
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 203 ~g~ 205 (324)
T cd06368 203 VGM 205 (324)
T ss_pred hcc
Confidence 666
No 147
>cd06347 PBP1_ABC_ligand_binding_like_12 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=57.03 E-value=37 Score=37.71 Aligned_cols=69 Identities=14% Similarity=-0.010 Sum_probs=47.6
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....+.|++.+++.|+|+..++.++... .+|..++.++++. ++. ++++..........+ +++.+
T Consensus 148 ~~~~~~~~~~~~~~~~g~~v~~~~~~~~~~-----~d~~~~~~~~~~~-~~d-------~i~~~~~~~~~~~~~-~~~~~ 213 (334)
T cd06347 148 YSKGLAKAFKEAFKKLGGEIVAEETFNAGD-----TDFSAQLTKIKAK-NPD-------VIFLPGYYTEVGLIA-KQARE 213 (334)
T ss_pred hhHHHHHHHHHHHHHcCCEEEEEEEecCCC-----CcHHHHHHHHHhc-CCC-------EEEEcCchhhHHHHH-HHHHH
Confidence 445567889998888899999988887542 2699999999764 555 666666555554444 44455
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 214 ~g~ 216 (334)
T cd06347 214 LGI 216 (334)
T ss_pred cCC
Confidence 554
No 148
>cd06343 PBP1_ABC_ligand_binding_like_8 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=55.70 E-value=41 Score=38.12 Aligned_cols=69 Identities=19% Similarity=0.105 Sum_probs=49.0
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....+.|++.+++.|+++..++.++.. ..+|...+.+|+.. +.. +|++.....+....+ +++++
T Consensus 156 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~-----~~d~~~~v~~i~~~-~~d-------~v~~~~~~~~~~~~~-~~~~~ 221 (362)
T cd06343 156 FGKDYLKGLKDGLGDAGLEIVAETSYEVT-----EPDFDSQVAKLKAA-GAD-------VVVLATTPKFAAQAI-RKAAE 221 (362)
T ss_pred HHHHHHHHHHHHHHHcCCeEEEEeeecCC-----CccHHHHHHHHHhc-CCC-------EEEEEcCcHHHHHHH-HHHHH
Confidence 56678899999999999999999988855 23799999999754 444 555554444454444 45566
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 222 ~g~ 224 (362)
T cd06343 222 LGW 224 (362)
T ss_pred cCC
Confidence 665
No 149
>cd06335 PBP1_ABC_ligand_binding_like_2 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters, such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=52.90 E-value=50 Score=37.26 Aligned_cols=69 Identities=10% Similarity=-0.015 Sum_probs=50.2
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....+.|++.+++.|+++...+.++... .+|...+++|+.. ... +|++.....+....++ ++++
T Consensus 150 ~g~~~~~~~~~~~~~~G~~v~~~~~~~~~~-----~d~s~~i~~i~~~-~~d-------~v~~~~~~~~~~~~~~-~~~~ 215 (347)
T cd06335 150 WGRSNRKDLTAALAARGLKPVAVEWFNWGD-----KDMTAQLLRAKAA-GAD-------AIIIVGNGPEGAQIAN-GMAK 215 (347)
T ss_pred hhhhHHHHHHHHHHHcCCeeEEEeeecCCC-----ccHHHHHHHHHhC-CCC-------EEEEEecChHHHHHHH-HHHH
Confidence 566778899999999999999988887542 2688999999764 445 5565555566665554 4456
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 216 ~g~ 218 (347)
T cd06335 216 LGW 218 (347)
T ss_pred cCC
Confidence 666
No 150
>cd06332 PBP1_aromatic_compounds_like Type I periplasmic binding proteins of active transport systems that are predicted to be involved in transport of aromatic compounds such as 2-nitrobenzoic acid and alkylbenzenes. This group includes the type I periplasmic binding proteins of active transport systems that are predicted to be involved in transport of aromatic compounds such as 2-nitrobenzoic acid and alkylbenzenes; their substrate specificities are not well characterized, however. Members also exhibit close similarity to active transport systems for short chain amides and/or urea found in bacteria and archaea.
Probab=51.91 E-value=28 Score=38.67 Aligned_cols=54 Identities=22% Similarity=0.273 Sum_probs=41.1
Q ss_pred HHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCccee
Q psy1666 675 FVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARY 742 (981)
Q Consensus 675 ~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~Y 742 (981)
..|||++.++.|+.+. ... ..++..+.+.|++.+|.+..| .+.||++|+....+
T Consensus 275 ~~yda~~~~~~a~~~a-----g~~--------~~~~~~v~~al~~~~~~~~~g-~i~f~~~~~~~~~~ 328 (333)
T cd06332 275 QGYDAAQLLDAALRAV-----GGD--------LSDKDALRAALRAADFDSPRG-PFKFNPNHNPIQDF 328 (333)
T ss_pred HHHHHHHHHHHHHHHh-----cCC--------CCCHHHHHHHHhcCceecCcc-ceeECCCCCcccce
Confidence 6899999999999653 110 123456889999999999888 69999999875544
No 151
>cd06336 PBP1_ABC_ligand_binding_like_3 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This group includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters (HAAT), such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=50.78 E-value=43 Score=37.77 Aligned_cols=69 Identities=13% Similarity=0.055 Sum_probs=50.2
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecch-hHHHHHHHHHH
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRET-TAFEELEVLLA 83 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~-~~~~~l~~~~~ 83 (981)
++....+.|++.+++.|++|..++.++.. ..+|...+++|++. .+. ++++..... +....+++ ++
T Consensus 150 ~g~~~~~~~~~~l~~~G~~vv~~~~~~~~-----~~D~s~~i~~i~~~-~~d-------~v~~~~~~~~~~~~~~~~-~~ 215 (347)
T cd06336 150 YGQPWVAAYKAAWEAAGGKVVSEEPYDPG-----TTDFSPIVTKLLAE-KPD-------VIFLGGPSPAPAALVIKQ-AR 215 (347)
T ss_pred hhHHHHHHHHHHHHHcCCEEeeecccCCC-----CcchHHHHHHHHhc-CCC-------EEEEcCCCchHHHHHHHH-HH
Confidence 56778899999999999999999888754 23799999999753 556 565555555 55555554 45
Q ss_pred hCCe
Q psy1666 84 KSSI 87 (981)
Q Consensus 84 ~~gI 87 (981)
+.|+
T Consensus 216 ~~g~ 219 (347)
T cd06336 216 ELGF 219 (347)
T ss_pred HcCC
Confidence 6565
No 152
>cd06349 PBP1_ABC_ligand_binding_like_14 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in the uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=50.02 E-value=56 Score=36.60 Aligned_cols=69 Identities=10% Similarity=0.074 Sum_probs=48.4
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....+.|++.+++.|+||..++.++.. ..+|+..+++|+.. ++. +|++.....+... |.+++++
T Consensus 147 ~g~~~~~~~~~~~~~~g~~v~~~~~~~~~-----~~d~~~~v~~l~~~-~~d-------~v~~~~~~~~~~~-~~~~~~~ 212 (340)
T cd06349 147 WGRTSADIFVKAAEKLGGQVVAHEEYVPG-----EKDFRPTITRLRDA-NPD-------AIILISYYNDGAP-IARQARA 212 (340)
T ss_pred HhHHHHHHHHHHHHHcCCEEEEEEEeCCC-----CCcHHHHHHHHHhc-CCC-------EEEEccccchHHH-HHHHHHH
Confidence 55667889999999999999998887744 22699999999653 555 5555554455554 4445556
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 213 ~g~ 215 (340)
T cd06349 213 VGL 215 (340)
T ss_pred cCC
Confidence 665
No 153
>cd06382 PBP1_iGluR_Kainate N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the kainate receptors. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the kainate receptors, non-NMDA ionotropic receptors which respond to the neurotransmitter glutamate. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Kainate receptors have five subunits, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeri
Probab=49.92 E-value=13 Score=41.54 Aligned_cols=36 Identities=22% Similarity=0.435 Sum_probs=28.3
Q ss_pred CCCCCeEEeccCCCCc-ceeeEEEeEEcCCCcEEEEEEEEEEC
Q psy1666 724 GLSEDHFKFDKDGDGP-ARYNIIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 724 ~~~g~~v~Fd~~Gd~~-~~YdI~n~~~~~~~~~~~~~VG~~~~ 765 (981)
|.+|. |.||++||+. -.|||+|.+ ...+++||.|++
T Consensus 286 g~tG~-v~f~~~g~r~~~~~~~~~~~-----~~~~~~vg~w~~ 322 (327)
T cd06382 286 GLTGR-IEFDSSGQRSNFTLDVIELT-----ESGLRKVGTWNS 322 (327)
T ss_pred ecccc-eeeCCCCCEeeeEEEEEecc-----ccCceEEEEECC
Confidence 78884 9999999986 478888764 234688999974
No 154
>cd06359 PBP1_Nba_like Type I periplasmic binding component of active transport systems that are predicted to be involved in 2-nitrobenzoic acid degradation pathway. This group includes the type I periplasmic binding component of active transport systems that are predicted to be involved in 2-nitrobenzoic acid degradation pathway; their substrate specificities are not well characterized.
Probab=49.04 E-value=32 Score=38.48 Aligned_cols=58 Identities=17% Similarity=0.223 Sum_probs=42.9
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNII 745 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~ 745 (981)
...|+|++++|.|+.+. .. . ..++..+.+.|++..|.+..| .+.|+++|+.....-++
T Consensus 274 ~~~yda~~~~~~A~~~a-----g~----~----~~~~~~v~~al~~~~~~~~~G-~~~~~~~~~~~~~~~~~ 331 (333)
T cd06359 274 AQAYDAAQLLDSAVRKV-----GG----N----LSDKDALRAALRAADFKSVRG-AFRFGTNHFPIQDFYLR 331 (333)
T ss_pred HHHHHHHHHHHHHHHHh-----cC----C----CCCHHHHHHHHhcCccccCcc-ceEECCCCCcceeEEEE
Confidence 36899999999998643 11 0 124567999999999999888 79999988876544443
No 155
>PTZ00359 hypothetical protein; Provisional
Probab=48.50 E-value=59 Score=36.87 Aligned_cols=97 Identities=13% Similarity=0.015 Sum_probs=51.4
Q ss_pred cccccccccchhhH-HHHHHHHHHHHHHHHHHhh------hheeecCcceeeeCCcc---chHHHHHHHHHHHhhheeee
Q psy1666 846 EIPAMFIEITSTWA-IGAMALSSTGILMTLLIVG------VFIRHNNTPVVKAAGRE---LSYVLLFGILLCYLVTFVLV 915 (981)
Q Consensus 846 ~~~~~~l~~~~~~~-i~~~~~s~~~~~~t~~v~~------ifi~~r~tpiVka~n~~---Ls~~lL~~l~l~fl~~~~fi 915 (981)
|+..+-.+|--|+. +.+++.+++|+..+.+.+. +-++.-++-=.|-.|.. ||+++|++.++..++..= -
T Consensus 17 p~v~~~~~yllp~~~~lFivvaiLG~g~c~ALllnavv~~~~~~~l~~~~~~dkn~~~t~LS~~Ill~yi~LH~lGYy-C 95 (443)
T PTZ00359 17 PKVADQVRYLMPIAKLLFILVAILGFGFCMAMLLNATVEAIEIKALQTEEFKLKNADMTALSIAICLSHLALHFLGYK-C 95 (443)
T ss_pred ccccchhhhhchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccccCCCCcchHHHHHHHHHHHHHHhccc-c
Confidence 34443344443333 3344555555444333322 22223233333445555 888777666655543221 1
Q ss_pred ecCceeeechhhhhhHHHHHHHHHHHHH
Q psy1666 916 LKPSDLVCAIQRFGAGFCFTVVYAALLT 943 (981)
Q Consensus 916 g~p~~~~C~lr~~~f~i~ft~~~s~il~ 943 (981)
.--....|.-+++++..+|.+.+++-++
T Consensus 96 ~yvktpls~~~~~lii~GflvV~~Af~a 123 (443)
T PTZ00359 96 RFMKLHWTSWDSGLFILGFVVVISAFFA 123 (443)
T ss_pred ceeecchhHHHHHHHHhhhHHHHHHhhh
Confidence 1124457899999999999998887553
No 156
>cd06348 PBP1_ABC_ligand_binding_like_13 Type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in uptake of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine/isoleucine/valine binding protein (LIVBP); however its ligand specificity has not been determined experimentally.
Probab=48.48 E-value=59 Score=36.47 Aligned_cols=69 Identities=6% Similarity=0.107 Sum_probs=51.0
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....++|++.+++.|+++...+.++.. ..+|..++++|+.. .+. +|++.....++...++ ++++
T Consensus 149 ~g~~~~~~~~~~~~~~g~~v~~~~~~~~~-----~~d~~~~v~~i~~~-~~d-------~vi~~~~~~~~~~~~~-~~~~ 214 (344)
T cd06348 149 FSVSETEIFQKALRDQGLNLVTVQTFQTG-----DTDFQAQITAVLNS-KPD-------LIVISALAADGGNLVR-QLRE 214 (344)
T ss_pred HHHHHHHHHHHHHHHcCCEEEEEEeeCCC-----CCCHHHHHHHHHhc-CCC-------EEEECCcchhHHHHHH-HHHH
Confidence 45677889999999999999998888744 23799999999764 566 6666666666665544 5556
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 215 ~g~ 217 (344)
T cd06348 215 LGY 217 (344)
T ss_pred cCC
Confidence 665
No 157
>cd06340 PBP1_ABC_ligand_binding_like_6 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=42.10 E-value=77 Score=35.69 Aligned_cols=69 Identities=10% Similarity=0.033 Sum_probs=48.3
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....+.|.+.+++.|+++...+.++.. ..+|...+++|+.. ++. +|++.....+....+ +++++
T Consensus 156 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~-----~~d~~~~i~~l~~~-~~d-------~v~~~~~~~~~~~~~-~~~~~ 221 (347)
T cd06340 156 FGTSVAEAIKKFAKERGFEIVEDISYPAN-----ARDLTSEVLKLKAA-NPD-------AILPASYTNDAILLV-RTMKE 221 (347)
T ss_pred HhHHHHHHHHHHHHHcCCEEEEeeccCCC-----CcchHHHHHHHHhc-CCC-------EEEEcccchhHHHHH-HHHHH
Confidence 45667888888888899999998888754 23799999999653 455 555554445555444 45566
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 222 ~G~ 224 (347)
T cd06340 222 QRV 224 (347)
T ss_pred cCC
Confidence 665
No 158
>cd04509 PBP1_ABC_transporter_GCPR_C_like Family C of G-protein coupled receptors and their close homologs, the type I periplasmic-binding proteins of ATP-binding cassette transporter-like systems. This CD includes members of the family C of G-protein coupled receptors and their close homologs, the type I periplasmic-binding proteins of ATP-binding cassette transporter-like systems. The family C GPCR includes glutamate/glycine-gated ion channels such as the NMDA receptor, G-protein-coupled receptors, metabotropic glutamate, GABA-B, calcium sensing, phermone receptors, and atrial natriuretic peptide-guanylate cyclase receptors. The glutamate receptors that form cation-selective ion channels, iGluR, can be classified into three different subgroups according to their binding-affinity for the agonists NMDA (N-methyl-D-asparate), AMPA (alpha-amino-3-dihydro-5-methyl-3-oxo-4-isoxazolepropionic acid), and kainate. L-glutamate is a major neurotransmitter in the brain of vertebrates and acts th
Probab=37.85 E-value=1.1e+02 Score=32.77 Aligned_cols=69 Identities=14% Similarity=0.136 Sum_probs=45.9
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
.+.+..+.|++.+++.|+++.....++... .++..+++++++. ..+ +++.......+...++ ++.+
T Consensus 148 ~~~~~~~~~~~~~~~~g~~i~~~~~~~~~~-----~~~~~~~~~l~~~-~~~-------~v~~~~~~~~~~~~~~-~~~~ 213 (299)
T cd04509 148 YGRGLLEAFKAAFKKKGGTVVGEEYYPLGT-----TDFTSLLQKLKAA-KPD-------VIVLCGSGEDAATILK-QAAE 213 (299)
T ss_pred HHHHHHHHHHHHHHHcCCEEEEEecCCCCC-----ccHHHHHHHHHhc-CCC-------EEEEcccchHHHHHHH-HHHH
Confidence 455678889888888899998776665432 2577889988753 345 5555555466665555 4456
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 214 ~g~ 216 (299)
T cd04509 214 AGL 216 (299)
T ss_pred cCC
Confidence 665
No 159
>cd01391 Periplasmic_Binding_Protein_Type_1 Type 1 periplasmic binding fold superfamily. Type 1 periplasmic binding fold superfamily. This model and hierarchy represent the ligand binding domains of the LacI family of transcriptional regulators, periplasmic binding proteins of the ABC-type transport systems, the family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases including the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domains of the ionotropic glutamate receptors (iGluRs). In LacI-like transcriptional regulator and the bacterial periplasmic binding proteins the ligands are monosaccharides including lactose, ribose, fructose, xylose, arabinose, galactose/glucose, and other sugars, with a few exceptions. Periplasmic sugar binding proteins are one of the components of ABC transporters and are involved in the active transport of water-soluble ligands. The LacI family of proteins con
Probab=37.46 E-value=1.4e+02 Score=30.86 Aligned_cols=81 Identities=25% Similarity=0.399 Sum_probs=48.3
Q ss_pred hHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccC-CceEEE
Q psy1666 73 TAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNAT-GSFSWV 151 (981)
Q Consensus 73 ~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~-g~~vWI 151 (981)
...+.+++.+++.|+.+......+... ...++.....+.+..++++|++..+ ..+..++.++.+.++. +...|+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~i~~~~~-~~a~~~~~~~~~~g~~~~~~~ii 214 (269)
T cd01391 140 ERLEGFKAALKKAGIEVVAIEYGDLDT----EKGFQALLQLLKAAPKPDAIFACND-EMAAGALKAAREAGLTPGDISII 214 (269)
T ss_pred HHHHHHHHHHHhcCcEEEeccccCCCc----cccHHHHHHHHhcCCCCCEEEEcCc-hHHHHHHHHHHHcCCCCCCCEEE
Confidence 345677777778886654433333221 1233444444333336777777665 7788888888887775 345788
Q ss_pred EeccCcc
Q psy1666 152 GSDGWSA 158 (981)
Q Consensus 152 ~s~~W~~ 158 (981)
+.+.|..
T Consensus 215 ~~~~~~~ 221 (269)
T cd01391 215 GFDGSPA 221 (269)
T ss_pred ecccccc
Confidence 7777654
No 160
>cd06333 PBP1_ABC-type_HAAT_like Type I periplasmic binding component of ABC (ATPase Binding Cassette)-type transport systems that are predicted to be involved in uptake of amino acids. This subgroup includes the type I periplasmic binding component of ABC (ATPase Binding Cassette)-type transport systems that are predicted to be involved in uptake of amino acids. Members of this subgroup are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters (HAAT), such as leucine-isoleucine-valine-binding protein (LIVBP); their ligand specificity has not been determined experimentally, however.
Probab=37.12 E-value=3.3e+02 Score=29.85 Aligned_cols=78 Identities=19% Similarity=0.318 Sum_probs=50.1
Q ss_pred hhHHHHHHHHHHhCCeeEEEEEEeecCCcchhhhhHHHHHHHHhcCCCcEEEEEEcchhhHHHHHHHHHhhccCCceEEE
Q psy1666 72 TTAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARGVIVFGSDQEVAGVMRAVRRLNATGSFSWV 151 (981)
Q Consensus 72 ~~~~~~l~~~~~~~gICIA~~~~ip~~~~~~~~~~~~~ii~~li~~s~a~VIVl~~s~~~a~~~~~~~~~~~l~g~~vWI 151 (981)
+...+.+++.+++.|+++.....++.... +....+.+++ .+.+.+|++......+..++.++.++++... +|
T Consensus 147 ~~~~~~~~~~~~~~G~~v~~~~~~~~~~~-----d~~~~~~~l~-~~~pdaIi~~~~~~~~~~~~~~l~~~g~~~p-~~- 218 (312)
T cd06333 147 ESGLKELKALAPKYGIEVVADERYGRTDT-----SVTAQLLKIR-AARPDAVLIWGSGTPAALPAKNLRERGYKGP-IY- 218 (312)
T ss_pred HHHHHHHHHHHHHcCCEEEEEEeeCCCCc-----CHHHHHHHHH-hCCCCEEEEecCCcHHHHHHHHHHHcCCCCC-EE-
Confidence 34456778888899999987777654321 3444455543 3446777777766667778888888877664 33
Q ss_pred EeccCc
Q psy1666 152 GSDGWS 157 (981)
Q Consensus 152 ~s~~W~ 157 (981)
+++++.
T Consensus 219 ~~~~~~ 224 (312)
T cd06333 219 QTHGVA 224 (312)
T ss_pred eecCcC
Confidence 444444
No 161
>cd06360 PBP1_alkylbenzenes_like Type I periplasmic binding component of active transport systems that are predicted be involved in anaerobic biodegradation of alkylbenzenes such as toluene and ethylbenzene. This group includes the type I periplasmic binding component of active transport systems that are predicted be involved in anaerobic biodegradation of alkylbenzenes such as toluene and ethylbenzene; their substrate specificity is not well characterized, however.
Probab=37.06 E-value=1.1e+02 Score=33.92 Aligned_cols=69 Identities=7% Similarity=0.098 Sum_probs=47.5
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....+.|++.+++.|+.+..++.++.. ..+|..++.+|+.. +.. +|++.....+....++ ++++
T Consensus 146 ~g~~~~~~~~~~~~~~G~~v~~~~~~~~~-----~~d~~~~v~~~~~~-~pd-------~v~~~~~~~~~~~~~~-~~~~ 211 (336)
T cd06360 146 FGYEVVEGFKEAFTEAGGKIVKELWVPFG-----TSDFASYLAQIPDD-VPD-------AVFVFFAGGDAIKFVK-QYDA 211 (336)
T ss_pred hhHHHHHHHHHHHHHcCCEEEEEEecCCC-----CcchHHHHHHHHhc-CCC-------EEEEecccccHHHHHH-HHHH
Confidence 34455788989999999999988777644 23799999999764 444 4555555556655554 4456
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 212 ~g~ 214 (336)
T cd06360 212 AGL 214 (336)
T ss_pred cCC
Confidence 676
No 162
>KOG4418|consensus
Probab=36.46 E-value=14 Score=41.31 Aligned_cols=40 Identities=23% Similarity=0.230 Sum_probs=36.2
Q ss_pred cCceeeechhhhhhHHHHHHHHHHHHHHHHHHHHHhccCC
Q psy1666 917 KPSDLVCAIQRFGAGFCFTVVYAALLTKTNRISRIFNAGK 956 (981)
Q Consensus 917 ~p~~~~C~lr~~~f~i~ft~~~s~il~Kt~~v~~~F~~~~ 956 (981)
.|+...|+++.|.-..+|++.|..+|-||+|+..+|+..+
T Consensus 5 ~~~ts~c~a~~w~rH~gF~iTyt~lLlkiwr~S~~~nv~s 44 (438)
T KOG4418|consen 5 TTTTSSCSAYTWWRHHGFIITYTYLLLKIWRTSGARNVVS 44 (438)
T ss_pred cccchhHHHHHHHHhhchhhhhhhhHhhcccccceeeccc
Confidence 4567889999999999999999999999999999998654
No 163
>PF00020 TNFR_c6: TNFR/NGFR cysteine-rich region; InterPro: IPR001368 A number of proteins, some of which are known to be receptors for growth factors have been found to contain a cysteine-rich domain at the N-terminal region that can be subdivided into four (or in some cases, three) repeats containing six conserved cysteines all of which are involved in intrachain disulphide bonds []. CD27 (also called S152 or T14) mediates a co-stimulatory signal for T and B cell activation and is involved in murine T cell development. Tyrosine-phosphorylation of ZAP-70 following CD27 ligation of T cells has been reported [], but not confirmed independently. CD30 was originally identified as Ki-1, an antigen expressed on Reed-Sternberg cells in Hodgkin's lymphomas and other non-Hodgkin's lymphomas, particularly diffuse large-cell lymphoma and immunoblastic lymphoma. CD30 has pleiotropic effects on CD30-positive lymphoma cell lines ranging from cell proliferation to cell death. It is thought to be involved in negative selection of T-cells in the thymus and is involved in TCR-mediated cell death. CD30 is a member of the TNFR family of molecules, activate NFkB through interaction with TRAF2 and TRAF5. CD40 (Bp50) plays a central role in the regulation of cell-mediated immunity as well as antibody mediated immunity. It is central to T cell dependent (TD)-responses and may influence survival of B cell lymphomas. CD95 (also called APO-1, fas antigen, Fas tumour necrosis factor receptor superfamily, member 6, TNFRSF6 or apoptosis antigen 1, APT1) is expressed, typically at high levels, on activated T and B cells. It is involved in the mediation of apoptosis-inducing signals. Other proteins known to belong to this family [, , , ] are, tumour Necrosis Factor type I and type II receptors (TNFR), Rabbit fibroma virus soluble TNF receptor (protein T2), lymphotoxin alpha/beta receptor, low-affinity nerve growth factor receptor (LA-NGFR) (p75), T-cell antigen OX40, Wsl-1, a receptor (for a yet undefined ligand) that mediates apoptosis and Vaccinia virus protein A53 (SalF19R). CD molecules are leucocyte antigens on cell surfaces. CD antigens nomenclature is updated at Protein Reviews On The Web (http://prow.nci.nih.gov/).; GO: 0005488 binding; PDB: 3TJE_F 3QD6_S 3ALQ_U 3IJ2_Y 3BUK_D 1SG1_X 1NCF_B 1EXT_A 1FT4_B 1TNR_R ....
Probab=35.66 E-value=17 Score=26.76 Aligned_cols=27 Identities=26% Similarity=0.496 Sum_probs=14.5
Q ss_pred CCCCcEEeeecCcceeeccccCCCCcee
Q psy1666 793 CDIGQAKKYVEGESCCWHCFNCSQYQIR 820 (981)
Q Consensus 793 C~pG~~k~~~~g~~CC~~C~~C~~g~is 820 (981)
|++|++... ++..=|..|..|++|++.
T Consensus 1 C~~g~y~~~-~~~~~C~~C~~C~~g~~~ 27 (39)
T PF00020_consen 1 CPPGTYSDS-ENHPQCLPCSRCPPGQYV 27 (39)
T ss_dssp ECTTEEEES-SCSSSEEEEESBTTTEEE
T ss_pred CccCcccCC-CCCCcCCccCCcCcCCEE
Confidence 566755543 222345555666667653
No 164
>cd06327 PBP1_SBP_like_1 Periplasmic solute-binding domain of active transport proteins that belong to the type I periplasmic binding fold protein family. Periplasmic solute-binding domain of active transport proteins that belong to the type I periplasmic binding fold protein family. Solute binding proteins are the primary specific receptors that initiate uptake of a broad range of solutes, including amino acids, peptides and inorganic ions. The members are predicted to have a similar function to an active transport system for short chain amides and urea by sequence comparison and phylogenetic analysis. Moreover, this binding domain has high sequence identity to the family of hydrophobic amino acid transporters (HAAT), and thus may also be involved in transport of amino acids.
Probab=33.87 E-value=99 Score=34.50 Aligned_cols=69 Identities=7% Similarity=-0.018 Sum_probs=48.1
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....+.|++.+++.|++|...+.++.. ..+|..++++|+.. ... ++++.....+....+ +++++
T Consensus 147 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~-----~~d~~~~v~~l~~~-~~d-------~v~~~~~~~~~~~~~-~~~~~ 212 (334)
T cd06327 147 FGHSLERDARKVVKANGGKVVGSVRHPLG-----TSDFSSYLLQAQAS-GAD-------VLVLANAGADTVNAI-KQAAE 212 (334)
T ss_pred HhHHHHHHHHHHHHhcCCEEcCcccCCCC-----CccHHHHHHHHHhC-CCC-------EEEEeccchhHHHHH-HHHHH
Confidence 45667888988888899999988887754 23799999999764 444 555544445555444 45566
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 213 ~g~ 215 (334)
T cd06327 213 FGL 215 (334)
T ss_pred hCC
Confidence 665
No 165
>KOG1052|consensus
Probab=33.48 E-value=1.3e+02 Score=37.31 Aligned_cols=85 Identities=16% Similarity=0.220 Sum_probs=51.1
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCC-CCCCChhhHhhhhccccccCCCCC--eEEeccCCCCc-ceeeEEEeEE
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDA-MRPTKGPELLKYLRKVSFQGLSED--HFKFDKDGDGP-ARYNIIHFKQ 749 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~-~~~~~~~qL~~~L~~v~F~~~~g~--~v~Fd~~Gd~~-~~YdI~n~~~ 749 (981)
-..|||++++|.|.+++.. .....-.|.. ........+.+++++....+..|. .+.++.+|... -.|+|.|...
T Consensus 102 ~~~~D~~~~~a~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~n~~~ 179 (656)
T KOG1052|consen 102 LWAYDAIQALARAVESLLN--IGNLSLSCGRNNSWLDALGVFNFGKKLLVVNLSGVTGQFQFFRGGLLEYFKYEILNLNG 179 (656)
T ss_pred hHHHHHHHHHHHHHHHhhc--CCCCceecCCCCcccchhHHHHHHHhhhhhccccceeEEEecCCCccccceEEEEEecC
Confidence 3789999999999988863 1111123442 112344567788888776665432 34455444433 4788888643
Q ss_pred cCCCcEEEEEEEEEEC
Q psy1666 750 IRPGVYQWVQVGEYLE 765 (981)
Q Consensus 750 ~~~~~~~~~~VG~~~~ 765 (981)
. ....||.|++
T Consensus 180 ~-----~~~~ig~W~~ 190 (656)
T KOG1052|consen 180 S-----GERRIGYWYP 190 (656)
T ss_pred c-----CceeEEEecC
Confidence 2 2234899985
No 166
>PF14946 DUF4501: Domain of unknown function (DUF4501)
Probab=33.30 E-value=1.5e+02 Score=29.24 Aligned_cols=10 Identities=20% Similarity=0.541 Sum_probs=6.1
Q ss_pred CCCCcEEeee
Q psy1666 793 CDIGQAKKYV 802 (981)
Q Consensus 793 C~pG~~k~~~ 802 (981)
|.||-++.+.
T Consensus 28 CgPGcyr~~~ 37 (180)
T PF14946_consen 28 CGPGCYRHWN 37 (180)
T ss_pred cCCcceeeec
Confidence 7888544443
No 167
>cd06329 PBP1_SBP_like_3 Periplasmic solute-binding domain of active transport proteins. Periplasmic solute-binding domain of active transport proteins found in bacteria and Archaea. Members of this group are initial receptors in the process of active transport across cellular membrane, but their substrate specificities are not known in detail. However, they closely resemble the group of AmiC and active transport systems for short-chain amides and urea (FmdDEF), and thus are likely to exhibit a ligand-binding mode similar to that of the amide sensor protein AmiC from Pseudomonas aeruginosa. Moreover, this binding domain has high sequence identity to the family of hydrophobic amino acid transporters (HAAT), and thus it may also be involved in transport of amino acids.
Probab=33.02 E-value=1.2e+02 Score=33.97 Aligned_cols=70 Identities=11% Similarity=0.048 Sum_probs=47.9
Q ss_pred chhhHHHHHHHHHhh--cCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHH
Q psy1666 5 CYYIAFEELEVLLAK--SSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLL 82 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~--~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~ 82 (981)
+..+..+.|++.+++ .|++|..++..+... ..+|+.++.+|+.. ... +|++.....+....++ ++
T Consensus 155 ~g~~~~~~~~~~~~~~~~G~~vv~~~~~~~~~----~~d~~~~i~~l~~~-~~d-------~v~~~~~~~~~~~~~~-~~ 221 (342)
T cd06329 155 WGQDVAAAFKAMLAAKRPDIQIVGEDLHPLGK----VKDFSPYVAKIKAS-GAD-------TVITGNWGNDLLLLVK-QA 221 (342)
T ss_pred HHHHHHHHHHHHHHhhcCCcEEeceeccCCCC----CCchHHHHHHHHHc-CCC-------EEEEcccCchHHHHHH-HH
Confidence 566788999999998 899999888777542 02699999999764 334 4444444455554444 44
Q ss_pred HhCCe
Q psy1666 83 AKSSI 87 (981)
Q Consensus 83 ~~~gI 87 (981)
++.|+
T Consensus 222 ~~~g~ 226 (342)
T cd06329 222 ADAGL 226 (342)
T ss_pred HHcCC
Confidence 56666
No 168
>KOG4611|consensus
Probab=32.13 E-value=28 Score=38.04 Aligned_cols=49 Identities=27% Similarity=0.556 Sum_probs=30.4
Q ss_pred CCCC-ccCCccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCC
Q psy1666 783 SPPE-SVCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEG 834 (981)
Q Consensus 783 ~~P~-S~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~ 834 (981)
.+|. ..-|-.|...+....+.|. --.|..||||+.|. +|+.-|..|..+
T Consensus 25 tipsddmmsckcsknqieifrngf--vptceecpegtlss-pdqtgclncnng 74 (747)
T KOG4611|consen 25 TIPSDDMMSCKCSKNQIEIFRNGF--VPTCEECPEGTLSS-PDQTGCLNCNNG 74 (747)
T ss_pred CCCcccceecccccchhhHhhcCC--CCccccCCCcccCC-CccCCceecCCC
Confidence 4553 2333345555555555554 22567889998874 688889998765
No 169
>cd06334 PBP1_ABC_ligand_binding_like_1 Type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. This subgroup includes the type I periplasmic ligand-binding domain of uncharacterized ABC (ATPase Binding Cassette)-type active transport systems that are predicted to be involved in transport of amino acids, peptides, or inorganic ions. Members of this group are sequence-similar to members of the family of ABC-type hydrophobic amino acid transporters, such as leucine-isoleucine-valine-binding protein (LIVBP); however their ligand specificity has not been determined experimentally.
Probab=31.63 E-value=1.3e+02 Score=34.14 Aligned_cols=69 Identities=7% Similarity=-0.008 Sum_probs=49.5
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....+.|++.+++.|+.|...+..|.. ..+|...+.+|+.. .+. +|++.....+....++ ++++
T Consensus 152 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~-----~~D~~~~v~~i~~~-~pd-------~V~~~~~~~~~~~~~~-~~~~ 217 (351)
T cd06334 152 FGKEPIEALKALAEKLGFEVVLEPVPPPG-----PNDQKAQWLQIRRS-GPD-------YVILWGWGVMNPVAIK-EAKR 217 (351)
T ss_pred cchhhHHHHHHHHHHcCCeeeeeccCCCC-----cccHHHHHHHHHHc-CCC-------EEEEecccchHHHHHH-HHHH
Confidence 56778899999999999999988887754 23799999999764 555 5555555555555554 4456
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 218 ~G~ 220 (351)
T cd06334 218 VGL 220 (351)
T ss_pred cCC
Confidence 665
No 170
>KOG4611|consensus
Probab=31.19 E-value=22 Score=38.84 Aligned_cols=48 Identities=19% Similarity=0.397 Sum_probs=28.4
Q ss_pred ccCCCCcEEeeecCcceeecc----ccCCCCcee--------cCccccccccCCCCCCCCcc
Q psy1666 791 LPCDIGQAKKYVEGESCCWHC----FNCSQYQIR--------LPSDETQCLTCPEGTKPDLL 840 (981)
Q Consensus 791 ~~C~pG~~k~~~~g~~CC~~C----~~C~~g~is--------n~~d~~~C~~C~~~~~~n~~ 840 (981)
+.|+.|+...+.+. =|-.| -.||....- -.++..-|-.|..+.+.|.+
T Consensus 53 eecpegtlsspdqt--gclncnngtchcpsqstlifrdasgnlltndafcgncasgfyrndn 112 (747)
T KOG4611|consen 53 EECPEGTLSSPDQT--GCLNCNNGTCHCPSQSTLIFRDASGNLLTNDAFCGNCASGFYRNDN 112 (747)
T ss_pred ccCCCcccCCCccC--CceecCCCccCCCCcceEEEEcCCCCeeccccccccccccceECCC
Confidence 67999987665332 23333 246644311 01344569999999888765
No 171
>cd06394 PBP1_iGluR_Kainate_KA1_2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the KA1 and KA2 subunits of Kainate receptor. N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the KA1 and KA2 subunits of Kainate receptor. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. There are five types of kainate receptors, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeric receptor channels act
Probab=30.88 E-value=52 Score=37.18 Aligned_cols=36 Identities=22% Similarity=0.539 Sum_probs=27.5
Q ss_pred CCCCCeEEeccCCCCcc-eeeEEEeEEcCCCcEEEEEEEEEEC
Q psy1666 724 GLSEDHFKFDKDGDGPA-RYNIIHFKQIRPGVYQWVQVGEYLE 765 (981)
Q Consensus 724 ~~~g~~v~Fd~~Gd~~~-~YdI~n~~~~~~~~~~~~~VG~~~~ 765 (981)
|.+| .|.||++|.+.. ..||+... .+ ..++||+|++
T Consensus 291 glTg-~i~f~~~g~R~~~~l~v~~l~--~~---g~~kig~W~~ 327 (333)
T cd06394 291 GLTG-RIEFNSKGQRSNYTLKILQKT--RS---GFRQIGQWHS 327 (333)
T ss_pred eeec-ceecCCCCcCcccEEEEEEec--CC---cceEEEEEeC
Confidence 7788 799999999874 67777765 22 3689999985
No 172
>COG0683 LivK ABC-type branched-chain amino acid transport systems, periplasmic component [Amino acid transport and metabolism]
Probab=30.88 E-value=1.6e+02 Score=33.63 Aligned_cols=62 Identities=16% Similarity=0.187 Sum_probs=46.0
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccc-cCCCCCeEEeccCCCCc-ceeeEEEeEEc
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSF-QGLSEDHFKFDKDGDGP-ARYNIIHFKQI 750 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F-~~~~g~~v~Fd~~Gd~~-~~YdI~n~~~~ 750 (981)
...|+||+.++.|+.+.-. ..++..+.+.|+...+ .+.+| .+.||++||.. ..|.|..|+..
T Consensus 292 ~~~y~a~~~~~~ai~~a~~--------------~~d~~~v~~al~~~~~~~~~~G-~v~~~~~~~~~~~~~~i~~~~~~ 355 (366)
T COG0683 292 AAAYDAVKLLAKAIEKAGK--------------SSDREAVAEALKGGKFFDTAGG-PVTFDEKGDRGSKPVYVGQVQKG 355 (366)
T ss_pred HHHHHHHHHHHHHHHHHhc--------------CCCHHHHHHHHhhCCCCccCCc-ceeECCCCCcCCCceEEEEEEec
Confidence 3689999999999866531 0115678889998874 55556 69999999965 68888888753
No 173
>cd06328 PBP1_SBP_like_2 Periplasmic solute-binding domain of active transport proteins found in gram-negative and gram-positive bacteria. Periplasmic solute-binding domain of active transport proteins found in gram-negative and gram-positive bacteria. Members of this group are initial receptors in the process of active transport across cellular membrane, but their substrate specificities are not known in detail. However, they closely resemble the group of AmiC and active transport systems for short-chain amides and urea (FmdDEF), and thus are likely to exhibit a ligand-binding mode similar to that of the amide sensor protein AmiC from Pseudomonas aeruginosa. Moreover, this binding domain has high sequence identity to the family of hydrophobic amino acid transporters (HAAT), and thus it may also be involved in transport of amino acids.
Probab=30.59 E-value=1.4e+02 Score=33.47 Aligned_cols=43 Identities=14% Similarity=0.145 Sum_probs=35.7
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcC
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTK 52 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~ 52 (981)
++..+.++|++.++++|+.+..++.++.. ..+|...+.+|+..
T Consensus 148 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~-----~~d~~~~v~~l~~~ 190 (333)
T cd06328 148 FGRDGVAAFKAALEKLGAAIVTEEYAPTD-----TTDFTPYAQRLLDA 190 (333)
T ss_pred ccHHHHHHHHHHHHhCCCEEeeeeeCCCC-----CcchHHHHHHHHhc
Confidence 56778899999999999999998888754 33799999999764
No 174
>PF05915 DUF872: Eukaryotic protein of unknown function (DUF872); InterPro: IPR008590 This entry represents several uncharacterised eukaryotic transmembrane proteins. The function of this currently unknown.
Probab=29.73 E-value=1.2e+02 Score=28.50 Aligned_cols=40 Identities=20% Similarity=0.276 Sum_probs=23.1
Q ss_pred ccccCcccccccccccchhhHHHHHHHHHHHHHHHHHHhhhheeec
Q psy1666 839 LLRQNCLEIPAMFIEITSTWAIGAMALSSTGILMTLLIVGVFIRHN 884 (981)
Q Consensus 839 ~~~~~C~~~~~~~l~~~~~~~i~~~~~s~~~~~~t~~v~~ifi~~r 884 (981)
.++..|.|+. ..||-.+.++++++.+.++++++++++...
T Consensus 28 ~~~~~c~P~~------k~pwK~I~la~~Lli~G~~li~~g~l~~~~ 67 (115)
T PF05915_consen 28 FNRSPCHPKV------KIPWKSIALAVFLLIFGTVLIIIGLLLFFG 67 (115)
T ss_pred cccCcchhhh------HHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 3444564433 335666666666666666666666665544
No 175
>cd06331 PBP1_AmiC_like Type I periplasmic components of amide-binding protein (AmiC) and the active transport system for short-chain and urea (FmdDEF). This group includes the type I periplasmic components of amide-binding protein (AmiC) and the active transport system for short-chain and urea (FmdDEF), found in bacteria and Archaea. AmiC controls expression of the amidase operon by a ligand-triggered conformational switch. In the absence of ligand or presence of butyramide (repressor), AmiC (the ligand sensor and negative regulator) adopts an open conformation and inhibits the transcription antitermination function of AmiR by direct protein-protein interaction. In the presence of inducing ligands such as acetamide, AmiC adopts a closed conformation which disrupts a silencing AmiC-AmiR complex and the expression of amidase and other genes of the operon is induced. FmdDEF is predicted to be an ATP-dependent transporter and closely resembles the periplasmic binding protein and the two t
Probab=28.00 E-value=2e+02 Score=32.06 Aligned_cols=69 Identities=12% Similarity=0.076 Sum_probs=50.0
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
++....+.|.+.+++.|.-+...+.+|... .+|+.++.+++.. .+. +|+......+....++ ++.+
T Consensus 144 ~g~~~~~~~~~~~~~~G~~vv~~~~~~~~~-----~d~~~~v~~~~~~-~~d-------~v~~~~~~~~~~~~~~-~~~~ 209 (333)
T cd06331 144 WPRESNRIARALLEELGGEVVGEEYLPLGT-----SDFGSVIEKIKAA-GPD-------VVLSTLVGDSNVAFYR-QFAA 209 (333)
T ss_pred hHHHHHHHHHHHHHHcCCEEEEEEEecCCc-----ccHHHHHHHHHHc-CCC-------EEEEecCCCChHHHHH-HHHH
Confidence 345677888888888899999888888552 3799999999753 555 6666666667765554 4456
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|.
T Consensus 210 ~g~ 212 (333)
T cd06331 210 AGL 212 (333)
T ss_pred cCC
Confidence 666
No 176
>PF03302 VSP: Giardia variant-specific surface protein; InterPro: IPR005127 During infection, the intestinal protozoan parasite Giardia lamblia virus undergoes continuous antigenic variation which is determined by diversification of the parasite's major surface antigen, named VSP (variant surface protein).
Probab=27.55 E-value=57 Score=37.81 Aligned_cols=87 Identities=18% Similarity=0.326 Sum_probs=49.8
Q ss_pred cCCccCCCCcEEeeecCcceeeccccCCCCceecCccccccccCCCCCCCCccccCcccccc------cccccchhhHHH
Q psy1666 788 VCSLPCDIGQAKKYVEGESCCWHCFNCSQYQIRLPSDETQCLTCPEGTKPDLLRQNCLEIPA------MFIEITSTWAIG 861 (981)
Q Consensus 788 ~Cs~~C~pG~~k~~~~g~~CC~~C~~C~~g~isn~~d~~~C~~C~~~~~~n~~~~~C~~~~~------~~l~~~~~~~i~ 861 (981)
.| ..|.+||.+... . |-.|..|..+ ...+....|..|-+.. ++.+.-.|..+.. -=|+=.-..+|.
T Consensus 302 ~C-t~C~~Gyy~~~~---~-c~~C~~c~~~--~~v~Gv~~C~~C~~p~-s~~g~v~C~~~~~~~~~n~s~LstgaIaGIs 373 (397)
T PF03302_consen 302 TC-TACADGYYKSGS---G-CVKCTSCSSN--NGVTGVKGCVSCAPPS-SNTGSVTCYSMKDSGSTNKSGLSTGAIAGIS 373 (397)
T ss_pred cc-cchhcccccccc---C-CccccccCCC--CcCcCCCcCcccCCCC-cCCCcccccccccccCcccccccccceeeee
Confidence 44 568888765421 1 3456666554 1233566788886543 2334445643221 123333455788
Q ss_pred HHHHHHHHHHHHHHHhhhhee
Q psy1666 862 AMALSSTGILMTLLIVGVFIR 882 (981)
Q Consensus 862 ~~~~s~~~~~~t~~v~~ifi~ 882 (981)
++++.++|-|+-++.|++.-|
T Consensus 374 vavvvvVgglvGfLcWwf~cr 394 (397)
T PF03302_consen 374 VAVVVVVGGLVGFLCWWFICR 394 (397)
T ss_pred ehhHHHHHHHHHHHhhheeec
Confidence 888888888887777765543
No 177
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor
Probab=26.50 E-value=1.4e+02 Score=33.13 Aligned_cols=67 Identities=22% Similarity=0.333 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHHHHhhhheeecCcceeeeCCccchHHHHHHHHHHHhhhe---eeeecCceeeechhhhhhHH
Q psy1666 861 GAMALSSTGILMTLLIVGVFIRHNNTPVVKAAGRELSYVLLFGILLCYLVTF---VLVLKPSDLVCAIQRFGAGF 932 (981)
Q Consensus 861 ~~~~~s~~~~~~t~~v~~ifi~~r~tpiVka~n~~Ls~~lL~~l~l~fl~~~---~fig~p~~~~C~lr~~~f~i 932 (981)
+..++|++|.++.+++...+=++| +|+ +|-+-|+-+.+++....+.+ ..-..++...|.+|-++...
T Consensus 15 ~~s~lSllGclfiI~tf~~~k~~r-~~~----~rli~yl~~~~ll~~v~~~~~~~~~~~~~~s~lC~~Qafliq~ 84 (303)
T PF05462_consen 15 VASVLSLLGCLFIIITFCLFKRLR-KPI----NRLIFYLSIANLLTNVASMIMTLSPSAGENSFLCQFQAFLIQF 84 (303)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhC-ccH----HHHHHHHHHHHHHHHHHHHHHHhcccCCCCCcchhhHhHHHHH
Confidence 334455555554444444444444 443 56566666655554443332 23345578889998766543
No 178
>PF09463 Opy2: Opy2 protein; InterPro: IPR018571 Opy2p acts as a membrane anchor in the HOG signalling pathway []. This entry represents a conserved N-terminal domain.
Probab=26.33 E-value=38 Score=24.52 Aligned_cols=23 Identities=22% Similarity=0.655 Sum_probs=15.6
Q ss_pred ccccCCCCceecCccccccccCCC
Q psy1666 810 HCFNCSQYQIRLPSDETQCLTCPE 833 (981)
Q Consensus 810 ~C~~C~~g~isn~~d~~~C~~C~~ 833 (981)
.|..|++||+=..+ ..+|..||.
T Consensus 10 ~CP~C~~ge~C~~t-~~tC~~C~~ 32 (35)
T PF09463_consen 10 SCPSCPSGEECVLT-SQTCTSCPT 32 (35)
T ss_pred CCCCCCCCCEEEec-CCChhhccc
Confidence 36677788775554 667888875
No 179
>PF05571 DUF766: Protein of unknown function (DUF766); InterPro: IPR008485 This family consists of several eukaryotic proteins of unknown function.
Probab=25.88 E-value=92 Score=34.04 Aligned_cols=22 Identities=18% Similarity=0.496 Sum_probs=12.5
Q ss_pred ccccCCCCceecCccccccccCCC
Q psy1666 810 HCFNCSQYQIRLPSDETQCLTCPE 833 (981)
Q Consensus 810 ~C~~C~~g~isn~~d~~~C~~C~~ 833 (981)
+|-+||.|.-+| +..-|.+|.+
T Consensus 22 ~CGaCprG~R~n--~~~iC~pC~~ 43 (296)
T PF05571_consen 22 ECGACPRGYRVN--ESSICQPCDD 43 (296)
T ss_pred cCCCCCCccccC--CCcccccCCC
Confidence 566666665543 2345776654
No 180
>cd06330 PBP1_Arsenic_SBP_like Periplasmic solute-binding domain of active transport proteins. Periplasmic solute-binding domain of active transport proteins found in bacteria and Archaea that is predicted to be involved in the efflux of toxic compounds. Members of this subgroup include proteins from Herminiimonas arsenicoxydans, which is resistant to arsenic and various heavy metals such as cadmium and zinc. Moreover, they show significant sequence similarity to the cluster of AmiC and active transport systems for short-chain amides and urea (FmdDEF), and thus are likely to exhibit a ligand-binding mode similar to that of the amide sensor protein AmiC from Pseudomonas aeruginosa.
Probab=24.72 E-value=1.6e+02 Score=32.96 Aligned_cols=71 Identities=11% Similarity=0.104 Sum_probs=43.7
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....+.|++.+++.|.|+........... ..+|+.++++|+.. +.. ++++.....+....+++ +.+
T Consensus 150 ~g~~~~~~~~~~~~~~g~~~~~v~~~~~~~~---~~d~~~~v~~i~~~-~~d-------~ii~~~~~~~~~~~~~~-~~~ 217 (346)
T cd06330 150 YGQDAWADFKAALKRLRPDVEVVSEQWPKLG---APDYGSEITALLAA-KPD-------AIFSSLWGGDLVTFVRQ-ANA 217 (346)
T ss_pred HHHHHHHHHHHHHHHhCCCCeecccccCCCC---CcccHHHHHHHHhc-CCC-------EEEEecccccHHHHHHH-HHh
Confidence 4566788899988888888764322111112 33799999999754 445 55555555555555554 455
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 218 ~g~ 220 (346)
T cd06330 218 RGL 220 (346)
T ss_pred cCc
Confidence 554
No 181
>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins. Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A ....
Probab=24.62 E-value=27 Score=26.13 Aligned_cols=24 Identities=21% Similarity=0.427 Sum_probs=14.5
Q ss_pred ecCccccccccCCCCCCCCccccCc
Q psy1666 820 RLPSDETQCLTCPEGTKPDLLRQNC 844 (981)
Q Consensus 820 sn~~d~~~C~~C~~~~~~n~~~~~C 844 (981)
.|+....+|. ||+++..+.+..+|
T Consensus 19 ~N~~Gsy~C~-C~~Gy~~~~~~~~C 42 (42)
T PF07645_consen 19 VNTEGSYSCS-CPPGYELNDDGTTC 42 (42)
T ss_dssp EEETTEEEEE-ESTTEEECTTSSEE
T ss_pred EcCCCCEEee-CCCCcEECCCCCcC
Confidence 4555666676 77777655555544
No 182
>PF13433 Peripla_BP_5: Periplasmic binding protein domain; PDB: 1QNL_A 1QO0_A 1PEA_A.
Probab=24.47 E-value=1.6e+02 Score=33.64 Aligned_cols=66 Identities=14% Similarity=0.180 Sum_probs=42.5
Q ss_pred hHHHHHHHHHHHHHHHhHHhhccCCCCCCCCCCCCChhhHhhhhccccccCCCCCeEEeccCCCCcceeeEEEeEEcCCC
Q psy1666 674 QFVSDAVMAFSIALDHMHADLCQGKVGLCDAMRPTKGPELLKYLRKVSFQGLSEDHFKFDKDGDGPARYNIIHFKQIRPG 753 (981)
Q Consensus 674 ~~vydAVyaiAhALh~~l~~~c~~~~~~c~~~~~~~~~qL~~~L~~v~F~~~~g~~v~Fd~~Gd~~~~YdI~n~~~~~~~ 753 (981)
-..|.+|+.+|.|+.+. . ..++.++.+.|..++|..+.| .|.+|.. .+.
T Consensus 279 eaaY~~v~l~a~Av~~a-----g----------s~d~~~vr~al~g~~~~aP~G-~v~id~~---------------n~H 327 (363)
T PF13433_consen 279 EAAYFQVHLWAQAVEKA-----G----------SDDPEAVREALAGQSFDAPQG-RVRIDPD---------------NHH 327 (363)
T ss_dssp HHHHHHHHHHHHHHHHH-----T----------S--HHHHHHHHTT--EEETTE-EEEE-TT---------------TSB
T ss_pred HHHHHHHHHHHHHHHHh-----C----------CCCHHHHHHHhcCCeecCCCc-ceEEcCC---------------CCe
Confidence 36899999999999643 2 235788999999999999998 5888852 223
Q ss_pred cEEEEEEEEEEC-ceEEE
Q psy1666 754 VYQWVQVGEYLE-GELRL 770 (981)
Q Consensus 754 ~~~~~~VG~~~~-~~l~i 770 (981)
......||+.+. .++.|
T Consensus 328 ~~l~~rIg~~~~dG~f~I 345 (363)
T PF13433_consen 328 TWLPPRIGRVNADGQFDI 345 (363)
T ss_dssp EEB--EEEEE-TTS-EEE
T ss_pred ecccceEEEEcCCCCEEE
Confidence 456677888874 45553
No 183
>PF01422 zf-NF-X1: NF-X1 type zinc finger; InterPro: IPR000967 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule. Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target. This entry represents a domain presumed to be a zinc binding domain. The following pattern describes the zinc finger: C-X(1-6)-H-X-C-X3-C(H/C)-X(3-4)-(H/C)-X(1-10)-C where X can be any amino acid, and numbers in brackets indicate the number of residues. The two position can be either His or Cys. This domain is found in the human transcriptional repressor NK-X1, a repressor of HLA-DRA transcription; the Drosophila shuttle craft protein, which plays an essential role during the late stages of embryonic neurogenesis; and a yeast hypothetical protein YNL023C. More information about these proteins can be found at Protein of the Month: Zinc Fingers [].; GO: 0003700 sequence-specific DNA binding transcription factor activity, 0008270 zinc ion binding, 0006355 regulation of transcription, DNA-dependent, 0005634 nucleus
Probab=24.37 E-value=51 Score=20.72 Aligned_cols=9 Identities=33% Similarity=0.877 Sum_probs=6.8
Q ss_pred cCCccCCCC
Q psy1666 788 VCSLPCDIG 796 (981)
Q Consensus 788 ~Cs~~C~pG 796 (981)
.|.+.|.+|
T Consensus 5 ~C~~~CH~G 13 (20)
T PF01422_consen 5 TCQQLCHPG 13 (20)
T ss_pred ccCCcccCC
Confidence 577778777
No 184
>cd06326 PBP1_STKc_like Type I periplasmic binding domain of uncharacterized extracellular ligand-binding proteins. The type I periplasmic binding domain of uncharacterized extracellular ligand-binding proteins, some of which contain a conserved catalytic serine/threonine protein kinase (STKc) domain in the N-terminal region. Members of this group are sequence-similar to the branched-chain amino acid ABC transporter leucine-isoleucine-valine-binding protein (LIVBP); their ligand specificity has not been determined experimentally, however.
Probab=24.17 E-value=2.5e+02 Score=31.04 Aligned_cols=69 Identities=13% Similarity=0.073 Sum_probs=45.9
Q ss_pred chhhHHHHHHHHHhhcCeEEEEeeeeccCCcccccchHHHHHHHHhcCCCCCCCCCcceeeEEeecchhHHHHHHHHHHh
Q psy1666 5 CYYIAFEELEVLLAKSSICIAVKEKLVKDSGVAEERAYDDIVTKLMTKPRARDDPDFIPVLMLFLRETTAFEELEVLLAK 84 (981)
Q Consensus 5 ~~~~g~~~~~~~~~~~~~Cia~~~~i~~~~~~~~~~~~~~i~~~l~~~psa~~q~~a~~~lv~f~~~~~~~~~l~~~~~~ 84 (981)
+.....++|++.+++.|+++.....++.. ..++..+++++++. ... +|+....+..+...++ ++++
T Consensus 148 ~~~~~~~~~~~~~~~~G~~~~~~~~~~~~-----~~d~~~~~~~l~~~-~~d-------av~~~~~~~~a~~~i~-~~~~ 213 (336)
T cd06326 148 FGKDGLAGVEKALAARGLKPVATASYERN-----TADVAAAVAQLAAA-RPQ-------AVIMVGAYKAAAAFIR-ALRK 213 (336)
T ss_pred chHHHHHHHHHHHHHcCCCeEEEEeecCC-----cccHHHHHHHHHhc-CCC-------EEEEEcCcHHHHHHHH-HHHh
Confidence 44567889999999999998777666643 22688889998764 334 5555444455665554 5466
Q ss_pred CCe
Q psy1666 85 SSI 87 (981)
Q Consensus 85 ~gI 87 (981)
.|+
T Consensus 214 ~G~ 216 (336)
T cd06326 214 AGG 216 (336)
T ss_pred cCC
Confidence 665
No 185
>COG3671 Predicted membrane protein [Function unknown]
Probab=23.87 E-value=2.6e+02 Score=26.18 Aligned_cols=44 Identities=16% Similarity=0.204 Sum_probs=33.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHHHHHHHHH
Q psy1666 440 YMIAFGYPIFLIVVCTVYAILTRNIPEAFNESKHIGFTMYTTCVI 484 (981)
Q Consensus 440 ~~~~l~Y~~lL~l~c~~~Af~~R~lP~nfNEAK~ItFsml~~~iv 484 (981)
++..-.-.+++.+++.++|++-|+--|+++++ +=.|-.=+||..
T Consensus 30 Ly~~G~v~git~lvgvi~AYv~rd~~~~~~~S-Hy~f~iRTFw~~ 73 (125)
T COG3671 30 LYLLGAVTGITPLVGVIFAYVNRDKADSIAAS-HYEFLIRTFWLA 73 (125)
T ss_pred HHHHHHHHHHHHHHHHHHHhcccccccchHHH-HHHHHHHHHHHH
Confidence 33344456789999999999999999999999 445555555543
No 186
>PF13829 DUF4191: Domain of unknown function (DUF4191)
Probab=23.34 E-value=82 Score=33.10 Aligned_cols=51 Identities=20% Similarity=0.324 Sum_probs=37.0
Q ss_pred chhhHHHHHHHHHHHHHHHHHHhhhheeecCcceeeeCCccchHHHHHHHHHHHhhheeeeec
Q psy1666 855 TSTWAIGAMALSSTGILMTLLIVGVFIRHNNTPVVKAAGRELSYVLLFGILLCYLVTFVLVLK 917 (981)
Q Consensus 855 ~~~~~i~~~~~s~~~~~~t~~v~~ifi~~r~tpiVka~n~~Ls~~lL~~l~l~fl~~~~fig~ 917 (981)
+||+..-+++.+.++.++..+++++++. ..-|.+++|+++..+..++.+++
T Consensus 23 ~dp~l~~~ml~a~l~~~~v~v~ig~l~~------------~~~~~~i~gi~~g~l~am~vl~r 73 (224)
T PF13829_consen 23 EDPKLPWLMLGAFLGPIAVFVLIGLLFG------------SWWYWLIIGILLGLLAAMIVLSR 73 (224)
T ss_pred HCcchHHHHHHHHHHHHHHHHHHHHHHc------------cHHHHHHHHHHHHHHHHHHHHHH
Confidence 4677777777777777777777777764 44588899999988877655443
No 187
>PF12191 stn_TNFRSF12A: Tumour necrosis factor receptor stn_TNFRSF12A_TNFR domain; InterPro: IPR022316 The tumour necrosis factor (TNF) receptor (TNFR) superfamily comprises more than 20 type-I transmembrane proteins. Family members are defined based on similarity in their extracellular domain - a region that contains many cysteine residues arranged in a specific repetitive pattern []. The cysteines allow formation of an extended rod-like structure, responsible for ligand binding []. Upon receptor activation, different intracellular signalling complexes are assembled for different members of the TNFR superfamily, depending on their intracellular domains and sequences []. Activation of TNFRs can therefore induce a range of disparate effects, including cell proliferation, differentiation, survival, or apoptotic cell death, depending upon the receptor involved []. TNFRs are widely distributed and play important roles in many crucial biological processes, such as lymphoid and neuronal development, innate and adaptive immunity, and maintenance of cellular homeostasis []. Drugs that manipulate their signalling have potential roles in the prevention and treatment of many diseases, such as viral infections, coronary heart disease, transplant rejection, and immune disease []. TNF receptor 12 (also known as TWEAK receptor, and fibroblast growth factor-inducible-14 (Fn14)) has been implicated in endothelial cell growth and migration []. The receptor may also play a role in cell-matrix interactions [].; PDB: 2KN0_A 2RPJ_A 2KMZ_A 2EQP_A.
Probab=21.92 E-value=34 Score=32.21 Aligned_cols=54 Identities=24% Similarity=0.404 Sum_probs=22.6
Q ss_pred ccCCCCceecCccccccccCCC-CCCCCcc-ccCcccccccccccchhhHHHHHHHHHH
Q psy1666 812 FNCSQYQIRLPSDETQCLTCPE-GTKPDLL-RQNCLEIPAMFIEITSTWAIGAMALSST 868 (981)
Q Consensus 812 ~~C~~g~isn~~d~~~C~~C~~-~~~~n~~-~~~C~~~~~~~l~~~~~~~i~~~~~s~~ 868 (981)
.+||+|+.=+ .|.+.|.+|.- +.+|..+ -..|-..+..- |...|.|...+++++
T Consensus 34 ~~Cp~G~sWs-~dLdkCm~CssC~~~P~S~~C~~C~a~p~~p--~~l~~pi~~sal~v~ 89 (129)
T PF12191_consen 34 TPCPRGSSWS-ADLDKCMSCSSCPAYPKSPFCQGCPAAPPAP--FPLLWPILGSALSVV 89 (129)
T ss_dssp SSS-SSEEEE-TTTTEEEECCCHCC-TT-CCCCCHSS-SSS---SSSS-----------
T ss_pred CCCCCCCcCc-ccccccccCccCCCCCCCccccCCCCCCCCC--cceehhhhhhHHHHH
Confidence 4899998654 46677777753 2344332 23555555444 777777665555554
No 188
>PF04341 DUF485: Protein of unknown function, DUF485; InterPro: IPR007436 This family includes several putative integral membrane proteins.
Probab=21.06 E-value=3.2e+02 Score=24.35 Aligned_cols=51 Identities=8% Similarity=0.058 Sum_probs=40.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCCC-CcchhhhHHHHHHHHHHHHHHHh
Q psy1666 438 ASYMIAFGYPIFLIVVCTVYAILTRNIP-EAFNESKHIGFTMYTTCVIWLAF 488 (981)
Q Consensus 438 ~~~~~~l~Y~~lL~l~c~~~Af~~R~lP-~nfNEAK~ItFsml~~~ivWiaf 488 (981)
.+......|.++..+.++.=.++++++. ++.|-+=..++.++.++.+....
T Consensus 21 l~~i~l~~y~~~~ll~a~~p~~m~~~v~~G~~t~g~~~g~~~~~~~~~l~~~ 72 (91)
T PF04341_consen 21 LSAIFLVLYFGFVLLSAFAPELMATPVFPGSLTLGIVLGLGQIVFAWVLTWL 72 (91)
T ss_pred HHHHHHHHHHHHHHHHHHCHHHHcCcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 4455677788888888888899999999 77998888888888776665543
Done!